73590-58-6 | 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$7.00	$5.00
25g	98%	in stock	$26.00	$18.00
100g	98%	in stock	$80.00	$56.00
500g	98%	in stock	$323.00	$226.00

Description

• Catalog Number: AB77978
• Chemical Name: 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole
• CAS Number: 73590-58-6
• Molecular Formula: C17H19N3O3S
• Molecular Weight: 345.4161
• MDL Number: MFCD00083192
• SMILES: COc1ccc2c(c1)[nH]c(n2)S(=O)Cc1ncc(c(c1C)OC)C

Computed Properties

• Complexity: 453
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 24
• Hydrogen Bond Acceptor Count: 6
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 5
• Undefined Atom Stereocenter Count: 1
• XLogP3: 2.2

Literature

• Hesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats.

  Chemico-biological interactions 20180801

• Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.

  Toxicology and applied pharmacology 20170301

• 3D engineered In vitro hepatospheroids for studying drug toxicity and metabolism.

  Toxicology in vitro : an international journal published in association with BIBRA 20170201

• Gastroprotective and ulcer healing effects of hydroethanolic extract of leaves of Caryocar coriaceum: Mechanisms involved in the gastroprotective activity.

  Chemico-biological interactions 20170105

• High-content imaging-based BAC-GFP toxicity pathway reporters to assess chemical adversity liabilities.

  Archives of toxicology 20170101

• The effects of baicalein on gastric mucosal ulcerations in mice: Protective pathways and anti-secretory mechanisms.

  Chemico-biological interactions 20161225

• Omeprazole induces heme oxygenase-1 in fetal human pulmonary microvascular endothelial cells via hydrogen peroxide-independent Nrf2 signaling pathway.

  Toxicology and applied pharmacology 20161115

• Evaluation of protective effects of costunolide and dehydrocostuslactone on ethanol-induced gastric ulcer in mice based on multi-pathway regulation.

  Chemico-biological interactions 20160425

• Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class.

  Toxicology letters 20160122

• Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR.

  PloS one 20160101

• Transactivation Assays to Assess Canine and Rodent Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR) Activation.

  PloS one 20160101

• Apocynin protects against ethanol-induced gastric ulcer in rats by attenuating the upregulation of NADPH oxidases 1 and 4.

  Chemico-biological interactions 20151205

• Omeprazole Attenuates Pulmonary Aryl Hydrocarbon Receptor Activation and Potentiates Hyperoxia-Induced Developmental Lung Injury in Newborn Mice.

  Toxicological sciences : an official journal of the Society of Toxicology 20151101

• Improved assays for xenosensor activation based on reverse transfection.

  Toxicology in vitro : an international journal published in association with BIBRA 20151001

• Baicalin Protects Mice from Aristolochic Acid I-Induced Kidney Injury by Induction of CYP1A through the Aromatic Hydrocarbon Receptor.

  International journal of molecular sciences 20150701

• TCDD and omeprazole prime platelets through the aryl hydrocarbon receptor (AhR) non-genomic pathway.

  Toxicology letters 20150519

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway.

  Chemical research in toxicology 20150518

• Environmental contaminants activate human and polar bear (Ursus maritimus) pregnane X receptors (PXR, NR1I2) differently.

  Toxicology and applied pharmacology 20150401

• Systematic toxicity mechanism analysis of proton pump inhibitors: an in silico study.

  Chemical research in toxicology 20150316

• Gastroprotective effect of crocin in ethanol-induced gastric injury in rats.

  Chemico-biological interactions 20150305

• Omeprazole, a gastric proton pump inhibitor, inhibits melanogenesis by blocking ATP7A trafficking.

  The Journal of investigative dermatology 20150301

• The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjects.

  BMC pharmacology & toxicology 20150101

• CYP2C19 polymorphisms account for inter-individual variability of drug metabolism in cynomolgus macaques.

  Biochemical pharmacology 20140915

• Aggregate culture of human embryonic stem cell-derived hepatocytes in suspension are an improved in vitro model for drug metabolism and toxicity testing.

  Toxicological sciences : an official journal of the Society of Toxicology 20140701

• Interactions of sesquiterpenes zederone and germacrone with the human cytochrome P450 system.

  Toxicology in vitro : an international journal published in association with BIBRA 20130901

• The inhibition of major human hepatic cytochrome P450 enzymes by 18 pesticides: comparison of the N-in-one and single substrate approaches.

  Toxicology in vitro : an international journal published in association with BIBRA 20130801

• Identification of potent Yes1 kinase inhibitors using a library screening approach.

  Bioorganic & medicinal chemistry letters 20130801

• In vitro evaluation of cytochrome P450 induction and the inhibition potential of mitragynine, a stimulant alkaloid.

  Toxicology in vitro : an international journal published in association with BIBRA 20130301

• Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.

  Journal of applied toxicology : JAT 20130201

• Interactions of pharmaceuticals and other xenobiotics on key detoxification mechanisms and cytoskeleton in Poeciliopsis lucida hepatocellular carcinoma, PLHC-1 cell line.

  Toxicology in vitro : an international journal published in association with BIBRA 20130201

• Helicobacter pylori eradication with ecabet sodium, omeprazole, amoxicillin, and clarithromycin versus bismuth, omeprazole, amoxicillin, and clarithromycin quadruple therapy: a randomized, open-label, phase IV trial.

  Helicobacter 20121201

• Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan.

  British journal of clinical pharmacology 20121101

• Safety profile of enantiomers vs. racemic mixtures: it's the same?

  British journal of clinical pharmacology 20121101

• DL-trans-3,4-dihydroxy-1-selenolane (DHS(red)) accelerates healing of indomethacin-induced stomach ulceration in mice.

  Free radical research 20121101

• Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells.

  The Journal of pharmacology and experimental therapeutics 20121101

• Gastroprotective effects of extracts and guttiferone A isolated from Garcinia achachairu Rusby (Clusiaceae) against experimentally induced gastric lesions in mice.

  Naunyn-Schmiedeberg's archives of pharmacology 20121101

• Proton pump inhibitors: potential adverse effects.

  Current opinion in gastroenterology 20121101

• The influence of omeprazole on platelet inhibition of clopidogrel in various CYP2C19 mutant alleles.

  Genetic testing and molecular biomarkers 20121101

• Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.

  World journal of gastroenterology 20121021

• Inhibition of gastric perception of mild distention by omeprazole in volunteers.

  World journal of gastroenterology 20121021

• Blindness following severe midfacial trauma--case report and review.

  Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20121001

• Generation of proliferating human hepatocytes using Upcyte® technology: characterisation and applications in induction and cytotoxicity assays.

  Xenobiotica; the fate of foreign compounds in biological systems 20121001

• Lessons from two cases of anaphylaxis to proton pump inhibitors.

  Journal of clinical pharmacy and therapeutics 20121001

• Effects of omeprazole consumption on serum levels of trace elements.

  Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) 20121001

• Comparative study of novel spectrophotometric methods manipulating ratio spectra: an application on pharmaceutical ternary mixture of omeprazole, tinidazole and clarithromycin.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121001

• Thalidomide-induced acute cholestatic hepatitis: case report and review of the literature.

  Gastroenterologia y hepatologia 20121001

• Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.

  Alimentary pharmacology & therapeutics 20121001

• The innovative potential of Lactobacillus rhamnosus LR06, Lactobacillus pentosus LPS01, Lactobacillus plantarum LP01, and Lactobacillus delbrueckii Subsp. delbrueckii LDD01 to restore the 'gastric barrier effect' in patients chronically treated with PPI: a pilot study.

  Journal of clinical gastroenterology 20121001

• Influence of Helicobacter pylori infection on gastric acid secretion in pre-school Bangladeshi children.

  Helicobacter 20121001

• Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot study in US Hispanics.

  Helicobacter 20121001

• A preliminary investigation of laparoscopic fundoplication treatment on gastroesophageal reflux disease-related respiratory symptoms.

  Surgical laparoscopy, endoscopy & percutaneous techniques 20121001

• Influence of Helicobacter pylori infection on ghrelin levels in children.

  World journal of gastroenterology 20120928

• Novel formulations of dipyridamole with microenvironmental pH-modifiers for improved dissolution and bioavailability under hypochlorhydria.

  International journal of pharmaceutics 20120915

• Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) induced by omeprazole.

  International journal of dermatology 20120901

• A clinically significant interaction between tacrolimus and multiple proton pump inhibitors in a kidney transplant recipient.

  Pediatric transplantation 20120901

• Interleukin-6 and cytochrome-P450, reason for concern?

  Rheumatology international 20120901

• Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.

  Journal of gastroenterology and hepatology 20120901

• Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.

  Drug metabolism and disposition: the biological fate of chemicals 20120901

• Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial.

  The Journal of antimicrobial chemotherapy 20120901

• Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.

  Pharmacotherapy 20120901

• Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR).

  Alimentary pharmacology & therapeutics 20120901

• Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial.

  Current medical research and opinion 20120901

• Drug-induced gynecomastia: an evidence-based review.

  Expert opinion on drug safety 20120901

• Variation in omeprazole pharmacokinetics in a random Iranian population: a pilot study.

  Biopharmaceutics & drug disposition 20120901

• Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy.

  Journal of clinical biochemistry and nutrition 20120901

• Effect of Linum usitatissimum (linseed/flaxseed) fixed oil on experimental esophagitis in albino rats.

  Acta gastro-enterologica Belgica 20120901

• Increase in gastric pH reduces hypotensive effect of oral sodium nitrite in rats.

  Free radical biology & medicine 20120815

• Cytoprotective effect of benzyl N'-(5-chloro-indol-3-yl-methylidene)-hydrazinecarbodithioate against ethanol-induced gastric mucosal injury in rats.

  Molecules (Basel, Switzerland) 20120803

• In with the new: the determinants of prescribing innovation by general practitioners in Ireland.

  The European journal of health economics : HEPAC : health economics in prevention and care 20120801

• Cocktail approach for in vivo phenotyping of 5 major CYP450 isoenzymes: development of an effective sampling, extraction, and analytical procedure and pilot study with comparative genotyping.

  Journal of clinical pharmacology 20120801

• Omeprazole impairs the absorption of mycophenolate mofetil but not of enteric-coated mycophenolate sodium in healthy volunteers.

  Journal of clinical pharmacology 20120801

• ¹³¹I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma.

  European journal of nuclear medicine and molecular imaging 20120801

• The role of proton pump inhibitors in adenoid hypertrophy in children.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20120801

• Efficacy of omeprazole paste in the prevention of gastric ulcers in 2 years old Thoroughbreds.

  The Journal of veterinary medical science 20120801

• Hydroxylation of R(+)- and S(-)-omeprazole after racemic dosing are different among the CYP2C19 genotypes.

  Pharmaceutical research 20120801

• Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature.

  Journal of pharmacy practice 20120801

• Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study.

  Alimentary pharmacology & therapeutics 20120801

• Respiratory response to proton pump inhibitor treatment in children with obstructive sleep apnea syndrome and gastroesophageal reflux disease.

  Sleep medicine 20120801

• Helicobacter pylori infection: sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate.

  Helicobacter 20120801

• [Impact of proton pump inhibitor omeprazole on the antiplatelet effect of clopidogrel in individuals with various CYP2C19*2 genotypes].

  Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 20120801

• Antiulcerogenic activity of hydroalcoholic fruit extract of Pithecellobium dulce in different experimental ulcer models in rats.

  Journal of ethnopharmacology 20120713

• Lycopene an adjunctive therapy for Helicobacter pylori eradication: a quasi-control trial.

  Journal of complementary & integrative medicine 20120702

• The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the rat.

  British journal of pharmacology 20120701

• Different effects of proton pump inhibitors and famotidine on the clopidogrel metabolic activation by recombinant CYP2B6, CYP2C19 and CYP3A4.

  Xenobiotica; the fate of foreign compounds in biological systems 20120701

• Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patient.

  The Journal of antimicrobial chemotherapy 20120701

• Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection.

  Gastroenterology 20120701

• Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers.

  The American journal of gastroenterology 20120701

• Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction.

  Thrombosis and haemostasis 20120701

• Randomised clinical trial: esomeprazole for the prevention of nonsteroidal anti-inflammatory drug-related peptic ulcers in Japanese patients.

  Alimentary pharmacology & therapeutics 20120701

• High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates.

  Alimentary pharmacology & therapeutics 20120701

• Differential inhibitory effects of proton pump inhibitors on the metabolism and antiplatelet activities of clopidogrel and prasugrel.

  Biopharmaceutics & drug disposition 20120701

• A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution.

  The Journal of pharmacy and pharmacology 20120701

• Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection.

  The new microbiologica 20120701

• [Effects of omeprazole on the proliferation and apoptosis of hepatoma cell line HepG2].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20120701

• Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.

  Gut 20120601

• Inhibitors of acid secretion can benefit gastric wound repair independent of luminal pH effects on the site of damage.

  Gut 20120601

• Patient socioeconomic determinants for the choice of the cheapest molecule within a cluster: evidence from Belgian prescription data.

  The European journal of health economics : HEPAC : health economics in prevention and care 20120601

• The elegance of the gastric mucosal barrier: designed by nature for nature.

  Gut 20120601

• A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia.

  Gut 20120601

• A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity.

  Rheumatology international 20120601

• Effect of a traditional Chinese medicine Liu Wei Di Huang Wan on the activities of CYP2C19, CYP2D6 and CYP3A4 in healthy volunteers.

  Xenobiotica; the fate of foreign compounds in biological systems 20120601

• Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs.

  FEMS microbiology ecology 20120601

• Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20120601

• A difficult diagnosis: drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE.

  Clinical and experimental dermatology 20120601

• Comparison of prescription drug costs in the United States and the United Kingdom, part 2: proton pump inhibitors.

  Pharmacotherapy 20120601

• Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori.

  Helicobacter 20120601

• Enantioseparation of omeprazole--effect of different packing particle size on productivity.

  Journal of chromatography. A 20120601

• Diminished mycophenolic acid exposure caused by omeprazole may be clinically relevant in the first week posttransplantation.

  Therapeutic drug monitoring 20120601

• Co-treatment of dichloroacetate, omeprazole and tamoxifen exhibited synergistically antiproliferative effect on malignant tumors: in vivo experiments and a case report.

  Hepato-gastroenterology 20120601

• Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.

  Cancer research 20120601

• Recurrence of Helicobacter pylori After Eradication in Patients with Peptic Ulcer.

  Southern medical journal 20120601

• Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidine.

  Medical molecular morphology 20120601

• [Clinical efficacy of electroacupuncture combined with dalitong granule for gastroesophageal reflux disease and its mechanism].

  Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20120601

• Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.

  Journal of medicinal chemistry 20120524

• Clopidogrel and proton pump inhibitors--where do we stand in 2012?

  World journal of gastroenterology 20120514

• Peripheral arterial disease of the lower extremities.

  Archives of medical science : AMS 20120509

• Gastroprotective activities of Turnera diffusa Willd. ex Schult. revisited: Role of arbutin.

  Journal of ethnopharmacology 20120507

• Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats.

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20120501

• Suboptimal response to ferrous sulfate in iron-deficient patients taking omeprazole.

  American journal of therapeutics 20120501

• N-substituted aminomethanephosphonic and aminomethane-P-methylphosphinic acids as inhibitors of ureases.

  Amino acids 20120501

• Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium.

  Journal of clinical pharmacology 20120501

• Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood.

  European journal of clinical pharmacology 20120501

• High-dose esomeprazole is required for intraesophageal acid control in gastroesophageal reflux disease patients with hiatus hernia.

  Journal of gastroenterology and hepatology 20120501

• Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers.

  European journal of clinical pharmacology 20120501

• Mucosal barrier defects in gastric intestinal metaplasia: in vivo evaluation by confocal endomicroscopy.

  Gastrointestinal endoscopy 20120501

• Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.

  Drug metabolism and disposition: the biological fate of chemicals 20120501

• Prescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patients.

  The American journal of gastroenterology 20120501

• Molecular mechanism of the anti-inflammatory activity of a natural diarylnonanoid, malabaricone C.

  Free radical biology & medicine 20120501

• The effect of once daily omeprazole and succinic acid (VECAM) vs once daily omeprazole on 24-h intragastric pH.

  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20120501

• Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.

  Journal of gastroenterology 20120501

• High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120501

• Conservative long-term treatment of children with eosinophilic esophagitis.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20120501

• Relative bioavailability and pharmacokinetic comparison of two different enteric formulations of omeprazole.

  Journal of Zhejiang University. Science. B 20120501

• [A pilot trial on the treatment of gastroesophageal reflux-related cough in infants].

  Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20120501

• Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.

  Expert review of clinical pharmacology 20120501

• Improved dissolution and pharmacokinetic behavior of dipyridamole formulation with microenvironmental pH-modifier under hypochlorhydria.

  International journal of pharmaceutics 20120415

• [Blurred vision: a rare secondary effect of proton pump inhibitors].

  Revue medicale suisse 20120411

• A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.

  Journal of the American College of Cardiology 20120403

• Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19.

  European journal of clinical pharmacology 20120401

• Omeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping.

  European journal of clinical pharmacology 20120401

• How informative is a negative finding in a small pharmacogenetic study?

  The pharmacogenomics journal 20120401

• Esophageal reflux disease proton pump inhibitor therapy impact on sleep disturbance: a systematic review.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20120401

• A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism.

  Alimentary pharmacology & therapeutics 20120401

• Enantioselective disposition of omeprazole, pantoprazole, and lansoprazole in a same Brazilian subjects group.

  Chirality 20120401

• Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors: a focus on ketoprofen/omeprazole.

  Clinical drug investigation 20120401

• Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy.

  Alimentary pharmacology & therapeutics 20120401

• Low dose or high dose of proton pump inhibitor for ulcer bleeding?

  European journal of internal medicine 20120401

• Interventions to improve anticoagulation with warfarin.

  Therapeutic drug monitoring 20120401

• Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.

  Pharmacotherapy 20120401

• Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitors.

  The oncologist 20120401

• Treatment of idiopathic persistent hiccups with positive pressure ventilation -a case report-.

  The Korean journal of pain 20120401

• Asian consensus report on functional dyspepsia.

  Journal of neurogastroenterology and motility 20120401

• Bravo 48-hour Wireless pH Monitoring in Patients With Non-cardiac Chest Pain. Objective Gastroesophageal Reflux Disease Parameters Predict the Responses to Proton Pump Inhibitors.

  Journal of neurogastroenterology and motility 20120401

• The Therapeutic and Diagnostic Value of 2-week High Dose Proton Pump Inhibitor Treatment in Overlapping Non-erosive Gastroesophageal Reflux Disease and Functional Dyspepsia Patients.

  Journal of neurogastroenterology and motility 20120401

• [Effect of omeprazole on gene expression profile of human umbilical vein endothelial cell line and bioinformatics analysis].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120401

• Role of enhanced visibility in evaluating polyposis syndromes using a newly developed contrast image capsule endoscope.

  Gut and liver 20120401

• Ask the doctor. I recently switched from Prilosec to its generic form omeprazole, and it doesn't relieve my heartburn as well as Prilosec. Aren't generics supposed to be the same as the brand-name drugs?

  Harvard women's health watch 20120401

• Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.

  Journal of the National Cancer Institute 20120321

• Gastroprotective effect of Senecio candicans DC on experimental ulcer models.

  Journal of ethnopharmacology 20120306

• Effects of Pithecellobium jiringa ethanol extract against ethanol-induced gastric mucosal injuries in Sprague-Dawley rats.

  Molecules (Basel, Switzerland) 20120306

• Influence of different proton pump inhibitors on activity of cytochrome P450 assessed by [(13)C]-aminopyrine breath test.

  Journal of clinical pharmacology 20120301

• Metabolism of thalidomide by human liver microsome cytochrome CYP2C19 is required for its antimyeloma and antiangiogenic activities in vitro.

  Hematological oncology 20120301

• [Clinical importance of the clopidogrel - omeprazole interaction: a question to solve].

  Atencion primaria 20120301

• In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.

  Acta dermato-venereologica 20120301

• The safety of fetal exposure to proton-pump inhibitors during pregnancy.

  Digestive diseases and sciences 20120301

• Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction.

  The American journal of gastroenterology 20120301

• Gastroprotective effect of anti-cancer compound rohitukine: possible role of gastrin antagonism and H(+) K (+)-ATPase inhibition.

  Naunyn-Schmiedeberg's archives of pharmacology 20120301

• Identification of phthalates in medications and dietary supplement formulations in the United States and Canada.

  Environmental health perspectives 20120301

• Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers.

  The American journal of gastroenterology 20120301

• Integrating interacting drugs and genetic variations to improve the predictability of warfarin maintenance dose in Chinese patients.

  Pharmacogenetics and genomics 20120301

• Esomeprazole relieves upper gastrointestinal symptoms in high-risk and average-risk NSAID users in daily clinical practice: results from an open-label study.

  European journal of gastroenterology & hepatology 20120301

• Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori.

  European journal of internal medicine 20120301

• Induction of CYP2C19 and CYP3A activity following repeated administration of efavirenz in healthy volunteers.

  Clinical pharmacology and therapeutics 20120301

• Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.

  Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 20120301

• Acetylsalicylic acid/esomeprazole fixed-dose combination.

  Drugs & aging 20120301

• Pneumatosis cystoides intestinalis in scleroderma-related conditions.

  Internal medicine journal 20120301

• Reducing co-administration of clopidogrel and proton pump inhibitors in acute coronary syndromes.

  The journal of the Royal College of Physicians of Edinburgh 20120301

• Amino acid and vitamin supplementation improved health conditions in elderly participants.

  Journal of clinical biochemistry and nutrition 20120301

• Anti-Helicobacter pylori effects of IgY from egg york of immunized hens.

  Laboratory animal research 20120301

• Effects of Ougan juice on P450 activities using a cocktail method.

  Die Pharmazie 20120301

• I've taken aspirin for years to prevent heart attack, and now I've developed an ulcer. My doctor told me to keep taking aspirin along with Prilosec. Why keep taking aspirin if it caused my ulcer?

  Mayo Clinic health letter (English ed.) 20120301

• Ameliorative effects of Panax quinquefolium on experimentally induced reflux oesophagitis in rats.

  The Indian journal of medical research 20120301

• Ligand-based design of a potent and selective inhibitor of cytochrome P450 2C19.

  Journal of medicinal chemistry 20120209

• Different 8-hydroxyquinolines protect models of TDP-43 protein, α-synuclein, and polyglutamine proteotoxicity through distinct mechanisms.

  The Journal of biological chemistry 20120203

• Development and validation of a highly sensitive LC-MS/MS method for quantitation of dexlansoprazole in human plasma: application to a human pharmacokinetic study.

  Biomedical chromatography : BMC 20120201

• Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20120201

• Repeated administration of berberine inhibits cytochromes P450 in humans.

  European journal of clinical pharmacology 20120201

• Antibiotic susceptibility and intracellular localization of Diplorickettsia massiliensis.

  FEMS immunology and medical microbiology 20120201

• Clopidogrel and PPI interaction: clinically relevant or not?

  Current cardiology reports 20120201

• Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study.

  Alimentary pharmacology & therapeutics 20120201

• Optimal management of antiplatelet therapy and proton pump inhibition following percutaneous coronary intervention.

  Current treatment options in cardiovascular medicine 20120201

• Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review.

  Drug safety 20120201

• Calcium [¹³C]carbonate breath test for quantitative measurement of total gastric acid in rats.

  Scandinavian journal of gastroenterology 20120201

• Evolution of GERD over 5 years.

  Alimentary pharmacology & therapeutics 20120201

• Evaluation of a four-drug, three-antibiotic, nonbismuth-containing 'concomitant' therapy as first-line Helicobacter pylori eradication regimen in Greece.

  Helicobacter 20120201

• Recent safety concerns with proton pump inhibitors.

  Journal of clinical gastroenterology 20120201

• Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.

  Scandinavian journal of gastroenterology 20120201

• Acid inhibition effect of ilaprazole on Helicobacter pylori-negative healthy volunteers: an open randomized cross-over study.

  Journal of digestive diseases 20120201

• Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi.

  Expert review of pharmacoeconomics & outcomes research 20120201

• Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland.

  Expert review of pharmacoeconomics & outcomes research 20120201

• Combatting the cough that won't quit.

  The Journal of family practice 20120201

• Psidium guajava Linn confers gastro protective effects on rats.

  European review for medical and pharmacological sciences 20120201

• A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20120201

• Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20120201

• [Effect of high altitude hypoxia on the activity and protein expression of CYP2C9 and CYP2C19].

  Yao xue xue bao = Acta pharmaceutica Sinica 20120201

• Treatment with histamine-type 2 receptor antagonists and omeprazole increase the risk of diarrhoea in neonatal foals treated in intensive care units.

  Equine veterinary journal. Supplement 20120201

• Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120115

• A validated stability indicating ultra performance liquid chromatographic method for determination of impurities in Esomeprazole magnesium gastro resistant tablets.

  Journal of pharmaceutical and biomedical analysis 20120105

• Precision improvement for omeprazole determination through stability evaluation.

  Drug testing and analysis 20120101

• Now you see it. Now you don't: fair balance and adequate provision in advertisements for drugs before and after the switch from prescription to over-the-counter.

  Health communication 20120101

• Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study.

  Journal of gastroenterology and hepatology 20120101

• Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats.

  International journal of oncology 20120101

• Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes.

  Drug metabolism and disposition: the biological fate of chemicals 20120101

• [The efficiency of drug prescription: impact of a therapeutic exchange program].

  Gaceta sanitaria 20120101

• Effects of omeprazole and genetic polymorphism of CYP2C19 on the clopidogrel active metabolite.

  Drug metabolism and disposition: the biological fate of chemicals 20120101

• A rare case of iron deficiency.

  European journal of gastroenterology & hepatology 20120101

• Prediction of relative in vivo metabolite exposure from in vitro data using two model drugs: dextromethorphan and omeprazole.

  Drug metabolism and disposition: the biological fate of chemicals 20120101

• Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.

  Alimentary pharmacology & therapeutics 20120101

• Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial.

  Current medical research and opinion 20120101

• Results of ambulatory pH monitoring do not reliably predict response to therapy in patients with eosinophilic oesophagitis.

  Alimentary pharmacology & therapeutics 20120101

• Assessment of the use of clopidogrel associated with gastroprotective medications in outpatients.

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20120101

• [Impact of pharmacotherapeutic warnings on the prescription of clopidogrel and proton pump inhibitors in hospitalised patients].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20120101

• [Sound therapy in sudden deafness].

  Acta otorrinolaringologica espanola 20120101

• Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.

  Journal of veterinary internal medicine 20120101

• Seeking an optimal eradication therapy for Helicobacter pylori infection.

  Journal of gastroenterology and hepatology 20120101

• Gastroesophageal reflux disease and tooth erosion.

  International journal of dentistry 20120101

• Early effects of oral administration of omeprazole and roxatidine on intragastric pH.

  Journal of Zhejiang University. Science. B 20120101

• Orally administered L-arginine and glycine are highly effective against acid reflux esophagitis in rats.

  Medical science monitor : international medical journal of experimental and clinical research 20120101

• Impact of laparoscopic fundoplication for the treatment of laryngopharyngeal reflux: review of the literature.

  International journal of otolaryngology 20120101

• Analysis of nonformulary use of PPIs and excess drug cost in a Veterans Affairs population.

  Journal of managed care pharmacy : JMCP 20120101

• Bleeding tendency in dual antiplatelet therapy with aspirin/clopidogrel: rescue of the template bleeding time in a single-center prospective study.

  Thrombosis journal 20120101

• Impact of antisecretory treatment on respiratory symptoms of gastroesophageal reflux disease in children.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20120101

• Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study.

  BMJ (Clinical research ed.) 20120101

• Impact of concomitant antacid administration on gabapentin plasma exposure and oral bioavailability in healthy adult subjects.

  Drug metabolism and pharmacokinetics 20120101

• Agranulocytosis induced by proton pump inhibitors.

  Journal of clinical gastroenterology 20120101

• Reflux revisited: advancing the role of pepsin.

  International journal of otolaryngology 20120101

• Melastoma malabathricum (L.) Smith Ethnomedicinal Uses, Chemical Constituents, and Pharmacological Properties: A Review.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Recurrent subacute visual loss presenting in a 52-year-old Caucasian woman with chronic relapsing inflammatory optic neuropathy: a case report.

  Journal of medical case reports 20120101

• Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101

• Applicability of a short/rapid 13C-urea breath test for Helicobacter pylori: retrospective multicenter chart review study.

  BMC gastroenterology 20120101

• Is quadruple therapy the new triple therapy for H pylori?

  Canadian family physician Medecin de famille canadien 20120101

• Air column in esophagus and symptoms of gastroesophageal reflux disease.

  BMC medical imaging 20120101

• Autophagy in pancreatic cancer.

  International journal of cell biology 20120101

• Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study.

  BMJ (Clinical research ed.) 20120101

• Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology.

  Frontiers in pharmacology 20120101

• Clarithromycin versus metronidazole in first-line Helicobacter pylori eradication. Prospective randomized study of 85 Tunisian adults.

  La Tunisie medicale 20120101

• Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors.

  International journal of molecular sciences 20120101

• What is the correct assignment on enrolled patients receiving various doses of medication in a study design?

  Journal of neurogastroenterology and motility 20120101

• Proteinuria: an ignored marker of inflammation and cardiovascular disease in chronic hemodialysis.

  International journal of nephrology and renovascular disease 20120101

• Yellow brain culinary-medicinal mushroom, Tremella mesenterica Ritz.:Fr. (higher Basidiomycetes), is subjectively but not objectively effective for eradication of Helicobacter pylori: a prospective controlled trial.

  International journal of medicinal mushrooms 20120101

• Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings.

  HIV/AIDS (Auckland, N.Z.) 20120101

• Effects of combined aspirin and clopidogrel therapy on cardiovascular outcomes: a systematic review and meta-analysis.

  PloS one 20120101

• Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.

  BMC gastroenterology 20120101

• Immunological response as a source to variability in drug metabolism and transport.

  Frontiers in pharmacology 20120101

• Recent advances in noncardiac chest pain in Korea.

  Gut and liver 20120101

• Efficacy of the Combination of Tetracycline, Amoxicillin, and Lansoprazole in the Eradication of Helicobacter pylori in Treatment-Naïve Patients and in Patients Who Are Not Responsive to Clarithromycin-Based Regimens: A Pilot Study.

  Gut and liver 20120101

• Treatment of laryngopharyngeal reflux: a comparison between domperidone plus omeprazole and omeprazole alone.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120101

• Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options.

  Vascular health and risk management 20120101

• Pharmacokinetics and Excretion Studies on CDRI-85/92, an Antiulcer Proton Pump Inhibitor.

  Scientia pharmaceutica 20120101

• Methanol extract of Bauhinia purpurea leaf possesses anti-ulcer activity.

  Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20120101

• Cardiac arrest due to lymphocytic colitis: a case report.

  Journal of medical case reports 20120101

• Pharmacological mechanisms underlying gastroprotective activities of the fractions obtained from Polygonum minus in Sprague Dawley rats.

  International journal of molecular sciences 20120101

• An isolated neurofibromal polyp of the colon.

  Case reports in gastroenterology 20120101

• Calcium channel blockers and esophageal sclerosis: should we expect exacerbation of interstitial lung disease?

  Case reports in gastroenterology 20120101

• Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.

  Substance abuse treatment, prevention, and policy 20120101

• Non-steroidal anti-inflammatory drugs for the treatment of pain and immobility-associated osteoarthritis: consensus guidance for primary care.

  BMC family practice 20120101

• [Severe hypomagnesemia refractory to oral supplementation associated to omeprazole treatment].

  Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20120101

• Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models.

  BMC complementary and alternative medicine 20120101

• Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH.

  BMC gastroenterology 20120101

• In Vitro Assessment of Cytochrome P450 2C19 Potential of Naoxintong.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.

  BMC gastroenterology 20120101

• Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.

  Clinical and experimental gastroenterology 20120101

• Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy.

  Journal of atherosclerosis and thrombosis 20120101

• Gastric carcinomas localized to the cardia.

  Gastroenterology research and practice 20120101

• Use of warfarin in long-term care: a systematic review.

  BMC geriatrics 20120101

• Vitamin K: food composition and dietary intakes.

  Food & nutrition research 20120101

• The influence of esomeprazole and cisapride on gastroesophageal reflux during anesthesia in dogs.

  Journal of veterinary internal medicine 20120101

• Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence.

  PloS one 20120101

• Helicobacter pylori: Eradication or Preservation.

  F1000 medicine reports 20120101

• A simple and safe anastomosis for pancreatogastrostomy using one binding purse-string and two transfixing mattress sutures.

  International journal of surgical oncology 20120101

• HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.

  International journal of hepatology 20120101

• In vitro H(+) -K(+) ATPase inhibitory potential of methanolic extract of Cissus quadrangularis Linn.

  Pharmacognosy research 20120101

• Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization.

  PloS one 20120101

• Analysis of delayed bleeding after endoscopic submucosal dissection for gastric epithelial neoplasms.

  Gastroenterology research and practice 20120101

• Rescue Therapy for Helicobacter pylori Infection 2012.

  Gastroenterology research and practice 20120101

• Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).

  BMC gastroenterology 20120101

• Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter Pylori Eradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study.

  Gastroenterology research and practice 20120101

• Mechanisms of Gastroprotective Effects of Ethanolic Leaf Extract of Jasminum sambac against HCl/Ethanol-Induced Gastric Mucosal Injury in Rats.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Lifestyle factors affecting gastroesophageal reflux disease symptoms: a cross-sectional study of healthy 19864 adults using FSSG scores.

  BMC medicine 20120101

• Simultaneous HPTLC determination of strychnine and brucine in strychnos nux-vomica seed.

  Journal of pharmacy & bioallied sciences 20120101

• Moxifloxacin (avelox) induced thrombotic thrombocytopenic purpura.

  Case reports in medicine 20120101

• New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir.

  HIV/AIDS (Auckland, N.Z.) 20120101

• Bone remodeling after administration of proton pump (H+/K+-ATPase) inhibitors and alendronate in ovariectomized rats.

  Acta poloniae pharmaceutica 20120101

• Chronic cough, reflux, postnasal drip syndrome, and the otolaryngologist.

  International journal of otolaryngology 20120101

• Stent thrombosis: incidence, predictors and new technologies.

  Thrombosis 20120101

• The gut microbiota and irritable bowel syndrome: friend or foe?

  International journal of inflammation 20120101

• Unilateral hemiparesis with thoracic epidural in an adolescent.

  Case reports in anesthesiology 20120101

• Orbital aspergillosis: voriconazole - the new standard treatment?

  Case reports in ophthalmology 20120101

• A prospective nonrandomized comparison of laparoscopic Nissen fundoplication and laparoscopic Toupet fundoplication in Indian population using detailed objective and subjective criteria.

  Journal of minimal access surgery 20120101

• The protective role of Aegle marmelos on aspirin-induced gastro-duodenal ulceration in albino rat model: a possible involvement of antioxidants.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101

• Ethionamide-induced gynecomastia.

  Journal of pharmacology & pharmacotherapeutics 20120101

• Adverse events in patients with blood loss: a pooled analysis of 51 clinical studies from the celecoxib clinical trial database.

  The open rheumatology journal 20120101

• Expressions of MMPs and TIMP-1 in gastric ulcers may differentiate H. pylori-infected from NSAID-related ulcers.

  TheScientificWorldJournal 20120101

• Short bowel syndrome presenting with re-feeding syndrome in a Han Chinese patient: a case report.

  Journal of medical case reports 20120101

• Efficacy of esomeprazole in treating acid-related diseases in Japanese populations.

  Clinical and experimental gastroenterology 20120101

• Efficacy of a 'Rescue' Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures.

  Gastroenterology research and practice 20120101

• Macrolides in chronic inflammatory skin disorders.

  Mediators of inflammation 20120101

• Liver tumor promoting effect of omeprazole in rats and its possible mechanism of action.

  The Journal of toxicological sciences 20120101

• Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy.

  Gastroenterology research and practice 20120101

• A Rare Case of Cholecystitis Caused by Raoultella planticola.

  Case reports in medicine 20120101

• Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland.

  Gastroenterology research and practice 20120101

• Nine cases of allergy to omeprazole.

  Journal of investigational allergology & clinical immunology 20120101

• Barrett's Esophagus: Emerging Knowledge and Management Strategies.

  Pathology research international 20120101

• Evaluation of anti-ulcer effect of amlodipine in gastric ulcer models in rats.

  Indian journal of pharmacology 20120101

• [Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors].

  Terapevticheskii arkhiv 20120101

• Can injection of pentagastrin stimulate the identification of metastases of medullary thyroid carcinoma by (18)F-FDG PET/CT?

  Hellenic journal of nuclear medicine 20120101

• Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System.

  International journal of medical sciences 20120101

• Impact of dual antiplatelet therapy with proton pump inhibitors on the outcome of patients with acute coronary syndrome undergoing drug-eluting stent implantation.

  ISRN cardiology 20120101

• Proton pump (H+/K+-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats.

  Pharmacological reports : PR 20120101

• Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study.

  Circulation journal : official journal of the Japanese Circulation Society 20120101

• In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine.

  Digestion 20120101

• Removal of trace organic chemical contaminants by a membrane bioreactor.

  Water science and technology : a journal of the International Association on Water Pollution Research 20120101

• Improved diabetes control and pancreatic function in a type 2 diabetic after omeprazole administration.

  Case reports in endocrinology 20120101

• Severe gastrooesophageal reflux disease associated with foetal alcohol syndrome.

  Case reports in pediatrics 20120101

• Gallic Acid Enriched Fraction of Phyllanthus emblica Potentiates Indomethacin-Induced Gastric Ulcer Healing via e-NOS-Dependent Pathway.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Inhibitory effects of kale ingestion on metabolism by cytochrome P450 enzymes in rats.

  Biomedical research (Tokyo, Japan) 20120101

• Proton-pump inhibitors could be innocent when used concomitantly with clopidogrel.

  Circulation journal : official journal of the Japanese Circulation Society 20120101

• Late hypersensitivity to omeprazole and other proton pump inhibitors.

  Acta clinica Belgica 20120101

• Enhanced liver tumor promotion but not liver initiation activity in rats subjected to combined administration of omeprazole and β-naphthoflavone.

  The Journal of toxicological sciences 20120101

• Effect of high-dose oral rabeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.

  Gastroenterology research and practice 20120101

• Stability of omeprazole in SyrSpend SF Alka (reconstituted).

  International journal of pharmaceutical compounding 20120101

• Decitabine induced transient cardiomyopathy: a case report.

  Clinical Medicine Insights. Oncology 20120101

• Lipids, blood pressure, kidney - what was new in 2011?

  Archives of medical science : AMS 20111231

• Differential effects of Cu(II) and Fe(III) on the binding of omeprazole and pantoprazole to bovine serum albumin: toxic effect of metal ions on drugs.

  Journal of pharmaceutical and biomedical analysis 20111215

• Use of comprehensive screening methods to detect selective human CAR activators.

  Biochemical pharmacology 20111215

• Antiprotozoal activity of proton-pump inhibitors.

  Bioorganic & medicinal chemistry letters 20111215

• Aspirin-induced small bowel injuries and the preventive effect of rebamipide.

  World journal of gastroenterology 20111214

• Membranoproliferative glomerulonephritis and a rare bleeding disorder: Factor X deficiency.

  International urology and nephrology 20111201

• Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer.

  Cancer chemotherapy and pharmacology 20111201

• Pharmacokinetics of two formulations of omeprazole administered through a gastrostomy tube in patients with severe neurodevelopmental problems.

  British journal of clinical pharmacology 20111201

• Sequential therapy versus tailored triple therapies for Helicobacter pylori infection in children.

  Journal of pediatric gastroenterology and nutrition 20111201

• Effect of multiple doses of omeprazole on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban.

  Journal of cardiovascular pharmacology 20111201

• [Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111201

• The Golgi apparatus in the endomembrane-rich gastric parietal cells exist as functional stable mini-stacks dispersed throughout the cytoplasm.

  Biology of the cell 20111201

• Update on the endoscopic management of peptic ulcer bleeding.

  Current gastroenterology reports 20111201

• Inhibitors of gastric acid secretion increase the risk of prion infection in mice.

  Scandinavian journal of gastroenterology 20111201

• Assessment and treatment of gastroesophageal reflux in healthy infants with apneic episodes: a retrospective analysis of 87 consecutive patients.

  Clinical pediatrics 20111201

• Novel stably transfected gene reporter human hepatoma cell line for assessment of aryl hydrocarbon receptor transcriptional activity: construction and characterization.

  Environmental science & technology 20111201

• A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.

  Annals of medicine 20111201

• Pharmacodynamic evaluation of clopidogrel plus PA32540: the Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) study.

  Clinical pharmacology and therapeutics 20111201

• Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection.

  Helicobacter 20111201

• Antibacterial effects of the urushiol component in the sap of the lacquer tree (Rhus verniciflua Stokes) on Helicobacter pylori.

  Helicobacter 20111201

• Analysing the role of COX-2 in acute oesophagitis and in melatonin-exerted protection against experimental reflux oesophagitis in rats.

  The Journal of pharmacy and pharmacology 20111201

• Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.

  Clinical therapeutics 20111201

• Ventricular bigeminy associated with voriconazole, methadone and esomeprazole.

  International journal of clinical pharmacy 20111201

• Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study.

  International journal of clinical pharmacology and therapeutics 20111201

• Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline: a multicenter prospective observational study.

  Journal of Korean medical science 20111201

• Medical reversal: why we must raise the bar before adopting new technologies.

  The Yale journal of biology and medicine 20111201

• Severe exfoliative dermatitis caused by esomeprazole.

  Journal of the American Geriatrics Society 20111201

• A survey of recently published cardiovascular, hematological and pneumological original articles in the Brazilian scientific press.

  Clinics (Sao Paulo, Brazil) 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Treatment for Eradication of Helicobacter pylori Infection among Chronic Hepatitis C Patients.

  Gut and liver 20111201

• [Gastric MALT lymphoma: anatomo-clinical data and outcome of early stage H. pylori-associated gastric MALT-lymphoma resistant to treatment].

  La Tunisie medicale 20111201

• [Long-term efficacy and safety research on functional dyspepsia treated with electroacupuncture and Zhizhu Kuanzhong capsule].

  Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20111201

• A case of ciliate protozoa colpoda spp. (Ciliata: colpodidae) detected in human urine.

  Iranian journal of parasitology 20111201

• To compare the efficacy of triple therapy with furazolidone, amoxicillin and omeprazole for two weeks and three weeks in the eradication of Helicobacter pylori in Bangladeshi duodenal ulcer patients.

  Bangladesh Medical Research Council bulletin 20111201

• The Pattern of Use of Oral NSAIDs with or without Co-prescription of Gastroprotective Agent for Arthritic Knee by Korean Practitioners.

  Knee surgery & related research 20111201

• Helicobacter pylori eradication in functional dyspepsia: HEROES trial.

  Archives of internal medicine 20111128

• Gastroprotective activity of hydroalcoholic extract obtained from the leaves of Brassica oleracea var. acephala DC in different animal models.

  Journal of ethnopharmacology 20111118

• Omeprazole attenuates hyperoxic injury in H441 cells via the aryl hydrocarbon receptor.

  Free radical biology & medicine 20111115

• Warfarin.

  BMJ (Clinical research ed.) 20111102

• Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study.

  Cancer chemotherapy and pharmacology 20111101

• The effect of antireflux treatment on patients with gastroesophageal reflux disease undergoing a mental arithmetic stressor.

  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20111101

• Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.

  Gut 20111101

• Formulation of multiparticulate systems as lyophilised orally disintegrating tablets.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20111101

• Doubling the dose of clopidogrel restores the loss of antiplatelet effect induced by esomeprazole.

  Thrombosis research 20111101

• The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel.

  Drug metabolism and disposition: the biological fate of chemicals 20111101

• Small-molecular virulence inhibitors show divergent and immunomodulatory effects in infection models of Salmonella enterica serovar Typhimurium.

  International journal of antimicrobial agents 20111101

• Withdrawing PPI therapy after healing esophagitis does not worsen symptoms or cause persistent hypergastrinemia: analysis of dexlansoprazole MR clinical trial data.

  The American journal of gastroenterology 20111101

• Duodenal ulceration in a patient with celiac disease and plasminogen I deficiency: coincidence or cofactors?

  Pediatrics 20111101

• Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations.

  Clinical pharmacokinetics 20111101

• A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori.

  The American journal of gastroenterology 20111101

• Clinical update on nursing home medicine: 2011.

  Journal of the American Medical Directors Association 20111101

• Gastric antral diverticulum with heterotopic pancreas in a teenage patient.

  Journal of pediatric gastroenterology and nutrition 20111101

• Will H. pylori stagger under the weight of this LOAD? A novel but expensive eradication regimen.

  The American journal of gastroenterology 20111101

• Discontinuation of unnecessary medications in older adults.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20111101

• Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trial.

  American heart journal 20111101

• Gastric ulcer healing after treatment of endoscopic submucosal dissection in Japanese: comparison of H(2) receptor antagonist and proton pump inhibitor administration.

  Journal of clinical biochemistry and nutrition 20111101

• Pacemaker limitation of tachycardia in hypovolemic shock.

  The western journal of emergency medicine 20111101

• Comparison of the efficacy and safety between generic intravenous omeprazole (Zefxon) and original omeprazole (Losec) in the adjunct treatment of non-variceal upper gastrointestinal bleeding in Siriraj Hospital.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20111101

• Chromium in drinking water: sources, metabolism, and cancer risks.

  Chemical research in toxicology 20111017

• Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?

  British journal of clinical pharmacology 20111001

• Addition of omeprazole to dual antiplatelet therapy with clopidogrel plus aspirin lowers the risk of upper gastrointestinal bleeding.

  Evidence-based medicine 20111001

• CLSM as quantitative method to determine the size of drug crystals in a solid dispersion.

  Pharmaceutical research 20111001

• [Esomeprazole-induced subacute cutaneous lupus erythematosus].

  Actas dermo-sifiliograficas 20111001

• Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study.

  Respirology (Carlton, Vic.) 20111001

• [Severe hypomagnesemia related to omeprazole].

  Revista clinica espanola 20111001

• Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.

  Gastroenterology 20111001

• Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of cytochrome P4501A enzymes.

  The Journal of pharmacology and experimental therapeutics 20111001

• Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials.

  Alimentary pharmacology & therapeutics 20111001

• Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.

  Pharmacoepidemiology and drug safety 20111001

• Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study.

  Alimentary pharmacology & therapeutics 20111001

• Ligand-independent activation of the arylhydrocarbon receptor by ETK (Bmx) tyrosine kinase helps MCF10AT1 breast cancer cells to survive in an apoptosis-inducing environment.

  Biological chemistry 20111001

• Synthesis and antigastric ulcer activity of novel 5-isoproyl-3,8-dimethylazulene derivatives.

  Bioorganic & medicinal chemistry letters 20111001

• Proton pump inhibitors omeprazole, lansoprazole and pantoprazole induce relaxation in the rat lower oesophageal sphincter.

  The Journal of pharmacy and pharmacology 20111001

• Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabeprazole.

  European journal of gastroenterology & hepatology 20111001

• Fixed drug eruption caused by three unrelated drugs: promethazine, pethidine and omeprazole.

  Clinical and experimental dermatology 20111001

• Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study.

  Croatian medical journal 20111001

• Prescribing proton pump inhibitor and clopidogrel together: current state of recommendations.

  Current opinion in gastroenterology 20111001

• Expression of albumin and cytochrome P450 enzymes in HepG2 cells cultured with a nanotechnology-based culture plate with microfabricated scaffold.

  The Journal of toxicological sciences 20111001

• Antioxidant and gastroprotective activities of Andrographis paniculata (Hempedu Bumi) in Sprague Dawley rats.

  Indian journal of experimental biology 20111001

• Overlap syndrome of functional dyspepsia and irritable bowel syndrome - are both diseases mutually exclusive?

  Journal of neurogastroenterology and motility 20111001

• Should we still subcategorize helicobacter pylori-associated dyspepsia as functional disease?

  Journal of neurogastroenterology and motility 20111001

• Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded.

  Journal of neurogastroenterology and motility 20111001

• Do histamine-2 receptor antagonists and proton pump inhibitors really have no effect on the gastric emptying rate?

  Journal of neurogastroenterology and motility 20111001

• Combination of PPI with a prokinetic drug in gastroesophageal reflux disease.

  Acta medica Indonesiana 20111001

• Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20111001

• Elusive cause of hypomagnesaemia.

  BMJ (Clinical research ed.) 20110930

• The methanolic extract of Boesenbergia rotunda (L.) Mansf. and its major compound pinostrobin induces anti-ulcerogenic property in vivo: possible involvement of indirect antioxidant action.

  Journal of ethnopharmacology 20110902

• Does laryngopharyngeal reflux cause intraoral burning sensations? A preliminary study.

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20110901

• A rare association of inlet patch with laryngospasm: a report of two children and literature review.

  Pediatric pulmonology 20110901

• In vitro studies investigating the interactions between degarelix, a decapeptide gonadotropin-releasing hormone blocker, and cytochrome P450.

  Basic & clinical pharmacology & toxicology 20110901

• Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis.

  European journal of drug metabolism and pharmacokinetics 20110901

• Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure.

  Scandinavian journal of gastroenterology 20110901

• AAPS workshop report: strategies to address therapeutic protein-drug interactions during clinical development.

  The AAPS journal 20110901

• Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.

  The Journal of pharmacology and experimental therapeutics 20110901

• Aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator expression in human and rat placentas and transcription activity in human trophoblast cultures.

  Toxicological sciences : an official journal of the Society of Toxicology 20110901

• Whole-cell oxidation of omeprazole sulfide to enantiopure esomeprazole with Lysinibacillus sp. B71.

  Bioresource technology 20110901

• Clopidogrel with proton pump inhibitors: safe or not?

  Clinical cardiology 20110901

• Randomized comparison of two nonbismuth-containing rescue therapies for Helicobacter pylori.

  The American journal of the medical sciences 20110901

• Gastroprotective activity of methanol extract and marrubiin obtained from leaves of Marrubium vulgare L. (Lamiaceae).

  The Journal of pharmacy and pharmacology 20110901

• Luciferin IPA-based higher throughput human hepatocyte screening assays for CYP3A4 inhibition and induction.

  Journal of biomolecular screening 20110901

• Effectiveness of the proton pump inhibitor omeprazole associated with calcium hydroxide as intracanal medication: an in vivo study.

  Journal of endodontics 20110901

• Short-term healing process of artificial ulcers after gastric endoscopic submucosal dissection.

  Gut and liver 20110901

• Cow's Milk Allergy among Children with Gastroesophageal Reflux Disease.

  Gut and liver 20110901

• A multicenter, randomized, comparative study to determine the appropriate dose of lansoprazole for use in the diagnostic test for gastroesophageal reflux disease.

  Gut and liver 20110901

• Phased whole-genome genetic risk in a family quartet using a major allele reference sequence.

  PLoS genetics 20110901

• Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.

  Prescrire international 20110901

• Outpatient drug oversupply at a teaching hospital in Thailand.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110901

• The role of trefoil factor family in apparently healthy subjects administrated gastroprotective agents for the primary prevention of gastrointestinal injuries from low-dose acetylsalicylic acid: a preliminary study.

  Journal of clinical biochemistry and nutrition 20110901

• Correlation between creatinine clearance and Helicobacter pylori infection eradication with sequential and triple therapeutic regimens: A randomised clinical trial.

  Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 20110901

• Metronidazole-based quadruple versus standard triple therapy: which is better as first-line therapy for Helicobacter pylori eradication?

  Expert review of clinical pharmacology 20110901

• The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver.

  Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20110901

• Chiral assay of omeprazole and metabolites and its application to a pharmacokinetics related to CYP2C19 genotypes.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110815

• Ulcerative cystitis associated with phenylbutazone administration in two horses.

  Journal of the American Veterinary Medical Association 20110815

• Helicobacter pylori associated with chronic urticaria.

  Journal of infection in developing countries 20110812

• Supplementation of Los Angeles classification with esophageal mucosa index of hemoglobin can predict the treatment response of erosive reflux esophagitis.

  Surgical endoscopy 20110801

• Mitochondrial dependent apoptosis: ameliorative effect of flunarizine on ischemia-reperfusion of celiac artery-induced gastric lesions in the rat.

  Digestive diseases and sciences 20110801

• Assessment of a novel β2-adrenoceptor agonist, trantinterol, for interference with human liver cytochrome P450 enzymes activities.

  Toxicology in vitro : an international journal published in association with BIBRA 20110801

• Influence of esomeprazole on hypoglycemic activity of oral antidiabetic agents in rats and rabbits.

  Molecular and cellular biochemistry 20110801

• Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture.

  Drug metabolism and disposition: the biological fate of chemicals 20110801

• Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial.

  The Journal of antimicrobial chemotherapy 20110801

• Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.

  Alimentary pharmacology & therapeutics 20110801

• Randomized double-blind placebo-controlled crossover study to determine the effects of esomeprazole on inhibition of platelet function by clopidogrel.

  Journal of thrombosis and haemostasis : JTH 20110801

• In vitro inhibitory effects of Wen-pi-tang-Hab-Wu-ling-san on human cytochrome P450 isoforms.

  Journal of clinical pharmacy and therapeutics 20110801

• Occupational contact allergy to omeprazole and fluoxetine.

  Contact dermatitis 20110801

• The reason for failure of on-demand PPI therapy in NERD patients.

  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20110801

• Multicentre trial in people with arthritis finds increased risk of clinically significant gastrointestinal events with diclofenac plus omeprazole compared with celecoxib.

  Evidence-based medicine 20110801

• Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid.

  Expert review of gastroenterology & hepatology 20110801

• The potential inhibitory effect of revaprazan, an acid pump antagonist, on anticoagulation with warfarin.

  The Tohoku journal of experimental medicine 20110801

• Hoarseness and chronic cough: would you suspect reflux?

  The Journal of family practice 20110801

• [Evaluation of pharmacokinetic drug-drug-interactions. Critical considerations of the relevance of pharmacokinetic drug-drug interactions of proton pump inhibitors in self medication].

  Medizinische Monatsschrift fur Pharmazeuten 20110801

• Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol.

  Journal of Korean medical science 20110801

• Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer.

  Southern medical journal 20110801

• Effect of Helicobacter pylori eradication therapy in iron deficiency anaemia of pregnancy - a pilot study.

  The Indian journal of medical research 20110801

• [Diagnosis and treatment of laryngopharyngeal reflux disease].

  Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery 20110801

• Effects of intrarectally administered omeprazole paste on gastric fluid pH in healthy adult horses.

  The Veterinary record 20110730

• Buspirone, fexofenadine, and omeprazole: quantification of probe drugs and their metabolites in human plasma.

  Journal of pharmaceutical and biomedical analysis 20110715

• Identification and quantification of glutathione adducts of clozapine using ultra-high-performance liquid chromatography with orthogonal acceleration time-of-flight mass spectrometry and inductively coupled plasma mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20110715

• A reverse method for diversity introduction of benzimidazole to synthesize H(+)/K(+)-ATP enzyme inhibitors.

  Bioorganic & medicinal chemistry letters 20110715

• Differential ligand-dependent activation and a role for Y322 in aryl hydrocarbon receptor-mediated regulation of gene expression.

  Biochemical and biophysical research communications 20110715

• Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.

  Journal of medicinal chemistry 20110714

• Cure of alopecia areata after eradication of Helicobacter pylori: a new association?

  World journal of gastroenterology 20110714

• [Hypomagnesemia related to the use of omeprazole with negative result for mutation in the TRPM6 gene].

  Medicina clinica 20110709

• Efficacy of serology driven 'test and treat strategy' for eradication of H. pylori in patients with rheumatic disease in the Netherlands.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20110701

• Sequential therapy compared with standard triple therapy for Helicobacter pylori eradication in children: a double-blind, randomized, controlled trial.

  The Journal of pediatrics 20110701

• Helicobacter pylori chronic gastritis in children: to eradicate or not to eradicate?

  The Journal of pediatrics 20110701

• Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteers.

  The Journal of antimicrobial chemotherapy 20110701

• Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial.

  Journal of gastroenterology 20110701

• Black tea and theaflavins suppress various inflammatory modulators and i-NOS mediated nitric oxide synthesis during gastric ulcer healing.

  Free radical research 20110701

• Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study.

  Journal of gastroenterology 20110701

• Measurement of mucosal conductivity by MII is a potential marker of mucosal integrity restored in infants on acid-suppression therapy.

  Journal of pediatric gastroenterology and nutrition 20110701

• A marked increase in gastric fluid volume during cardiopulmonary bypass.

  Journal of clinical biochemistry and nutrition 20110701

• Lansoprazole inhibits mitochondrial superoxide production and cellular lipid peroxidation induced by indomethacin in RGM1 cells.

  Journal of clinical biochemistry and nutrition 20110701

• Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms.

  Cell death & disease 20110701

• Effects of Histamine-2 Receptor Antagonists and Proton Pump Inhibitors on the Rate of Gastric Emptying: A Crossover Study Using a Continuous Real-Time C Breath Test (BreathID System).

  Journal of neurogastroenterology and motility 20110701

• How Useful the Combined Impedance-pH Monitoring Is for Evaluation of Refractory Reflux Symptoms?: Author's Reply.

  Journal of neurogastroenterology and motility 20110701

• [The effects of pronase on drugs concentrations for treatment of Helicobacter pylori infection in gastric tissue].

  Zhonghua nei ke za zhi 20110701

• Hypomagnesaemia/hypokalemia associated with the use of esomeprazole.

  Current drug safety 20110701

• The usefulness of the original questionnaire in the evaluation of quality of life in patients with gastroesophageal reflux disease.

  Polski przeglad chirurgiczny 20110701

• Comparison of oral and intravenous proton pump inhibitor on patients with high risk bleeding peptic ulcers: a prospective, randomized, controlled clinical trial.

  Iranian Red Crescent medical journal 20110701

• Glycosylation of mucins present in gastric juice: the effect of helicobacter pylori eradication treatment.

  Clinical and experimental medicine 20110601

• Impact of acid suppression on upper gastrointestinal pH and motility.

  Digestive diseases and sciences 20110601

• Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease.

  Surgical endoscopy 20110601

• A newly developed DNA microarray is useful to assess induction of cytochromes p450 in the cynomolgus monkey.

  Drug metabolism and pharmacokinetics 20110601

• Transient stabbing headache from an acute thalamic hemorrhage.

  The journal of headache and pain 20110601

• Anti-ulcer constituents of Annona squamosa twigs.

  Fitoterapia 20110601

• Melatonin and steroid hormones activate intermembrane Cu,Zn-superoxide dismutase by means of mitochondrial cytochrome P450.

  Free radical biology & medicine 20110601

• Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.

  International journal of clinical pharmacy 20110601

• [Omeprazole and hypomagnesemia].

  Revista clinica espanola 20110601

• Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.

  Journal of gastroenterology 20110601

• Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials.

  Current medical research and opinion 20110601

• Intravenous esomeprazole: a pharmacoeconomic profile of its use in the prevention of recurrent peptic ulcer bleeding.

  PharmacoEconomics 20110601

• Effects of different proton pump inhibitors on cardiac contractility in isolated human failing myocardium.

  The Journal of cardiovascular surgery 20110601

• High eradication rates of Helicobacter pylori infection following sequential therapy: the Israeli experience treating naïve patients.

  Helicobacter 20110601

• Helicobacter pylori eradication: A new, single-capsule bismuth-containing quadruple therapy.

  Nature reviews. Gastroenterology & hepatology 20110601

• Prospective, randomized, placebo-controlled evaluation of esomeprazole in coronary artery disease patients. EPAC: esomeprazole prevention of atypical chest pains.

  The Journal of invasive cardiology 20110601

• Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial.

  Journal of Korean medical science 20110601

• European countries with small populations can obtain low prices for drugs: Lithuania as a case history.

  Expert review of pharmacoeconomics & outcomes research 20110601

• Anti-ulcerogenic and proton pump (H+, K+ ATPase) inhibitory activity of Kolaviron from Garcinia kola Heckel in rodents.

  Indian journal of experimental biology 20110601

• The role of laryngopharyngeal reflux as a risk factor in laryngeal cancer: a preliminary report.

  Clinical and experimental otorhinolaryngology 20110601

• Helicobacter pylori infection: is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20110601

• Role of the COX-independent pathways in the ulcer-healing action of epigallocatechin gallate.

  Food & function 20110601

• [Gastric acid suppression of a new oral powder omeprazole suspension for infants with gastroesophageal reflux disease. A pilot study].

  Acta gastroenterologica Latinoamericana 20110601

• [Profile of use of anti tumor necrosis factor in Colombian patients].

  Biomedica : revista del Instituto Nacional de Salud 20110601

• Separate dosing of clopidogrel and omeprazole may improve platelet inhibition on dual antiplatelet therapy.

  International journal of cardiology 20110519

• Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial.

  JAMA 20110518

• Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON).

  Heart (British Cardiac Society) 20110515

• Internal standard tracked dilution to overcome challenges in dried blood spots and robotic sample preparation for liquid chromatography/tandem mass spectrometry assays.

  Rapid communications in mass spectrometry : RCM 20110515

• Confounding factors for variation of clozapine plasma levels: drug interactions with proton pump inhibitor or infectious etiologies?

  European journal of clinical pharmacology 20110501

• Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori.

  Gut 20110501

• [A hazard scale for severe interactions: a tool for establishing prioritising strategies to improve the safety of the prescription in family medicine].

  Atencion primaria 20110501

• Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding.

  The British journal of surgery 20110501

• Evaluation of the effects of 20 nonsynonymous single nucleotide polymorphisms of CYP2C19 on S-mephenytoin 4'-hydroxylation and omeprazole 5'-hydroxylation.

  Drug metabolism and disposition: the biological fate of chemicals 20110501

• Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation.

  Coronary artery disease 20110501

• Proton pump inhibitors reduce interferon-γ-induced neurotoxicity and STAT3 phosphorylation of human astrocytes.

  Glia 20110501

• Melatonin or L-tryptophan accelerates healing of gastroduodenal ulcers in patients treated with omeprazole.

  Journal of pineal research 20110501

• Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett's oesophagus for 1 year.

  Alimentary pharmacology & therapeutics 20110501

• Proton pump inhibitors and the risk of overanticoagulation during acenocoumarol maintenance treatment.

  British journal of haematology 20110501

• Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.

  Pediatrics 20110501

• Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction.

  European journal of gastroenterology & hepatology 20110501

• Rabeprazole extended-release 50 mg compared with esomeprazole 40 mg and rabeprazole delayed release 20 mg.

  Alimentary pharmacology & therapeutics 20110501

• Quantitative plasma analysis using automated online solid-phase extraction with column switching LC-MS/MS for characterising cytochrome P450 2D6 and 2C19 metabolism.

  Journal of separation science 20110501

• Helicobacter pylori infection: a randomized, controlled study comparing 2 rescue therapies after failure of standard triple therapies.

  Medicine 20110501

• Prevalence and risk factor of erosive esophagitis observed in Korean National Cancer Screening Program.

  Journal of Korean medical science 20110501

• Evaluation of gastrointestinal injury and blood flow of small bowel during low-dose aspirin administration.

  Journal of clinical biochemistry and nutrition 20110501

• Long-term follow-up of a child with primary lymph node gastrinoma and Zollinger-Ellison syndrome.

  Journal of pediatric surgery 20110501

• Identification and characterization of the acid phosphatase HppA in Helicobacter pylori.

  Journal of microbiology and biotechnology 20110501

• Coadministration of clopidogrel and proton pump inhibitors.

  Cleveland Clinic journal of medicine 20110501

• [Evaluation of efficacy of esomeprazole treatment in patients with laryngopharyngeal reflux].

  Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery 20110501

• A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening.

  International journal of pharmaceutics 20110415

• Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes.

  Toxicology letters 20110410

• Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians.

  The pharmacogenomics journal 20110401

• Risk factors associated with Helicobacter pylori infection treatment failure in a high prevalence area.

  Epidemiology and infection 20110401

• A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial.

  Journal of clinical gastroenterology 20110401

• Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.

  Clinical and experimental dermatology 20110401

• Patients with gastroesophageal reflux disease and respiratory manifestations do not present lung function disorders during cardiopulmonary exercise test.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20110401

• Effects of long-term PPI treatment on producing bowel symptoms and SIBO.

  European journal of clinical investigation 20110401

• 'War and Peace' with Barrett's esophagus.

  Digestive diseases and sciences 20110401

• Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20110401

• Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: a prospective cross-over drug-drug interaction study.

  European journal of cancer (Oxford, England : 1990) 20110401

• An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers.

  Alimentary pharmacology & therapeutics 20110401

• Long-term safety of naproxen and esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAID-associated gastric ulcers.

  Current medical research and opinion 20110401

• One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial.

  International journal of clinical practice 20110401

• Clinical outcomes in patients with the concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention: an analysis from the Guthrie Health Off-Label Stent (GHOST) investigators.

  Circulation. Cardiovascular interventions 20110401

• Comparison of infusion or low-dose proton pump inhibitor treatments in upper gastrointestinal system bleeding.

  European journal of internal medicine 20110401

• New effective treatment regimen for children infected with a double-resistant Helicobacter pylori strain.

  Journal of pediatric gastroenterology and nutrition 20110401

• Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.

  Journal of managed care pharmacy : JMCP 20110401

• What is the evidence? Portosystemic shunt in a dog.

  Journal of the American Veterinary Medical Association 20110401

• Antidepressant-mediated gastroesophageal reflux disease.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20110401

• Esomeprazole but not pantoprazole is associated with lower plasma concentrations of clopidogrel's active metabolite.

  The Annals of pharmacotherapy 20110401

• Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations.

  JACC. Cardiovascular interventions 20110401

• False elevation of chromogranin A due to proton pump inhibitors.

  The Netherlands journal of medicine 20110401

• Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence.

  Indian journal of pharmacology 20110401

• Noncardiac chest pain: epidemiology, natural course and pathogenesis.

  Journal of neurogastroenterology and motility 20110401

• Yield of combined impedance-pH monitoring for refractory reflux symptoms in clinical practice.

  Journal of neurogastroenterology and motility 20110401

• Change of gastric emptying with chewing gum: evaluation using a continuous real-time C breath test (BreathID system).

  Journal of neurogastroenterology and motility 20110401

• [Generic substitution, replacement and substitution of drugs: contemporary extent].

  Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 20110401

• Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor.

  Clinics (Sao Paulo, Brazil) 20110401

• [The diagnosis of chest pain syndrome under conditions at a medical and prophylactic facility].

  Voenno-meditsinskii zhurnal 20110401

• Omeprazole decreases magnesium transport across Caco-2 monolayers.

  World journal of gastroenterology 20110328

• Proton pump inhibitor step-down therapy for GERD: a multi-center study in Japan.

  World journal of gastroenterology 20110321

• Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits.

  World journal of gastrointestinal endoscopy 20110316

• Clopidogrel-drug interactions.

  Journal of the American College of Cardiology 20110315

• ACP Journal Club. Adding omeprazole to clopidogrel reduced GI events and did not increase CV events.

  Annals of internal medicine 20110315

• Quadruple or triple therapy to eradicate H pylori.

  Lancet (London, England) 20110312

• Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.

  Lancet (London, England) 20110312

• Gastroesophageal reflux disease management according to contemporary international guidelines: a translational study.

  World journal of gastroenterology 20110307

• Adverse effects of long-term proton pump inhibitor use: a review for the otolaryngologist.

  Journal of voice : official journal of the Voice Foundation 20110301

• Effect of low-dose omeprazole (20 mg daily) on the pharmacokinetics of multiple-dose atazanavir with ritonavir in healthy subjects.

  Journal of clinical pharmacology 20110301

• Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301

• The application of atomic absorption spectrometry for the determination of residual active pharmaceutical ingredients in cleaning validation samples.

  Drug development and industrial pharmacy 20110301

• Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study.

  Scandinavian journal of gastroenterology 20110301

• Regulation of gastric acid secretion by the serum and glucocorticoid inducible kinase isoform SGK3.

  Journal of gastroenterology 20110301

• Proton pump inhibitor treatment for congenital chloride diarrhea.

  Digestive diseases and sciences 20110301

• Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis.

  Basic & clinical pharmacology & toxicology 20110301

• Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis.

  Gastroenterology 20110301

• Proton pump inhibitor co-therapy with clopidogrel: is there GI benefit or cardiovascular harm?

  Gastroenterology 20110301

• Naproxen/esomeprazole fixed-dose combination: for the treatment of arthritic symptoms and to reduce the risk of gastric ulcers.

  Drugs & aging 20110301

• Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.

  Pharmacotherapy 20110301

• Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors.

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110301

• Mitochondrial disorders in NSAIDs-induced small bowel injury.

  Journal of clinical biochemistry and nutrition 20110301

• The efficacy of a 1-week triple therapy for eradication of Helicobacter pylori infection in children.

  Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 20110301

• Omeprazole affects clopidogrel efficacy but not ischemic events in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention.

  Chinese medical journal 20110301

• Impact of a bleeding care pathway in the management of acute upper gastrointestinal bleeding.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20110301

• Different antiulcer activities of pantoprazole in stress, alcohol and pylorus ligation-induced ulcer models.

  Laboratory animal research 20110301

• Clopidogrel with or without omeprazole in coronary disease.

  The New England journal of medicine 20110217

• Clopidogrel with or without omeprazole in coronary disease.

  The New England journal of medicine 20110217

• Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study.

  Pediatric blood & cancer 20110201

• In vivo analysis of mouse gastrin gene regulation in enhanced GFP-BAC transgenic mice.

  American journal of physiology. Gastrointestinal and liver physiology 20110201

• CYP1D1, pseudogenized in human, is expressed and encodes a functional drug-metabolizing enzyme in cynomolgus monkey.

  Biochemical pharmacology 20110201

• Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110201

• Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.

  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20110201

• Chronic pain after laparoscopic transabdominal preperitoneal hernia repair: a randomized comparison of light and extralight titanized polypropylene mesh.

  World journal of surgery 20110201

• Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study.

  Alimentary pharmacology & therapeutics 20110201

• The efficacy and safety of long-term Helicobacter species quadruple therapy in asymptomatic cats with naturally acquired infection.

  Journal of feline medicine and surgery 20110201

• Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping.

  Alimentary pharmacology & therapeutics 20110201

• Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.

  Advances in therapy 20110201

• The role of proton pump inhibitors on early mycophenolic acid exposure in kidney transplantation: evidence from the CLEAR study.

  Therapeutic drug monitoring 20110201

• Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy.

  Current clinical pharmacology 20110201

• Evaluation of bioequivalence between a single-capsule formulation of esomeprazole 40 mg and acetylsalicylic acid 325 mg and the monotherapies given separately in healthy volunteers.

  International journal of clinical pharmacology and therapeutics 20110201

• GERD in 2010: diagnosis, novel mechanisms of disease and promising agents.

  Nature reviews. Gastroenterology & hepatology 20110201

• It is difficult to discontinue PPI treatment in patients with GERD.

  The American journal of gastroenterology 20110201

• [About a case of multiple endocrine neoplasia type 1. Review of some clinical manifestations and treatment controversies].

  Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20110201

• Remission of high-grade B-cell lymphoma in a pediatric patient following Helicobacter pylori eradication.

  Pediatrics international : official journal of the Japan Pediatric Society 20110201

• [Strategy to manage low dose aspirin-induced gastrointestinal injury].

  Nihon rinsho. Japanese journal of clinical medicine 20110201

• Does antireflux surgery prevent progression of Barrett's esophagus?

  Minerva chirurgica 20110201

• Medicine prices, availability and affordability in Sri Lanka.

  Indian journal of pharmacology 20110201

• Effect of esomeprazole on the pharmacokinetics of carbamazepine.

  Indian journal of pharmacology 20110201

• Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20110201

• Effect of progressive resistance exercise on strength evolution of elderly patients living with HIV compared to healthy controls.

  Clinics (Sao Paulo, Brazil) 20110201

• [Warm-needle moxibustion therapy may reduce aspirin-induced gastric mucosal injury in rats].

  Zhen ci yan jiu = Acupuncture research 20110201

• The favourable effect of Helicobacter pylori eradication therapy in patients with recurrent angina-like chest pain and non-responsive to proton pump inhibitors - a preliminary study.

  Archives of medical science : AMS 20110201

• [Severe hypomagnesaemia due to long-term treatment with omeprazole].

  Medicina clinica 20110129

• In vitro modulatory effects of Andrographis paniculata, Centella asiatica and Orthosiphon stamineus on cytochrome P450 2C19 (CYP2C19).

  Journal of ethnopharmacology 20110127

• Double-dose clopidogrel in patients undergoing PCI for ACS.

  Lancet (London, England) 20110122

• ACP Journal Club. Celecoxib reduced GI events more than diclofenac plus omeprazole in patients with osteoarthritis or rheumatoid arthritis.

  Annals of internal medicine 20110118

• Gastroprotective Effect of Ginger Rhizome (Zingiber officinale) Extract: Role of Gallic Acid and Cinnamic Acid in H(+), K(+)-ATPase/H. pylori Inhibition and Anti-Oxidative Mechanism.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Traditional Medicine to Modern Pharmacogenomics: Ayurveda Prakriti Type and CYP2C19 Gene Polymorphism Associated with the Metabolic Variability.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Pharmacokinetics and dose recommendations of Niaspan® in chronic kidney disease and dialysis patients.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110101

• Anaphylaxis to omeprazole. Cross-reactivity with the other proton pump inhibitors.

  Allergologia et immunopathologia 20110101

• Zinc salts provide a novel, prolonged and rapid inhibition of gastric acid secretion.

  The American journal of gastroenterology 20110101

• Mechanistic characterization of gastric copper transport in rainbow trout.

  Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology 20110101

• Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies.

  Clinical pharmacology and therapeutics 20110101

• Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.

  Journal of gastroenterology 20110101

• Black tea and theaflavins assist healing of indomethacin-induced gastric ulceration in mice by antioxidative action.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.

  Pharmacological research 20110101

• Biphasic Effect of Phyllanthus emblica L. Extract on NSAID-Induced Ulcer: An Antioxidative Trail Weaved with Immunomodulatory Effect.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Randomised clinical trial: identification of responders to short-term treatment with esomeprazole for dyspepsia in primary care - a randomised, placebo-controlled study.

  Alimentary pharmacology & therapeutics 20110101

• Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled study.

  Alimentary pharmacology & therapeutics 20110101

• Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.

  Journal of pharmacological and toxicological methods 20110101

• Randomised clinical trial: a novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two double-blind studies.

  Alimentary pharmacology & therapeutics 20110101

• Animal models to study the role of long-term hypergastrinemia in gastric carcinogenesis.

  Journal of biomedicine & biotechnology 20110101

• Pharmacokinetic interactions between etravirine and non-antiretroviral drugs.

  Clinical pharmacokinetics 20110101

• Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs.

  Journal of veterinary internal medicine 20110101

• Should prophylactic low-dose aspirin therapy be continued in peptic ulcer bleeding?

  Drugs 20110101

• Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection.

  Journal of gastroenterology and hepatology 20110101

• A new technique for bedside placement of enteral feeding tubes: a prospective cohort study.

  Critical care (London, England) 20110101

• WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.

  World journal of emergency surgery : WJES 20110101

• The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy.

  Molecular vision 20110101

• Secretion of beta-human chorionic gonadotropin by non-small cell lung cancer: a case report.

  Journal of medical case reports 20110101

• CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population.

  BMC medical genetics 20110101

• Curcumin alleviates matrix metalloproteinase-3 and -9 activities during eradication of Helicobacter pylori infection in cultured cells and mice.

  PloS one 20110101

• Effects of structured follow-up and of more effective acid inhibitory treatment in the management of GORD patients in a Swedish primary-care setting: a randomized, open-label study.

  Clinical drug investigation 20110101

• Primary effusion lymphoma associated with Human Herpes Virus-8 and Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a case report.

  Journal of medical case reports 20110101

• Effects of omeprazole on symptoms and quality of life in Japanese patients with reflux esophagitis: final results of OMAREE, a large-scale clinical experience investigation.

  BMC gastroenterology 20110101

• Portal hypertensive enteropathy diagnosed by capsule endoscopy and demonstration of the ileal changes after transjugular intrahepatic portosystemic shunt placement: a case report.

  Journal of medical case reports 20110101

• Managing pregnancy in inflammatory rheumatological diseases.

  Arthritis research & therapy 20110101

• Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort.

  PloS one 20110101

• [Confounding bias due to indication and severity in observational studies].

  Gaceta sanitaria 20110101

• Prophylactic use of omeprazole associated with a reduced risk of peptic ulcer disease among maintenance hemodialysis patients.

  Renal failure 20110101

• Sex differences in drug disposition.

  Journal of biomedicine & biotechnology 20110101

• Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial.

  Critical care (London, England) 20110101

• Weak up-regulation of serum response factor in gastric ulcers in patients with co-morbidities is associated with increased risk of recurrent bleeding.

  BMC gastroenterology 20110101

• Potential drug interactions in patients with rheumatoid arthritis.

  Revista brasileira de reumatologia 20110101

• Phaeochromocytoma mimicking scleroderma.

  International journal of endocrinology 20110101

• Nutritional Composition, Antioxidant Activities, and Antiulcer Potential of Lentinus squarrosulus (Mont.) Mycelia Extract.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel.

  Thrombosis journal 20110101

• Differences in cerebral response to esophageal acid stimuli and psychological anticipation in GERD subtypes--an fMRI study.

  BMC gastroenterology 20110101

• Effects of intravenously administered esomeprazole sodium on gastric juice pH in adult female horses.

  Journal of veterinary internal medicine 20110101

• Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.

  European journal of medical research 20110101

• Good agreement between questionnaire and administrative databases for health care use and costs in patients with osteoarthritis.

  BMC medical research methodology 20110101

• The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin.

  BMC gastroenterology 20110101

• Expression of multiple forms of 3'-end variant CCK2 receptor mRNAs in human pancreatic adenocarcinomas.

  BMC research notes 20110101

• The concept of 'compartment allergy': prilocaine injected into different skin layers.

  Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20110101

• [Correction of negative influence of long-term hypergastrinemia on gastric acid secretion].

  Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20110101

• Possible gabapentin and ketamine interaction causing prolonged central nervous system depression during post-operative recovery following cervical laminoplasty: a case report.

  Journal of medical case reports 20110101

• Does a proton pump inhibitor cause hypokalemia?

  Internal medicine (Tokyo, Japan) 20110101

• ['Pilot study: sequential therapy in erradicating Helicobacter pylori in the Cayetano Heredia Hospital'].

  Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20110101

• Impact of laparoscopic Nissen fundoplication on non-complicated Barrett's esophagus.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20110101

• Proton Pump Inhibitors in the Management of Tachypnoea following Panproctocolectomy: A Case of High Output Ileostomy.

  Case reports in gastroenterology 20110101

• Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study.

  BMJ (Clinical research ed.) 20110101

• Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole.

  BMC gastroenterology 20110101

• Stimulation of growth of the human gastric pathogen Helicobacter pylori by atmospheric level of oxygen under high carbon dioxide tension.

  BMC microbiology 20110101

• Predicting drug side-effect profiles: a chemical fragment-based approach.

  BMC bioinformatics 20110101

• Epigallocatechin gallate accelerates healing of indomethacin-induced stomach ulcers in mice.

  Pharmacological reports : PR 20110101

• Correction of iron deficiency in the cardiorenal syndrome.

  International journal of nephrology 20110101

• Real-time PCR improves Helicobacter pylori detection in patients with peptic ulcer bleeding.

  PloS one 20110101

• Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells.

  PloS one 20110101

• Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation.

  Frontiers in psychiatry 20110101

• Dengue shock.

  Journal of emergencies, trauma, and shock 20110101

• [Toxic epidermal necrolysis with fatal ending due to the concurrent use of carbamazepine, cilostazol and omeprazol: a case report].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101

• Effect of magnesium infusion on thoracic epidural analgesia.

  Saudi journal of anaesthesia 20110101

• Evaluating ranitidine, pantoprazole and placebo on gastric pH in elective surgery.

  Saudi journal of anaesthesia 20110101

• Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors.

  Journal of hematology & oncology 20110101

• Development and validation of a stability indicating method for the enantioselective estimation of omeprazole enantiomers in the enteric-coated formulations by high-performance liquid chromatography.

  Journal of pharmacy & bioallied sciences 20110101

• Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial.

  Gastroenterology research and practice 20110101

• Fully covered self-expanding metal stents placed temporarily in the bile duct: safety profile and histologic classification in a porcine model.

  BMC gastroenterology 20110101

• Ca2+ activated K+ channel Kca3.1 as a determinant of gastric acid secretion.

  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20110101

• Thromboembolism in inflammatory bowel diseases: a report from Saudi Arabia.

  Clinical and experimental gastroenterology 20110101

• Update on the optimal use of voriconazole for invasive fungal infections.

  Infection and drug resistance 20110101

• [Cardiac invasive aspergillosis in a heart transplant recipient].

  Revista iberoamericana de micologia 20110101

• The prevalence of co-administration of clopidogrel and proton pump inhibitors.

  Quality in primary care 20110101

• Epidermolysis bullosa acquisita with moderately severe Dysphagia due to esophageal strictures.

  Indian journal of dermatology 20110101

• Metabolic myopathy presenting with polyarteritis nodosa: a case report.

  Journal of medical case reports 20110101

• Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trial.

  European journal of medical research 20110101

• Situs inversus totalis with perforated duodenal ulcer: a case report.

  Journal of medical case reports 20110101

• Choledochal cyst: A review of 79 cases and the role of hepaticodochoduodenostomy.

  Journal of Indian Association of Pediatric Surgeons 20110101

• Anti-ulcerogenic and in vitro antioxidant activities of Lagenaria breviflora (LB) whole fruit ethanolic extract in laboratory animals.

  Pharmacognosy research 20110101

• Milk alkali and hydrochlorothiazide: a case report.

  Case reports in medicine 20110101

• Characterization of a novel and spontaneous mouse model of inflammatory arthritis.

  Arthritis research & therapy 20110101

• Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs.

  International journal of nanomedicine 20110101

• Enzyme replacement therapy for pancreatic insufficiency: present and future.

  Clinical and experimental gastroenterology 20110101

• Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease.

  Drug, healthcare and patient safety 20110101

• Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry.

  International journal of analytical chemistry 20110101

• Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.

  Digestion 20110101

• To compare the efficacy of two kinds of Zhizhu pills in the treatment of functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized group sequential comparative trial.

  BMC gastroenterology 20110101

• Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study.

  BMC infectious diseases 20110101

• [Interaction between clopidogrel and proton pump inhibitors].

  Nederlands tijdschrift voor geneeskunde 20110101

• Comparison of the effect of a single dose of erythromycin with pantoprazole on gastric content volume and acidity in elective general surgery patients.

  Journal of anaesthesiology, clinical pharmacology 20110101

• Carbon dioxide embolism during laparoscopic sleeve gastrectomy.

  Journal of anaesthesiology, clinical pharmacology 20110101

• Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).

  PloS one 20110101

• Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention.

  Vascular health and risk management 20110101

• Gastroprotective Properties of Karanjin from Karanja (Pongamia pinnata) Seeds; Role as Antioxidant and H, K-ATPase Inhibitor.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Diagnosing GORD in Respiratory Medicine.

  Frontiers in pharmacology 20110101

• A 41-Year-Old Man with Two Types of Metachronous Peptic Ulcer Complication due to Zollinger-Ellison Syndrome-Regression of Pancreatic Primary after Chemoembolization of Hepatic Metastases: A Case Report.

  Case reports in medicine 20110101

• Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.

  BMJ (Clinical research ed.) 20110101

• Clopidogrel pharmacogenetics: metabolism and drug interactions.

  Drug metabolism and drug interactions 20110101

• A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis.

  BMC neurology 20110101

• Comparison of the effects of omeprazole and rabeprazole on ticlopidine metabolism in vitro.

  Journal of pharmacological sciences 20110101

• The pain system in oesophageal disorders: mechanisms, clinical characteristics, and treatment.

  Gastroenterology research and practice 20110101

• A biochemical study on the gastroprotective effect of hydroalcoholic extract of Andrographis paniculata in rats.

  Indian journal of pharmacology 20110101

• Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.

  Therapeutics and clinical risk management 20110101

• Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis.

  Frontiers in pharmacology 20110101

• Mast cells are critical for protection against peptic ulcers induced by the NSAID piroxicam.

  PloS one 20110101

• Acute pancreatitis with saw palmetto use: a case report.

  Journal of medical case reports 20110101

• [Changes of NO-ergic activity in the salivary glands of rats under conditions of omeprazole-induced hypergastrinemia].

  Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20110101

• Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20110101

• Clinical profile and outcome of surgical treatment of perforated peptic ulcers in Northwestern Tanzania: A tertiary hospital experience.

  World journal of emergency surgery : WJES 20110101

• Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori.

  Scientia pharmaceutica 20110101

• Airway management of an unusual case of recurrent rhinoscleroma.

  Journal of anaesthesiology, clinical pharmacology 20110101

• Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety.

  Journal of pharmacology & pharmacotherapeutics 20110101

• Comparative anti-ulcerogenic study of pantoprazole formulation with and without sodium bicarbonate buffer on pyloric ligated rat.

  Journal of pharmacology & pharmacotherapeutics 20110101

• Dysphagia as a manifestation of esophageal tuberculosis: a report of two cases.

  Journal of medical case reports 20110101

• Aortoesophageal fistula after endovascular aortic aneurysm repair of a mycotic thoracic aneurysm.

  International journal of vascular medicine 20110101

• Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic relevance.

  Clinical proteomics 20110101

• Herpes simplex ulcerative esophagitis in healthy children.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20110101

• Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey.

  The Libyan journal of medicine 20110101

• [Characteristics of duodenogastric reflux in duodenal ulcer patients and its dynamics after Helicobacter pylori eradication].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101

• Kinetics of omeprazole degradation in solid state.

  Acta poloniae pharmaceutica 20110101

• Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey.

  Health and quality of life outcomes 20110101

• Primary molecular disorders and secondary biological adaptations in bartter syndrome.

  International journal of nephrology 20110101

• Upregulation of CYP 450s expression of immortalized hepatocyte-like cells derived from mesenchymal stem cells by enzyme inducers.

  BMC biotechnology 20110101

• CpG site degeneration triggered by the loss of functional constraint created a highly polymorphic macaque drug-metabolizing gene, CYP1A2.

  BMC evolutionary biology 20110101

• Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement.

  Journal of pharmacy & bioallied sciences 20110101

• Reversion of pH-induced physiological drug resistance: a novel function of copolymeric nanoparticles.

  PloS one 20110101

• A challenging case of gastric outlet obstruction (Bouveret's syndrome): a case report.

  Journal of medical case reports 20110101

• The effect of omeprazole on gastric myoelectrical activity and emptying.

  Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20110101

• Functional evaluation of genetic and environmental regulators of p450 mRNA levels.

  PloS one 20110101

• Recovery from intracranial hemorrhage due to leptospirosis.

  Case reports in medicine 20110101

• The history of cystinosis: lessons for clinical management.

  International journal of nephrology 20110101

• Radiological evaluation of the patency of duodenal-esophageal anastomosis during a long postoperative follow-up: effectiveness of an alkaline reflux model in rats.

  Clinical and experimental gastroenterology 20110101

• Comparator pH study to evaluate the single-dose pharmacodynamics of dual delayed-release dexlansoprazole 60 mg and delayed-release esomeprazole 40 mg.

  Clinical and experimental gastroenterology 20110101

• Inverse agonism and its therapeutic significance.

  Indian journal of pharmacology 20110101

• Evaluation of anti-ulcer activity of Samanea saman (Jacq) merr bark on ethanol and stress induced gastric lesions in albino rats.

  Indian journal of pharmacology 20110101

• Esophagitis in a high H. pylori prevalence area: severe disease is rare but concomitant peptic ulcer is frequent.

  PloS one 20110101

• An in vitro co-culture model of esophageal cells identifies ascorbic acid as a modulator of cell competition.

  BMC cancer 20110101

• Bioequivalence study of two esomeprazole enteric coated formulations in healthy Chinese volunteers.

  Arzneimittel-Forschung 20110101

• Successful treatment of reactive airways dysfunction syndrome by high-dose vitamin D.

  Journal of asthma and allergy 20110101

• Air travel can be safe and well tolerated in patients with clinically stable pulmonary hypertension.

  Pulmonary circulation 20110101

• Scrub typhus-induced serious gastric ulcer bleeding.

  Internal medicine (Tokyo, Japan) 20110101

• Targeting GIRK Channels for the Development of New Therapeutic Agents.

  Frontiers in pharmacology 20110101

• Disturbances in body ownership in schizophrenia: evidence from the rubber hand illusion and case study of a spontaneous out-of-body experience.

  PloS one 20110101

• Impact of inhalation therapy on oral health.

  Lung India : official organ of Indian Chest Society 20110101

• Diffuse Idiopathic Skeletal Hyperostosis (DISH)-A Rare Etiology of Dysphagia.

  Clinical medicine insights. Arthritis and musculoskeletal disorders 20110101

• Evaluation of clinical outcome after laparoscopic antireflux surgery in clinical practice: still a controversial issue.

  Minimally invasive surgery 20110101

• Preparation and evaluation of antimicrobial activity of nanosystems for the control of oral pathogens Streptococcus mutans and Candida albicans.

  International journal of nanomedicine 20110101

• Effect of Helicobacter pylori infection on pregnancy rates and early pregnancy loss after intracytoplasmic sperm injection.

  International journal of women's health 20110101

• The objective assessment of cough frequency: accuracy of the LR102 device.

  Cough (London, England) 20110101

• Evaluation of antiulcerogenic activity of aqueous extract of Brassica oleracea var. capitata (cabbage) on Wistar rat gastric ulceration.

  Arquivos de gastroenterologia 20110101

• Effects of grape seed extract, vitamin C, and vitamin e on ethanol- and aspirin-induced ulcers.

  Advances in pharmacological sciences 20110101

• Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions.

  Therapeutics and clinical risk management 20110101

• Clopidogrel and proton pump inhibitors: is there a significant drug-drug interaction?

  Canadian journal of cardiovascular nursing = Journal canadien en soins infirmiers cardio-vasculaires 20110101

• [Drug-induced tubulointerstitial nephritis].

  Nederlands tijdschrift voor geneeskunde 20110101

• Pharmacotherapy options in advanced renal cell carcinoma: what role for pazopanib?

  Clinical Medicine Insights. Oncology 20110101

• Omeprazole does not change the oral bioavailability or pharmacokinetics of vinpocetine in rats.

  Pharmacological reports : PR 20110101

• Complications and management of acute copper sulphate poisoning; a case discussion.

  Journal of occupational medicine and toxicology (London, England) 20110101

• Synthesis and antiulcer activity evaluation of conjugates of amino acids with N-aroyl- N, N'-dicyclohexyl urea.

  Chemistry Central journal 20110101

• Postprandial fullness correlates with rapid inflow of gastric content into duodenum but not with chronic gastritis.

  BMC gastroenterology 20110101

• Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors.

  Journal of translational medicine 20110101

• Effects of proton pump inhibitors and h(2) receptor antagonists on the ileum motility.

  Gastroenterology research and practice 20110101

• Recurrent upper quadrant pain: a fish bone secondary to gastric perforation and liver abscess.

  Case reports in gastroenterology 20110101

• Indigenous anti-ulcer activity of Musa sapientum on peptic ulcer.

  Pharmacognosy research 20110101

• Critical appraisal of ticagrelor in the management of acute coronary syndrome.

  Therapeutics and clinical risk management 20110101

• Venous thrombosis in multiple sclerosis patients after high-dose intravenous methylprednisolone: the preventive effect of enoxaparin.

  Thrombosis 20110101

• Induced Sputum Substance P in Children with Difficult-to-Treat Bronchial Asthma and Gastroesophageal Reflux: Effect of Esomeprazole Therapy.

  International journal of pediatrics 20110101

• Influence of proton pump inhibitors on dexamethasone-induced gastric mucosal damage in rats.

  Indian journal of pharmaceutical sciences 20110101

• [Chronic pancreatitis: microbe-intestinal tissue complex and systemic inflammatory response].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101

• [Prevention of acute stress ulcer and gastrointestinal bleeding in patients with acute necrotizing pancreatitis].

  Anesteziologiia i reanimatologiia 20110101

• The comparative study of the effectiveness of cimetidine, ranitidine, famotidine, and omeprazole in treatment of children with dyspepsia.

  ISRN pediatrics 20110101

• [Effect of acidophilic multiprobiotic symbiter on pathological changes in bone periodontal tissue under hypo-acidic condition].

  Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20110101

• Evaluation of Ondansetron-induced QT interval prolongation in the prophylaxis of postoperative emesis.

  Journal of natural science, biology, and medicine 20110101

• Saliva secretion and efficacy of helicobacter pylori eradication in peptic ulcer patients.

  Journal of dentistry (Tehran, Iran) 20110101

• Perforated duodenal ulcer in pregnancy-a rare cause of acute abdominal pain in pregnancy: a case report and literature review.

  Case reports in obstetrics and gynecology 20110101

• Cytochrome P450 2C19 Polymorphism in Iranian Patients with Coronary Artery Disease.

  ARYA atherosclerosis 20110101

• Self-expandable metal stenting of refractory upper gut corrosive strictures: a new role for endoscopy?

  Case reports in gastrointestinal medicine 20110101

• Growth Impairment and Nutritional Deficiencies in a Cow's Milk-Allergic Infant Fed by Unmodified Donkey's Milk.

  Case reports in pediatrics 20110101

• Glomus tumor of the stomach: a rare cause of upper gastrointestinal bleeding.

  Case reports in surgery 20110101

• Development and validation of simple titrimetric method for the determination of magnesium content in esomeprazole magnesium.

  Indian journal of pharmaceutical sciences 20110101

• Prophylactic role of a herbomineral drug 'Thamira parpam' against cysteamine-induced oxidative stress in liver and duodenum of rats.

  Biological trace element research 20101201

• Acid control cannot be improved with a modified-release formulation of a proton pump inhibitor compared with twice-daily dosing of the conventional formulation.

  Digestive diseases and sciences 20101201

• Do proton pump inhibitors decrease calcium absorption?

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101201

• Iatrogenic gastric wall abscess infected with Enterobacter cloacae after biopsy.

  Gastrointestinal endoscopy 20101201

• Appropriateness of treatment recommendations for PPI in hospital discharge letters.

  European journal of clinical pharmacology 20101201

• A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells.

  Biochemical pharmacology 20101201

• Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis.

  Journal of pediatric gastroenterology and nutrition 20101201

• Intracellular calcium release and protein kinase C activation stimulate sonic hedgehog gene expression during gastric acid secretion.

  Gastroenterology 20101201

• Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.

  Toxicological sciences : an official journal of the Society of Toxicology 20101201

• Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.

  European journal of endocrinology 20101201

• Nanosilver particle effects on drug metabolism in vitro.

  Drug metabolism and disposition: the biological fate of chemicals 20101201

• Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis.

  Diabetes research and clinical practice 20101201

• Novel approaches to inhibition of gastric acid secretion.

  Current gastroenterology reports 20101201

• Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.

  Journal of cardiovascular pharmacology and therapeutics 20101201

• Identifying, evaluating, and controlling bioanalytical risks resulting from nonuniform matrix ion suppression/enhancement and nonlinear liquid chromatography-mass spectrometry assay response.

  Analytical chemistry 20101201

• Effect of omeprazole on the expression of transcription factors in osteoclasts and osteoblasts.

  International journal of molecular medicine 20101201

• Cost reduction associated with restriction policy on dispensing intravenous esomeprazole in Lebanon.

  Pharmacy world & science : PWS 20101201

• The effect of cytochrome P2C19 and interleukin-1 polymorphisms on H. pylori eradication rate of 1-week triple therapy with omeprazole or rabeprazole, amoxycillin and clarithromycin in Chinese people.

  Journal of clinical pharmacy and therapeutics 20101201

• Antiplatelet drug interactions.

  Journal of internal medicine 20101201

• Sequential metronidazole-furazolidone or clarithromycin-furazolidone compared to clarithromycin-based quadruple regimens for the eradication of Helicobacter pylori in peptic ulcer disease: a double-blind randomized controlled trial.

  Helicobacter 20101201

• Enantioseparation of rabeprazole and omeprazole by nonaqueous capillary electrophoresis with an ephedrine-based ionic liquid as the chiral selector.

  Biomedical chromatography : BMC 20101201

• Effect of omeprazole on the concentration of interleukin-6 and transforming growth factor-β1 in patients receiving dual antiplatelet therapy after percutaneous coronary intervention.

  European cytokine network 20101201

• Esomeprazole for the treatment of peptic ulcer bleeding.

  Expert review of gastroenterology & hepatology 20101201

• Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?

  European journal of internal medicine 20101201

• A comprehensive development strategy in buccal drug delivery.

  AAPS PharmSciTech 20101201

• Warfarin therapy: how the less interesting half just got interesting.

  Journal of thrombosis and haemostasis : JTH 20101201

• Late-onset omeprazole-associated acute interstitial nephritis.

  Journal of the American Geriatrics Society 20101201

• Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications.

  Expert review of pharmacoeconomics & outcomes research 20101201

• Haematological side effect of Helicobacter pylori eradication.

  Journal of the Egyptian Society of Parasitology 20101201

• [Atypical manifestations of acute posterior placoid pigment epitheliopathy].

  Archivos de la Sociedad Espanola de Oftalmologia 20101201

• [Duodenal ulcers caused by chloroquine-proguanil association].

  Medecine tropicale : revue du Corps de sante colonial 20101201

• Comparative healing property of kombucha tea and black tea against indomethacin-induced gastric ulceration in mice: possible mechanism of action.

  Food & function 20101201

• Case Review of Sarcoidosis Resembling Sjogren's Syndrome.

  Journal of clinical medicine research 20101201

• In brief: Clopidogrel and omeprazole.

  The Medical letter on drugs and therapeutics 20101129

• Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients.

  Journal of infection in developing countries 20101124

• Clopidogrel with or without omeprazole in coronary artery disease.

  The New England journal of medicine 20101111

• Interaction of clopidogrel and omeprazole.

  The New England journal of medicine 20101111

• Development of stably transfected human and rat hepatoma cell lines for the species-specific assessment of xenobiotic response enhancer module (XREM)-dependent induction of drug metabolism.

  Toxicology 20101109

• Clinical problem-solving. Bitter pills.

  The New England journal of medicine 20101104

• Efficacy of standard triple therapy in the treatment of Helicobacter pylori infection: experience from Kuwait.

  Digestive diseases and sciences 20101101

• Evaluation of Myrtus communis Linn. berries (common myrtle) in experimental ulcer models in rats.

  Human & experimental toxicology 20101101

• The proton pump inhibitor test for gastroesophageal reflux disease: optimal cut-off value and duration.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20101101

• A dispensing error resulting in possible fluoxetine overdose and subsequent discontinuation syndrome in a child.

  Clinical pediatrics 20101101

• Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.

  Journal of pediatric gastroenterology and nutrition 20101101

• The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests.

  Journal of cardiovascular pharmacology 20101101

• Optimization and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the determination of 13 top-prescribed pharmaceuticals in influent wastewater.

  Analytical and bioanalytical chemistry 20101101

• The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial.

  The American journal of gastroenterology 20101101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Treatment of clinically diagnosed laryngopharyngeal reflux disease.

  Archives of otolaryngology--head & neck surgery 20101101

• Pharmacists' interventions in prescribing errors at hospital discharge: an observational study in the context of an electronic prescribing system in a UK teaching hospital.

  Drug safety 20101101

• Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia.

  Nature reviews. Gastroenterology & hepatology 20101101

• Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.

  Gut 20101101

• The effects of dose and timing of esomeprazole administration on 24-h, daytime and night-time acid inhibition in healthy volunteers.

  Alimentary pharmacology & therapeutics 20101101

• Rhabdomyolysis in a patient receiving ranolazine and simvastatin.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20101101

• [Dilemma between gastroprotection and cardiovascular prevention].

  Deutsche medizinische Wochenschrift (1946) 20101101

• Treatment strategies for acid reflux: EncomPASSing practical solutions for primary care.

  The American journal of gastroenterology 20101101

• Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds.

  Bioanalysis 20101101

• Validation of individual quantitative methods for determination of cytochrome P450 probe substrates in human dried blood spots with HPLC-MS/MS.

  Bioanalysis 20101101

• Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Chinese adults.

  Clinical therapeutics 20101101

• Evaluation of the pharmacokinetic interaction between lesogaberan (AZD3355) and esomeprazole in healthy subjects.

  Drugs in R&D 20101101

• Endoscopic jejunal biopsy culture: a simple and effective method to study jejunal microflora.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20101101

• [Should we believe in the interaction between proton pump inhibitors (PPI) and clopidogrel].

  Revue medicale suisse 20101020

• Application of one-step liquid chromatography-electrospray tandem MS/MS and collision-induced dissociation to quantification of ezetimibe and identification of its glucuronated metabolite in human serum: A pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20101015

• Interactive medical case. Bitter pills.

  The New England journal of medicine 20101014

• Liquid chromatographic resolution of proton pump inhibitors including omeprazole on a ligand exchange chiral stationary phase.

  Journal of chromatography. A 20101008

• Which is the best choice for gastroesophageal disorders: Melatonin or proton pump inhibitors?

  World journal of gastrointestinal pharmacology and therapeutics 20101006

• Regulation of basal gastric acid secretion by the glycogen synthase kinase GSK3.

  Journal of gastroenterology 20101001

• Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms.

  The American journal of gastroenterology 20101001

• Pharmacist- versus physician-acquired medication history: a prospective study at the emergency department.

  Quality & safety in health care 20101001

• Marked increase in proton pump inhibitors use in Australia.

  Pharmacoepidemiology and drug safety 20101001

• Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients.

  Clinical and experimental nephrology 20101001

• Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse.

  European journal of gastroenterology & hepatology 20101001

• Interactions of pharmaceuticals and other xenobiotics on hepatic pregnane X receptor and cytochrome P450 3A signaling pathway in rainbow trout (Oncorhynchus mykiss).

  Aquatic toxicology (Amsterdam, Netherlands) 20101001

• Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel.

  Circulation journal : official journal of the Japanese Circulation Society 20101001

• Racemization of the gastrointestinal antisecretory chiral drug esomeprazole magnesium via the pyramidal inversion mechanism: A theoretical study.

  Chirality 20101001

• Stress-related mucosal disease: incidence of bleeding and the role of omeprazole in its prophylaxis.

  European journal of internal medicine 20101001

• Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study.

  International journal of clinical practice 20101001

• Hypotension and bradycardia associated with concomitant tizanidine and lisinopril therapy.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20101001

• Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover study.

  Circulation. Cardiovascular interventions 20101001

• Pattern of intravenous proton pump inhibitors use in ICU and Non-ICU setting: a prospective observational study.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20101001

• Considerable use of furazolidone in Iran.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20101001

• Risk factors and prevention of upper gastrointestinal hemorrhage after a coronary artery bypass grafting operation.

  Surgery today 20101001

• Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance.

  Journal of digestive diseases 20101001

• Infection: Bismuth improves PPI-based triple therapy for H. pylori eradication.

  Nature reviews. Gastroenterology & hepatology 20101001

• The effects of high-dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett's oesophagus.

  Alimentary pharmacology & therapeutics 20101001

• Anti-ulcer & antioxidant activities of Hedranthera barteri {(Hook F.) Pichon} with possible involvement of H+, K+ ATPase inhibitory activity.

  The Indian journal of medical research 20101001

• Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.

  PLoS medicine 20101001

• [Clinical observation on acupoint injection therapy for chronic gastritis of gastric blood stasis type].

  Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20101001

• Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole.

  The Netherlands journal of medicine 20101001

• Non-erosive reflux disease manifested exclusively by protracted hiccups.

  Journal of neurogastroenterology and motility 20101001

• Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells.

  Cell death & disease 20101001

• Inappropriate Use of Intravenous PPI for Stress Ulcer Prophylaxis in an Inner City Community Hospital.

  Journal of clinical medicine research 20101001

• Ninety-seven Years Old Hispanic Male With Mantle Cell Lymphoma.

  Journal of clinical medicine research 20101001

• [Effects of Helicobacter pylori, omeprazole and gastrin on the proliferation and apoptosis of gastric epithelial cell].

  Zhonghua yi xue za zhi 20100928

• Proton pump inhibitors and acute interstitial nephritis.

  BMJ (Clinical research ed.) 20100922

• Naproxen/esomeprazole (Vimovo).

  The Medical letter on drugs and therapeutics 20100920

• Differential response of A 68930 and sulpiride in stress-induced gastric ulcers in rats.

  European journal of pharmacology 20100915

• Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication.

  World journal of gastroenterology 20100914

• Direct HPLC enantioseparation of omeprazole and its chiral impurities: application to the determination of enantiomeric purity of esomeprazole magnesium trihydrate.

  Journal of pharmaceutical and biomedical analysis 20100905

• Gastrin suppresses the interdependent expression of p16 and anion exchanger 1 favoring growth inhibition of gastric cancer cells.

  International journal of cancer 20100901

• The effect of acid reduction with a proton pump inhibitor on the pharmacokinetics of lopinavir or ritonavir in HIV-infected patients on lopinavir/ritonavir-based therapy.

  Journal of clinical pharmacology 20100901

• Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori.

  Journal of gastrointestinal cancer 20100901

• Nonpigmented fixed drug eruption induced by esomeprazole.

  Cutaneous and ocular toxicology 20100901

• Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers.

  Scandinavian journal of gastroenterology 20100901

• Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis.

  Free radical biology & medicine 20100901

• Diagnostic exercise: chronic vomiting in a dog.

  Veterinary pathology 20100901

• Clinically significant CYP2C inhibition by noscapine but not by glucosamine.

  Clinical pharmacology and therapeutics 20100901

• Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes.

  British journal of clinical pharmacology 20100901

• Role of cytochrome P450 2C19 genetic polymorphisms in the therapeutic efficacy of omeprazole in Iranian patients with erosive reflux esophagitis.

  Archives of Iranian medicine 20100901

• [Effect of birid triple viable on peptic ulcer patients with Helicobacter pylori infection].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20100901

• Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors.

  Anticancer research 20100901

• [On-demand treatment of nonerosive reflux disease: omeprazole plus bicarbonate powder versus omeprazole capsules].

  Acta gastroenterologica Latinoamericana 20100901

• Biochemical and analytical development of the CIME cocktail for drug fate assessment in humans.

  Rapid communications in mass spectrometry : RCM 20100830

• Effectiveness comparison of endoscopic methods of non-varicose upper gastrointestinal bleeding treatment.

  Archives of medical science : AMS 20100830

• Protective effects of methanolic extract of Hedyotis puberula (G. Don) R. Br. ex Arn. against experimentally induced gastric ulcers in rat.

  Journal of ethnopharmacology 20100819

• Angioedema after nonsteroidal antiinflammatory drug initiation in a patient stable on an angiotensin-converting-enzyme inhibitor.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100815

• Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.

  Chinese medical journal 20100805

• Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States.

  Journal of gastroenterology 20100801

• [37-year old patient with fever, diarrhea and lymphadenopathy].

  Der Internist 20100801

• E3710, a new proton pump inhibitor, with a long-lasting inhibitory effect on gastric acid secretion.

  The Journal of pharmacology and experimental therapeutics 20100801

• Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteers.

  Alimentary pharmacology & therapeutics 20100801

• Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone.

  Alimentary pharmacology & therapeutics 20100801

• A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing?

  Alimentary pharmacology & therapeutics 20100801

• Effect of the proton pump inhibitor esomeprazole on the oral absorption and pharmacokinetics of nilotinib.

  Journal of clinical pharmacology 20100801

• Gastroprotection in trauma patients receiving non-steroidal anti-inflammatory drugs.

  The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 20100801

• Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.

  European journal of internal medicine 20100801

• Drug-drug interaction profiles of proton pump inhibitors.

  Clinical pharmacokinetics 20100801

• Novel application of proton pump inhibitor for the prevention of colitis-induced colorectal carcinogenesis beyond acid suppression.

  Cancer prevention research (Philadelphia, Pa.) 20100801

• Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy.

  Helicobacter 20100801

• Differential effect of Helicobacter pylori eradication on time-trends in brady/hypokinesia and rigidity in idiopathic parkinsonism.

  Helicobacter 20100801

• Pharmacokinetics of intrarectal omeprazole in alpacas.

  Journal of veterinary pharmacology and therapeutics 20100801

• Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.

  Pharmacotherapy 20100801

• Clinical study on the treatment of gastroesophageal reflux by acupuncture.

  Chinese journal of integrative medicine 20100801

• A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20100801

• Evaluation of the anti-ulcer activity of NR-ANX-C (a polyherbal formulation) in aspirin & pyloric ligature induced gastric ulcers in albino rats.

  The Indian journal of medical research 20100801

• Hyperprolactinaemia induced by proton pump inhibitor.

  JPMA. The Journal of the Pakistan Medical Association 20100801

• Gastric wall abscess--an uncommon condition treated by an alternative form.

  Clinics (Sao Paulo, Brazil) 20100801

• [Impact of different proton pump inhibitors on the antiplatelet activity of clopidogrel in combination with aspirin for patients undergoing coronary stent implantation].

  Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20100801

• [Active pharmacosurveillance of patients affiliated to the Colombian general social security/health system].

  Revista de salud publica (Bogota, Colombia) 20100801

• Antiulcer effects of Achyrocline satureoides (Lam.) DC (Asteraceae) (Marcela), a folk medicine plant, in different experimental models.

  Journal of ethnopharmacology 20100720

• NSAIDs and risk of lower gastrointestinal bleeding.

  Lancet (London, England) 20100717

• Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.

  Lancet (London, England) 20100717

• Omeprazole-induced cough in a patient with gastroesophageal reflux disease.

  European journal of gastroenterology & hepatology 20100701

• pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity.

  International journal of cancer 20100701

• Gedunin and photogedunin of Xylocarpus granatum show significant anti-secretory effects and protect the gastric mucosa of peptic ulcer in rats.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20100701

• [Variability in the measurement of the pharmaceutical prescription quality by autonomous communities].

  Atencion primaria 20100701

• Antisecretory, antioxidative and antiapoptotic effects of montelukast on pyloric ligation and water immersion stress induced peptic ulcer in rat.

  Prostaglandins, leukotrienes, and essential fatty acids 20100701

• A case series of proton pump inhibitor-induced hypomagnesemia.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20100701

• Esomeprazole-induced rhabdomyolysis in a patient with heart failure.

  Intensive care medicine 20100701

• Proton pump inhibitors and clopidogrel: is it a significant drug interaction?

  Expert opinion on drug safety 20100701

• Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting.

  Journal of cardiovascular pharmacology 20100701

• Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients.

  International immunopharmacology 20100701

• Clinical trial: gastric acid suppression in Hispanic adults with symptomatic gastro-oesophageal reflux disease - comparator study of esomeprazole, lansoprazole and pantoprazole.

  Alimentary pharmacology & therapeutics 20100701

• Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.

  Alimentary pharmacology & therapeutics 20100701

• Efficacy and safety of modified sequential three-step empirical therapy for chronic cough.

  Respirology (Carlton, Vic.) 20100701

• Editorial: just how 'difficult' is it to withdraw PPI treatment?

  The American journal of gastroenterology 20100701

• Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20100701

• Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease.

  Gastrointestinal endoscopy 20100701

• Role of 7,8-dimethoxycoumarin in anti-secretary and anti-inflammatory action on pyloric ligation-induced gastritis in rats.

  Journal of Asian natural products research 20100701

• Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers.

  British journal of clinical pharmacology 20100701

• A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin.

  Health technology assessment (Winchester, England) 20100701

• Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin.

  Journal of clinical biochemistry and nutrition 20100701

• Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study.

  Clinical therapeutics 20100701

• Duodenal implications in the pathophysiology of functional dyspepsia.

  Journal of neurogastroenterology and motility 20100701

• Comparison of Direct Medical Care Costs Between Erosive Reflux Disease and Non-erosive Reflux Disease in Korean Tertiary Medical Center.

  Journal of neurogastroenterology and motility 20100701

• Is there any association of osteoporosis with proton pump inhibitor use? (Gastroenterology 2010;138:896-904).

  Journal of neurogastroenterology and motility 20100701

• [Feeding disorders, ALTE syndrome, Sandifer syndrome and gastroesophageal reflux disease in the course of food hypersensitivity in 8-month old infant].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20100701

• Neutropenic enterocolitis: A continuing medical and surgical challenge.

  North American journal of medical sciences 20100701

• A column-switching method for quantification of the enantiomers of omeprazole in native matrices of waste and estuarine water samples.

  Talanta 20100630

• Postoperative pneumonia in elderly patients receiving acid suppressants: a retrospective cohort analysis.

  BMJ (Clinical research ed.) 20100621

• Hemifacial paralysis in a child treated for leukemia: unusual side effect of omeprazole?

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20100601

• Effect of soybean administration on the pharmacokinetics of carbamazepine and omeprazole in rats.

  Fundamental & clinical pharmacology 20100601

• Recurrent cytomegalovirus infection in ileal pouch-anal anastomosis for ulcerative colitis.

  Inflammatory bowel diseases 20100601

• A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir.

  Clinical pharmacology and therapeutics 20100601

• Prospective randomized controlled trial of an injectable esophageal prosthesis versus a sham procedure for endoscopic treatment of gastroesophageal reflux disease.

  Surgical endoscopy 20100601

• Impact of the CYP2C19*17 allele on the pharmacokinetics of omeprazole and pantoprazole in children: evidence for a differential effect.

  Drug metabolism and disposition: the biological fate of chemicals 20100601

• Cadmium inhibits acid secretion in stimulated frog gastric mucosa.

  Toxicology and applied pharmacology 20100601

• Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes.

  Xenobiotica; the fate of foreign compounds in biological systems 20100601

• Distribution of small intestinal mucosal injuries as a result of NSAID administration.

  European journal of clinical investigation 20100601

• Influence of CYP2C19 on the relationship between pharmacokinetics and intragastric pH of omeprazole administered by successive intravenous infusions in Chinese healthy volunteers.

  European journal of clinical pharmacology 20100601

• Update on antithrombotic therapy for stroke prevention in atrial fibrillation.

  Current treatment options in cardiovascular medicine 20100601

• Withdrawal symptoms after gabapentin discontinuation.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100601

• Population pharmacokinetics of tacrolimus in kidney transplant patients.

  International journal of clinical pharmacology and therapeutics 20100601

• Prevalence and typology of potential drug interactions occurring in primary care patients.

  The European journal of general practice 20100601

• Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study.

  Gut 20100601

• High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.

  Helicobacter 20100601

• Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice.

  Journal of gastrointestinal and liver diseases : JGLD 20100601

• Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20100601

• Early postoperative care of liver transplantation for infants with biliary atresia during pediatric intensive care unit stay.

  Transplantation proceedings 20100601

• Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study).

  Journal of clinical pharmacy and therapeutics 20100601

• Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects.

  Journal of clinical pharmacy and therapeutics 20100601

• Determination of the antiulcer properties of sodium cromoglycate in pylorus-ligated albino rats.

  Indian journal of pharmacology 20100601

• [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].

  Giornale italiano di cardiologia (2006) 20100601

• Is the prevalence of CYP2C19 genetic variants different in Pacific people than in New Zealand Europeans?

  The New Zealand medical journal 20100528

• Safety of the long-term use of proton pump inhibitors.

  World journal of gastroenterology 20100521

• Use of (S)-BINOL as NMR chiral solvating agent for the enantiodiscrimination of omeprazole and its analogs.

  Chirality 20100515

• Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study.

  American journal of respiratory and critical care medicine 20100515

• Diagnosis of gastroesophageal reflux disease.

  American family physician 20100515

• Proton pump inhibitor administration via nasogastric tube in pediatric practice: comparative analysis with protocol optimization.

  International journal of pharmaceutics 20100510

• [Prevalence of rebleeding from peptic ulcer in patients treated with proton pump inhibitors].

  Medicina clinica 20100508

• Omeprazole induces gastric permeability to digoxin.

  Digestive diseases and sciences 20100501

• Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis.

  Digestive diseases and sciences 20100501

• Long-term quality of life improvement in subjects with healed erosive esophagitis: treatment with lansoprazole.

  Digestive diseases and sciences 20100501

• Influence of number of calibration standards within a defined range on pharmacokinetic disposition-case studies with omeprazole and clopidogrel carboxylic acid.

  Biomedical chromatography : BMC 20100501

• Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial.

  The American journal of gastroenterology 20100501

• A placebo-controlled trial of 10-day bismuth-based quadruple therapy to eradicate Helicobacter pylori infection; a pilot study for the large Linqu County trial.

  European journal of gastroenterology & hepatology 20100501

• Can a short course of prophylactic low-dose proton pump inhibitor therapy prevent stomal ulceration after laparoscopic Roux-en-Y gastric bypass?

  Obesity surgery 20100501

• Proton pump inhibitor lansoprazole is a nuclear liver X receptor agonist.

  Biochemical pharmacology 20100501

• Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis.

  European journal of gastroenterology & hepatology 20100501

• Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20100501

• Ventricular tachycardia after ondansetron administration in a child with undiagnosed long QT syndrome.

  Canadian journal of anaesthesia = Journal canadien d'anesthesie 20100501

• Intravenous esomeprazole pharmacodynamics in critically ill patients.

  Current medical research and opinion 20100501

• If I take the blood thinner Plavix, should I avoid using Prilosec or other heartburn medications?

  Mayo Clinic women's healthsource 20100501

• Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS--a high throughput approach to evaluate drug-drug interactions.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100501

• Balancing gastrointestinal benefit-risk in individuals who are prescribed NSAIDs for arthritis.

  Rheumatology (Oxford, England) 20100501

• Patient benefit-risk in arthritis--a rheumatologist's perspective.

  Rheumatology (Oxford, England) 20100501

• Identifying and assessing benefit-risk in primary care--a family physician's perspective.

  Rheumatology (Oxford, England) 20100501

• A review of the gastrointestinal safety data--a gastroenterologist's perspective.

  Rheumatology (Oxford, England) 20100501

• Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.

  Journal of managed care pharmacy : JMCP 20100501

• Gastric acid-reducing medications and clopidogrel: what are the latest FDA recommendations?

  The American journal of gastroenterology 20100501

• Iron deficiency anaemia can be improved after eradication of Helicobacter pylori.

  Postgraduate medical journal 20100501

• Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20100501

• Progression from chronic atrophic gastritis to gastric cancer; tangle, toggle, tackle with Korea red ginseng.

  Journal of clinical biochemistry and nutrition 20100501

• Brief Questioning by Nursing Staffs before Endoscopic Examination May Not Always Pick Up Clinical Symptoms of Endoscopic Reflux Esophagitis.

  Journal of clinical biochemistry and nutrition 20100501

• Regulation of gastric acid secretion by PKB/Akt2.

  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20100501

• Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype.

  British journal of clinical pharmacology 20100501

• Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.

  Journal of gastroenterology and hepatology 20100501

• Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D.

  Journal of the American Association for Laboratory Animal Science : JAALAS 20100501

• [Safety and interactions of proton pump inhibitors: lessons learned in millions of patients].

  Gastroenterologia y hepatologia 20100501

• Treatment with double dose of omeprazole increases β-endorphin plasma level in patients with coronary artery disease.

  Archives of medical science : AMS 20100430

• Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.

  British journal of cancer 20100427

• TSU-16, (Z)-3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-2-indolinone, is a potent activator of aryl hydrocarbon receptor and increases CYP1A1 and CYP1A2 expression in human hepatocytes.

  Chemico-biological interactions 20100415

• Evidence for interaction between clopidogrel and proton-pump inhibitors.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100415

• Gastrin release: Antrum microdialysis reveals a complex neural control.

  Regulatory peptides 20100409

• Therapeutic effect of Streptococcus thermophilus CRL 1190-fermented milk on chronic gastritis.

  World journal of gastroenterology 20100407

• Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100401

• Eradication of Helicobacter pylori can facilitate immune reconstitution in HIV-1-infected immunological non-responders.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100401

• Treatment of chronic nasopharyngitis with monopolar suction diathermy.

  The Journal of laryngology and otology 20100401

• [Prophylaxis use of posaconazole (P) in an hemato-oncology unit: a retrospective study].

  Pathologie-biologie 20100401

• Inversed Y cardioplasty plus a truncal vagotomy-antrectomy and a Roux-en-Y gastrojejunostomy performed in patients with stricture of the esophagogastric junction after a failed cardiomyotomy or endoscopic procedure in patients with achalasia of the esophagus.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20100401

• The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying.

  Journal of gastroenterology 20100401

• Pharmacokinetics of intravenous omeprazole in critically ill paediatric patients.

  European journal of clinical pharmacology 20100401

• Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.

  Alimentary pharmacology & therapeutics 20100401

• The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.

  Critical care medicine 20100401

• Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability.

  Journal of clinical gastroenterology 20100401

• Rebamipide may be comparable to H2 receptor antagonist in healing iatrogenic gastric ulcers created by endoscopic mucosal resection: a prospective randomized pilot study.

  Journal of Korean medical science 20100401

• Interaction study between levofloxacin and omeprazole using urinary pharmacokinetic data.

  Pakistan journal of pharmaceutical sciences 20100401

• Upregulation of the esophago-UES relaxation response: a possible pathophysiological mechanism in suspected reflux laryngitis.

  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20100401

• A randomized controlled trial: efficacy and safety of azithromycin, ofloxacin, bismuth, and omeprazole compared with amoxicillin, clarithromycin, bismuth, and omeprazole as second-line therapy in patients with Helicobacter pylori infection.

  Helicobacter 20100401

• 11 month-old twins with food avoidance.

  Journal of developmental and behavioral pediatrics : JDBP 20100401

• Omeprazole-induced subacute cutaneous lupus erythematosus.

  Clinical and experimental dermatology 20100401

• Recent concepts on cyclic vomiting syndrome in children.

  Journal of neurogastroenterology and motility 20100401

• Clinical distinct features of noncardiac chest pain in young patients.

  Journal of neurogastroenterology and motility 20100401

• [Clinical observation on acupuncture for treatment of reflux esophagitis of heat stagnation of liver and stomach type].

  Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20100401

• Modification of gastric pH in the fasted dog.

  The Journal of pharmacy and pharmacology 20100401

• [Evaluation of the effect of ilaprazole on intragastric pH in patients with duodenal ulcer].

  Zhonghua nei ke za zhi 20100401

• Possible acute thrombocytopenia post esomeprazole and hydantoin coadministration.

  Journal of pharmacy practice 20100401

• Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.

  Annals of internal medicine 20100316

• Factors influencing intercellular spaces in the rat esophageal epithelium.

  World journal of gastroenterology 20100307

• Omeprazole induces gastric transmucosal permeability to the peptide bradykinin.

  World journal of gastroenterology 20100307

• PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic success.

  Pathology oncology research : POR 20100301

• Inappropriate use of proton pump inhibitors.

  Irish journal of medical science 20100301

• Wernicke encephalopathy complicating hyperemesis gravidarum: a case report.

  European journal of obstetrics, gynecology, and reproductive biology 20100301

• The pharmacodynamics and pharmacokinetics of S-tenatoprazole-Na 30 mg, 60 mg and 90 mg vs. esomeprazole 40 mg in healthy male subjects.

  Alimentary pharmacology & therapeutics 20100301

• Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.

  Drug metabolism and disposition: the biological fate of chemicals 20100301

• A bio-analytical hydrophilic interaction LC-MS/MS method for the simultaneous quantification of omeprazole and lansoprazole in human plasma in support of a pharmacokinetic omeprazole study in children.

  Journal of separation science 20100301

• Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective.

  Digestive diseases and sciences 20100301

• Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.

  The Annals of pharmacotherapy 20100301

• The role of L-arginine in inclusion complexes of omeprazole with cyclodextrins.

  AAPS PharmSciTech 20100301

• Validated assay for studying activity profiles of human liver UGTs after drug exposure: inhibition and induction studies.

  Analytical and bioanalytical chemistry 20100301

• A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

  Clinical pharmacokinetics 20100301

• Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward.

  Journal of managed care pharmacy : JMCP 20100301

• Risk factors of drug interaction between warfarin and nonsteroidal anti-inflammatory drugs in practical setting.

  Journal of Korean medical science 20100301

• In vitro antibacterial and morphological effects of the urushiol component of the sap of the Korean lacquer tree (Rhus vernicifera Stokes) on Helicobacter pylori.

  Journal of Korean medical science 20100301

• Treating silent reflux disease does not improve poorly controlled asthma.

  Cleveland Clinic journal of medicine 20100301

• Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17.

  British journal of clinical pharmacology 20100301

• Recurrence of acute myocardial infarction in patients discharged on clopidogrel and a proton pump inhibitor after stent placement for acute myocardial infarction.

  Clinical cardiology 20100301

• The impact of smoking on post-clopidogrel platelet reactivity in patients with acute myocardial infarction.

  Korean circulation journal 20100301

• Counselling by primary care physicians may help patients with heartburn-predominant uninvestigated dyspepsia.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20100301

• Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors.

  Anticancer research 20100301

• Sensitivity and proportionality assessment of metabolites from microdose to high dose in rats using LC-MS/MS.

  Bioanalysis 20100301

• Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR.

  Nutrients 20100301

• Reinfection Rate after Successful Helicobacter pylori Eradication in Children.

  Iranian journal of pediatrics 20100301

• Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients.

  World journal of gastroenterology 20100227

• Proton pump inhibitors.

  British dental journal 20100227

• Development of a pH-responsive drug delivery system for enantioselective-controlled delivery of racemic drugs.

  Journal of controlled release : official journal of the Controlled Release Society 20100225

• WITHDRAWN: Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.

  The Cochrane database of systematic reviews 20100217

• Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial.

  British journal of cancer 20100216

• Pharmacokinetic profile of immediate-release omeprazole in patients with gastro-oesophageal reflux associated with gastroparesis.

  Alimentary pharmacology & therapeutics 20100215

• Stimulatory effect of N-methyltyramine, a congener of beer, on pancreatic secretion in conscious rats.

  Alcoholism, clinical and experimental research 20100201

• Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.

  Toxicology in vitro : an international journal published in association with BIBRA 20100201

• Latin american consensus on gastroesophageal reflux disease: an update on therapy.

  Gastroenterologia y hepatologia 20100201

• GERD-related health care utilization, therapy, and reasons for transfer of GERD patients between primary care providers and gastroenterologists in a US managed care setting.

  Digestive diseases and sciences 20100201

• Combined treatment of achalasia - botulinum toxin injection followed by pneumatic dilatation: long-term results.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20100201

• The effect of esomeprazole 20 mg twice daily on acoustic and perception parameters of the voice in laryngopharyngeal reflux.

  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20100201

• Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.

  The American journal of gastroenterology 20100201

• Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100201

• Interleukin-1beta promotes gastric atrophy through suppression of Sonic Hedgehog.

  Gastroenterology 20100201

• Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance.

  Combinatorial chemistry & high throughput screening 20100201

• Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.

  Drug development and industrial pharmacy 20100201

• Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications.

  Expert review of pharmacoeconomics & outcomes research 20100201

• Omeprazole and clopidogrel: Should clinicians be worried?

  Cleveland Clinic journal of medicine 20100201

• The impact of treatment with omeprazole on the effectiveness of clopidogrel drug therapy during the first year after successful coronary stenting.

  The Canadian journal of cardiology 20100201

• Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea.

  Helicobacter 20100201

• Controversial warning on Plavix and stomach-protecting medications.

  Harvard heart letter : from Harvard Medical School 20100201

• Generics offer pharmacy plans specific benefits.

  Managed care (Langhorne, Pa.) 20100201

• Effect of pantoprazole and its interactions with vecuronium on the neuromuscular junction.

  Indian journal of pharmacology 20100201

• Cyclic vomiting syndrome in a male patient with history of renal cell carcinoma status post nephrectomy.

  Journal of clinical medicine research 20100201

• CYP1A inhibition in fish gill filaments: a novel assay applied on pharmaceuticals and other chemicals.

  Aquatic toxicology (Amsterdam, Netherlands) 20100131

• A prospective randomized trial of lafutidine vs rabeprazole on post-ESD gastric ulcers.

  World journal of gastrointestinal endoscopy 20100116

• Effectiveness of voice therapy in reflux-related voice disorders.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20100101

• Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis.

  European journal of clinical pharmacology 20100101

• Stress ulcer, gastritis, and gastrointestinal bleeding prophylaxis in critically ill pediatric patients: a systematic review.

  Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 20100101

• A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism.

  Alimentary pharmacology & therapeutics 20100101

• Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.

  Drug metabolism and disposition: the biological fate of chemicals 20100101

• Effects of Kollicoat IR and hydroxypropyl-beta-cyclodextrin on the dissolution rate of omeprazole from its microparticles and enteric-coated capsules.

  Pharmaceutical development and technology 20100101

• Pharmacogenetics of phase I and phase II drug metabolism.

  Current pharmaceutical design 20100101

• Oral buffered esomeprazole is superior to i.v. pantoprazole for rapid rise of intragastric pH: a wireless pH metry analysis.

  Journal of gastroenterology and hepatology 20100101

• A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract.

  The Journal of rheumatology 20100101

• Proton pump inhibitor and clopidogrel interaction: fact or fiction?

  The American journal of gastroenterology 20100101

• Gemfibrozil-induced myositis in a patient with normal renal function.

  The Annals of pharmacotherapy 20100101

• Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.

  Bioorganic & medicinal chemistry letters 20100101

• Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist.

  Digestion 20100101

• Interaction between capecitabine and brivudin in a patient with breast cancer.

  Nature reviews. Clinical oncology 20100101

• Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20100101

• Metronidazole is still the drug of choice for treatment of anaerobic infections.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100101

• The potential therapeutic effect of melatonin in Gastro-Esophageal Reflux Disease.

  BMC gastroenterology 20100101

• Efficacy of omeprazole versus high-dose famotidine for prevention of exercise-induced gastritis in racing Alaskan sled dogs.

  Journal of veterinary internal medicine 20100101

• [Proton pump inhibitors and calcium absorption?].

  Medizinische Monatsschrift fur Pharmazeuten 20100101

• Immediate-release oral proton pump inhibitors: Panacea or a flash in the pan?

  Journal of gastroenterology and hepatology 20100101

• Effects of omeprazole on the antiplatelet activity of clopidogrel.

  International heart journal 20100101

• Gastroesophageal reflux symptoms in infants in a rural population: longitudinal data over the first six months.

  BMC pediatrics 20100101

• Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding.

  PharmacoEconomics 20100101

• Characteristics of primary health care units with focus on drug information from the pharmaceutical industry and adherence to prescribing objectives: a cross-sectional study.

  BMC clinical pharmacology 20100101

• Profile of etravirine for the treatment of HIV infection.

  Therapeutics and clinical risk management 20100101

• Irreversible encephalopathy after treatment with high-dose intravenous metronidazole.

  Clinical therapeutics 20100101

• Drug utilisation among older inpatients in a teaching hospital in Western Nepal.

  Singapore medical journal 20100101

• Modern role for clopidogrel in management of atrial fibrillation and stroke reduction.

  Vascular health and risk management 20100101

• Examination of equine glandular stomach lesions for bacteria, including Helicobacter spp by fluorescence in situ hybridisation.

  BMC microbiology 20100101

• Revisiting Methicillin-Resistant Staphylococcus aureus Infections.

  Journal of global infectious diseases 20100101

• Toxic tacrolimus blood levels with rifampin administration in a renal transplant recipient.

  Annals of transplantation 20100101

• Volume density, distribution, and ultrastructure of secretory and basolateral membranes and mitochondria predict parietal cell secretory (dys)function.

  Journal of biomedicine & biotechnology 20100101

• [Drugs and feeding tubes].

  Revista da Associacao Medica Brasileira (1992) 20100101

• Can omeprazole reduce the incidence of hypercalcemia in dialysis patients using calcium containing phosphate binders?

  Journal of nephrology 20100101

• Splenic abscess as a paradoxical response to chemotherapy in tuberculous pleural effusion.

  Annals of thoracic medicine 20100101

• Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome.

  PloS one 20100101

• Aripiprazole Improves Depressive Symptoms and Immunological Response to Antiretroviral Therapy in an HIV-Infected Subject with Resistant Depression.

  Case reports in medicine 20100101

• Severe metabolic alkalosis and recurrent acute on chronic kidney injury in a patient with Crohn's disease.

  BMC nephrology 20100101

• Effect of eradication of Helicobacter pylori and iron supplementation on the iron status of children with iron deficiency.

  Archives of medical research 20100101

• Impact of gastro-oesophageal reflux disease on work productivity despite therapy with proton pump inhibitors in Germany.

  European journal of medical research 20100101

• Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20100101

• Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy.

  Journal of experimental & clinical cancer research : CR 20100101

• Clinical research on liver reserve function by 13C-phenylalanine breath test in aged patients with chronic liver diseases.

  BMC geriatrics 20100101

• Study of cross-reactivity between proton pump inhibitors.

  Journal of investigational allergology & clinical immunology 20100101

• Kounis syndrome: report of 5 cases.

  Journal of investigational allergology & clinical immunology 20100101

• Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection.

  PloS one 20100101

• New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children.

  Neuropsychiatric disease and treatment 20100101

• Esophageal hematoma mimicking downhill varices: resolution after esomeprazole therapy.

  Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20100101

• Nonerosive Reflux Disease (NERD) - An Update.

  Journal of neurogastroenterology and motility 20100101

• [Modeling osteoporosis].

  Vestnik Rossiiskoi akademii meditsinskikh nauk 20100101

• Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study.

  BMC pediatrics 20100101

• Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?

  European journal of medical research 20100101

• Nutcracker esophagus: an acid related disease or a primary motor disorder?

  Gastroenterologie clinique et biologique 20100101

• Bleeding from ruptured hepatic metastases as a cause of syncope in an octogenarian: a case report.

  Journal of medical case reports 20100101

• Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole.

  Clinical drug investigation 20100101

• Transformation of a cutaneous follicle center lymphoma to a diffuse large B-cell lymphoma-an unusual presentation.

  Case reports in medicine 20100101

• Prolonged neuromuscular blockade following succinylcholine administration to a patient with a reduced butyrylcholinesterase activity.

  Case reports in medicine 20100101

• Multiple recurrent stent thrombosis in a patient with coexisting clopidogrel resistance and increased anticardiolipin antibodies: a case report.

  Case reports in medicine 20100101

• Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients.

  Therapeutics and clinical risk management 20100101

• Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduction.

  Therapeutics and clinical risk management 20100101

• Pharmacotherapy and the risk for community-acquired pneumonia.

  BMC geriatrics 20100101

• Influence of cyclodextrin complexation with NSAIDs on NSAID/cold stress-induced gastric ulceration in rats.

  International journal of medical sciences 20100101

• Osteogenic activity of locally applied small molecule drugs in a rat femur defect model.

  Journal of biomedicine & biotechnology 20100101

• Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine.

  Neuropsychiatric disease and treatment 20100101

• Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)).

  German medical science : GMS e-journal 20100101

• Stability-indicating high-performance thin-layer chromatographic method for quantitative determination of omeprazole in capsule dosage form.

  Journal of AOAC International 20100101

• [Polypectomy and endoscopic management of a giant gastric polyp].

  Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20100101

• Renal carcinoma infiltrating inferior vena cava and combined valvular heart disease--one-stage uro-cardiological procedure: a case report.

  World journal of surgical oncology 20100101

• Retrograde intubation in a case of ankylosing spondylitis posted for correction of deformity of spine.

  Saudi journal of anaesthesia 20100101

• Further decrease in glycated hemoglobin following ingestion of a LoBAG30 diet for 10 weeks compared to 5 weeks in people with untreated type 2 diabetes.

  Nutrition & metabolism 20100101

• Banha-sasim-tang as an herbal formula for the treatment of functional dyspepsia: a randomized, double-blind, placebo-controlled, two-center trial.

  Trials 20100101

• Oxidative stress and mitochondrial functions in the intestinal Caco-2/15 cell line.

  PloS one 20100101

• Differences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella review.

  PloS one 20100101

• Randomized controlled trial: roxatidine vs omeprazole for non-erosive reflux disease.

  Hepato-gastroenterology 20100101

• Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells.

  PloS one 20100101

• Probable tacrolimus toxicity from tibolone co-administration in a woman: a case report.

  Journal of medical case reports 20100101

• [Omeprazole of limited value in crying babies].

  Nederlands tijdschrift voor geneeskunde 20100101

• The Influence of Neocate in Paediatric Short Bowel Syndrome on PN Weaning.

  Journal of nutrition and metabolism 20100101

• Early marginal ulcer following Roux-en-Y gastric bypass under proton pump inhibitor treatment: prospective multicentric study.

  Arquivos de gastroenterologia 20100101

• Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?

  Frontiers in aging neuroscience 20100101

• Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease.

  Trials 20100101

• Esomeprazole-induced photoallergic dermatitis.

  Journal of postgraduate medicine 20100101

• Burden of anemia in patients with osteoarthritis and rheumatoid arthritis in French secondary care.

  BMC geriatrics 20100101

• Opioid induced hypogonadism.

  BMJ (Clinical research ed.) 20100101

• Small-bowel capsule endoscopy in patients with suspected Crohn's disease-diagnostic value and complications.

  Diagnostic and therapeutic endoscopy 20100101

• Palmaria palmata (Dulse) as an unusual maritime aetiology of hyperkalemia in a patient with chronic renal failure: a case report.

  Journal of medical case reports 20100101

• Diagnosis and management of Barrett's oesophagus.

  BMJ (Clinical research ed.) 20100101

• Getting the balance right: Established and emerging therapies for major depressive disorders.

  Neuropsychiatric disease and treatment 20100101

• Brief assessment of negative dysmorphic signs.

  Neuropsychiatric disease and treatment 20100101

• Effects of multiple-dose esomeprazole and pantoprazole on diazepam pharmacokinetic profile and pharmacodynamic effects on cognitive and psychomotor function in healthy volunteers.

  Arzneimittel-Forschung 20100101

• Liver fibrosis impairs hepatic pharmacokinetics of liver transplant drugs in the rat model.

  Drug metabolism and pharmacokinetics 20100101

• Spectrophotometric determination of peptic ulcer sulfur-containing drugs in bulk form and in tablets.

  Drug testing and analysis 20100101

• Validation of a novel, fully automated high throughput high-performance liquid chromatographic/tandem mass Spectrometric method for quantification of pantoprazole in human plasma.

  Journal of AOAC International 20100101

• [Duodenal involvement in Henoch-Schonlein purpura. Report of a case].

  Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20100101

• Relationship between the acid-inhibitory effects of two proton pump inhibitors and CYP2C19 genotype in Japanese subjects: a randomized two-way crossover study.

  The Journal of international medical research 20100101

• A case of gastric polyposis in antral area of stomach following prolonged proton-pump therapy.

  German medical science : GMS e-journal 20100101

• Marine polysaccharides in pharmaceutical applications: an overview.

  Marine drugs 20100101

• Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis.

  Neuropsychiatric disease and treatment 20100101

• De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study.

  Medicina (Kaunas, Lithuania) 20100101

• Pancreatitis of the gastroduodenal groove: a case report.

  Case reports in medicine 20100101

• Identification and modeling of a drug target for Clostridium perfringens SM101.

  Bioinformation 20100101

• Pazopanib for the treatment of patients with advanced renal cell carcinoma.

  Clinical Medicine Insights. Oncology 20100101

• Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole.

  Therapeutics and clinical risk management 20100101

• Psoriasis and cardiomyopathy: an intriguing association.

  Indian journal of dermatology 20100101

• Myocardium functional recovery protection by omeprazole after ischemia-reperfusion in isolated rat hearts.

  Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular 20100101

• [Dynamics of regeneration of epitheliocytes from gastric mucosa at different modes of antirelapse treatment of ulcer disease].

  Klinicheskaia meditsina 20100101

• Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.

  Drug design, development and therapy 20100101

• [Prevention of NSAID gastropathy: the difference between a coxibs and the addition of a PPI].

  Nederlands tijdschrift voor geneeskunde 20100101

• The potential interaction between clopidogrel and proton pump inhibitors: a systematic review.

  BMC medicine 20100101

• Cardiogenic shock associated with loco-regional anesthesia rescued with left ventricular assist device implantation.

  Journal of cardiothoracic surgery 20100101

• Vitamin B6 is required for full motility and virulence in Helicobacter pylori.

  mBio 20100101

• Clopidogrel: a pharmacogenomic perspective on its use in coronary artery disease.

  Clinical Medicine Insights. Cardiology 20100101

• Nitration of the egg-allergen ovalbumin enhances protein allergenicity but reduces the risk for oral sensitization in a murine model of food allergy.

  PloS one 20100101

• Cerebral sinus thrombosis: a fatal neurological complication of ulcerative colitis.

  Pathology research international 20100101

• Cost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern.

  BMC health services research 20100101

• Pica associated with iron deficiency or depletion: clinical and laboratory correlates in 262 non-pregnant adult outpatients.

  BMC blood disorders 20100101

• VKORC1 pharmacogenetics and pharmacoproteomics in patients on warfarin anticoagulant therapy: transthyretin precursor as a potential biomarker.

  PloS one 20100101

• Comparative study of proton pump inhibitors on dexamethasone plus pylorus ligation induced ulcer model in rats.

  Indian journal of pharmaceutical sciences 20100101

• Complications of regional and general anaesthesia in obstetric practice.

  Indian journal of anaesthesia 20100101

• Pilot study: rapidly cycling hypobaric pressure improves pain after 5 days in adiposis dolorosa.

  Journal of pain research 20100101

• Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch.

  Journal of pain research 20100101

• A prospective study of aspirin use and the risk of gastrointestinal bleeding in men.

  PloS one 20100101

• Formulation and evaluation of omeprazole tablets for duodenal ulcer.

  Indian journal of pharmaceutical sciences 20100101

• Role of intravenous omeprazole on non-variceal upper gastrointestinal bleeding after endoscopic treatment: a comparative study.

  Medicinski arhiv 20100101

• Morbidly obese parturient: Challenges for the anaesthesiologist, including managing the difficult airway in obstetrics. What is new?

  Indian journal of anaesthesia 20100101

• Enteral feed obstructing its own way.

  Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 20100101

• A study on drug-drug interaction of esomeprazole and anti-diabetic drugs.

  Journal of young pharmacists : JYP 20100101

• [Dynamics of inflammatory periodontal diseases under the influence of gastroesophageal reflux disease therapy].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101

• Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.

  British journal of biomedical science 20100101

• Efficacy and safety of fentanyl buccal for cancer pain management by administration through a soluble film: an update.

  Cancer management and research 20100101

• Differential effects of esomeprazole on the antiplatelet activity of clopidogrel in healthy individuals and patients after coronary stent implantation.

  The Journal of international medical research 20100101

• Ultra-fast gradient LC method for omeprazole analysis using a monolithic column: assay development, validation, and application to the quality control of omeprazole enteric-coated pellets.

  Journal of AOAC International 20100101

• Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation.

  PPAR research 20100101

• PYODERMA VEGETANS WITH lg A DEFICIENCY.

  Indian journal of dermatology 20100101

• New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin.

  Diabetes, metabolic syndrome and obesity : targets and therapy 20100101

• Saxagliptin for type 2 diabetes.

  Diabetes, metabolic syndrome and obesity : targets and therapy 20100101

• Benign intermittent gastric outlet obstruction in an elderly: endoscopic management and brief review.

  Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria 20100101

• Helicobacter pylori eradication and histopathological esophagitis in dyspeptic patients.

  Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20100101

• [Drug UDCA (Ursosan) in therapeutic management of patients Barrett's esophagus].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101

• A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy.

  Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20100101

• Laparoscopic resection of a small bowel lipoma with incidental intussusception.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20100101

• An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease.

  Clinical and experimental gastroenterology 20100101

• Delayed-release oral suspension of omeprazole for the treatment of erosive esophagitis and gastroesophageal reflux disease in pediatric patients: a review.

  Clinical and experimental gastroenterology 20100101

• Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease.

  Clinical and experimental gastroenterology 20100101

• Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection.

  Infection and drug resistance 20100101

• Clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections.

  Drug, healthcare and patient safety 20100101

• Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin.

  Drug, healthcare and patient safety 20100101

• Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases.

  Drug, healthcare and patient safety 20100101

• Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes.

  Frontiers in pharmacology 20100101

• Chryseomonas luteola from Bile Culture in an Adult Male with Severe Jaundice.

  Journal of laboratory physicians 20100101

• Patent protection strategies.

  Journal of pharmacy & bioallied sciences 20100101

• Development and validation of a headspace gas chromatographic method for the determination of residual solvents in arterolane (RBx11160) maleate bulk drug.

  Journal of pharmacy & bioallied sciences 20100101

• Policies to enhance prescribing efficiency in europe: findings and future implications.

  Frontiers in pharmacology 20100101

• Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.

  Frontiers in pharmacology 20100101

• Antibacterial activity of garlic extract on streptomycin-resistant Staphylococcus aureus and Escherichia coli solely and in synergism with streptomycin.

  Journal of natural science, biology, and medicine 20100101

• Current and emerging strategies for the treatment of acute pericarditis: a systematic review.

  Journal of inflammation research 20100101

• Role of etravirine in the management of treatment-experienced patients with human immunodeficiency virus type 1.

  HIV/AIDS (Auckland, N.Z.) 20100101

• Long-term treatment of patients with HIV-1: the role of atazanavir.

  HIV/AIDS (Auckland, N.Z.) 20100101

• Interaction between clopidogrel and proton-pump  inhibitors.

  Expert review of clinical pharmacology 20100101

• The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?

  Clinical pharmacology : advances and applications 20100101

• Omeprazole.

  Profiles of drug substances, excipients, and related methodology 20100101

• Chemotherapy-induced oesophageal stricture in a child with osteosarcoma: a case report.

  Chemotherapy research and practice 20100101

• Preparation and in-vitro evaluation of indomethacin nanoparticles.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101

• Formulation and In Vitro evaluation of pH sensitive oil entrapped polymeric blended gellan gum buoyant beads of clarithromycin.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101

• Clinical practice. Barrett's esophagus.

  The New England journal of medicine 20091224

• [Risky to combine clopidogrel with proton pump inhibitor?].

  Lakartidningen 20091222

• An academic perspective on the APPEs' educational significance.

  American journal of pharmaceutical education 20091217

• LC-UV and LC-MS evaluation of stress degradation behaviour of tenatoprazole.

  Journal of pharmaceutical and biomedical analysis 20091205

• Evaluation of the humoral immune response and fecal shedding in weanling foals following oral and intra-rectal administration of an avirulent live vaccine of Lawsonia intracellularis.

  Veterinary journal (London, England : 1997) 20091201

• Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20091201

• Requirements for generic anti-epileptic medicines: a regulatory perspective.

  Journal of neurology 20091201

• Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?

  Helicobacter 20091201

• Oral antiplatelet therapy for acute and chronic management of NSTE ACS: residual ischemic risk and opportunities for improvement.

  Cardiovascular drugs and therapy 20091201

• Drug-facilitated sexual assault provoked by the victim's religious beliefs: a case report.

  The American journal of forensic medicine and pathology 20091201

• [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].

  Presse medicale (Paris, France : 1983) 20091201

• A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example.

  PLoS medicine 20091201

• Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A.

  British journal of clinical pharmacology 20091201

• [Delayed hypersensitivity to sodium lauryl sulphate in omeprazole].

  Annales de dermatologie et de venereologie 20091201

• [A study on the active efflux system in methicillin-resistant Staphylococcus aureus].

  Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue 20091201

• [Anti-Helicobacter pylori treatment in patients with idiopathic thrombocytopenic purpura].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20091201

• Stool transplantation for older patients with Clostridium difficile infection.

  Journal of the American Geriatrics Society 20091201

• [Acid suppression capacity of omeprazole, sodium bicarbonate and alginic acid in an oral powder combination].

  Acta gastroenterologica Latinoamericana 20091201

• [Effect of yiqi huoxue formula on healing quality and recurrence rate of peptic ulcer].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20091201

• A case of variegate porphyria in association with coeliac disease and bisphosphonate associated dental osteonecrosis.

  Journal of clinical medicine research 20091201

• A single dose of intravenous esomeprazole decreases gastric secretion in healthy volunteers.

  Alimentary pharmacology & therapeutics 20091115

• [Effect of esomeprazole upon intestinal mucosal damage following traumatic brain injury in rats].

  Zhonghua yi xue za zhi 20091103

• Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.

  The American journal of gastroenterology 20091101

• Quantification of dental erosions in patients with GERD using optical coherence tomography before and after double-blind, randomized treatment with esomeprazole or placebo.

  The American journal of gastroenterology 20091101

• Identification of new CYP2C19 variants exhibiting decreased enzyme activity in the metabolism of S-mephenytoin and omeprazole.

  Drug metabolism and disposition: the biological fate of chemicals 20091101

• Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity.

  American journal of respiratory and critical care medicine 20091101

• Case reports--resolution of Barrett's disease and esophageal epithelial atypia after gastric bypass and LAP-BAND.

  Obesity surgery 20091101

• Involvement of cytochrome P450 3A4 and P-glycoprotein in first-pass intestinal extraction of omeprazole in rabbits.

  Acta pharmacologica Sinica 20091101

• Interaction between liquid protein solution and omeprazole suspension.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20091101

• Simple and sensitive LC-ESI-MS method for the quantitation of sildenafil in plasma samples.

  Journal of separation science 20091101

• [Medical case of successful therapy of polymyositis by high doses of glucocorticoid].

  Voenno-meditsinskii zhurnal 20091101

• The inducibility of human cytochrome P450 1A by environmental-relevant xenobiotics in the human hepatoma derived cell line HepG2.

  Environmental toxicology and pharmacology 20091101

• Missed opportunities in the trial on proton-pump inhibitor therapy in bleeding peptic ulcers.

  Annals of internal medicine 20091020

• Missed opportunities in the trial on proton-pump inhibitor therapy in bleeding peptic ulcers.

  Annals of internal medicine 20091020

• Missed opportunities in the trial on proton-pump inhibitor therapy in bleeding peptic ulcers.

  Annals of internal medicine 20091020

• Long-term treatment with proton pump inhibitor is associated with undesired weight gain.

  World journal of gastroenterology 20091014

• Early use of omeprazole benefits patients with acute myocardial infarction.

  Journal of thrombosis and thrombolysis 20091001

• Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers.

  Basic & clinical pharmacology & toxicology 20091001

• In vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipran.

  Drug metabolism and disposition: the biological fate of chemicals 20091001

• Standardization of the fully stapled laparoscopic Roux-en-Y gastric bypass for obesity reduces early immediate postoperative morbidity and mortality: a single center study on 2606 patients.

  Obesity surgery 20091001

• Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate.

  Helicobacter 20091001

• Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsia.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20091001

• Recurrent peptic ulcer disease in a pediatric patient with type 1 neurofibromatosis and primary ciliary dyskinesia.

  Minerva pediatrica 20091001

• The effect of omeprazole on oesophageal pH in dogs during anaesthesia.

  The Journal of small animal practice 20091001

• Nanoparticulation of poorly water soluble drugs using a wet-mill process and physicochemical properties of the nanopowders.

  Chemical & pharmaceutical bulletin 20091001

• Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future.

  Expert review of pharmacoeconomics & outcomes research 20091001

• [Prostaglandin E(2) and omeprazole in treating poisoning related acute mucosal lesion].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20091001

• Importance of CYP2C19 genetic polymorphism in the eradication of Helicobacter pylori in north Indians.

  The Indian journal of medical research 20091001

• [Omeprazole increases the risk of myocardial infarction in patients treated with clopidogrel].

  Lakartidningen 20091001

• Hypersensitivity to generic drugs with soybean oil.

  The New England journal of medicine 20090924

• Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.

  Journal of the American College of Cardiology 20090922

• Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials.

  Alimentary pharmacology & therapeutics 20090915

• Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?

  World journal of gastroenterology 20090914

• Aspirin in the primary prevention of vascular disease.

  Lancet (London, England) 20090912

• Furazolidone, co-amoxiclav, colloidal bismuth subcitrate, and esomeprazole for patients who failed to eradicate Helicobacter pylori with triple therapy.

  Digestive diseases and sciences 20090901

• Effect of rebamipide on quality of peptic ulcer healing in rat.

  Digestive diseases and sciences 20090901

• Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease.

  Gut 20090901

• A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease.

  Gut 20090901

• The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090901

• Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities.

  Gastrointestinal endoscopy 20090901

• New P2Y12 antagonists.

  Current opinion in hematology 20090901

• Predictors of heartburn resolution and erosive esophagitis in patients with GERD.

  Current medical research and opinion 20090901

• The pharmacology of esomeprazole and its role in gastric acid related diseases.

  Expert opinion on drug metabolism & toxicology 20090901

• Thienopyridine therapy and risk for cardiovascular events in secondary prevention.

  Current atherosclerosis reports 20090901

• Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma.

  The Journal of allergy and clinical immunology 20090901

• Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication.

  The British journal of surgery 20090901

• An improved LC-MS/MS method for quantitative determination of ilaprazole and its metabolites in human plasma and its application to a pharmacokinetic study.

  Acta pharmacologica Sinica 20090901

• Insights into the future of gastric acid suppression.

  Nature reviews. Gastroenterology & hepatology 20090901

• Pylera for the eradication of Helicobacter pylori infection.

  Expert review of anti-infective therapy 20090901

• Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.

  British journal of clinical pharmacology 20090901

• Evaluation of the pharmacokinetic interaction between esomeprazole (40 mg) and acetylsalicylic acid (325 mg) in healthy volunteers.

  International journal of clinical pharmacology and therapeutics 20090901

• Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole.

  Journal of clinical biochemistry and nutrition 20090901

• Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults.

  Postgraduate medicine 20090901

• Antral ulcers induced by alendronate, a nitrogen-containing biphophonate, in rat stomachs - prophylactic effect of rebamipide.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20090901

• [The administration of proton-pump inhibitors in little children or patients with difficulties in deglutition].

  Journal de pharmacie de Belgique 20090901

• Subcutaneous infusion of esomeprazole in elderly patients in palliative care: a report of two cases.

  Journal of the American Geriatrics Society 20090901

• Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.

  Alimentary pharmacology & therapeutics 20090815

• Lichenoid drug eruption.

  Dermatology online journal 20090815

• Off-label use of medicines in children: can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease.

  European journal of clinical pharmacology 20090801

• Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.

  Digestive diseases and sciences 20090801

• Long-term efficacy of lansoprazole in preventing relapse of erosive reflux esophagitis.

  Digestive diseases and sciences 20090801

• Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease.

  The Journal of pediatrics 20090801

• Evaluation of luciferin-isopropyl acetal as a CYP3A4 substrate for human hepatocytes: effects of organic solvents, cytochrome P450 (P450) inhibitors, and P450 inducers.

  Drug metabolism and disposition: the biological fate of chemicals 20090801

• Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.

  The American journal of gastroenterology 20090801

• Effect of processed and red meat on endogenous nitrosation and DNA damage.

  Carcinogenesis 20090801

• Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication.

  The Laryngoscope 20090801

• Effect of a gastrin-releasing peptide receptor antagonist and a proton pump inhibitor association in an animal model of gastritis.

  Peptides 20090801

• Generic omeprazole delayed-release capsules: in vitro performance evaluations.

  Drug development and industrial pharmacy 20090801

• A biodegradable esophageal stent in the treatment of a corrosive esophageal stenosis in a child.

  Journal of pediatric gastroenterology and nutrition 20090801

• CYP2C19 haplotypes in Koreans as a marker of enzyme activity evaluated with omeprazole.

  Journal of clinical pharmacy and therapeutics 20090801

• Preclinical assessment of the treatment of second-stage African trypanosomiasis with cordycepin and deoxycoformycin.

  PLoS neglected tropical diseases 20090801

• Toxic epidermal necrolysis and neutropaenia: complications of omeprazole.

  The Australasian journal of dermatology 20090801

• It is premature to recommend low-dose intravenous proton pump inhibition after endoscopic hemostasis in patients with bleeding ulcers.

  The American journal of gastroenterology 20090801

• Long-term use of proton pump inhibitors: are they really safe? A case of delayed acute interstitial nephritis.

  Journal of the American Geriatrics Society 20090801

• Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis.

  Clinics (Sao Paulo, Brazil) 20090801

• Sevelamer reduces the efficacy of many other drugs.

  Prescrire international 20090801

• The Inhibitory Effect of Quercetin-3-O-beta-D-Glucuronopyranoside on Gastritis and Reflux Esophagitis in Rats.

  The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 20090801

• Gastroprotective activity of alkaloid extract and 2-phenylquinoline obtained from the bark of Galipea longiflora Krause (Rutaceae).

  Chemico-biological interactions 20090715

• Esomeprazole for asthma.

  The New England journal of medicine 20090709

• Esomeprazole for asthma.

  The New England journal of medicine 20090709

• Esomeprazole for asthma.

  The New England journal of medicine 20090709

• Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090701

• Transmucosal gastric leak induced by proton pump inhibitors.

  Digestive diseases and sciences 20090701

• Microscopic colitis associated with omeprazole and esomeprazole exposure.

  Journal of clinical gastroenterology 20090701

• Proton pump inhibitors as a treatment method for type II diabetes.

  Medical hypotheses 20090701

• Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study.

  Biomedical chromatography : BMC 20090701

• Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy.

  Gastroenterology 20090701

• The gastric ulcer-healing action of allylpyrocatechol is mediated by modulation of arginase metabolism and shift of cytokine balance.

  European journal of pharmacology 20090701

• Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease.

  European heart journal 20090701

• H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.

  The American journal of gastroenterology 20090701

• Clinical trial: intragastric acid control in patients who have Barrett's oesophagus--comparison of once- and twice-daily regimens of esomeprazole and lansoprazole.

  Alimentary pharmacology & therapeutics 20090701

• Drug-drug interaction between clopidogrel and the proton pump inhibitors.

  The Annals of pharmacotherapy 20090701

• Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat.

  Gastroenterology 20090701

• Do the association of cytochrome P450 interacting drugs, influence clopidogrel efficacity?

  American heart journal 20090701

• Lansoprazole, a Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis Factor-alpha and Interleukin-1beta Induced by Lipopolysaccharide and Helicobacter Pylori Bacterial Components in Human Monocytic Cells via Inhibition of Activation of Nuclear Factor-kappaB and Extracellular Signal-Regulated Kinase.

  Journal of clinical biochemistry and nutrition 20090701

• Variation of the intercellular space in the esophageal epithelium in response to hydrochloridric acid infusion in patients with erosive esophagitis.

  Clinics (Sao Paulo, Brazil) 20090701

• Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma.

  Clinics (Sao Paulo, Brazil) 20090701

• Esophageal trachealization: a feature of eosinophilic esophagitis.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20090701

• Management of acute peptic ulcers: how ethnicity, different proton pump inhibitors and mechanism of delivery alter the equation.

  Journal of gastroenterology and hepatology 20090701

• Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.

  Journal of gastroenterology and hepatology 20090701

• Phytochemical analyses and gastroprotective effects of Eugenia umbelliflora (Myrtaceae) on experimental gastric ulcers.

  Natural product communications 20090701

• Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3'immunoglobulin heavy chain regulatory region.

  Toxicology 20090630

• The anti-ulcer activities of bisabolangelone from Angelica polymorpha.

  Journal of ethnopharmacology 20090622

• Interaction between clopidogrel and proton pump inhibitors.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090609

• Determination of tenatoprazole enantiomers and their enantioselective pharmacokinetics in rats.

  Chirality 20090601

• The use of neem for controlling gastric hyperacidity and ulcer.

  Phytotherapy research : PTR 20090601

• Effects of allicin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes.

  European journal of clinical pharmacology 20090601

• Clinical course of laryngo-respiratory symptoms in gastro-oesophageal reflux disease during routine care--a 5-year follow-up.

  Alimentary pharmacology & therapeutics 20090601

• Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy.

  Gastrointestinal endoscopy 20090601

• Delayed upper gastrointestinal bleeding after laparoscopic treatment of forme fruste choledochal cyst.

  Journal of laparoendoscopic & advanced surgical techniques. Part A 20090601

• Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090601

• Quantitative prediction of in vivo profiles of CYP3A4 induction in humans from in vitro results with a reporter gene assay.

  Drug metabolism and disposition: the biological fate of chemicals 20090601

• Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis--results from the maintenance phase of the EXPO study.

  Alimentary pharmacology & therapeutics 20090601

• Ligand diversity of human and chimpanzee CYP3A4: activation of human CYP3A4 by lithocholic acid results from positive selection.

  Drug metabolism and disposition: the biological fate of chemicals 20090601

• Recent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers.

  Clinical research in cardiology : official journal of the German Cardiac Society 20090601

• Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers.

  The Journal of antimicrobial chemotherapy 20090601

• Proton pump inhibitors and clopidogrel: a difficult dilemma.

  American heart journal 20090601

• Gene expression profiling in rat liver treated with various hepatotoxic-compounds inducing coagulopathy.

  The Journal of toxicological sciences 20090601

• The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis.

  The American journal of gastroenterology 20090601

• Effect of gastric ulceration on physiologic responses to exercise in horses.

  American journal of veterinary research 20090601

• [Clinical observation on transcutaneous electrical acupoint stimulation for treatment of functional dyspepsia].

  Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20090601

• [Pharmacy compounding of an omeprazole suspension].

  Journal de pharmacie de Belgique 20090601

• Case report: peptic ulcer disease in a professional athlete.

  The Physician and sportsmedicine 20090601

• Monoclinic modification of N-[(1,1-dimethyl-ethoxy)carbon-yl]-3-[(R)-prop-2-en-1-ylsulfin-yl]-(R)-alanine ethyl ester at 200 (1) K.

  Acta crystallographica. Section E, Structure reports online 20090601

• Cytochrome P-450 polymorphisms and response to clopidogrel.

  The New England journal of medicine 20090521

• Inactivation by omeprazole of the carnitine transporter (OCTN2) reconstituted in liposomes.

  Chemico-biological interactions 20090515

• Regulation of glycolytic oscillations by mitochondrial and plasma membrane H+-ATPases.

  Biophysical journal 20090506

• Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.

  British journal of cancer 20090505

• The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube.

  European journal of clinical pharmacology 20090501

• Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg.

  Alimentary pharmacology & therapeutics 20090501

• Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis--results from the EXPO study.

  Alimentary pharmacology & therapeutics 20090501

• Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity.

  Experimental neurology 20090501

• Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease.

  Journal of neurology 20090501

• Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial.

  The Journal of antimicrobial chemotherapy 20090501

• Clopidogrel inhibits CYP2C19-dependent hydroxylation of omeprazole related to CYP2C19 genetic polymorphisms.

  Journal of clinical pharmacology 20090501

• Delayed-type hypersensitivity reactions due to sodium lauryl sulphate in omeprazole.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20090501

• Helicobacter pylori infection in patients with chronic urticaria: correlation with pathologic findings in gastric biopsies.

  International journal of dermatology 20090501

• Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.

  Journal of managed care pharmacy : JMCP 20090501

• Effects of omeprazole treatment on nucleoside transporter expression and adenosine uptake in rat gastric mucosa.

  Canadian journal of physiology and pharmacology 20090501

• Sporadic medullary thyroid carcinoma: clinical data from a university hospital.

  Clinics (Sao Paulo, Brazil) 20090501

• [Clinical observation on acupuncture for treatment of chronic atrophic gastritis].

  Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20090501

• Pneumomediastinum, stomach wall and hepatic portal vein gas secondary to partial necrosis of the stomach wall.

  Singapore medical journal 20090501

• Clinical use of pharmacogenomic tests in 2009.

  The Clinical biochemist. Reviews 20090501

• Hypomagnesaemia due to use of proton pump inhibitors--a review.

  The Netherlands journal of medicine 20090501

• [Eosinophilic esophagitis: report of three cases].

  Revista medica de Chile 20090501

• Esophageal candidiasis in an immunocompetent girl.

  World journal of pediatrics : WJP 20090501

• Party pills and drug-drug interactions.

  The New Zealand medical journal 20090424

• Effect of proton pump inhibition on the gastric volume: assessed by magnetic resonance imaging.

  Alimentary pharmacology & therapeutics 20090415

• Efficacy of esomeprazole for treatment of poorly controlled asthma.

  The New England journal of medicine 20090409

• Silent acid reflux and asthma control.

  The New England journal of medicine 20090409

• Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.

  Annals of internal medicine 20090407

• Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.

  Journal of clinical gastroenterology 20090401

• Highly sensitive method for the determination of omeprazole in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study.

  Biomedical chromatography : BMC 20090401

• Levofloxacin, Amoxicillin, and Omeprazole as first-line triple therapy for Helicobacter pylori eradication.

  Journal of clinical gastroenterology 20090401

• Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer.

  International journal of surgery (London, England) 20090401

• Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients.

  Drug metabolism and disposition: the biological fate of chemicals 20090401

• Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori.

  Journal of drug targeting 20090401

• Faster clearance of omeprazole in mutant Nagase analbuminemic rats: possible roles of increased protein expression of hepatic CYP1A2 and lower plasma protein binding.

  Biopharmaceutics & drug disposition 20090401

• Regulation of arginase/nitric oxide synthesis axis via cytokine balance contributes to the healing action of malabaricone B against indomethacin-induced gastric ulceration in mice.

  International immunopharmacology 20090401

• A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country.

  Helicobacter 20090401

• A high-throughput assay using liquid chromatography-tandem mass spectrometry for simultaneous in vivo phenotyping of 5 major cytochrome p450 enzymes in patients.

  Therapeutic drug monitoring 20090401

• Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children.

  Journal of pediatric gastroenterology and nutrition 20090401

• Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial.

  Endoscopy 20090401

• Clopidogrel and proton pump inhibitors: gastric protection at expense of vascular benefit?

  Thrombosis and haemostasis 20090401

• Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.

  Thrombosis and haemostasis 20090401

• The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection.

  European journal of gastroenterology & hepatology 20090401

• Mucosa-associated lymphoid tissue gastric lymphoma regression in a renal transplant patient after conversion of the immunosuppression to sirolimus: a case report.

  Transplantation proceedings 20090401

• The prevalence and clinical characteristics of reflux esophagitis in koreans and its possible relation to metabolic syndrome.

  Journal of Korean medical science 20090401

• Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo.

  Current drug delivery 20090401

• Helicobacter pylori infection in children.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20090401

• Schatzki's Ring in Angelman Syndrome: A Diagnostic Dilemma in Neurodevelopmentally Disabled Patients.

  Journal of clinical medicine research 20090401

• Screening of antibiotics in surface and wastewater samples by ultra-high-pressure liquid chromatography coupled to hybrid quadrupole time-of-flight mass spectrometry.

  Journal of chromatography. A 20090320

• Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model.

  International journal of cancer 20090315

• Omeprazole significantly reduces posaconazole serum trough level.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090315

• Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

  JAMA 20090304

• Efficacy of a new therapeutic regimen versus two routinely prescribed treatments for eradication of Helicobacter pylori: a randomized, double-blind study of doxycycline, co-amoxiclav, and omeprazole in Iranian patients.

  Digestive diseases and sciences 20090301

• Tuberculosis in a patient on temozolomide: a case report.

  Journal of neuro-oncology 20090301

• Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers.

  Antimicrobial agents and chemotherapy 20090301

• Experimental oesophagitis in the rat is associated with decreased voluntary movement.

  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20090301

• Rapid correction of metabolic alkalosis in hypertrophic pyloric stenosis with intravenous cimetidine: preliminary results.

  Pediatric surgery international 20090301

• Using omeprazole to link the components of the post-prandial alkaline tide in the spiny dogfish, Squalus acanthias.

  The Journal of experimental biology 20090301

• Is body mass index really the most important factor determining the healing of reflux esophagitis by esomeprazole?

  The American journal of gastroenterology 20090301

• Effect of proton pump inhibitors on vitamins and iron.

  The American journal of gastroenterology 20090301

• The Calcium Carbonate Breath Test, a noninvasive test of stimulated gastric acid secretion: preliminary communication.

  European journal of gastroenterology & hepatology 20090301

• Relative bioavailability and pharmacokinetic study of omeprazole 20 mg enteric-coated tablet in healthy Bangladeshi volunteers.

  International journal of clinical pharmacology and therapeutics 20090301

• Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication.

  The Netherlands journal of medicine 20090301

• Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.

  Journal of clinical biochemistry and nutrition 20090301

• Evaluation of use of proton pump inhibitors in Greece.

  European journal of internal medicine 20090301

• Acute gastroduodenal injury after ingestion of diluted herbicide pendimethalin.

  Singapore medical journal 20090301

• Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection.

  British journal of clinical pharmacology 20090301

• Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis.

  World journal of gastroenterology 20090227

• PPI interactions with clopidogrel revisited.

  The Medical letter on drugs and therapeutics 20090223

• Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor.

  Biochemical pharmacology 20090215

• Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes.

  Toxicology and applied pharmacology 20090215

• Effects of omeprazole on plasma levels of raltegravir.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090215

• Analysis of omeprazole and its main metabolites by liquid chromatography using hybrid micellar mobile phases.

  Analytica chimica acta 20090209

• In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20090201

• Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.

  Journal of clinical gastroenterology 20090201

• N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.

  The Journal of pharmacology and experimental therapeutics 20090201

• Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.

  Journal of clinical pharmacy and therapeutics 20090201

• Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.

  Journal of clinical pharmacy and therapeutics 20090201

• Antiulcerogenic and anti-inflammatory activities of the essential oil from Pterodon emarginatus seeds.

  The Journal of pharmacy and pharmacology 20090201

• Design and in vitro/in vivo evaluation of multi-layer film coated pellets for omeprazole.

  Chemical & pharmaceutical bulletin 20090201

• Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients.

  International journal of clinical practice 20090201

• Esomeprazole: a proton pump inhibitor.

  Expert review of gastroenterology & hepatology 20090201

• Osteomalacia and vitamin D deficiency in the elderly.

  Clinics (Sao Paulo, Brazil) 20090201

• [Antiangiogenic activity of thalidomide in vitro mediated by cytochrome CYP2C19].

  Zhongguo shi yan xue ye xue za zhi 20090201

• After move to tier 3, Nexium scripts fall 25%.

  Managed care (Langhorne, Pa.) 20090201

• Medications as a potential source of exposure to phthalates in the U.S. population.

  Environmental health perspectives 20090201

• [Medical treatment efficient in chronic reflux. Also surgery has a given place in long-term therapy--for certain patients].

  Lakartidningen 20090201

• [Pepsin immunoassay in the sputum for detection of laryngopharyngeal reflux].

  Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 20090201

• [A pilot study on the diagnosis of laryngopharyngeal reflux diseases].

  Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 20090201

• [Therapy of gastric acid-induced illnesses in general practice. The first pantoprazole generic drug has arrived].

  MMW Fortschritte der Medizin 20090129

• Physico-chemical solid-state characterization of omeprazole sodium: thermal, spectroscopic and crystallinity studies.

  Journal of pharmaceutical and biomedical analysis 20090115

• Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats.

  Regulatory peptides 20090108

• Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD.

  Journal of clinical epidemiology 20090101

• Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole.

  Digestive diseases and sciences 20090101

• A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children.

  Acta paediatrica (Oslo, Norway : 1992) 20090101

• Optimal dose regimens of esomeprazole for gastric acid suppression with minimal influence of the CYP2C19 polymorphism.

  European journal of clinical pharmacology 20090101

• Cost analysis of long-term treatment of patients with symptomatic gastroesophageal reflux disease (GERD) with esomeprazole on-demand treatment or esomeprazole continuous treatment: an open, randomized, multicenter study in Switzerland.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101

• Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH.

  European journal of clinical pharmacology 20090101

• Impact of CYP2C19 polymorphisms on the clinical action of proton pump inhibitors (PPIs).

  European journal of clinical pharmacology 20090101

• Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia.

  Gastroenterology 20090101

• Increase in vertebral fracture risk in postmenopausal women using omeprazole.

  Calcified tissue international 20090101

• Prognostic value of circulating chromogranin A levels in acute coronary syndromes.

  European heart journal 20090101

• Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy.

  British journal of clinical pharmacology 20090101

• Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel.

  American heart journal 20090101

• Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.

  The American journal of gastroenterology 20090101

• [MALT lymphoma of the rectum: a case report treated by radiotherapy].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20090101

• Probable trimethoprim/sulfamethoxazole-induced higher-level gait disorder and nocturnal delirium in an elderly man.

  The Annals of pharmacotherapy 20090101

• The Australian rise of esomeprazole-was expenditure on samples a contributor?

  Pharmacoepidemiology and drug safety 20090101

• Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary.

  Journal of managed care pharmacy : JMCP 20090101

• Death following bilateral complete Achilles tendon rupture in a patient on fluoroquinolone therapy: a case report.

  Journal of medical case reports 20090101

• Probe for label-free quantitative analysis in liquid chromatography/mass spectrometry.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20090101

• Cough in adult cystic fibrosis: diagnosis and response to fundoplication.

  Cough (London, England) 20090101

• Exogenous luminal nitric oxide exacerbates esophagus tissue damage in a reflux esophagitis model of rats.

  Scandinavian journal of gastroenterology 20090101

• Hepatitis following famotidine: a case report.

  Cases journal 20090101

• Proton pump inhibitors for prevention of bleeding episodes in cardiac patients with dual antiplatelet therapy - between Scylla and Charybdis?

  International journal of clinical pharmacology and therapeutics 20090101

• Pharmacokinetics and bioequivalence of 20 mg omeprazole capsule in 24 healthy Korean male volunteers.

  International journal of clinical pharmacology and therapeutics 20090101

• Chemoprevention of oesophageal cancer and the AspECT trial.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20090101

• Alternative vs. conventional treatment given on-demand for gastroesophageal reflux disease: a randomised controlled trial.

  BMC complementary and alternative medicine 20090101

• Systematic review on quality control for drug management programs: is quality reported in the literature?

  BMC health services research 20090101

• APC sensitive gastric acid secretion.

  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20090101

• Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.

  Wiener klinische Wochenschrift 20090101

• Raltegravir, elvitegravir, and metoogravir: the birth of 'me-too' HIV-1 integrase inhibitors.

  Retrovirology 20090101

• Spectrophotometric and chromatographic determination of omeprazole in pharmaceutical formulations.

  Pharmaceutical development and technology 20090101

• Does treatment with proton pump inhibitors for gastroesophageal reflux disease (GERD) improve asthma symptoms in children with asthma and GERD? A systematic review.

  Journal of investigational allergology & clinical immunology 20090101

• Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors.

  Journal of investigational allergology & clinical immunology 20090101

• Hypersensitivity reaction to omeprazole in a child.

  Journal of investigational allergology & clinical immunology 20090101

• Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.

  Journal of gastroenterology 20090101

• Chronic cough and laryngeal dysfunction improve with specific treatment of cough and paradoxical vocal fold movement.

  Cough (London, England) 20090101

• Intravenous proton pump inhibitors: an evidence-based review of their use in gastrointestinal disorders.

  Drugs 20090101

• The transferome of metabolic genes explored: analysis of the horizontal transfer of enzyme encoding genes in unicellular eukaryotes.

  Genome biology 20090101

• Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.

  BMC gastroenterology 20090101

• Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.

  The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20090101

• Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin's lymphoma or multiple myeloma.

  Clinical pharmacokinetics 20090101

• [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].

  Khirurgiia 20090101

• Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers.

  Journal of gastroenterology 20090101

• Helicobacter pylori related dyspepsia: prevalence and treatment outcomes at University Kebangsaan Malaysia-Primary Care Centre.

  Asia Pacific family medicine 20090101

• Treatment and chemoprevention of NSAID-associated gastrointestinal complications.

  Therapeutics and clinical risk management 20090101

• Role of atazanavir in the treatment of HIV infection.

  Therapeutics and clinical risk management 20090101

• Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review.

  Paediatric drugs 20090101

• Maintenance therapy of gastroesophageal reflux disease patients with omeprazole.

  Hepato-gastroenterology 20090101

• Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication.

  BMC gastroenterology 20090101

• [Analysis of prescriptions given on discharge from the emergencies department. Economic impact].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101

• [Stevens-Johnson syndrome and toxic hepatitis due to esomeprazole].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101

• Proton pump inhibitors exert anti-allergic effects by reducing TCTP secretion.

  PloS one 20090101

• Application of a stability-indicating thin-layer chromatographic method to the determination of tenatoprazole in pharmaceutical dosage forms.

  Journal of AOAC International 20090101

• Afferent signalling from the acid-challenged rat stomach is inhibited and gastric acid elimination is enhanced by lafutidine.

  BMC gastroenterology 20090101

• Bioequivalence and pharmacokinetic study of two different omeprazole capsule formulations in healthy Bangladeshi volunteers.

  Arzneimittel-Forschung 20090101

• Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

  BMC cancer 20090101

• Suppressive effect of sulindac on branch duct-intraductal papillary mucinous neoplasms.

  Journal of gastroenterology 20090101

• Relevance of metabolic activation pathways: the example of clopidogrel and prasugrel.

  Arzneimittel-Forschung 20090101

• [Eradication therapy and processes of proliferation and apoptosis in the stomach of patients with duodenal ulcer].

  Klinicheskaia meditsina 20090101

• Improving quality of magnetic resonance cholangiopancreaticography: esomeprazole versus ranitidine.

  Hepato-gastroenterology 20090101

• Duodenal bulb mucosa with hypertrophic gastric oxyntic heterotopia in patients with zollinger ellison syndrome.

  Diagnostic and therapeutic endoscopy 20090101

• Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.

  BMJ (Clinical research ed.) 20090101

• Influences of CYP2C19 polymorphism on recurrence of reflux esophagitis during proton pump inhibitor maintenance therapy.

  Hepato-gastroenterology 20090101

• Azithromycin effect on helicobacter pylori eradication: double blind randomized clinical trial.

  Hepato-gastroenterology 20090101

• Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice.

  BMC gastroenterology 20090101

• Proton pump inhibitors--their pharmacological impact on the clinical management of acid-related disorders.

  Arzneimittel-Forschung 20090101

• Effect of addition of vitamin C to clarithromycin-amoxicillin-omeprazol triple regimen on Helicobacter pylori eradication.

  Acta gastro-enterologica Belgica 20090101

• Laparoscopic repair for perforated peptic ulcers with U-CLIP(R).

  World journal of emergency surgery : WJES 20090101

• High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study.

  Digestion 20090101

• Pulmonary manifestations of gastroesophageal reflux disease.

  Annals of thoracic medicine 20090101

• [Complex metabolic disorders revealing a gastric ulcer of the bulb. A case report].

  Annales de biologie clinique 20090101

• Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study.

  BMJ (Clinical research ed.) 20090101

• [Combined treatment of gastric ulcers induced by nonsteroid antiinflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate].

  Terapevticheskii arkhiv 20090101

• [Antihelicobacteric therapy for the patients with recurrent complicated postoperative gastroduodenal ulcer: indications, principles of conduction, efficacy].

  Klinichna khirurhiia 20090101

• Immunotherapy of head and neck cancer: current and future considerations.

  Journal of oncology 20090101

• Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.

  International journal of chronic obstructive pulmonary disease 20090101

• [Effect of eradication therapy on nitrogen oxide activity in the gastric juice of patients with chronic gastritis and ulcer disease].

  Klinicheskaia meditsina 20090101

• Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

  Therapeutics and clinical risk management 20090101

• Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir.

  Therapeutics and clinical risk management 20090101

• Short bowel patients treated for two years with glucagon-like Peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function.

  Gastroenterology research and practice 20090101

• Pioglitazone induced gastric acid secretion.

  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20090101

• Esomeprazole for the management of upper gastrointestinal symptoms in patients who require NSAIDs: a review of the NASA and SPACE double-blind, placebo-controlled studies.

  Clinical drug investigation 20090101

• Interactions between herbal medicines and prescribed drugs: an updated systematic review.

  Drugs 20090101

• Five-Year Long-Term Followup of a Primary Lymph node Gastrinoma: Is a Pancreaticoduodenectomy Justified?

  Case reports in medicine 20090101

• Palliation with oesophageal metal stent of pseudoachalasia from gastric carcinoma at the cardia: a case report.

  Diagnostic and therapeutic endoscopy 20090101

• Role of rasagiline in treating Parkinson's disease: Effect on disease progression.

  Therapeutics and clinical risk management 20090101

• Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin.

  PloS one 20090101

• [Why some proton pump inhibitors are more equal than others].

  Nederlands tijdschrift voor geneeskunde 20090101

• Esophageal leiomyomatosis combined with intrathoracic stomach and gastric volvulus.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20090101

• Patient risk factors and adverse drug interactions in the treatment of acute gouty arthritis in the elderly: a case report.

  Cases journal 20090101

• Atypical presentation of an oesophageal carcinoma with metastases to the left buttock: a case report.

  Cases journal 20090101

• Anaesthetic management of an adult patient with DOOR syndrome: a case report.

  Cases journal 20090101

• Patient satisfaction with switching to esomeprazole from existing proton pump inhibitor therapy for gastro-oesophageal reflux disease: an observational, multicentre study.

  Clinical drug investigation 20090101

• [Esomeprazole based triple therapy for the eradication of helicobacter pylori in patients with non-ulcer dyspepsia].

  Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20090101

• Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

  Vascular health and risk management 20090101

• Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles.

  Arthritis research & therapy 20090101

• The effect of moxidectin 0,1% vs ivermectin 0,08% on milk production in sheep naturally infected by gastrointestinal nematodes.

  BMC veterinary research 20090101

• Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis.

  BMC urology 20090101

• A patient with osteoarthritis and cardiovascular disease presenting with bilateral hip pain: a case report.

  Cases journal 20090101

• Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study.

  BMC gastroenterology 20090101

• [Study of gene polymorphism responsible for metabolism of proton pump inhibitors in children with H. pylori infection: is there a correlation with efficacy of eradication treatment?].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101

• [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].

  Nederlands tijdschrift voor geneeskunde 20090101

• Simultaneous determination of omeprazole and domperidone in dog plasma by LC-MS method.

  Journal of chromatographic science 20090101

• Proton pump inhibitors and pain.

  Pain physician 20090101

• Drospirenone/ethinyl estradiol 3 mg/20 mug (24/4 day regimen): hormonal contraceptive choices - use of a fourth-generation progestin.

  Patient preference and adherence 20090101

• Negative chronotropic effect of proton pump inhibitors on frog-heart preparation.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20090101

• Pantoprazole: a proton pump inhibitor.

  Clinical drug investigation 20090101

• A rare case of supraventricular tachycardia induced by Infliximab: a case report.

  Cases journal 20090101

• Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.

  BMC medical genetics 20090101

• [Effect of components and some protocols of anti-ulcer therapy on content and activity of monooxigenase system enzymes of the stomach mucosa in experimental stomach ulcer].

  Likars'ka sprava 20090101

• Drug-drug interactions with raltegravir.

  European journal of medical research 20090101

• Aspirin resistance.

  Advances in hematology 20090101

• The effect of Acid-reducing pharmacotherapy on the severity of nausea and vomiting of pregnancy.

  Obstetrics and gynecology international 20090101

• Drug-induced hematologic syndromes.

  Advances in hematology 20090101

• [Comparative evaluation of the omeprasol and pantoprasol efficacy in treatment of gastropathy induced by non-steroid anti-inflammatory drugs in the patients with rheumatoid arthritis].

  Likars'ka sprava 20090101

• [Omeprazol and ezomeprazol pharmacokinetics, duration of antisecretory effect, and reasons for their probable changes in duodenal ulcer].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101

• [Effect of CYP2C19 gene polymorphism on eradication treatment efficacy of Helicobacter pylori infection].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101

• Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.

  Neuropsychiatric disease and treatment 20090101

• Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.

  Vascular health and risk management 20090101

• Fast track liver resection: the effect of a comprehensive care package and analgesia with single dose intrathecal morphine with gabapentin or continuous epidural analgesia.

  HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 20090101

• Enhanced Interaction between Warfarin and High-Dose Ketoconazole: A Case Report.

  Case reports in medicine 20090101

• Position-dependent urinary retention in a traumatic brain injury patient: a case report.

  Cases journal 20090101

• Intramural duodenal hematoma and hemoperitoneum after endoscopic treatment in a patient with chronic renal failure on hemodialysis: a case report.

  Cases journal 20090101

• Lanthanum associated abnormal liver function tests in two patients on dialysis: a case report.

  Journal of medical case reports 20090101

• Ceftriaxone-induced toxic epidermal necrolysis mimicking burn injury: a case report.

  Journal of medical case reports 20090101

• Peptic ulcer bleeding following therapeutic endoscopy: a new indication for intravenous esomeprazole.

  Reviews in gastroenterological disorders 20090101

• Urticaria and infections.

  Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20090101

• Gastroesophageal reflux disease: medical or surgical treatment?

  Gastroenterology research and practice 20090101

• [Posterior gastric wall ulceration as a complication of percutaneous endoscopic gastrostomy. A report of 2 cases].

  Medycyna wieku rozwojowego 20090101

• An unusual presentation of metastatic adenocarcinoma of lung: a case report.

  Cases journal 20090101

• Long-term survival in a patient with carcinoid syndrome receiving treatment for Zollinger-Ellison syndrome.

  International surgery 20090101

• Fish faddism causing low-level mercury poisoning in the Caribbean: two case reports.

  Cases journal 20090101

• New sensitive kinetic spectrophotometric methods for determination of omeprazole in dosage forms.

  International journal of analytical chemistry 20090101

• Long-Term Alendronate Use Not without Consequences?

  International journal of rheumatology 20090101

• Usefulness of assessment of voice capabilities in female patients with reflux-related dysphonia.

  Medicina (Kaunas, Lithuania) 20090101

• Nadroparine-induced skin necrosis on a patient with essential thrombocythaemia: a case report.

  Cases journal 20090101

• [Effectiveness of Ultop 10 mg using at treatment of functional (nonulcer) dyspepsia syndrome].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101

• [Usage of Nexium (ezomeprazole) at children with acid depended inflammatory diseases of upper gastrointestinal tract].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101

• [Comparative study of esomeprazole and omeprazole using for initialism therapy for elderly-senile and young-adulthood patients with GERD].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101

• Acute perforated duodenal ulcer in Maiduguri: experience with simple closure and Helicobacter pylori eradication.

  West African journal of medicine 20090101

• Protective Effect of Ginger oil on Aspirin and Pylorus Ligation-Induced Gastric Ulcer model in Rats.

  Indian journal of pharmaceutical sciences 20090101

• Anesthesia for subglottic stenosis in pediatrics.

  Saudi journal of anaesthesia 20090101

• Drugs impact on CYP-450 enzyme family: A pharmacogenetical study of response variation.

  Indian journal of human genetics 20090101

• Raltegravir: The evidence of its therapeutic value in HIV-1 infection.

  Core evidence 20090101

• Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection.

  Core evidence 20090101

• Recent advances in peptic ulcer bleeding.

  F1000 medicine reports 20090101

• Diffuse panbronchiolitis: not just an Asian disease: Australian case series and review of the literature.

  Biomedical imaging and intervention journal 20090101

• Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors.

  Drug, healthcare and patient safety 20090101

• Nutritional muscular dystrophy in a four-day-old Connemara foal.

  Irish veterinary journal 20090101

• Comparative bioavailability of two oral formulations of omeprazole.

  Proceedings of the Western Pharmacology Society 20090101

• Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2 microm particle size column.

  Journal of chromatography. A 20081226

• Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection.

  Digestive diseases and sciences 20081201

• A glass of water immediately increases gastric pH in healthy subjects.

  Digestive diseases and sciences 20081201

• Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects.

  European journal of clinical pharmacology 20081201

• Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase.

  Alimentary pharmacology & therapeutics 20081201

• A rapid lateral flow stool antigen immunoassay and (14)C-urea breath test for the diagnosis and eradication of Helicobacter pylori infection in children.

  Diagnostic microbiology and infectious disease 20081201

• Hydroxychloroquine-induced hyperpigmentation: the staining pattern.

  Journal of cutaneous pathology 20081201

• Gastroesophageal scintigraphy in the evaluation of adult patients with chronic cough due to gastroesophageal reflux disease.

  Nuclear medicine communications 20081201

• Myristica malabarica heals stomach ulceration by increasing prostaglandin synthesis and angiogenesis.

  Planta medica 20081201

• Man better man: the politics of disappearance.

  Studies in history and philosophy of biological and biomedical sciences 20081201

• Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice.

  Comparative medicine 20081201

• Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.

  Helicobacter 20081201

• The effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitor.

  International journal of clinical practice 20081201

• Toward achieving optimal response: understanding and managing antidepressant side effects.

  Dialogues in clinical neuroscience 20081201

• [Drugs used in bone marrow transplantation: a study about combinations of antimicrobial potentially interactives].

  Revista da Escola de Enfermagem da U S P 20081201

• A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.

  Journal of vector borne diseases 20081201

• Impact of PPIs on patient focused symptomatology in GERD.

  Therapeutics and clinical risk management 20081201

• Effects of treatment with antimicrobial agents on the human colonic microflora.

  Therapeutics and clinical risk management 20081201

• Effect of feeding nitrite, ascorbate, hemin, and omeprazole on excretion of fecal total apparent N-nitroso compounds in mice.

  Chemical research in toxicology 20081201

• [Proton pump inhibition: more than only reflux therapy].

  MMW Fortschritte der Medizin 20081113

• Development and validation of an improved high-throughput method for the determination of anastrozole in human plasma by LC-MS/MS and atmospheric pressure chemical ionization.

  Journal of pharmaceutical and biomedical analysis 20081104

• Acute gastrointestinal bleeding. Firstly, improve availability of endoscopy.

  BMJ (Clinical research ed.) 20081103

• Symptom-focused results after laparoscopic fundoplication for refractory gastroesophageal reflux disease--a prospective study.

  Langenbeck's archives of surgery 20081101

• Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.

  The Journal of laryngology and otology 20081101

• Biochemical mechanism of healing activity of the natural phenolic, allylpyrocatechol against indomethacin-induced gastric ulceration in mice.

  Digestive diseases and sciences 20081101

• Enantioseparation of omeprazole and its metabolite 5-hydroxyomeprazole using open tubular capillary electrochromatography with immobilized avidin as chiral selector.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081101

• [Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism?].

  Annales d'endocrinologie 20081101

• Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol.

  Clinical pharmacology and therapeutics 20081101

• Causal relationship of Helicobacter pylori with iron-deficiency anemia or failure of iron supplementation in children.

  Gastroenterology 20081101

• Omeprazole alleviates benzo[a]pyrene cytotoxicity by inhibition of CYP1A1 activity in human and mouse hepatoma cells.

  Basic & clinical pharmacology & toxicology 20081101

• Analyses of CYP2C in porcine microsomes.

  Basic & clinical pharmacology & toxicology 20081101

• A K(+)/H (+) P-ATPase transport in the accessory cell membrane of the blowfly taste chemosensilla sustains the transepithelial potential.

  Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology 20081101

• Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2. Use of intravenous omeprazole in gastrointestinal patients before endoscopy.

  Emergency medicine journal : EMJ 20081101

• Comparison of inducibility of multidrug resistance (MDR)1, multidrug resistance-associated protein (MRP)1, and MRP2 mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes.

  Biological & pharmaceutical bulletin 20081101

• Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori.

  Journal of drug targeting 20081101

• [Streptococcus pneumoniae infection: cause or consequence of pulmonary alveolar proteinosis?].

  Archivos de bronconeumologia 20081101

• Successful treatment of gastric perforation with thyrotoxic crisis.

  The American journal of emergency medicine 20081101

• (E)-1,1'-Bis[(E)-but-2-en-yl]-3,3'-(propane-1,3-di-yl)bis-(1H-benzimidazol-3-ium) dibromide monohydrate.

  Acta crystallographica. Section E, Structure reports online 20081101

• Bravo capsule system optimizes intragastric pH monitoring over prolonged time: effects of ghrelin on gastric acid and hormone secretion in the rat.

  World journal of gastroenterology 20081028

• Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease.

  World journal of gastroenterology 20081028

• CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype.

  British journal of cancer 20081021

• Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead.

  Bioorganic & medicinal chemistry letters 20081015

• Proton-pump inhibitors in peptic ulcer disease.

  Lancet (London, England) 20081004

• [Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts].

  MMW Fortschritte der Medizin 20081002

• Acid reflux into the oesophagus does not influence exercise-induced airway narrowing in bronchial asthma.

  British journal of sports medicine 20081001

• The effect of Helicobacter pylori eradication treatment on the MUC 1 and Lewis antigens level in human gastric juice: a preliminary study.

  Digestive diseases and sciences 20081001

• A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers.

  British journal of clinical pharmacology 20081001

• [General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study].

  Presse medicale (Paris, France : 1983) 20081001

• Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin.

  Naunyn-Schmiedeberg's archives of pharmacology 20081001

• Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.

  The American journal of gastroenterology 20081001

• Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20081001

• Heterogeneity of acid secretion induced by carbachol and histamine along the gastric gland axis and its relationship to [Ca2+]i.

  American journal of physiology. Gastrointestinal and liver physiology 20081001

• Involvement of CREM in CYP1A1 induction through ligand-independent activation pathway of aryl hydrocarbon receptor in HepG2 cells.

  Archives of biochemistry and biophysics 20081001

• Medical or surgical management of GERD patients with Barrett's esophagus: the LOTUS trial 3-year experience.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20081001

• Helicobacter infection decreases reproductive performance of IL10-deficient mice.

  Comparative medicine 20081001

• Effects of helicobacter pylori eradication on chronic nonspecific pharyngeal symptoms.

  Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 20081001

• [Effect of cytochrome CYP2C19 on the anti-myeloma activity of thalidomide in vitro].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20081001

• 1,3-Bis(3-phenyl-prop-yl)benzimidazolium bromide monohydrate.

  Acta crystallographica. Section E, Structure reports online 20081001

• Gastrointestinal pharmacology.

  Indian journal of pharmacology 20081001

• Miscellaneous.

  Indian journal of pharmacology 20081001

• Regulation of the nitric oxide synthesis pathway and cytokine balance contributes to the healing action of Myristica malabarica against indomethacin-induced gastric ulceration in mice.

  Drug discoveries & therapeutics 20081001

• Compatibility studies between mannitol and omeprazole sodium isomers.

  Journal of pharmaceutical and biomedical analysis 20080929

• Esophageal ulceration from high-intensity focused US catheter ablation for pulmonary vein isolation: a novel complication in the treatment of symptomatic refractory atrial fibrillation.

  Gastrointestinal endoscopy 20080901

• Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial.

  Gut 20080901

• Important amino acid residues that confer CYP2C19 selective activity to CYP2C9.

  Journal of biochemistry 20080901

• Assessment of chemical effects on neurite outgrowth in PC12 cells using high content screening.

  Toxicological sciences : an official journal of the Society of Toxicology 20080901

• Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers.

  European journal of clinical pharmacology 20080901

• Ischemia mobilizes histamine but not pancreastatin from ECL cells of rat stomach: evidence for a cytosolic histamine compartment.

  Cell and tissue research 20080901

• Physical and chemical stability of esomeprazole sodium solutions.

  The Annals of pharmacotherapy 20080901

• What is new in the management of Helicobacter pylori?

  Irish journal of medical science 20080901

• IgE-mediated anaphylaxis to proton pump inhibitors - cross-reacting study.

  Allergy 20080901

• Body mass index can determine the healing of reflux esophagitis with Los Angeles Grades C and D by esomeprazole.

  The American journal of gastroenterology 20080901

• Acetaminophen-induced, not desflurane-induced, hepatotoxicity.

  Anesthesiology 20080901

• Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20080901

• Treatment of non-cardiac chest pain.

  Disease-a-month : DM 20080901

• Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20080901

• A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure.

  Clinical therapeutics 20080901

• Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

  Biologics : targets & therapy 20080901

• Ulcer preventive and antioxidative properties of astaxanthin from Haematococcus pluvialis.

  European journal of pharmacology 20080820

• Preparation of esomeprazole zinc solid dispersion and study on its pharmacokinetics.

  International journal of pharmaceutics 20080806

• Laparoscopic partial posterior (Toupet) fundoplication improves esophageal bolus propagation on scintigraphy.

  Surgical endoscopy 20080801

• Severe hypomagnesaemia in long-term users of proton-pump inhibitors.

  Clinical endocrinology 20080801

• Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study.

  Digestive diseases and sciences 20080801

• Stages of motor output reorganization after hemispheric stroke suggested by longitudinal studies of cortical physiology.

  Cerebral cortex (New York, N.Y. : 1991) 20080801

• Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus.

  Gut 20080801

• Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report.

  Pharmacy world & science : PWS 20080801

• Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.

  Gut 20080801

• Minimal-change esophagitis on narrow-band imaging.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080801

• Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7-day triple therapy with regular proton pump inhibitor dosage.

  Journal of gastroenterology and hepatology 20080801

• Inhibition of H+/K+ ATPase in the gastroprotective effect of Baccharis illinita DC.

  The Journal of pharmacy and pharmacology 20080801

• Is there a role for intravenous omeprazole in patients with duodenal diverticular bleeding after successful initial endoscopic hemostasis?

  Gastrointestinal endoscopy 20080801

• Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.

  Helicobacter 20080801

• [Extraesophageal manifestations of gastroesophageal reflux disease].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080801

• [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080801

• Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice.

  Scandinavian journal of gastroenterology 20080801

• The use of calcium and vitamin D in the management of osteoporosis.

  Therapeutics and clinical risk management 20080801

• Ethyl 4-(tert-butyl-amino)-3-nitro-benzoate.

  Acta crystallographica. Section E, Structure reports online 20080801

• Effect of quercetin, flavonoids and alpha-tocopherol, an antioxidant vitamin, on experimental reflux oesophagitis in rats.

  European journal of pharmacology 20080728

• Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion.

  European journal of pharmacology 20080728

• Dilated intercellular spaces in gastroesophageal reflux disease patients and the changes of intercellular spaces after omeprazole treatment.

  Chinese medical journal 20080720

• Omeprazole and refractory hypomagnesaemia.

  BMJ (Clinical research ed.) 20080719

• Endoscopic findings and Helicobacter pylori in children on long-term hemodialysis.

  Pakistan journal of biological sciences : PJBS 20080715

• The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease--a randomised, double-blind, placebo controlled, crossover trial.

  International journal of cardiology 20080704

• 'Poppy seeds' in stomach aspirates: is oral omeprazole extemporaneous dispersion bioavailable?

  European journal of pediatrics 20080701

• Angiogenic and cell proliferating action of the natural diarylnonanoids, malabaricone B and malabaricone C during healing of indomethacin-induced gastric ulceration.

  Pharmaceutical research 20080701

• Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.

  Journal of clinical gastroenterology 20080701

• Postoperative severe uvular edema following tonsillectomy in a child with a history of obstructive sleep apnea.

  Paediatric anaesthesia 20080701

• Effect of some natural products either alone or in combination on gastritis induced in experimental rats.

  Digestive diseases and sciences 20080701

• Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and cytochrome P450 phenotypic data. III. In vitro-in vivo correlation with fluconazole.

  Drug metabolism and disposition: the biological fate of chemicals 20080701

• Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and cytochrome P450 phenotypic data. II. In vitro-in vivo correlation with ketoconazole.

  Drug metabolism and disposition: the biological fate of chemicals 20080701

• Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.

  Drug metabolism and disposition: the biological fate of chemicals 20080701

• Protective effects of vitamin E and omeprazole on the hypoxia/reoxygenation induced intestinal injury in newborn rats.

  Pediatric surgery international 20080701

• Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z.

  Alimentary pharmacology & therapeutics 20080701

• Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.

  Alimentary pharmacology & therapeutics 20080701

• Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements.

  Biochemical pharmacology 20080701

• Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite detection.

  Rapid communications in mass spectrometry : RCM 20080701

• Simultaneous determination of macrolides, sulfonamides, and other pharmaceuticals in water samples by solid-phase extraction and LC-(ESI) MS.

  Journal of separation science 20080701

• Rapid screening of glutathione-trapped reactive metabolites by linear ion trap mass spectrometry with isotope pattern-dependent scanning and postacquisition data mining.

  Chemical research in toxicology 20080701

• Faster clearance of omeprazole in rats with acute renal failure induced by uranyl nitrate: contribution of increased expression of hepatic cytochrome P450 (CYP) 3A1 and intestinal CYP1A and 3A subfamilies.

  The Journal of pharmacy and pharmacology 20080701

• Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy.

  The American journal of gastroenterology 20080701

• Omeprazole, lansoprazole and pantoprazole had no effect on blood pressure and electrocardiogram of anesthetized rat.

  Pharmacological research 20080701

• Changes in gene expression of gastric mucosa during therapeutic acid inhibition.

  European journal of gastroenterology & hepatology 20080701

• By the way, doctor. I was treated for two weeks with antibiotics and a proton pump inhibitor when I had an H.pylori infection. I've continued with the proton inhibitor to cut down on stomach acid. Could that be harmful?

  Harvard health letter 20080701

• [Preparation and dissolution in vitro of esomeprazole zinc solid dispersion].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20080701

• Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).

  Journal of medicinal chemistry 20080612

• Pharmacokinetics and safety of saquinavir/ritonavir and omeprazole in HIV-infected subjects.

  Clinical pharmacology and therapeutics 20080601

• Omeprazole-associated changes in the gastric mucosa of children.

  Journal of clinical pathology 20080601

• Clinical review: gastrointestinal bleeding after percutaneous coronary intervention: a deadly combination.

  QJM : monthly journal of the Association of Physicians 20080601

• Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMs.

  European journal of clinical pharmacology 20080601

• Standardization of surgical technique in antireflux surgery: the LOTUS Trial experience.

  World journal of surgery 20080601

• Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia.

  Pharmacoepidemiology and drug safety 20080601

• Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction.

  Drug metabolism and disposition: the biological fate of chemicals 20080601

• Population pharmacokinetics of infliximab in patients with ankylosing spondylitis.

  Journal of clinical pharmacology 20080601

• Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding.

  Gastrointestinal endoscopy 20080601

• Preformulation considerations for controlled release dosage forms. Part II. Selected candidate support.

  AAPS PharmSciTech 20080601

• Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients.

  European journal of gastroenterology & hepatology 20080601

• Hyponatremia associated with tolterodine therapy.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080601

• Anaphylactic reaction to omeprazole.

  The American journal of gastroenterology 20080601

• The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazole.

  Therapeutic drug monitoring 20080601

• Esomeprazole in acute and maintenance treatment of reflux oesophagitis: a multicentre prospective study.

  Advances in therapy 20080601

• Drug-induced immune thrombocytopenic purpura secondary to sunitinib.

  Current oncology (Toronto, Ont.) 20080601

• Omeprazole in infants 3 to 12 months old.

  Current gastroenterology reports 20080601

• Omeprazole in preterm infants.

  Current gastroenterology reports 20080601

• Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical.

  The AAPS journal 20080601

• [Upper gastrointestinal bleeding of infrequent cause].

  Acta gastroenterologica Latinoamericana 20080601

• [High intestinal haemorrhage in patient with Schöelin-Henoch purpura].

  Anales de medicina interna (Madrid, Spain : 1984) 20080601

• Evalution of anti-ulcer activity of Polyalthia longifolia (Sonn.) Thwaites in experimental animals.

  Indian journal of pharmacology 20080601

• [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].

  Zhonghua yi xue za zhi 20080527

• Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity?

  World journal of gastroenterology 20080514

• Chronic ulcerative gastroduodenitis as a first gastrointestinal manifestation of Hermansky-Pudlak syndrome in a 10-year-old child.

  World journal of gastroenterology 20080514

• Multimilligram enantioresolution of sulfoxide proton pump inhibitors by liquid chromatography on polysaccharide-based chiral stationary phase.

  Journal of pharmaceutical and biomedical analysis 20080512

• Differential expression of syndecans and glypicans in chronically inflamed synovium.

  Annals of the rheumatic diseases 20080501

• Helicobacter pylori recurrence and infection rate in Israeli adults.

  Digestive diseases and sciences 20080501

• Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial.

  American journal of hematology 20080501

• A first Portuguese epidemiological survey of fungaemia in a university hospital.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20080501

• Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians.

  British journal of clinical pharmacology 20080501

• Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080501

• Treating common problems of the nose and throat in pregnancy: what is safe?

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20080501

• Generation of mice transgenic for human CYP2C18 and CYP2C19: characterization of the sexually dimorphic gene and enzyme expression.

  Drug metabolism and disposition: the biological fate of chemicals 20080501

• Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers.

  British journal of clinical pharmacology 20080501

• Biochemical and histopathologic effects of omeprazole and vitamin E in rats with corrosive esophageal burns.

  Pediatric surgery international 20080501

• Randomised comparison of the FerX Ella antireflux stent and the ultraflex stent: proton pump inhibitor combination for prevention of post-stent reflux in patients with esophageal carcinoma involving the esophago-gastric junction.

  Journal of gastroenterology and hepatology 20080501

• Proton pump inhibitor-induced rhabdomyolysis and hyponatremic delirium.

  The American journal of emergency medicine 20080501

• Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis.

  Scandinavian journal of gastroenterology 20080501

• Omeprazole promotes gastric epithelial cell migration.

  The Journal of pharmacy and pharmacology 20080501

• Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir.

  Journal of clinical pharmacology 20080501

• Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.

  Cancer research 20080501

• Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.

  The American journal of gastroenterology 20080501

• [Acute generalized exanthematous pustulosis induced by omeprazole].

  Gastroenterologia y hepatologia 20080501

• [Stress ulcer prophylaxis in septic patients. Evidence-based overview].

  Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20080501

• The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption.

  Thyroid : official journal of the American Thyroid Association 20080501

• FDA approves nexium for use in children ages 1-11 years.

  Gastroenterology 20080501

• Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users.

  The American journal of gastroenterology 20080501

• Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease.

  Journal of pediatric gastroenterology and nutrition 20080501

• Preoperative administration of esomeprazole has no influence on frequency of refluxes.

  Journal of clinical anesthesia 20080501

• [Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080501

• [Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080501

• Gastric epithelial cell modality and proton pump inhibitor.

  Journal of clinical biochemistry and nutrition 20080501

• Accelerated Ulcer Healing and Resistance to Ulcer Recurrence with Gastroprotectants in Rat Model of Acetic Acid-induced Gastric Ulcer.

  Journal of clinical biochemistry and nutrition 20080501

• Is the required therapeutic effect always achieved by racemic switch of proton-pump inhibitors?

  World journal of gastroenterology 20080428

• The alternating current polarographic behavior and determination of lansoprazole and omeprazole in dosage forms and biological fluids.

  Journal of biochemical and biophysical methods 20080424

• [Palpable purpura with severe pruritus].

  MMW Fortschritte der Medizin 20080424

• The gastric ulcer protective and healing role of cysteine proteinases from Carica candamarcensis.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20080401

• Endoscopic analysis of gastric ulcer after one week's treatment with omeprazole and rabeprazole in relation to CYP2C19 genotype.

  Digestive diseases and sciences 20080401

• Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of Peptic Ulcer Bleed study.

  Alimentary pharmacology & therapeutics 20080401

• Upper gastrointestinal bleeding in patients with acute coronary syndromes: clinical predictors and prophylactic role of proton pump inhibitors.

  Journal of clinical gastroenterology 20080401

• Influence of CYP2C19*18 and CYP2C19*19 alleles on omeprazole 5-hydroxylation: in vitro functional analysis of recombinant enzymes expressed in Saccharomyces cerevisiae.

  Basic & clinical pharmacology & toxicology 20080401

• Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.

  European journal of gastroenterology & hepatology 20080401

• Idiopathic tracheal stenosis: successful outcome with antigastroesophageal reflux disease therapy.

  The Annals of thoracic surgery 20080401

• [Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080401

• Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

  Health technology assessment (Winchester, England) 20080401

• [Effect of Helicobacter pylori eradication on iron deficiency anemia of unknown origin].

  Gastroenterologia y hepatologia 20080401

• Pantoprazole: from drug metabolism to clinical relevance.

  Expert opinion on drug metabolism & toxicology 20080401

• Chronic urticaria and Helicobacter pylori.

  Indian journal of medical sciences 20080401

• Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers.

  Clinical therapeutics 20080401

• [Effect of abdominal needling in treating post-cardiosurgical operational gastrointestinal dysfunction].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20080401

• Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis.

  Therapeutics and clinical risk management 20080401

• Ectopic sebaceous glands in the esophagus: a case report and review of literature.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20080401

• Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20080401

• Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients.

  World journal of gastroenterology 20080328

• Comparison of esomeprazole enteric-coated capsules vs esomeprazole magnesium in the treatment of active duodenal ulcer: a randomized, double-blind, controlled study.

  World journal of gastroenterology 20080328

• Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg for controlling intragastric acidity in healthy adults.

  Alimentary pharmacology & therapeutics 20080315

• CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles.

  Drug metabolism and disposition: the biological fate of chemicals 20080301

• Omeprazole stimulates the induction of human insulin-like growth factor binding protein-1 through aryl hydrocarbon receptor activation.

  The Journal of pharmacology and experimental therapeutics 20080301

• Systematic and simultaneous gene profiling of 84 drug-metabolizing genes in primary human hepatocytes.

  Journal of biomolecular screening 20080301

• Metabolism and related human risk factors for hepatic damage by usnic acid containing nutritional supplements.

  Xenobiotica; the fate of foreign compounds in biological systems 20080301

• Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080301

• Proton pump inhibitors and gastritis.

  Journal of clinical biochemistry and nutrition 20080301

• Case of the month. Gastroesophageal reflux disease (GERD), heart failure, valvular heart disease.

  JAAPA : official journal of the American Academy of Physician Assistants 20080301

• [Effect of combined therapy with Kangyanling and Omeprazole on digestive dysfunction in burned patients].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20080301

• GABA(A) receptors in normal development and seizures: friends or foes?

  Current neuropharmacology 20080301

• Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.

  Alimentary pharmacology & therapeutics 20080215

• Detection and quantification of ppb level potassium in biological samples in the presence of high sodium by ion chromatographic method.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080215

• The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition.

  Oncogene 20080214

• Hypergastrinemia increases gastric epithelial susceptibility to apoptosis.

  Regulatory peptides 20080207

• Anemia in children with chronic kidney disease.

  Pediatric nephrology (Berlin, Germany) 20080201

• Omeprazole inhibits natural killer cell functions.

  Digestive diseases and sciences 20080201

• Long-term proton pump inhibitor use in children: a retrospective review of safety.

  Digestive diseases and sciences 20080201

• Treating common ear problems in pregnancy: what is safe?

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20080201

• The anti-secretory and anti-ulcer activities of esomeprazole in comparison with omeprazole in the stomach of rats and rabbits.

  Molecular and cellular biochemistry 20080201

• EMANCIPATE study: drawing conclusions may be difficult in the absence of fundamental information.

  European journal of gastroenterology & hepatology 20080201

• EMANCIPATE versus EXPO: different results can be explained by differing study designs.

  European journal of gastroenterology & hepatology 20080201

• One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin.

  Helicobacter 20080201

• In-practice predictors of response to proton pump inhibitor therapy in primary care patients with dyspepsia in an Asian population.

  Journal of clinical gastroenterology 20080201

• Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.

  Journal of clinical gastroenterology 20080201

• [Sequential therapy regimen for Helicobacter pylori infection in children].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20080201

• [Esophageal Crohn's disease].

  Gastroenterologia y hepatologia 20080201

• Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment.

  The American journal of gastroenterology 20080201

• Management of laryngopharyngeal reflux with proton pump inhibitors.

  Therapeutics and clinical risk management 20080201

• A review of ramelteon in the treatment of sleep disorders.

  Neuropsychiatric disease and treatment 20080201

• Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

  Journal of the American College of Cardiology 20080122

• Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.

  Journal of the American College of Cardiology 20080122

• Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080115

• Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action.

  European journal of pharmacology 20080114

• High-performance liquid chromatography enantioseparation of proton pump inhibitors using the immobilized amylose-based Chiralpak IA chiral stationary phase in normal-phase, polar organic and reversed-phase conditions.

  Journal of chromatography. A 20080104

• Epstein-Barr virus-associated smooth muscle tumour mimicking bilateral vocal process granuloma.

  The Journal of laryngology and otology 20080101

• Twenty-four hour tonometry in patients suspected of chronic gastrointestinal ischemia.

  Digestive diseases and sciences 20080101

• Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.

  The American journal of gastroenterology 20080101

• HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.

  Drug metabolism and disposition: the biological fate of chemicals 20080101

• An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure.

  Cardiology 20080101

• Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

  Intensive care medicine 20080101

• Proton pump inhibitors: do differences in pharmacokinetics translate into differences in clinical outcomes?

  Clinical pharmacokinetics 20080101

• Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects.

  Clinical pharmacokinetics 20080101

• The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals.

  Equine veterinary journal 20080101

• Significant decrease in nelfinavir systemic exposure after omeprazole coadministration in healthy subjects.

  Pharmacotherapy 20080101

• Response to Ray and colleagues: the called-for large clinical trial is already ongoing.

  Gastroenterology 20080101

• Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori.

  Journal of drug targeting 20080101

• Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors.

  Acta dermato-venereologica 20080101

• A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease.

  The American journal of gastroenterology 20080101

• Validation of a four-graded scale for severity of heartburn in patients with symptoms of gastroesophageal reflux disease.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20080101

• Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes.

  Arthritis research & therapy 20080101

• No effect of one-year treatment with indomethacin on Alzheimer's disease progression: a randomized controlled trial.

  PloS one 20080101

• Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer.

  Cancer science 20080101

• Going beyond efficacy: strategies for cancer pain management.

  Current oncology (Toronto, Ont.) 20080101

• Healing potential of Picrorhiza kurroa (Scrofulariaceae) rhizomes against indomethacin-induced gastric ulceration: a mechanistic exploration.

  BMC complementary and alternative medicine 20080101

• Gastrointestinal bleeding in a toddler secondary to chronic renal failure and hyper-gastrinemia.

  Indian journal of pediatrics 20080101

• Antiulcerogenic activity of fractions and 3,15-dioxo-21alpha-hydroxy friedelane isolated from Maytenus robusta (Celastraceae).

  Archives of pharmacal research 20080101

• Comparison of inducibility of sulfotransferase and UDP-glucuronosyltransferase mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes.

  Drug metabolism and pharmacokinetics 20080101

• Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.

  Cancer immunity 20080101

• Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years.

  BMC health services research 20080101

• Biomonitoring of complex occupational exposures to carcinogens: the case of sewage workers in Paris.

  BMC cancer 20080101

• Clinical efficacy of esomeprazole in the prevention and healing of gastrointestinal toxicity associated with NSAIDs in elderly patients.

  Drugs & aging 20080101

• Treatment of experimental colitis in mice with LMP-420, an inhibitor of TNF transcription.

  Journal of inflammation (London, England) 20080101

• No increased bone formation around alendronate or omeprazole loaded bioactive bone cements in a femoral defect.

  Tissue engineering. Part A 20080101

• Omeprazole induces apoptosis in normal human polymorphonuclear leucocytes.

  International journal of immunopathology and pharmacology 20080101

• Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.

  Journal of clinical gastroenterology 20080101

• Future expectations in the prophylaxis of intestinal bleeding.

  Best practice & research. Clinical gastroenterology 20080101

• [Role of anti-secretory treatment in addition to Helicobacter pylori eradication triple therapy in the treatment of peptic ulcer].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080101

• High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature.

  World journal of surgical oncology 20080101

• Managing a locally advanced malignant thymoma complicated by nephrotic syndrome: a case report.

  Journal of medical case reports 20080101

• Safety profile of esomeprazole: results of a prescription-event monitoring study of 11 595 patients in England.

  Drug safety 20080101

• Effect of age, feeding, and omeprazole administration on gastric tonometry in healthy neonatal foals.

  Journal of veterinary internal medicine 20080101

• Furazolidone, tetracycline and omeprazole: a low-cost alternative for Helicobacter pylori eradication in children.

  Jornal de pediatria 20080101

• Reversible lansoprazole-induced interstitial lung disease showing improvement after drug cessation.

  Korean journal of radiology 20080101

• A study of Clostridium difficile-associated disease at King Chulalongkorn Memorial Hospital, Thailand.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080101

• Stereoselective disposition of proton pump inhibitors.

  Clinical drug investigation 20080101

• Inverse association between gastroesophageal reflux and blood pressure: results of a large community based study.

  BMC gastroenterology 20080101

• Gastroesophageal reflux disease after Helicobacter pylori eradication in gastric ulcer patients: a one-year follow-up study.

  Medicina (Kaunas, Lithuania) 20080101

• [Medicamentous bezoar following pancreaticoduodenectomy: the combined use of cholestyramine and antisecretory medications as a risk factor in pancreatic surgery].

  Journal de chirurgie 20080101

• Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5.

  Drug metabolism and pharmacokinetics 20080101

• Esomeprazole: in gastroesophageal reflux disease in children and adolescents.

  Paediatric drugs 20080101

• Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.

  Journal of gastroenterology 20080101

• Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model.

  Digestive diseases (Basel, Switzerland) 20080101

• Pylera plus omeprazole: quadruple treatment for Helicobacter pylori.

  Reviews in gastroenterological disorders 20080101

• Effect of increasing esomeprazole and pantoprazole doses on acid control in patients with symptoms of gastro-oesophageal reflux disease: a randomized, dose-response study.

  Clinical drug investigation 20080101

• Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients.

  Critical care (London, England) 20080101

• Using macro-arrays to study routes of infection of Helicobacter pylori in three families.

  PloS one 20080101

• Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors.

  BMC gastroenterology 20080101

• Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history.

  BMC microbiology 20080101

• Absence of gastrointestinal infections in a cohort of patients with Zollinger-Ellison syndrome and other acid hypersecretors receiving long-term acid suppression with lansoprazole.

  BMC gastroenterology 20080101

• Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy.

  BMC gastroenterology 20080101

• Effect of Roux-en-Y surgery and medical intervention on Barrett's-type changes: an in vivo model.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20080101

• A search for Helicobacter pyloriin localized vulvodynia.

  Gynecologic and obstetric investigation 20080101

• The influence of a newly developed quinolone: antofloxacin, on CYP activity in rats.

  European journal of drug metabolism and pharmacokinetics 20080101

• Henoch-Schönlein purpura with intracerebral haemorrhage in an adult patient: a case report.

  Journal of medical case reports 20080101

• Activation and stabilization of drugs by supramolecular pKa shifts: drug-delivery applications tailored for cucurbiturils.

  Angewandte Chemie (International ed. in English) 20080101

• Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials.

  Drug safety 20080101

• Comparison of short- and long-term treatment protocols and the results of second-line quadruple therapy in children with Helicobacter pylori infection.

  Journal of gastroenterology 20080101

• Helicobacter pylori and gastroesophageal reflux disease.

  World journal of surgical oncology 20080101

• [Gastroduodenal ulcers in the practice of joint endoprosthesis].

  Klinichna khirurhiia 20080101

• Clinical experience of endoscopic banding ligation for bleeding gastric varices.

  Hepato-gastroenterology 20080101

• Melatonin for the treatment of gastroesophageal reflux disease.

  Alternative therapies in health and medicine 20080101

• [Eosinophilic esophagitis in 29 pediatric patients].

  Arquivos de gastroenterologia 20080101

• Chronic hypokalemia due to excessive cola consumption: a case report.

  Cases journal 20080101

• Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.

  Drugs 20080101

• [Acute pancreatitis as a complication of diagnostic gastroduodenal endoscopy at 10 years old girl--case report].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20080101

• [Twenty-two months old girl with haemorrhagic gastritis as a complication after the nonsteroid anti-inflammatory drugs application--case report].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20080101

• Does knowledge of medication prices predict physicians' support for cost effective prescribing policies.

  The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20080101

• Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies.

  Reviews in gastroenterological disorders 20080101

• Late and fatal deterioration of an intracerebral hemorrhage attributable to the onset of a high titer of acquired factor V inhibitor.

  European neurology 20080101

• Clinical drugs that interact with St. John's wort and implication in drug development.

  Current pharmaceutical design 20080101

• Mediastinal plasmacytoma with multiple myeloma presenting as a diagnostic dilemma.

  Cases journal 20080101

• Lingual infarction in Wegener's Granulomatosis: a case report and review of the literature.

  Head & face medicine 20080101

• Simultaneous fundoplication and gastric stimulation in a lung transplant recipient with gastroparesis and reflux.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20080101

• Doxycycline-induced ulceration mimicking esophageal cancer.

  Cases journal 20080101

• Effect of acid suppression on gastric myoelectrical activity in GERD.

  Hepato-gastroenterology 20080101

• Late development of esophageal stricture following radiation and chemotherapy for small cell carcinoma of the lung: A case report.

  Cases journal 20080101

• Efficacy and safety of omeprazole in Japanese patients with nonerosive reflux disease.

  Journal of gastroenterology 20080101

• Bioequivalence study of two capsule formulations of omeprazole in healthy volunteers.

  Arzneimittel-Forschung 20080101

• [Prevention of regurgitation and aspiration during emergency care of patients under general anesthesia].

  Anesteziologiia i reanimatologiia 20080101

• Bezoar in gastro-jejunostomy presenting with symptoms of gastric outlet obstruction: a case report and review of the literature.

  Journal of medical case reports 20080101

• The short-term medical management of non-variceal upper gastrointestinal bleeding.

  Drugs 20080101

• Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers.

  Scandinavian journal of gastroenterology 20080101

• The effect of omeprazole on asthmatic adolescents with gastroesophageal reflux disease.

  Allergy and asthma proceedings 20080101

• Role of cytochrome P450 in drug interactions.

  Nutrition & metabolism 20080101

• The prince and the pauper. A tale of anticancer targeted agents.

  Molecular cancer 20080101

• Smoking and drinking habits are important predictors of Helicobacter pylori eradication.

  Advances in medical sciences 20080101

• Lisfranc fracture-dislocation precipitating acute Charcot arthopathy in a neuropathic diabetic foot: a case report.

  Cases journal 20080101

• Effect of proton pump inhibitors on gastric juice volume, gastric pH and gastric intramucosal pH in critically ill patients : a randomized, double-blind, placebo-controlled study.

  Clinical drug investigation 20080101

• I was recently diagnosed with 'dyspepesia.' Is this a fancy term for heartburn? Are there other ways of preventing and easing symptoms besides yoga classes to reduce stress and Prilosec for reflux?

  DukeMedicine healthnews 20080101

• Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors.

  Cost effectiveness and resource allocation : C/E 20080101

• Classification of tumours.

  Journal of experimental & clinical cancer research : CR 20080101

• Retinopathy induced by drugs and herbal medicines.

  European review for medical and pharmacological sciences 20080101

• Few alterations in clinical pathology and histopathology observed in a CYP2C18&19 humanized mice model.

  Acta veterinaria Scandinavica 20080101

• Black esophagus: a case report.

  Cases journal 20080101

• Gastrointestinal effects of Syzigium aromaticum (L) Merr. & Perry (Myrtaceae) in animal models.

  Nigerian quarterly journal of hospital medicine 20080101

• Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control study.

  Arthritis research & therapy 20080101

• Gastroesophageal reflux detected on the myocardial perfusion scan with (99m)Tc-MIBI.

  Hellenic journal of nuclear medicine 20080101

• Role of PDK1 in regulation of gastric acid secretion.

  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20080101

• Salmonella panama and acute respiratory distress syndrome in a traveler taking a proton pump inhibitor.

  Journal of travel medicine 20080101

• The effect of acid suppression on sleep and cardiac autonomic regulation in GERD.

  Hepato-gastroenterology 20080101

• The influence of Helicobacter pylori patients' treatment on MUC 1 content in gastric juice.

  Hepato-gastroenterology 20080101

• Limited Wegener's granulomatosis presenting as lung nodules in a patient with rheumatoid arthritis: a case report.

  Cases journal 20080101

• [Topical issues of paediatric gastroenterology].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101

• [NSAID-gastropathy: state-of-the-art therapy optimization capabilities in outpatient practice].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101

• [Interleukin-1beta gene polymorphism as a predictor of eradication treatment efficacy in gastric and duodenal ulcer associated with Helicobacter pylori].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101

• [Drug-drug interactions in patients from an internal medicine service].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20080101

• Evaluation of the inhibitory and induction potential of YM758, a novel If channel inhibitor, for human P450-mediated metabolism.

  European journal of drug metabolism and pharmacokinetics 20080101

• Esomeprazole prevents aspirin-induced ulcers.

  Medscape journal of medicine 20080101

• Pharmacovigilance: effects of herbal components on human drugs interactions involving cytochrome P450.

  Bioinformation 20080101

• A primary Helicobacter pylori infection does not protect against reinfection in children after eradication therapy.

  Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20080101

• Evaluation and management of patients with noncardiac chest pain.

  Gastroenterology research and practice 20080101

• Methanolic extract of Tetracera potatoria, an antiulcer agent increases gastric mucus secretion and endogenous antioxidants.

  Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria 20080101

• Pheno- or genotype for the CYP2C19 drug metabolism polymorphism: the influence of disease.

  Proceedings of the Western Pharmacology Society 20080101

• Staving off death: a case study of the pharmaceutical industry's strategies to protect blockbuster franchises.

  Food and drug law journal 20080101

• High-performance liquid chromatographic method for determination of phenytoin in rabbits receiving sildenafil.

  Analytical chemistry insights 20080101

• Simultaneous HPTLC Determination of Rabeprazole and Itopride Hydrochloride From Their Combined Dosage Form.

  Indian journal of pharmaceutical sciences 20080101

• Diabetic nephropathy: prescription trends in tertiary care.

  Indian journal of pharmaceutical sciences 20080101

• Synthesis and Antiulcer Activity Studies of 2-(1'-Iminothioimido Substituted)-1'-Substituted Phenylbenzoic acids.

  Indian journal of pharmaceutical sciences 20080101

• A Validated HPTLC Method for Determination of Ondansetron in Combination with Omeprazole or Rabeprazole in Solid Dosage Form.

  Indian journal of pharmaceutical sciences 20080101

• Spectrophotometric determination of certain benzimidazole proton pump inhibitors.

  Indian journal of pharmaceutical sciences 20080101

• Simultaneous spectrophotometric determination of lansoprazole and domperidone in capsule dosage form.

  Indian journal of pharmaceutical sciences 20080101

• Simultaneous Estimation of Esomeprazole and Domperidone by UV Spectrophotometric Method.

  Indian journal of pharmaceutical sciences 20080101

• Gastroprotective effect of Benincasa hispida fruit extract.

  Indian journal of pharmacology 20080101

• Fexofenadine hydrochloride in the treatment of allergic disease: a review.

  Journal of asthma and allergy 20080101

• Toward a definition of pharmaceutical innovation.

  Open medicine : a peer-reviewed, independent, open-access journal 20080101

• Primary aorto-duodenal fistula as a late complication of radiotherapy: report of a case and review of the literature.

  Case reports in gastroenterology 20080101

• Selective extraction of sulfonamides, macrolides and other pharmaceuticals from sewage sludge by pressurized liquid extraction.

  Journal of chromatography. A 20071207

• [Therapeutic innovations in gastroesophageal reflux].

  Presse medicale (Paris, France : 1983) 20071201

• Quantification of tenatoprazole in rat plasma by HPLC: validation and its application to pharmacokinetic studies.

  Biomedical chromatography : BMC 20071201

• Proton pump inhibitor-induced acute interstitial nephritis.

  British journal of clinical pharmacology 20071201

• Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.

  The American journal of gastroenterology 20071201

• Water load test before and after PPI therapy in patients with gastro-oesophageal reflux disease.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20071201

• A comparison of community pharmacists' views of over-the-counter omeprazole and simvastatin.

  Pharmacoepidemiology and drug safety 20071201

• Accounting for the effect of GERD symptoms on patients' health-related quality of life: supporting optimal disease management by primary care physicians.

  International journal of clinical practice 20071201

• Pharmacokinetic interaction between oltipraz and omeprazole in rats: Competitive inhibition of metabolism of oltipraz by omeprazole via CYP1A1 and 3A2, and of omeprazole by oltipraz via CYP1A1/2, 2D1/2, and 3A1/2.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20071201

• A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20071201

• Stability of partial doses of omeprazole-sodium bicarbonate oral suspension.

  The Annals of pharmacotherapy 20071201

• Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice.

  Scandinavian journal of gastroenterology 20071201

• Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.

  Helicobacter 20071201

• Rabeprazole- versus esomeprazole-based eradication regimens for H. pylori infection.

  Helicobacter 20071201

• Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate.

  Helicobacter 20071201

• Failure of sequential therapy to eradicate Helicobacter pylori in previously treated subjects.

  Helicobacter 20071201

• Use of acid-suppressing drugs and the risk of bacterial gastroenteritis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20071201

• Advantage of eradication therapy for Helicobacter pylori before kidney transplantation in uremic patients.

  Transplantation proceedings 20071201

• Distinct effects of omeprazole and rabeprazole on the tacrolimus blood concentration in a kidney transplant recipient.

  Drug metabolism and pharmacokinetics 20071201

• A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection.

  Journal of Korean medical science 20071201

• [Duodenal ulcer and helicobacter pylori].

  Gastroenterologie clinique et biologique 20071201

• Peripheral arterial disease in the elderly.

  Clinical interventions in aging 20071201

• Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment.

  Therapeutics and clinical risk management 20071201

• Reduced pepsin A processing of sonic hedgehog in parietal cells precedes gastric atrophy and transformation.

  The Journal of biological chemistry 20071116

• Development of the 'Inje cocktail' for high-throughput evaluation of five human cytochrome P450 isoforms in vivo.

  Clinical pharmacology and therapeutics 20071101

• Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration.

  European journal of clinical pharmacology 20071101

• Esomeprazole-induced DRESS syndrome. Studies of cross-reactivity among proton-pump inhibitor drugs.

  Allergy 20071101

• The impact of body mass index on the application of on-demand therapy for Los Angeles grades A and B reflux esophagitis.

  The American journal of gastroenterology 20071101

• The aerial parts of Guazuma ulmifolia Lam. protect against NSAID-induced gastric lesions.

  Journal of ethnopharmacology 20071101

• Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.

  Alimentary pharmacology & therapeutics 20071101

• Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.

  Alimentary pharmacology & therapeutics 20071101

• A quintuple therapy for H. pylori eradication.

  The American journal of gastroenterology 20071101

• Gastroprotective properties of Myristica malabarica against indometacin-induced stomach ulceration: a mechanistic exploration.

  The Journal of pharmacy and pharmacology 20071101

• Reversible hearing loss in temporal association with chemoprophylactic mefloquine use.

  Travel medicine and infectious disease 20071101

• [Evidence based treatment strategy for dyspeptic symptoms].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20071101

• Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease.

  Journal of pediatric gastroenterology and nutrition 20071101

• Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease.

  Journal of pediatric gastroenterology and nutrition 20071101

• Collagenous gastritis: a rare cause of abdominal pain and iron-deficiency anemia.

  Journal of pediatric gastroenterology and nutrition 20071101

• Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome.

  The Annals of otology, rhinology, and laryngology 20071101

• [Drug treatment and surgical indications in gastroesophageal reflux].

  Revista de gastroenterologia de Mexico 20071101

• Exhaled breath marker in asthma patients with gastroesophageal reflux disease.

  Journal of clinical biochemistry and nutrition 20071101

• Lansoprazole Novel Effector Sites Revealed by Autoradiography: Relation to Helicobacter pylori, Colon, Esophagus and Others.

  Journal of clinical biochemistry and nutrition 20071101

• Transcriptome Analysis for Cytoprotective Actions of Rebamipide against Indomethacin-Induced Gastric Mucosal Injury in Rats.

  Journal of clinical biochemistry and nutrition 20071101

• [Clinical value of 24-hour pH monitoring in patients with laryngopharyngeal reflux disease].

  Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 20071101

• Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole.

  Alimentary pharmacology & therapeutics 20071015

• Acid-suppressive effects of various regimens of omeprazole in Helicobacter pylori-negative CYP2C19 homozygous extensive metabolizers: which regimen has the strongest effect?

  Digestive diseases and sciences 20071001

• [Repeated dual-probe pH monitoring as a diagnostic tool to control therapy for laryngopharyngeal reflux].

  HNO 20071001

• Gastric antisecretory drugs induce leukocyte-endothelial cell interactions through gastrin release and activation of CCK-2 receptors.

  The Journal of pharmacology and experimental therapeutics 20071001

• Enantioselective quantification of omeprazole and its main metabolites in human serum by chiral HPLC-atmospheric pressure photoionization tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071001

• Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.

  Helicobacter 20071001

• Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.

  Helicobacter 20071001

• Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test.

  Helicobacter 20071001

• Garlic, vitamin, and antibiotic treatment for Helicobacter pylori: a randomized factorial controlled trial.

  Helicobacter 20071001

• Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers.

  HIV medicine 20071001

• Effects of CYP2C19 genetic polymorphism on the pharmacokinetics and pharmacodynamics of omeprazole in Chinese people.

  Journal of clinical pharmacy and therapeutics 20071001

• Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20071001

• Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole.

  Acta pharmacologica Sinica 20071001

• The ghrelin system in acinar cells: localization, expression, and regulation in the exocrine pancreas.

  Pancreas 20071001

• [Surgical treatment of high-grade dysplasia in Barrett's esophagus].

  Cirugia espanola 20071001

• Prophylactic effect of lafutidine against the adverse reaction induced in rat stomach by repeated administration of 5-fluorouracil.

  Inflammopharmacology 20071001

• Gene expression profiling of rat liver treated with serum triglyceride-decreasing compounds.

  The Journal of toxicological sciences 20071001

• The role of sildenafil citrate in the protection of gastric mucosa from nonsteroidal anti-inflammatory drug-induced damage.

  Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES 20071001

• Influence of sulfobutylether-beta-cyclodextrin on the stability of S- and R- omeprazole.

  Current drug discovery technologies 20071001

• Proton pump inhibitor utilization patterns in infants.

  Journal of pediatric gastroenterology and nutrition 20071001

• Synthesis of new 4-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]quinoxaline and 5-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]thieno[3,2-e]pyrazine derivatives, as potential bacterial multidrug resistance pump inhibitors.

  Journal of enzyme inhibition and medicinal chemistry 20071001

• [Endoscopic changes in the stomach and duodenal mucosa caused by minidose acetylsalicylic acid therapy and their prevention].

  Vnitrni lekarstvi 20071001

• Gabapentin-induced coma: A MR-spectrometry analysis.

  Neuropsychiatric disease and treatment 20071001

• Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.

  World journal of gastroenterology 20070914

• Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.

  World journal of gastroenterology 20070907

• Evaluation of the antiulcerogenic activity of Maytenus robusta (Celastraceae) in different experimental ulcer models.

  Journal of ethnopharmacology 20070905

• Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20070901

• Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis.

  Gut 20070901

• Preparative chiral chromatography and chiroptical characterization of enantiomers of omeprazole and related benzimidazoles.

  Chirality 20070901

• [Helicobacter pylori infection and eradication are not related to glycosylated hemoglobin levels (HbA1c) in young patients with type 1 diabetes].

  Presse medicale (Paris, France : 1983) 20070901

• Oral erythromycin accelerates impaired gastrointestinal motility after endoscopic mucosal resection.

  Digestive diseases and sciences 20070901

• Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole.

  British journal of clinical pharmacology 20070901

• Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20070901

• Increased epithelial cell proliferation in the ileal pouch mucosa of patients with familial adenomatous polyposis.

  Virchows Archiv : an international journal of pathology 20070901

• Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.

  Gastrointestinal endoscopy 20070901

• One-week versus two-week furazolidone-based quadruple therapy as the first-line treatment for Helicobacter pylori infection in Iran.

  Journal of gastroenterology and hepatology 20070901

• [Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy].

  Actas dermo-sifiliograficas 20070901

• Reflux oesophagitis in children; the role of endoscopy. A multicentric Italian survey.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20070901

• High-dose versus low-dose esomeprazole-based triple therapy for Helicobacter pylori infection.

  European journal of clinical investigation 20070901

• One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study.

  Alimentary pharmacology & therapeutics 20070901

• Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?

  Alimentary pharmacology & therapeutics 20070901

• Duodenogastro-esophageal reflux in children with refractory gastro-esophageal reflux disease.

  The Journal of pediatrics 20070901

• Columnar-lined esophagus: lessons learnt from children.

  The American journal of gastroenterology 20070901

• Treatment interruptus: the need for withdrawal.

  The American journal of gastroenterology 20070901

• Dysphagia due to triple A syndrome: successful treatment of achalasia by balloon dilatation.

  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20070901

• CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.

  Pharmacogenomics 20070901

• Thermal care of functional dyspepsia based on bicarbonate-sulphate-calcium water: a sequential clinical trial.

  Evidence-based complementary and alternative medicine : eCAM 20070901

• [Chiral separation of tenatoprazole enantiomers using high performance liquid chromatography on vacomycin-bonded chiral stationary phase].

  Se pu = Chinese journal of chromatography 20070901

• Anti-inflammatory and anti-oxidative properties of proton pump inhibitors.

  Journal of clinical biochemistry and nutrition 20070901

• Immune and Inflammatory Responses in GERD and Lansoprazole.

  Journal of clinical biochemistry and nutrition 20070901

• Lansoprazole-induced improvement of esophageal submucosal injury.

  Journal of clinical biochemistry and nutrition 20070901

• Healing Properties of Some Indian Medicinal Plants against Indomethacin-Induced Gastric Ulceration of Rats.

  Journal of clinical biochemistry and nutrition 20070901

• High-grade dysplasia in Barrett's oesophagus. The case against oesophageal resection.

  Annals of the Royal College of Surgeons of England 20070901

• [Acid pump inhibitor before before gastroscopy for upper gastrointestinal bleeding].

  Ugeskrift for laeger 20070827

• High-performance liquid chromatographic separation of rolipram, bupivacaine and omeprazole using a tartardiamide-based stationary phase influence of flow rate and temperature on the enantioseparation.

  Journal of chromatography. A 20070824

• Analytical methodologies for the determination of omeprazole: an overview.

  Journal of pharmaceutical and biomedical analysis 20070815

• Stimulation programs for pediatric drug research--do children really benefit?

  European journal of pediatrics 20070801

• Banding without resection (endoscopic mucosal ligation) as a novel approach for the ablation of short-segment Barrett's epithelium: results of a pilot study.

  The American journal of gastroenterology 20070801

• Distension during gastroesophageal reflux: effects of acid inhibition and correlation with symptoms.

  American journal of physiology. Gastrointestinal and liver physiology 20070801

• Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease.

  International journal of clinical practice 20070801

• Effect of reflux-induced inflammation on transient receptor potential vanilloid one (TRPV1) expression in primary sensory neurons innervating the oesophagus of rats.

  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20070801

• Influence of omeprazole on pharmacokinetics of domperidone given as free base and maleate salt in healthy Chinese patients.

  Acta pharmacologica Sinica 20070801

• Reversal of migraine symptoms by Helicobacter pylori eradication therapy in patients with hepatitis-B-related liver cirrhosis.

  Helicobacter 20070801

• Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.

  Helicobacter 20070801

• Pharmaceutical brand substitution in Australia--are there multiple switches per prescription?

  Australian and New Zealand journal of public health 20070801

• Recent advances in chirally pure proton pump inhibitors.

  Journal of the Indian Medical Association 20070801

• Role of posaconazole in the management of oropharyngeal and esophageal candidiasis.

  Therapeutics and clinical risk management 20070801

• A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD).

  Therapeutics and clinical risk management 20070801

• Omeprazole before endoscopy in patients with gastrointestinal bleeding.

  The New England journal of medicine 20070719

• Omeprazole before endoscopy in patients with gastrointestinal bleeding.

  The New England journal of medicine 20070719

• Validation of chromatographic methods: evaluation of detection and quantification limits in the determination of impurities in omeprazole.

  Journal of chromatography. A 20070713

• Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients.

  Digestive diseases and sciences 20070701

• CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies.

  Drug metabolism and disposition: the biological fate of chemicals 20070701

• Pyramidal inversion mechanism of simple chiral and achiral sulfoxides: a theoretical study.

  Chirality 20070701

• Effect of baseline symptom severity on patient-reported outcomes in gastroesophageal reflux disease.

  European journal of gastroenterology & hepatology 20070701

• In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies.

  Journal of mass spectrometry : JMS 20070701

• Omeprazole for gastroesophageal reflux disease in the first 2 years of life: a dose-finding study with dual-channel pH monitoring.

  Journal of pediatric gastroenterology and nutrition 20070701

• Solid-phase extraction followed by liquid chromatography-time-of-flight-mass spectrometry to evaluate pharmaceuticals in effluents. A pilot monitoring study.

  Journal of environmental monitoring : JEM 20070701

• [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].

  Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue 20070701

• Duodenal gastric metaplasia and Helicobacter pylori infection in patients with diffuse nodular duodenitis.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20070701

• I was recently diagnosed with 'dyspepsia'. Is this just a fancy term for heartburn? Are there other ways of preventing and easing symptoms besides yoga classes to reduce stress and Prilosec for reflux?

  DukeMedicine healthnews 20070701

• [Morphological observation on gastric mucosa membrane of patients with gastric ulcer treated with combined use of Qifang Weitong Powder and omeprazole].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20070701

• A clinical trial comparing pantoprazole and esomeprazole to explore the concept of achieving 'complete remission' in gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20070615

• Antiulcerogenic activity of Zizyphus lotus (L.) extracts.

  Journal of ethnopharmacology 20070613

• Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile.

  World journal of gastroenterology 20070607

• Dexamethasone damages the rat stomach but not small intestine during inhibition of COX-1.

  Digestive diseases and sciences 20070601

• Rapid determination of omeprazole in human plasma by protein precipitation and liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070601

• Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?

  The American journal of gastroenterology 20070601

• Soraprazan: setting new standards in inhibition of gastric acid secretion.

  The Journal of pharmacology and experimental therapeutics 20070601

• Letter to the editor, re: Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum O, et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2007;33:3-12.

  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 20070601

• One week of esomeprazole triple therapy vs 1 week of omeprazole triple therapy plus 3 weeks of omeprazole for duodenal ulcer healding in Helicobacter pylori-positive patients.

  Digestive diseases and sciences 20070601

• Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.

  European journal of clinical pharmacology 20070601

• Severe systemic adverse reaction to proton pump inhibitors in an infant.

  Pediatric pulmonology 20070601

• Effect of cranberry juice on eradication of Helicobacter pylori in patients treated with antibiotics and a proton pump inhibitor.

  Molecular nutrition & food research 20070601

• 13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding.

  Helicobacter 20070601

• The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19.

  Journal of clinical psychopharmacology 20070601

• Can famotidine and omeprazole be combined on a once-daily basis?

  Scandinavian journal of gastroenterology 20070601

• Type I allergic reaction to benzimidazole antihelmintics.

  Allergy 20070601

• Effects of short-term light to heavy exercise on gastric ulcer development in horses and efficacy of omeprazole paste in preventing gastric ulceration.

  Journal of the American Veterinary Medical Association 20070601

• Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.

  Cancer research 20070601

• Effect of esomeprazole and rabeprazole on intragastric pH in healthy Chinese: an open, randomized crossover trial.

  Journal of gastroenterology and hepatology 20070601

• [Protonic pump inhibitors in kidney transplant patients: efficacy and safety].

  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 20070601

• [Different courses of esomeprazole-based triple therapy for Helicobactor pylori infection in children].

  Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20070601

• Successful treatment of severe gastrointestinal bleeding secondary to Crohn disease with recombinant factor VIIa.

  Southern medical journal 20070601

• Suppression of gastric acid with intravenous esomeprazole and omeprazole: results of 3 studies in healthy subjects.

  International journal of clinical pharmacology and therapeutics 20070601

• Comparison of inducibility of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes.

  Drug metabolism and pharmacokinetics 20070601

• Potential effect of over-the-counter sales on omeprazole calls to Texas poison centers.

  Texas medicine 20070601

• Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.

  Hepato-gastroenterology 20070601

• [Structure-function relationship of gastric proton pump].

  Seikagaku. The Journal of Japanese Biochemical Society 20070601

• [Simultaneous determination of the inhibitory potency of compounds on the activity of five cytochrome P-450 enzymes using a cocktail probe substrates method].

  Yao xue xue bao = Acta pharmaceutica Sinica 20070601

• [Effect of selenium-enriched garlic on chronic gastritis of the glandular stomach of Mongolian gerbils induced by H. pylori].

  Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 20070601

• [Gastroesophageal reflux as a cause of night sweating].

  Anales de medicina interna (Madrid, Spain : 1984) 20070601

• Long-term management of gastroesophageal reflux disease with pantoprazole.

  Therapeutics and clinical risk management 20070601

• Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy.

  Therapeutics and clinical risk management 20070601

• A review of rabeprazole in the treatment of acid-related diseases.

  Therapeutics and clinical risk management 20070601

• Tautomeric polymorphism in omeprazole.

  Chemical communications (Cambridge, England) 20070528

• [Anaphylaxis to proton pump inhibitors].

  Medicina clinica 20070526

• Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy.

  Alimentary pharmacology & therapeutics 20070515

• Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.

  Lancet (London, England) 20070512

• Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.

  British journal of cancer 20070507

• Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.

  The American journal of gastroenterology 20070501

• Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats.

  Digestive diseases and sciences 20070501

• Pathogenic importance of pepsin in ischemia/reperfusion-induced gastric injury.

  Life sciences 20070501

• The effect of omeprazole on the bioavailability and safety of garenoxacin in healthy volunteers.

  Journal of clinical pharmacology 20070501

• Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire.

  Alimentary pharmacology & therapeutics 20070501

• Single-session, graded esophageal dilation without fluoroscopy in outpatients with lower esophageal (Schatzki's) rings: a prospective, long-term follow-up study.

  Journal of gastroenterology and hepatology 20070501

• Eradication of Helicobacter bilis and H. hepaticus from infected mice by using a medicated diet.

  Lab animal 20070501

• Concomitant use of gastric acid-reducing agents is frequent among HIV-1-infected patients receiving protease inhibitor-based highly active antiretroviral therapy.

  HIV medicine 20070501

• Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcers.

  Expert opinion on pharmacotherapy 20070501

• Argon plasma coagulation for non-dysplastic Barrett's epithelium: a hard act to follow.

  The American journal of gastroenterology 20070501

• Getting categorical on GERD.

  The American journal of gastroenterology 20070501

• Quantitative analysis of in vitro compatibility of binary and ternary mixtures of nitroimidazole and macrolides in combination with omeprazole using a calorimetric technique.

  Die Pharmazie 20070501

• [Immunosuppressive treatment about the patient operated facial allotransplantation in perioperative period].

  Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery 20070501

• Effects of allyl isothiocyanate from horseradish on several experimental gastric lesions in rats.

  European journal of pharmacology 20070430

• Nodular gastritis and pathologic findings in children and young adults with Helicobacter pylori infection.

  Yonsei medical journal 20070430

• Omeprazole before endoscopy in patients with gastrointestinal bleeding.

  The New England journal of medicine 20070419

• Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004.

  Journal of toxicology and environmental health. Part A 20070415

• Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study.

  Alimentary pharmacology & therapeutics 20070415

• Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study.

  Gut 20070401

• Determination of esomeprazole and its two main metabolites in human, rat and dog plasma by liquid chromatography with tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070401

• Results from the pediatric European register for treatment of Helicobacter pylori (PERTH).

  Helicobacter 20070401

• Rebamipide contributes to reducing adverse effects of long-term administration of omeprazole in rats.

  Digestive diseases and sciences 20070401

• Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease.

  Archives of Iranian medicine 20070401

• Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs.

  Alimentary pharmacology & therapeutics 20070401

• Barrett's oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence.

  Alimentary pharmacology & therapeutics 20070401

• Pharmacologic treatment of peptic ulcer bleeding.

  Current treatment options in gastroenterology 20070401

• Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection.

  Medical science monitor : international medical journal of experimental and clinical research 20070401

• Post-tonsillectomy bleeding.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20070401

• [A case of gastroesophageal reflux disease with marked eosinophilia].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20070401

• Baccharis dracunculifolia, the main botanical source of Brazilian green propolis, displays antiulcer activity.

  The Journal of pharmacy and pharmacology 20070401

• Ecabet sodium prevents esophageal lesions induced by the reflux of gastric juice in rats.

  Inflammopharmacology 20070401

• Male breast cancer with mandibular metastasis. A case report.

  Minerva stomatologica 20070401

• Is this medicine really involved in a drug interaction?

  Southern medical journal 20070401

• Omeprazole-associated digoxin toxicity.

  Southern medical journal 20070401

• Lack of effect of gastric acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir in HIV-infected patients.

  AIDS patient care and STDs 20070401

• H. pylori infection in childhood chronic immune thrombocytopenic purpura.

  Haematologica 20070401

• A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers.

  Clinical therapeutics 20070401

• [Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice].

  Orvosi hetilap 20070325

• Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey.

  The New Zealand medical journal 20070323

• [The 10-minute-consultation: chronic singultus].

  MMW Fortschritte der Medizin 20070322

• Anti-ulcer activity of crude alcoholic extract of Toona ciliata Roemer (heart wood).

  Journal of ethnopharmacology 20070321

• Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux.

  World journal of gastroenterology 20070321

• alpha-Amino acid derivatives as proton pump inhibitors and potent anti-ulcer agents.

  European journal of medicinal chemistry 20070301

• Endoscopic hemoclip versus triclip placement in patients with high-risk peptic ulcer bleeding.

  The American journal of gastroenterology 20070301

• Acute kidney injury following proton pump inhibitor therapy.

  Kidney international 20070301

• Effect of omeprazole on the pharmacokinetics of paricalcitol in healthy subjects.

  Biopharmaceutics & drug disposition 20070301

• Helicobacter pylori eradication prevents recurrence after simple closure of perforated duodenal ulcer.

  Journal of gastroenterology and hepatology 20070301

• Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study.

  European journal of gastroenterology & hepatology 20070301

• Intracranial hypotension following motor vehicle accident: an overlooked cause of post-traumatic head and neck pain?

  Pain practice : the official journal of World Institute of Pain 20070301

• Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis.

  Alimentary pharmacology & therapeutics 20070301

• Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration.

  The Journal of pediatrics 20070301

• Chest pain during triple therapy for duodenal ulcer.

  Internal medicine journal 20070301

• Effect of antireflux treatment on asthma exacerbations in nonatopic children.

  Journal of pediatric gastroenterology and nutrition 20070301

• Quality of life in laryngopharyngeal reflux patients.

  The Laryngoscope 20070301

• Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal reflux.

  Scandinavian journal of gastroenterology 20070301

• Comparison of two invasive diagnostic tests for Helicobacter pylori after antimicrobial therapy.

  Scandinavian journal of gastroenterology 20070301

• Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.

  PLoS medicine 20070301

• By the way, doctor. I heard that taking a proton-pump inhibitor could cause hip fractures. I've been taking 20 mg of Prilosec every day for a year. Should I be concerned?

  Harvard women's health watch 20070301

• The inhibitory effects of H+ K+ ATPase inhibitors on human neutrophils in vitro: restoration by a K+ ionophore.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20070301

• [Study on integrated Chinese and Western therapy and criterion for efficacy evaluation of gastroesophageal reflux disease--a clinical observation on 116 cases].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20070301

• [Typhoid fever and acute pancreatitis: two cases].

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20070301

• Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan.

  Hepato-gastroenterology 20070301

• [Anti-Helicobacter pylori effect and regulation of T helper response of chitosan].

  Zhonghua nei ke za zhi 20070301

• Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.

  The American journal of geriatric pharmacotherapy 20070301

• Long-term management of GERD in the elderly with pantoprazole.

  Clinical interventions in aging 20070301

• Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDY.

  Journal of clinical biochemistry and nutrition 20070301

• Proton pump inhibitors for GERD in children.

  The Medical letter on drugs and therapeutics 20070226

• The management of upper gastrointestinal symptoms: is endoscopy indicated?

  The Medical journal of Australia 20070219

• Combined analysis of three crossover clinical pharmacology studies of effects of rabeprazole and esomeprazole on 24-h intragastric pH in healthy volunteers.

  Alimentary pharmacology & therapeutics 20070215

• Omeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin for H pylori eradication in Iranian population.

  World journal of gastroenterology 20070214

• Pharmacokinetics of omeprazole after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.

  International journal of pharmaceutics 20070207

• [Changes of intercellular spaces of esophageal epithelium in patients with gastroesophageal reflux disease before and after esomeprazole treatment].

  Zhonghua yi xue za zhi 20070206

• Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?

  Annals of oncology : official journal of the European Society for Medical Oncology 20070201

• [Validity of proton pump inhibitors' prescriptions in a department of internal medicine].

  La Revue de medecine interne 20070201

• Does esomeprazole prevent post-operative nausea and vomiting?

  Acta anaesthesiologica Scandinavica 20070201

• Interaction of omeprazole with a methylated derivative of beta-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation.

  Pharmaceutical research 20070201

• Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations.

  European journal of clinical pharmacology 20070201

• Which has superior acid-suppressive effect, 10 mg omeprazole once daily or 20 mg famotidine twice daily? Effects of single or repeated administration in Japanese Helicobacter pylori-negative CYP2C19 extensive metabolizers.

  Digestive diseases and sciences 20070201

• Pre-endoscopic PPI therapy reduces recurrent adverse outcomes in acute non-variceal upper gastrointestinal bleeding.

  Alimentary pharmacology & therapeutics 20070201

• Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.

  Helicobacter 20070201

• Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach.

  Helicobacter 20070201

• Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure.

  Helicobacter 20070201

• Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis.

  The British journal of surgery 20070201

• Effect of intravenous application of esomeprazole 40 mg versus pantoprazole 40 mg on 24-hour intragastric pH in healthy adults.

  European journal of gastroenterology & hepatology 20070201

• There are more confounders in omeprazole-calcium interaction.

  The American journal of medicine 20070201

• Efficacy of once-daily esomeprazole treatment in patients with laryngopharyngeal reflux evaluated by 24-hour pH monitoring.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20070201

• Laser eustachian tuboplasty: two-year results.

  The Laryngoscope 20070201

• Role of clinical presentation in diagnosing reflux-related non-cardiac chest pain.

  Journal of gastroenterology and hepatology 20070201

• Acidic and non-acidic reflux during sleep under conditions of powerful acid suppression.

  Chest 20070201

• Comparative drug effects: the case of GERD therapies.

  Disease management : DM 20070201

• Acid control with esomeprazole and lansoprazole: a comparative dose-response study.

  Scandinavian journal of gastroenterology 20070201

• Equine gastric ulcer syndrome in adult horses: a review.

  New Zealand veterinary journal 20070201

• Acid-related disorders and use of antisecretory medication.

  Danish medical bulletin 20070201

• Autoimmune haemolytic anaemia associated with use of omeprazole.

  British journal of hospital medicine (London, England : 2005) 20070201

• Promotion of cutaneous wound healing by famotidine in Wistar rats.

  The Indian journal of medical research 20070201

• Autoimmune haemolytic anaemia due to Omeprazole.

  Irish medical journal 20070201

• [The changes of esophageal epithelial intercellular spaces before and after omeprazole treatment in erosive esophagitis].

  Zhonghua nei ke za zhi 20070201

• [Proton pump inhibitors in developmental period medicine].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20070201

• Mechanism of action of AZD0865, a K+-competitive inhibitor of gastric H+,K+-ATPase.

  Biochemical pharmacology 20070115

• Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms.

  Alimentary pharmacology & therapeutics 20070115

• [Platelet inhibition and gastric problems].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070104

• Impact of malnutrition on gastrointestinal disorders and gross motor abilities in children with cerebral palsy.

  Brain & development 20070101

• Reactions of sulfenic acid with 2-mercaptoethanol: a mechanism for the inhibition of gastric (H+-K+)-adenosine triphosphate by omeprazole.

  Journal of pharmaceutical sciences 20070101

• A novel model for the prediction of drug-drug interactions in humans based on in vitro cytochrome p450 phenotypic data.

  Drug metabolism and disposition: the biological fate of chemicals 20070101

• Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers.

  The Journal of pharmacology and experimental therapeutics 20070101

• HPLC determination and pharmacokinetic study of tenatoprazole in dog plasma after oral administration of enteric-coated capsule.

  Biomedical chromatography : BMC 20070101

• Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070101

• Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study.

  Digestive diseases and sciences 20070101

• Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine.

  Naunyn-Schmiedeberg's archives of pharmacology 20070101

• Occupational airborne contact dermatitis from omeprazole.

  Contact dermatitis 20070101

• Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy.

  Acta paediatrica (Oslo, Norway : 1992) 20070101

• Systematic review of rosacea treatments.

  Journal of the American Academy of Dermatology 20070101

• Effect of oral esomeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.

  Journal of gastroenterology and hepatology 20070101

• Asymptomatic schwannoma of the heart.

  Journal of cardiothoracic surgery 20070101

• Effects of cysteine on the pharmacokinetic parameters of omeprazole in rats with protein-calorie malnutrition: partial restoration of some parameters to control levels by oral cysteine supplementation.

  JPEN. Journal of parenteral and enteral nutrition 20070101

• Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.

  Journal of pediatric gastroenterology and nutrition 20070101

• Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.

  Alimentary pharmacology & therapeutics 20070101

• [Omeprazole-induced acute cholestatic hepatitis].

  Gastroenterologia y hepatologia 20070101

• Corynebacterium endocarditis species-specific risk factors and outcomes.

  BMC infectious diseases 20070101

• The history of gastric surgery: the contribution of the Belfast School.

  The Ulster medical journal 20070101

• [Effect of mucosal protective on the quality of gastric ulcer healing].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20070101

• Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.

  Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20070101

• By the way, doctor. I recently switched from Prilosec to its generic form, omeprazole. The generic form doesn't give me as much relief from heartburn as Prilosec does. Aren't generics supposed to be the same as the brand-name drugs?

  Harvard women's health watch 20070101

• Adverse events reporting.

  Clinical drug investigation 20070101

• Helicobacter pylori: present status and future prospects in Japan.

  Journal of gastroenterology 20070101

• Rheumatoid peripheral blood phagocytes are primed for activation but have impaired Fc-mediated generation of reactive oxygen species.

  Arthritis research & therapy 20070101

• Defining the relationship between gastroesophageal reflux and cough: probabilities, possibilities and limitations.

  Cough (London, England) 20070101

• The clinical pharmacokinetics of escitalopram.

  Clinical pharmacokinetics 20070101

• Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies.

  Arthritis research & therapy 20070101

• Bioequivalence assessment of two capsule formulations of omeprazole in healthy volunteers.

  Arzneimittel-Forschung 20070101

• Risk of massive upper gastrointestinal bleeding in gastric bypass patients taking clopidogrel.

  Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 20070101

• Acute compartment syndrome of the hand in Henoch-Schonlein Purpura.

  Journal of medical case reports 20070101

• Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication.

  Hepato-gastroenterology 20070101

• Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population.

  Clinical and experimental pharmacology & physiology 20070101

• [Age and eradication treatment of duodenal ulcer].

  Terapevticheskii arkhiv 20070101

• [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].

  Terapevticheskii arkhiv 20070101

• Analysis and evaluation of environmental tobacco smoke exposure as a risk factor for chronic cough.

  Cough (London, England) 20070101

• Process of measuring in clinical medicine--implications of different definitions in clinical therapeutic studies.

  Digestion 20070101

• Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.

  Digestion 20070101

• Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse.

  Digestion 20070101

• [Rabeprazole test and comparison of the effectiveness of course treatment with rabeprazole in patients with gastroesophageal reflux disease and non-coronary chest pain].

  Klinicheskaia meditsina 20070101

• [Stress-dependent lesions of the gastroduodenal mucosa during operations with cardiopulmonary bypass].

  Klinicheskaia meditsina 20070101

• Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.

  Arthritis research & therapy 20070101

• [Antihelicobacter effects of melatonin].

  Klinicheskaia meditsina 20070101

• [Characteristics of a combined course of duodenal ulcer and gastroesophageal reflux disease].

  Klinicheskaia meditsina 20070101

• [The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors].

  Klinicheskaia meditsina 20070101

• Gynaecomastia associated with proton pump inhibitors: a case series from the Spanish Pharmacovigilance System.

  Drug safety 20070101

• Generic drug policy in Australia: a community pharmacy perspective.

  Australia and New Zealand health policy 20070101

• 'Linkage' pharmaceutical evergreening in Canada and Australia.

  Australia and New Zealand health policy 20070101

• Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal.

  Australia and New Zealand health policy 20070101

• [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101

• Comparative study of proton pump inhibitors for triple therapy in H. pylori eradication.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20070101

• Responsiveness of measures of heartburn improvement in non-erosive reflux disease.

  Health and quality of life outcomes 20070101

• Effect of proton pump inhibitor on amylase release from isolated pancreatic acini.

  In vitro cellular & developmental biology. Animal 20070101

• Cost-effectiveness analysis of two management strategies for dyspepsia.

  International journal of technology assessment in health care 20070101

• Bioequivalence study of a sustained release fixed dose combination capsule containing esomeprazole and domperidone in healthy subjects.

  Arzneimittel-Forschung 20070101

• An economic model of long-term use of celecoxib in patients with osteoarthritis.

  BMC gastroenterology 20070101

• Development of an omeprazole parenteral formulation with hydroxypropyl-beta-cyclodextrin.

  Pharmaceutical development and technology 20070101

• Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals.

  BMC clinical pharmacology 20070101

• Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.

  BMC gastroenterology 20070101

• Ileocolic intussusception due to endometriosis.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20070101

• Symptom resolution does not predict healing of erosive oesophagitis in Chinese.

  Digestion 20070101

• [Factors affecting efficacy of proton pump inhibitors in NAID-induced gastric ulcers].

  Terapevticheskii arkhiv 20070101

• Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome.

  European journal of dermatology : EJD 20070101

• Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk.

  BMC musculoskeletal disorders 20070101

• Macrolide resistance in the normal microbiota after Helicobacter pylori treatment.

  Scandinavian journal of infectious diseases 20070101

• Combined garlic-omeprazole versus standard quadruple therapy for eradication of Helicobacter pylori infection.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20070101

• In vivo bactericidal activities of Japanese rice-fluid against H. pylori in a Mongolian gerbil model.

  International journal of medical sciences 20070101

• Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia.

  Pain research & management 20070101

• [Changes in epithelium transport system function and morphological indexes in the colon mucosa of rats with hypergastrinemia of different duration].

  Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20070101

• PI3 kinase dependent stimulation of gastric acid secretion by dexamethasone.

  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20070101

• The concept of complete remission of gastro-oesophageal reflux disease : comparative efficacy of pantoprazole and esomeprazole using the ReQuest questionnaire.

  Clinical drug investigation 20070101

• Fast 3D shape screening of large chemical databases through alignment-recycling.

  Chemistry Central journal 20070101

• Nerolidol, an antiulcer constituent from the essential oil of Baccharis dracunculifolia DC (Asteraceae).

  Zeitschrift fur Naturforschung. C, Journal of biosciences 20070101

• [A survey of gastroprotective drugs: prescription-indication in hospitalized patients].

  Gaceta sanitaria 20070101

• Efficacy of famotidine for the prevention of exercise-induced gastritis in racing Alaskan sled dogs.

  Journal of veterinary internal medicine 20070101

• Determination of the in vitro susceptibility of feline tritrichomonas foetus to 5 antimicrobial agents.

  Journal of veterinary internal medicine 20070101

• [Clinical guidelines of diagnosis and treatment of gastroesophageal reflux disease].

  Revista de gastroenterologia de Mexico 20070101

• Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.

  Wiener klinische Wochenschrift 20070101

• [Modern attitude towards management of laryngopharyngeal form of gastroesophageal reflux disease. Lithuanian clinical practice guidelines for adults].

  Medicina (Kaunas, Lithuania) 20070101

• Prospective Acid Reflux Study of Iran (PARSI): methodology and study design.

  BMC gastroenterology 20070101

• Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors.

  Digestion 20070101

• Effect of intravenous esomeprazole 40 mg and pantoprazole 40 mg on intragastric pH in healthy subjects. A prospective, open, randomised, two-way cross-over comparative study.

  Arzneimittel-Forschung 20070101

• [Eradication of Helicobacter pylori: triple treatment scheme plus Lactobacillus vs. triple treatment alone].

  Cirugia y cirujanos 20070101

• External validation of a measurement tool to assess systematic reviews (AMSTAR).

  PloS one 20070101

• Posterior mediastinal hematoma - a rare case following a fall from standing height: a case report.

  Journal of medical case reports 20070101

• The effect of probiotics on Helicobacter pylori eradication.

  Hepato-gastroenterology 20070101

• Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20070101

• Assessment of the pharmaceutical quality of omeprazole capsule brands marketed in Egypt.

  Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 20070101

• [New approach to the treatment and prophylaxis of NSAID-induced gastropathies in ambulatory practics].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101

• [Efficiency and safety of the intravenous application of esomeprazole (nexium - Astra Zeneca) in high risk patients subjected to mechanic ventilation].

  Khirurgiia 20070101

• Inflammation and oxidative stress in gastroesophageal reflux disease.

  Journal of clinical biochemistry and nutrition 20070101

• [Influence of omeprasole and lansoprasole on Na+, K+ -ATPase and Mg2+ -ATPase activity of the plasmatic membrane of myometrium smooth muscle cells].

  Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20070101

• Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis.

  Core evidence 20070101

• Wallenberg's Syndrome: An Unusual Case of Dysphagia.

  Case reports in gastroenterology 20070101

• A head to head comparison of oral vs intravenous omeprazole for patients with bleeding peptic ulcers with a clean base, flat spots and adherent clots.

  World journal of gastroenterology 20061228

• Long-term proton pump inhibitor therapy and risk of hip fracture.

  JAMA 20061227

• Semipreparative enantiomeric separation of omeprazole by supercritical fluid chromatography.

  Journal of chromatography. A 20061222

• Cloning of a cDNA encoding a novel marmoset CYP2C enzyme, expression in yeast cells and characterization of its enzymatic functions.

  Biochemical pharmacology 20061215

• [Bartter syndrome--a rare cause of severe polyhydramnios].

  Ugeskrift for laeger 20061211

• A simple and sensitive bioanalytical assay for simultaneous determination of omeprazole and its three major metabolites in human blood plasma using RP-HPLC after a simple liquid-liquid extraction procedure.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061205

• Specific H+/K(+)-ATPase inhibitors decreased contractile responses of isolated rat vas deferens.

  Pharmacological research 20061201

• 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.

  Helicobacter 20061201

• Molecular pharmacological approach to drug actions on the afferent and efferent fibres of the vagal nerve involved in gastric mucosal protection in rats.

  Inflammopharmacology 20061201

• Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20061201

• Etiology of decreased gastric nitric oxide in the critically ill.

  Journal of investigative medicine : the official publication of the American Federation for Clinical Research 20061201

• A double blind, randomised placebo controlled trial of rifampicin with omeprazole in the treatment of human cutaneous leishmaniasis.

  Journal of vector borne diseases 20061201

• Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.

  Journal of Korean medical science 20061201

• Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response.

  Inflammopharmacology 20061201

• Utilization of a one-dimensional score for surveying chemical-induced changes in expression levels of multiple biomarker gene sets using a large-scale toxicogenomics database.

  The Journal of toxicological sciences 20061201

• An in vitro comparison of different providers to deliver four proton pump inhibitor products through a feeding tube.

  Alimentary pharmacology & therapeutics 20061201

• Boerhaave syndrome treated conservatively following early endoscopic diagnosis: a case report.

  Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20061201

• Continuous infusion or repeated intravenous bolus injection of high-dose omeprazole in patients at high risk of rebleeding from peptic ulcers?

  The American journal of gastroenterology 20061201

• Involvement of cyclooxygenase-1, prostaglandin E2 and EP1 receptors in acid-induced HCO3- secretion in stomach.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20061201

• [Safety of proton pump inhibitors].

  Medicina clinica 20061125

• Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.

  Alimentary pharmacology & therapeutics 20061115

• Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial.

  Alimentary pharmacology & therapeutics 20061115

• Stability and viscosity of a flavored omeprazole oral suspension for pediatric use.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20061115

• Conservative management of esophageal perforation following obesity surgery.

  Sao Paulo medical journal = Revista paulista de medicina 20061107

• [Antiplatelet therapy after aspirin-induced upper gastrointestinal bleeding].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20061102

• [Anaphylaxis caused by omeprazole].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20061101

• Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.

  American journal of physiology. Gastrointestinal and liver physiology 20061101

• Gastric type H+,K+-ATPase in the cochlear lateral wall is critically involved in formation of the endocochlear potential.

  American journal of physiology. Cell physiology 20061101

• Pharmacokinetics of omeprazole in rats with water deprivation for 72 hours.

  Biopharmaceutics & drug disposition 20061101

• Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin.

  Journal of thrombosis and haemostasis : JTH 20061101

• Finasteride 1 mg has no inhibitory effect on omeprazole metabolism in extensive and poor metabolizers for CYP2C19 in Japanese.

  European journal of clinical pharmacology 20061101

• Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease.

  The American journal of gastroenterology 20061101

• Randomized comparison of two rescue therapies for Helicobacter pylori infection.

  European journal of clinical investigation 20061101

• Excessively high doses of omeprazole being used in infants.

  Journal of paediatrics and child health 20061101

• Review article: from 1906 to 2006--a century of major evolution of understanding of gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20061101

• Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?

  International journal of clinical practice 20061101

• A 59-year-old woman with gastroesophageal reflux disease and barrett esophagus, 4 years later.

  JAMA 20061101

• Anti-ulcer effect of tea catechin in rats.

  Biological & pharmaceutical bulletin 20061101

• Pseudomonas simiae sp. nov., isolated from clinical specimens from monkeys (Callithrix geoffroyi).

  International journal of systematic and evolutionary microbiology 20061101

• Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status.

  Clinical pharmacology and therapeutics 20061101

• Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20061101

• Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20061101

• Treatment of gastroesophageal reflux disease.

  Jornal de pediatria 20061101

• Safety profile of proton pump inhibitors according to the spontaneous reports of suspected adverse reactions.

  International journal of clinical pharmacology and therapeutics 20061101

• Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: a randomized, open-label study.

  Clinical therapeutics 20061101

• Proton-pump inhibitors and hypomagnesemic hypoparathyroidism.

  The New England journal of medicine 20061026

• Therapeutic ritonavir-boosted atazanavir plasma concentration and concurrent omeprazole use.

  AIDS (London, England) 20061024

• Does delayed gastric emptying shorten the H pylori eradication period? A double blind clinical trial.

  World journal of gastroenterology 20061021

• Expression of HSP72 in the gastric mucosa is regulated by gastric acid in rats-correlation of HSP72 expression with mucosal protection.

  Biochemical and biophysical research communications 20061020

• Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.

  Alimentary pharmacology & therapeutics 20061015

• An in vitro investigation on acid catalyzed reactions of proton pump inhibitors in the absence of an electrophile.

  International journal of pharmaceutics 20061012

• Enantiomeric separation of omeprazole and its metabolite 5-hydroxyomeprazole using non-aqueous capillary electrophoresis.

  Journal of chromatography. A 20061006

• Endoplasmic reticulum stress response is involved in the pathogenesis of stress induced gastric lesions in rats.

  Life sciences 20061004

• [Long term results of treatment by simple surgical closure of perforated gastroduodenal ulcer followed by eradication of Helicobacter pylori].

  Annales de chirurgie 20061001

• Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data.

  Drug metabolism and disposition: the biological fate of chemicals 20061001

• Effect of acid secretion blockade on acute gastric mucosal lesions induced by Tityus serrulatus scorpion toxin in anaesthetized rats.

  Toxicon : official journal of the International Society on Toxinology 20061001

• Regression of gastroesophageal reflux disease symptoms using dietary supplementation with melatonin, vitamins and aminoacids: comparison with omeprazole.

  Journal of pineal research 20061001

• Urea, fluorofamide, and omeprazole treatments alter helicobacter colonization in the mouse gastric mucosa.

  Helicobacter 20061001

• Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.

  Journal of clinical pharmacology 20061001

• Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment.

  Scandinavian journal of gastroenterology 20061001

• Delivery of esomeprazole magnesium through nasogastric and gastrostomy tubes using an oral liquid vehicle as a suspending agent in vitro.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20061001

• Proton pump inhibitors: indigestion for nephrologists!

  Nephrology (Carlton, Vic.) 20061001

• Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases.

  Nephrology (Carlton, Vic.) 20061001

• Potential relationship between gastroesophageal reflux disease and atrial arrhythmias.

  Journal of clinical gastroenterology 20061001

• The role of proton-pump inhibitor therapy in patients with gastroesophageal reflux disease and difficult-to-control asthma.

  Expert opinion on pharmacotherapy 20061001

• Canine gastrinoma: a case study and literature review of therapeutic options.

  New Zealand veterinary journal 20061001

• Endothelin-1, inducible nitric oxide synthase and macrophage inflammatory protein-1alpha in the pathogenesis of stress ulcer in neurotraumatic patients.

  The Journal of trauma 20061001

• Proton pump inhibitors.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20061001

• [Laparoscopic Dor-hemifundoplication for therapy of gastroesophageal reflux disease].

  Zentralblatt fur Chirurgie 20061001

• Interaction studies of omeprazole with mefloquine, pyrimethamine and sulfadoxine.

  Pakistan journal of pharmaceutical sciences 20061001

• [The influence of gastroesophageal reflux on the course and therapy of bronchial asthma].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20061001

• Medical treatment of gastro-oesophageal reflux disease.

  Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20061001

• Diffuse gastroduodenitis and pouchitis associated with ulcerative colitis.

  World journal of gastroenterology 20060928

• [Dosaging of proton pumps inhibitors].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20060921

• pH-dependent nitration of para-hydroxyphenylacetic acid in the stomach.

  Free radical biology & medicine 20060915

• Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants.

  Free radical biology & medicine 20060915

• Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.

  Alimentary pharmacology & therapeutics 20060915

• Thyroxine in goiter, H. pylori infection, and gastritis.

  The New England journal of medicine 20060914

• Furazolidone-based triple therapy for H pylori gastritis in children.

  World journal of gastroenterology 20060914

• Determination of omeprazole, hydroxyomeprazole and omeprazole sulfone using automated solid phase extraction and micellar electrokinetic capillary chromatography.

  Journal of pharmaceutical and biomedical analysis 20060911

• Physical and thermal characterisation of chiral omeprazole sodium salts.

  Journal of pharmaceutical and biomedical analysis 20060911

• Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled 'ENTER' trial.

  The American journal of gastroenterology 20060901

• Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.

  The American journal of gastroenterology 20060901

• Gastric and esophageal pH in patients with Barrett's esophagus treated with three esomeprazole dosages: a randomized, double-blind, crossover trial.

  The American journal of gastroenterology 20060901

• Effects of single doses of rabeprazole 20 mg and esomeprazole 40 mg on 24-h intragastric pH in healthy subjects.

  European journal of clinical pharmacology 20060901

• Proton pump inhibitors reduce gallbladder function.

  Surgical endoscopy 20060901

• Gastroesophageal reflux disease in 2006. The imperfect diagnosis.

  Pediatric radiology 20060901

• Comparison of the efficacy of rabeprazole 10 mg and omeprazole 20 mg for the healing rapidity of peptic ulcer diseases.

  Journal of gastroenterology and hepatology 20060901

• Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism.

  Journal of gastroenterology and hepatology 20060901

• Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs.

  Alimentary pharmacology & therapeutics 20060901

• Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.

  Alimentary pharmacology & therapeutics 20060901

• Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20060901

• Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial.

  Digestive diseases and sciences 20060901

• Monitoring cytochrome P-450 activity during rabeprazole treatment in patients with gastresophageal reflux disease.

  Digestive diseases and sciences 20060901

• Esophageal intramural pseudodiverticulosis with esophageal strictures successfully treated with dilation therapy.

  The Annals of thoracic surgery 20060901

• Treatment of laryngopharyngeal reflux improves asthma symptoms in asthmatics.

  The Journal of asthma : official journal of the Association for the Care of Asthma 20060901

• Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency.

  Journal of clinical gastroenterology 20060901

• Treatment of chronic posterior laryngitis with esomeprazole.

  The Laryngoscope 20060901

• Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.

  The American journal of gastroenterology 20060901

• Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.

  The American journal of gastroenterology 20060901

• Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.

  The American journal of gastroenterology 20060901

• The effect of CYP2C19 substrate on the metabolism of melatonin in the elderly: A randomized, double-blind, placebo-controlled study.

  Methods and findings in experimental and clinical pharmacology 20060901

• [Influence of CYP2C19 polymorphism and Helicobacter pylori status on the antisecretory effect of omeprazole in gastroesophageal reflux disease].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060901

• Esomeprazole versus pantoprazole for healing erosive oesophagitis.

  Collegium antropologicum 20060901

• Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial.

  Clinical therapeutics 20060901

• 14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20060901

• Gastroprotective and ulcer-healing activity of oleanolic acid derivatives: in vitro-in vivo relationships.

  Life sciences 20060829

• Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.

  World journal of gastroenterology 20060814

• Pharmacodynamic and kinetic effect of rabeprazole on serum gastrin level in relation to CYP2C19 polymorphism in Chinese Hans.

  World journal of gastroenterology 20060807

• Effects of prototypical drug-metabolizing enzyme inducers on mRNA expression of housekeeping genes in primary cultures of human and rat hepatocytes.

  Biochemical and biophysical research communications 20060804

• Acid-suppressive effects of generic omeprazole: comparison of three brands of generic omeprazole with original omeprazole.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060801

• Induction of CYP1A and cyp2-mediated arachidonic acid epoxygenation and suppression of 20-hydroxyeicosatetraenoic acid by imidazole derivatives including the aromatase inhibitor vorozole.

  Drug metabolism and disposition: the biological fate of chemicals 20060801

• Generic versus brand-name medicinal products: are they really interchangeable?

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060801

• Letter to the Editor regarding pediatric postcricoid masses.

  International journal of pediatric otorhinolaryngology 20060801

• Use of omeprazole sulfone in a single plasma sample as a probe for CYP3A4.

  European journal of clinical pharmacology 20060801

• Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation.

  The American journal of gastroenterology 20060801

• Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole.

  The American journal of gastroenterology 20060801

• Silent reflux: ex juvantibus criteria for diagnosis and treatment of laryngeal disorders.

  Acta oto-laryngologica 20060801

• [Neurological manifestations in critically ill patients].

  Revista de neurologia 20060801

• Esomeprazole-based 1-week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children.

  Journal of pediatric gastroenterology and nutrition 20060801

• Efficacy and safety of rabeprazole, amoxicillin, and gatifloxacin after treatment failure of initial Helicobacter pylori eradication.

  Helicobacter 20060801

• Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.

  Helicobacter 20060801

• Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.

  The American journal of gastroenterology 20060801

• Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapy.

  The Annals of otology, rhinology, and laryngology 20060801

• Regulation of mRNA expression of MDR1, MRP1, MRP2 and MRP3 by prototypical microsomal enzyme inducers in primary cultures of human and rat hepatocytes.

  Drug metabolism and pharmacokinetics 20060801

• Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs.

  Pharmacy world & science : PWS 20060801

• Continuation of proton pump inhibitors from hospital to community.

  Pharmacy world & science : PWS 20060801

• Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.

  Pharmacy world & science : PWS 20060801

• [The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients].

  Zhonghua nei ke za zhi 20060801

• Effect of omeprazole on markers of performance in gastric ulcer-free standardbred horses.

  Equine veterinary journal. Supplement 20060801

• Azithromycin in one week quadruple therapy for H pylori eradication in Iran.

  World journal of gastroenterology 20060728

• Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

  Journal of the National Cancer Institute 20060719

• Predictors of treatment response in patients with non-erosive reflux disease.

  Alimentary pharmacology & therapeutics 20060715

• Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.

  Alimentary pharmacology & therapeutics 20060715

• The role of molecular interaction fields on enantioselective and nonselective separation of chiral sulfoxides.

  Journal of chromatography. A 20060714

• Use of proton pump inhibitors during pregnancy and breastfeeding.

  Canadian family physician Medecin de famille canadien 20060710

• Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells.

  Biochemical and biophysical research communications 20060707

• Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats.

  Biopharmaceutics & drug disposition 20060701

• Profiling the hepatic effects of flutamide in rats: a microarray comparison with classical aryl hydrocarbon receptor ligands and atypical CYP1A inducers.

  Drug metabolism and disposition: the biological fate of chemicals 20060701

• Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol from hops (Humulus lupulus L.).

  Drug metabolism and disposition: the biological fate of chemicals 20060701

• Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060701

• Can heterotopic gastric mucosa present as globus pharyngeus?

  The Journal of laryngology and otology 20060701

• Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts.

  Gut 20060701

• A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease.

  The Tohoku journal of experimental medicine 20060701

• Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo.

  European journal of clinical pharmacology 20060701

• Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060701

• Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.

  Alimentary pharmacology & therapeutics 20060701

• Influences of proinflammatory and anti-inflammatory cytokine polymorphisms on eradication rates of clarithromycin-sensitive strains of Helicobacter pylori by triple therapy.

  Clinical pharmacology and therapeutics 20060701

• Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole.

  Journal of clinical gastroenterology 20060701

• The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis.

  The American journal of gastroenterology 20060701

• Should the presence of polymorphisms of CYP2C19 enzymes influence the choice of the proton pump inhibitor for treatment of Helicobacter pylori infection?

  The American journal of gastroenterology 20060701

• Prediction of metabolic drug clearance in humans: in vitro-in vivo extrapolation vs allometric scaling.

  Xenobiotica; the fate of foreign compounds in biological systems 20060701

• By the way, doctor. I've been taking Prilosec for over a year for GERD. Recently, I read that long-term use of proton pump inhibitors increases the risk of certain gastric cancers. Your opinion?

  Harvard women's health watch 20060701

• Determination and validation of ketoprofen, pantoprazole and valsartan together in human plasma by high performance liquid chromatography.

  Die Pharmazie 20060701

• Enantiomeric separation of chiral sulfoxides by supercritical fluid chromatography.

  Journal of separation science 20060701

• Effects of rabeprazole or famotidine during cardiac surgery on perioperative gastric and esophageal pH readings.

  The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 20060701

• Severe laryngeal hyperkeratosis secondaryto laryngopharyngeal reflux.

  Ear, nose, & throat journal 20060701

• Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem.

  International journal of clinical pharmacology and therapeutics 20060701

• The complete remission concept.

  Drugs of today (Barcelona, Spain : 1998) 20060701

• Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.

  World journal of gastroenterology 20060628

• Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy.

  World journal of gastroenterology 20060628

• Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers.

  AIDS (London, England) 20060626

• Development and validation of a dissolution test for rabeprazole sodium in coated tablets.

  Journal of pharmaceutical and biomedical analysis 20060607

• Determination of omeprazole in rat plasma by high-performance liquid chromatography without solvent extraction.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060606

• Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20060601

• Evidence for the regulation of left-right asymmetry in Ciona intestinalis by ion flux.

  Developmental dynamics : an official publication of the American Association of Anatomists 20060601

• Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers.

  Journal of pharmaceutical sciences 20060601

• Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection.

  Helicobacter 20060601

• Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.

  Helicobacter 20060601

• Switch patterns before and after patent expiry of omeprazole: a case study in The Netherlands.

  Alimentary pharmacology & therapeutics 20060601

• Effect of frequent dosing of an oral proton pump inhibitor on intragastric pH.

  Alimentary pharmacology & therapeutics 20060601

• Review article: the opportunities and benefits of extended acid suppression.

  Alimentary pharmacology & therapeutics 20060601

• Effects of plastoquinones from the brown alga Sargassum micracanthum and a new chromene derivative converted from the plastoquinones on acute gastric lesions in rats.

  Biological & pharmaceutical bulletin 20060601

• Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products.

  Chemical & pharmaceutical bulletin 20060601

• Enantioselective disposition of lansoprazole and rabeprazole in human plasma.

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060601

• Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?

  European journal of clinical pharmacology 20060601

• Should we bravo?

  Gastroenterology 20060601

• Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.

  The American journal of gastroenterology 20060601

• Management of the dyspeptic patient: anything goes?

  The American journal of gastroenterology 20060601

• Eradication of Helicobacter pylori and dosages of esomeprazole.

  The American journal of gastroenterology 20060601

• Gastroesophageal reflux disease and asthma: the role of proton pump inhibitors.

  Chest 20060601

• Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve.

  Therapeutic drug monitoring 20060601

• Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.

  Lasers in surgery and medicine 20060601

• Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada.

  Journal of managed care pharmacy : JMCP 20060601

• The effect of luteolin-7-O-beta-D-glucuronopyranoside on gastritis and esophagitis in rats.

  Archives of pharmacal research 20060601

• Prediction of in vivo drug clearance from in vitro data. II: potential inter-ethnic differences.

  Xenobiotica; the fate of foreign compounds in biological systems 20060601

• The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan.

  Journal of gastroenterology 20060601

• [Effects of proton pump inhibitor on airway hyperresponsiveness in asthmatics with gastroesophageal reflux].

  Arerugi = [Allergy] 20060601

• Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.

  Journal of experimental & clinical cancer research : CR 20060601

• [Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori].

  La Tunisie medicale 20060601

• Voriconazole in the management of nosocomial invasive fungal infections.

  Therapeutics and clinical risk management 20060601

• Efficacy of one-day quadruple therapy for H pylori infection in Chinese patients.

  World journal of gastroenterology 20060521

• Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial.

  American journal of respiratory and critical care medicine 20060515

• Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20060515

• Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction.

  Journal of pharmaceutical and biomedical analysis 20060503

• Role of CYP3A4 in the regulation of the aryl hydrocarbon receptor by omeprazole sulphide.

  Cellular signalling 20060501

• Degradation of lansoprazole and omeprazole in the aquatic environment.

  Chemosphere 20060501

• In vitro activity of levofloxacin against Helicobacter pylori isolates from patients after treatment failure.

  Diagnostic microbiology and infectious disease 20060501

• Ion flow regulates left-right asymmetry in sea urchin development.

  Development genes and evolution 20060501

• Ritonavir-boosted atazanavir may be efficacious in HIV-infected patients concurrently receiving omeprazole.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial.

  European journal of gastroenterology & hepatology 20060501

• Helicobacter heilmanii gastritis in polymyositis.

  European journal of internal medicine 20060501

• Gastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy.

  Alimentary pharmacology & therapeutics 20060501

• Healing rates for moderate and severe oesophagitis.

  Alimentary pharmacology & therapeutics 20060501

• Proton pump inhibitors and acute interstitial nephritis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060501

• Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail.

  Journal of clinical pharmacology 20060501

• Coadministration of esomeprazole with fosamprenavir has no impact on steady-state plasma amprenavir pharmacokinetics.

  Journal of acquired immune deficiency syndromes (1999) 20060501

• Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.

  Journal of acquired immune deficiency syndromes (1999) 20060501

• A multicenter, randomized, double-blind, 8-week comparative trial of standard doses of esomeprazole (40 mg) and omeprazole (20 mg) for the treatment of erosive esophagitis.

  Digestive diseases and sciences 20060501

• Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.

  Pediatrics 20060501

• Cutaneous hyperpigmentation induced by omeprazole mimicking ashy dermatosis.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20060501

• Primary cutaneous MALT-type lymphoma and Helicobacter pylori: a possible relationship.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20060501

• Heliosphere Bag in the treatment of severe obesity: preliminary experience.

  Obesity surgery 20060501

• [Financial restrictions in health care systems could affect treatment quality of GERD-patients].

  Zeitschrift fur Gastroenterologie 20060501

• Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients.

  Digestive diseases and sciences 20060501

• A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis.

  Digestive diseases and sciences 20060501

• Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers.

  Clinical therapeutics 20060501

• Hydroxyl radical scavenging reactivity of proton pump inhibitors.

  Biochemical pharmacology 20060428

• Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.

  Biochemical pharmacology 20060428

• Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting.

  World journal of gastroenterology 20060428

• Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis.

  The New England journal of medicine 20060427

• Comparison of the effects of fasting morning, fasting evening and fed bedtime administration of tenatoprazole on intragastric pH in healthy volunteers: a randomized three-way crossover study.

  Alimentary pharmacology & therapeutics 20060415

• Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole.

  Alimentary pharmacology & therapeutics 20060415

• Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study.

  Alimentary pharmacology & therapeutics 20060415

• Proton pump inhibitor failure in gastro-oesophageal reflux disease--what about eosinophilic oesophagitis?

  Alimentary pharmacology & therapeutics 20060415

• Diagnostic and management problems of laryngopharyngeal reflux disease in children.

  International journal of pediatric otorhinolaryngology 20060401

• In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism.

  Drug metabolism and disposition: the biological fate of chemicals 20060401

• In silico and in vitro screening for inhibition of cytochrome P450 CYP3A4 by comedications commonly used by patients with cancer.

  Drug metabolism and disposition: the biological fate of chemicals 20060401

• Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation.

  Gut 20060401

• Esomeprazole for the prevention of postoperative nausea and vomiting. A randomized, placebo-controlled trial.

  European journal of anaesthesiology 20060401

• Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.

  The American journal of gastroenterology 20060401

• Comparison of the effects of proton pump inhibitors on human plasma adrenocorticotropic hormone and cortisol levels under the starved condition.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20060401

• Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infection.

  Pharmacotherapy 20060401

• Effect of omeprazole on bioavailability of an oral extended-release formulation of ciprofloxacin.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060401

• Proton pump inhibition prevents gastrointestinal bleeding in ultramarathon runners: a randomised, double blinded, placebo controlled study.

  British journal of sports medicine 20060401

• Pantoprazole-induced thrombocytopenia.

  The Annals of pharmacotherapy 20060401

• Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h.

  Alimentary pharmacology & therapeutics 20060401

• Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages.

  Alimentary pharmacology & therapeutics 20060401

• The effects of esomeprazole combined with aspirin or rofecoxib on prostaglandin E2 production in patients with Barrett's oesophagus.

  Alimentary pharmacology & therapeutics 20060401

• A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences.

  Clinical pharmacology and therapeutics 20060401

• Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor.

  Cancer research 20060401

• Design and evaluation of jingzhiguanxin monolithic osmotic pump tablet.

  Chemical & pharmaceutical bulletin 20060401

• Extramedullary relapse of multiple myeloma presenting as hematemesis and melena.

  Nature clinical practice. Oncology 20060401

• Porfimer: new drug. Endobrachyesophagus: encouraging preliminary results.

  Prescrire international 20060401

• Gastrin increases murine intestinal crypt regeneration following injury.

  Gastroenterology 20060401

• Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis.

  International journal of clinical pharmacology and therapeutics 20060401

• Chronic diarrhea and weight loss in three horses.

  The Veterinary clinics of North America. Equine practice 20060401

• Cholelithiasis and hepatic fibrosis in a standardbred mare.

  The Veterinary clinics of North America. Equine practice 20060401

• A COX-2-specific inhibitor plus a proton-pump inhibitor: is this a reasonable approach to reduction in NSAIDs' GI toxicity?

  The American journal of gastroenterology 20060401

• Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole.

  Journal of pediatric gastroenterology and nutrition 20060401

• Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease.

  Journal of pediatric gastroenterology and nutrition 20060401

• Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.

  Journal of gastroenterology and hepatology 20060401

• [Duodenal angiodysplasia and Turner's syndrome. Case report].

  Il Giornale di chirurgia 20060401

• Co-prescription of alginate based formulations & proton pump inhibitors (PPIs) in gastro-oesophageal reflux disease: time for rethink?

  The Indian journal of medical research 20060401

• Administration of an alginate based gastric reflux suppressant on the bioavailability of omeprazole.

  The Indian journal of medical research 20060401

• [Long-term treatment of patients with symptomatic gastroesophageal reflux disease comparing costs and efficacy over 6 months of treatment with Nexium On-Demand Treatment or Nexium continuous treatment. An open, randomised multi-center study].

  Praxis 20060329

• Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration.

  British journal of cancer 20060327

• Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial.

  World journal of gastroenterology 20060321

• Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.

  Alimentary pharmacology & therapeutics 20060315

• Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.

  Alimentary pharmacology & therapeutics 20060315

• Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.

  Biochemical pharmacology 20060314

• [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].

  Orvosi hetilap 20060312

• Antiulcerogenic and ulcer healing effects of Solanum nigrum (L.) on experimental ulcer models: possible mechanism for the inhibition of acid formation.

  Journal of ethnopharmacology 20060308

• Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060307

• Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.

  Respiratory medicine 20060301

• An amino acid transporter involved in gastric acid secretion.

  Pflugers Archiv : European journal of physiology 20060301

• Disease-modifying anti-rheumatic drugs are only one of a number of potential causes of myelosuppression: a careful drug history is necessary to elucidate the cause of an adverse event.

  Rheumatology (Oxford, England) 20060301

• Omeprazole-induced dermatomyositis.

  The British journal of dermatology 20060301

• The effects of changing temperature correction factors on measures of acidity calculated from gastric and oesophageal pH recordings.

  Alimentary pharmacology & therapeutics 20060301

• Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial.

  Alimentary pharmacology & therapeutics 20060301

• Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis.

  The Journal of rheumatology 20060301

• Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.

  Alimentary pharmacology & therapeutics 20060301

• Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status.

  British journal of clinical pharmacology 20060301

• Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes.

  British journal of clinical pharmacology 20060301

• Hydroxylation of lansoprazole in poor metabolizers of CYP2C19.

  British journal of clinical pharmacology 20060301

• Use of omeprazole as a CYP3A probe drug: effect of sex and menstrual cycle phase on CYP3A activity in healthy Caucasian adults.

  Journal of clinical pharmacology 20060301

• Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes.

  International journal of clinical practice 20060301

• Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials.

  Scandinavian journal of gastroenterology 20060301

• Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers.

  Pharmacotherapy 20060301

• Long-term results of upper respiratory syndrome surgery and gastrointestinal tract medical treatment in 51 brachycephalic dogs.

  The Journal of small animal practice 20060301

• Hypersensitivity to lansoprazole and rabeprazole with tolerance to other proton pump inhibitors.

  The Journal of allergy and clinical immunology 20060301

• Proton pump inhibitor therapy in atazanavir-treated patients: contraindicated?

  Journal of acquired immune deficiency syndromes (1999) 20060301

• Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.

  The American journal of gastroenterology 20060301

• Studies on drug interactions between esomeprazole, amoxicillin and clarithromycin in healthy subjects.

  International journal of clinical pharmacology and therapeutics 20060301

• [Nuclear factor-kappaB mRNA and protein expression in stomach tissue of rats with gastric ulcer recurrence and effect of jianwei yuyang granule on its expression].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20060301

• Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777.

  Digestive diseases and sciences 20060301

• Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20060301

• Pharmacokinetic properties of esomeprazole in adolescent patients aged 12 to 17 years with symptoms of gastroesophageal reflux disease: A randomized, open-label study.

  Clinical therapeutics 20060301

• Helicobacter pylori associated gastroduodenal problem among the Nepalese.

  Nepal Medical College journal : NMCJ 20060301

• Improving the gastrointestinal tolerability of aspirin in older people.

  Clinical interventions in aging 20060301

• Microscopic colitis associated with exposure to lansoprazole.

  The Medical journal of Australia 20060220

• [Gastric protection and treatment with low-dose aspirin].

  Medicina clinica 20060218

• Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries.

  European journal of pharmacology 20060215

• Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.

  Alimentary pharmacology & therapeutics 20060215

• Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20060215

• Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials.

  Alimentary pharmacology & therapeutics 20060215

• Validation of a symptom diary for patients with gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20060215

• Interaction between tacrolimus and omeprazole in a pediatric liver transplant recipient.

  Transplantation 20060215

• Omeprazole maintenance therapy prevents recurrent ulcer bleeding after surgery for duodenal ulcer.

  World journal of gastroenterology 20060207

• Sensitive quantification of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060202

• Obstructive sleep apnoea is improved by a prolonged treatment of gastrooesophageal reflux with omeprazole.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060201

• Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060201

• Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?

  Platelets 20060201

• Territrems B and C metabolism in human liver microsomes: major role of CYP3A4 and CYP3A5.

  Toxicology 20060201

• What is the relationship between gastro-oesophageal reflux and obstructive sleep apnoea?

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20060201

• Acute severe myopathy following a single infusion of omeprazole.

  The Annals of pharmacotherapy 20060201

• Acid decomposition of omeprazole in the absence of thiol: a differential pulse polarographic study at the static mercury drop electrode (SMDE).

  Journal of pharmaceutical sciences 20060201

• Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype.

  European journal of clinical pharmacology 20060201

• Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20060201

• Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions.

  Alimentary pharmacology & therapeutics 20060201

• Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.

  Helicobacter 20060201

• 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.

  Helicobacter 20060201

• Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection.

  Helicobacter 20060201

• Twice-a-day quadruple therapy for eradication of Helicobacter pylori in the elderly.

  Helicobacter 20060201

• Prevalence and treatment of Helicobacter pylori in patients with blepharitis.

  Investigative ophthalmology & visual science 20060201

• Proton-pump inhibitors for upper-gastrointestinal bleeding.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060201

• Proton-pump inhibitors for upper-gastrointestinal bleeding.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060201

• Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.

  The American journal of gastroenterology 20060201

• Treatment of chronic posterior laryngitis with esomeprazole.

  The Laryngoscope 20060201

• Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20060201

• [Comparison of the effectiveness of quadruple salvage regimen for Helicobacter pylori infection according to the duration of treatment].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060201

• Determinants of long-term outcome of patients with reflux-related ear, nose, and throat symptoms.

  Digestive diseases and sciences 20060201

• In vitro effects of some drugs on human red blood cell glucose-6-phosphate dehydrogenase enzyme activity.

  Journal of enzyme inhibition and medicinal chemistry 20060201

• Peptic ulcer disease in a patient with ankylosing spondylitis receiving a conventional nonsteroidal anti-inflammatory drug.

  Nature clinical practice. Rheumatology 20060201

• Clarithromycin-resistant genotypes and eradication of Helicobacter pylori.

  Annals of internal medicine 20060117

• Protective and antioxidant effects of Rhizophora mangle L. against NSAID-induced gastric ulcers.

  Journal of ethnopharmacology 20060116

• A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20060115

• Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border.

  Alimentary pharmacology & therapeutics 20060115

• Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus.

  Alimentary pharmacology & therapeutics 20060115

• Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.

  World journal of gastroenterology 20060107

• Analysis of omeprazole and 5-OH omeprazole in human plasma using hydrophilic interaction chromatography with tandem mass spectrometry (HILIC-MS/MS)--eliminating evaporation and reconstitution steps in 96-well liquid/liquid extraction.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060102

• Attenuation of acid induced oesophagitis in VR-1 deficient mice.

  Gut 20060101

• Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis.

  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20060101

• BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients.

  International journal of obesity (2005) 20060101

• Conformational spaces of the gastrointestinal antisecretory chiral drug omeprazole: stereochemistry and tautomerism.

  Chirality 20060101

• Evaluation of noncardiac chest pain: diagnostic approach, coping strategies and quality of life.

  European journal of pain (London, England) 20060101

• Novel mutations in the cytochrome P450 2C19 gene: a pitfall of the PCR-RFLP method for identifying a common mutation.

  Journal of human genetics 20060101

• Fatal toxic epidermal necrolysis due to lansoprazole.

  Clinical and experimental dermatology 20060101

• Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis.

  International journal of molecular medicine 20060101

• Neurotoxicity related to valganciclovir in a child with impaired renal function: usefulness of therapeutic drug monitoring.

  The Annals of pharmacotherapy 20060101

• Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study.

  Annals of surgery 20060101

• A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer.

  BMC gastroenterology 20060101

• Long-term management of patients with symptoms of gastro-oesophageal reflux disease -- a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting.

  International journal of clinical practice 20060101

• A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.

  Clinical pharmacology and therapeutics 20060101

• Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19.

  Clinical pharmacology and therapeutics 20060101

• Validation of the blood quininium resin test for assessing gastric hypochlorhydria.

  Digestive diseases and sciences 20060101

• Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.

  Digestive diseases and sciences 20060101

• Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis.

  Digestive diseases and sciences 20060101

• Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.

  Digestive diseases and sciences 20060101

• A 30-month evaluation of the effects on the cost and utilization of proton pump inhibitors from adding omeprazole OTC to drug benefit coverage in a state employee health plan.

  Journal of managed care pharmacy : JMCP 20060101

• Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060101

• Duodenal hematoma following endoscopic duodenal biopsy: a case report and review of the existing literature.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20060101

• [A randomized, prospective, comparative, multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060101

• [Levofloxacin-azithromycin combined triple therapy for Helicobacter pylori eradication].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060101

• [A Case of Cronkhite-Canada syndrome showing resolution with Helicobacter pylori eradication and omeprazole].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060101

• Efficacy of a proton pump inhibitor given in the early postoperative period to relieve symptoms of hiatal hernia after open heart surgery.

  Surgery today 20060101

• Anaphylaxis to omeprazole: diagnosis and desensitization protocol.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060101

• Inlet patch of gastric mucosa in upper esophagus causing chronic cough and vocal cord dysfunction.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060101

• Cholecystoduodenal fistula secondary to penetrating duodenal ulcer: a case of conservative management.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20060101

• Non-variceal upper gastrointestinal bleeding.

  The Ulster medical journal 20060101

• Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.

  Journal of gastroenterology and hepatology 20060101

• Pharmacokinetics of tenatoprazole, a newly synthesized proton pump inhibitor, in healthy male Caucasian volunteers.

  Arzneimittel-Forschung 20060101

• Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review.

  The Laryngoscope 20060101

• Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874].

  BMC cancer 20060101

• Helicobacter pylori infection prevents nocturnal gastric acid breakthrough.

  Hepato-gastroenterology 20060101

• 'Best practice' for Helicobacter pylori eradication in the primary care setting.

  Irish medical journal 20060101

• Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

  Xenobiotica; the fate of foreign compounds in biological systems 20060101

• Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.

  Gerontology 20060101

• [Melatonin in treatment of duodenal ulcer].

  Klinicheskaia meditsina 20060101

• [Medical, social, and economic effectiveness of treatment of day-case patients with peptic ulcer].

  Klinicheskaia meditsina 20060101

• [Pseudomembranous colitis after Helicobacter pylori eradication therapy].

  Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20060101

• Intravenous proton pump inhibitors.

  Reviews in gastroenterological disorders 20060101

• Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study.

  BMC health services research 20060101

• [Economic evaluation of the treatment with aspirin plus esomeprazole compared to clopidogrel in gastrointestinal bleeding prevention].

  Gaceta sanitaria 20060101

• [Comment. Higher safety for patients and lower costs for society].

  Gaceta sanitaria 20060101

• Increased microvascular permeability in early stage of dextran sulfate sodium-induced colitis: its interaction with lansoprazole binding sites.

  Clinical hemorheology and microcirculation 20060101

• Is omeprazole or misoprostol superior for improving indomethacin-induced delayed maturation of granulation tissue in rat gastric ulcers?

  Digestion 20060101

• Drug injury in the upper gastrointestinal tract: nonsteroidal anti-inflammatory drugs.

  Gastrointestinal endoscopy clinics of North America 20060101

• Severe airway stenosis associated with Crohn's disease: case report.

  BMC pulmonary medicine 20060101

• Tumid lupus erythematosus: an unusual scleredema-like presentation.

  Skinmed 20060101

• Identification of acid reflux cough using serial assays of exhaled breath condensate pH.

  Cough (London, England) 20060101

• [Complex evaluation of the action of inhibitors of hydrochloric acid secretion on gastric function in ulcer disease].

  Terapevticheskii arkhiv 20060101

• Functional complementation of the yeast P-type H-ATPase, PMA1, by the Pneumocystis carinii P-type H-ATPase, PCA1.

  The Journal of eukaryotic microbiology 20060101

• An adult cystic fibrosis patient presenting with persistent dyspnea: case report.

  BMC pulmonary medicine 20060101

• Acid suppression therapy: where do we go from here?

  Digestive diseases (Basel, Switzerland) 20060101

• Rifaximin-based regimens for eradication of Helicobacter pylori: a pilot study.

  Digestive diseases (Basel, Switzerland) 20060101

• Helicobacter pylori infection is not associated with an increased hemorrhagic risk in patients in the intensive care unit.

  Critical care (London, England) 20060101

• Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.

  Journal of gastroenterology and hepatology 20060101

• Pharmacokinetic and pharmacodynamic population modeling of orally administered rabeprazole in healthy Chinese volunteers by the NONMEM method.

  European journal of drug metabolism and pharmacokinetics 20060101

• Possible interethnic differences in omeprazole pharmacokinetics : comparison of Jordanian Arabs with other populations.

  Clinical pharmacokinetics 20060101

• Omeprazole and misoprostol for preventing gastric mucosa effects caused by indomethacin and celecoxib in rats.

  Acta cirurgica brasileira 20060101

• Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD).

  Journal of occupational medicine and toxicology (London, England) 20060101

• The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.

  Molecular diagnosis & therapy 20060101

• Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature.

  Journal of investigational allergology & clinical immunology 20060101

• Effect of proton pump inhibitors on hepatic regeneration.

  European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20060101

• [Symptomatic high chromogranin A level associated with rabeprazole and ranitidine].

  Therapie 20060101

• Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough: a Cochrane systematic review.

  Chinese journal of digestive diseases 20060101

• Pro/con debate: octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin?

  Critical care (London, England) 20060101

• A meta-analysis: comparison of esomeprazole and other proton pump inhibitors in eradicating Helicobacter pylori.

  Digestion 20060101

• Quality of life in GERD patients: medical treatment versus antireflux surgery.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20060101

• Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia.

  Annals of Saudi medicine 20060101

• HPLC determination of omeprazole in human plasma using a monolithic column.

  Arzneimittel-Forschung 20060101

• Late-onset life threatening hemorrhage of omeprazole-resistant duodenal ulcer managed by interventional radiology: report of a case.

  Internal medicine (Tokyo, Japan) 20060101

• [Parotid phlegmon with involvement of both lobes. Report of a case].

  Anales otorrinolaringologicos ibero-americanos 20060101

• The Efficacy of Helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura--the first study in Turkey.

  Acta haematologica 20060101

• Comparative study of salivary pH and volume in adults with chronic laryngopharyngitis by gastroesophageal reflux disease before and after treatment.

  Brazilian journal of otorhinolaryngology 20060101

• [The effectiveness of SCENAR therapy in complex treatment of duodenal ulcer, and the mechanisms of its action].

  Klinicheskaia meditsina 20060101

• Heartburn severity does not predict disease severity in patients with erosive esophagitis.

  MedGenMed : Medscape general medicine 20060101

• Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.

  Clinical pharmacokinetics 20060101

• Atypical symptoms of GORD in Belgium: epidemiological features, current management and open label treatment with 40 mg esomeprazole for one month.

  Acta gastro-enterologica Belgica 20060101

• Pharmacokinetic drug interaction profiles of proton pump inhibitors.

  Drug safety 20060101

• Regulated spatial distribution of cyclooxygenases and lipoxygenases in Crohn's ulcer.

  Mediators of inflammation 20060101

• Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.

  Reviews in gastroenterological disorders 20060101

• Experimental model in the qualitative and quantitative assessment of non-Helicobacter gastric microflora under proton pump inhibitors action.

  Acta cirurgica brasileira 20060101

• Economic evaluation of empirical antisecretory therapy versus Helicobacter pylori test for management of dyspepsia: a randomized trial in primary care.

  International journal of technology assessment in health care 20060101

• Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A.

  International journal of medical sciences 20060101

• Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.

  BMC musculoskeletal disorders 20060101

• Evaluation of the activity of CYP2C19 in Gujrati and Marwadi subjects living in Mumbai (Bombay).

  BMC clinical pharmacology 20060101

• Effects of intravenously administrated omeprazole on gastric juice pH and gastric ulcer scores in adult horses.

  Journal of veterinary internal medicine 20060101

• Gastrin-secreting neoplasia in a cat.

  Journal of veterinary internal medicine 20060101

• Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease.

  Hepato-gastroenterology 20060101

• Antibiotics are not needed during tube thoracostomy for spontaneous pneumothorax: an observational case study.

  Journal of cardiothoracic surgery 20060101

• Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending.

  Health affairs (Project Hope) 20060101

• Recurrence of upper gastrointestinal bleeding after donepezil administration.

  Alzheimer disease and associated disorders 20060101

• Hypersensitivity reaction to mizolastine: study of cross reactions.

  Journal of investigational allergology & clinical immunology 20060101

• Efficacy and safety of Helicobacter pylori eradication therapy with omeprazole, amoxicillin and high- and low-dose clarithromycin in Japanese patients: a randomised, double-blind, multicentre study.

  Clinical drug investigation 20060101

• Therapeutic approach to 'downhill' esophageal varices bleeding due to superior vena cava syndrome in Behcet's disease: a case report.

  BMC gastroenterology 20060101

• Effect of aqueous extract of neem (Azadirachta indica) leaves on offensive and diffensive gastric mucosal factors in rats.

  Indian journal of physiology and pharmacology 20060101

• Drug interactions. Atazanavir and acid-reducing agents.

  TreatmentUpdate 20060101

• Toxic epidermal necrolysis due to omeprazole.

  European journal of dermatology : EJD 20060101

• Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse.

  Digestion 20060101

• [Safety of proton pump inhibitors for long-term application].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20060101

• Fundic gland polyps and PPI: the Mozart effect of gastrointestinal pathology?

  Polish journal of pathology : official journal of the Polish Society of Pathologists 20060101

• [The course of Helicobacter pylori-associated duodenal ulcer concurrent with chronic opisthorchiasis].

  Meditsinskaia parazitologiia i parazitarnye bolezni 20060101

• Pattern of drug prescription and utilization among Bam residents during the first six months after the 2003 Bam earthquake.

  Prehospital and disaster medicine 20060101

• Diagnostic value of the Reflux Disease Questionnaire in general practice.

  Digestion 20060101

• [Glandular tularemia--case report].

  Otolaryngologia polska = The Polish otolaryngology 20060101

• Prevalence of Helicobacter pylori infection in advanced gastric carcinoma.

  Arquivos de gastroenterologia 20060101

• Balloon-based electrode for the ablation of non-dysplastic Barrett's esophagus: ablation of intestinal metaplasia (AIM II Trial).

  Boletin de la Asociacion Medica de Puerto Rico 20060101

• Importance of Helicobacter pylori eradcation for maintenance of remission of drug associated peptic ulcer disease.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20060101

• Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy.

  World journal of gastroenterology 20051228

• The calcium-sensing receptor acts as a modulator of gastric acid secretion in freshly isolated human gastric glands.

  American journal of physiology. Gastrointestinal and liver physiology 20051201

• Esomeprazole therapy for gastric acid hypersecretion in children with cystinosis.

  Pediatric nephrology (Berlin, Germany) 20051201

• Comparison of P-glycoprotein-mediated drug-digoxin interactions in Caco-2 with human and rodent intestine: relevance to in vivo prediction.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20051201

• Effects of omeprazole or cola beverage on the pharmacokinetics of oral DA-8159, a new erectogenic, in rats.

  Biopharmaceutics & drug disposition 20051201

• [ASS or clopidogrel plus esomeprazole after bleeding from an ulcer].

  Der Internist 20051201

• Interaction magnitude, pharmacokinetics and pharmacodynamics of ticlopidine in relation to CYP2C19 genotypic status.

  Pharmacogenetics and genomics 20051201

• Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail.

  Journal of clinical pharmacology 20051201

• The effect of regular and high doses of omeprazole on the intragastric acidity in patients with bleeding peptic ulcer treated endoscopically: a clinical trial with continuous intragastric pH monitoring.

  European journal of gastroenterology & hepatology 20051201

• Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication.

  European journal of gastroenterology & hepatology 20051201

• Cryoablation of Barrett's esophagus: a pilot study.

  Gastrointestinal endoscopy 20051201

• Clinical implications of immediate-release PPI therapy in the management of GERD and upper GI bleeding. Introduction.

  Alimentary pharmacology & therapeutics 20051201

• Review article: similarities and differences among delayed-release proton-pump inhibitor formulations.

  Alimentary pharmacology & therapeutics 20051201

• Review article: immediate-release proton-pump inhibitor therapy--potential advantages.

  Alimentary pharmacology & therapeutics 20051201

• Review article: putting immediate-release proton-pump inhibitors into clinical practice--improving nocturnal acid control and avoiding the possible complications of excessive acid exposure.

  Alimentary pharmacology & therapeutics 20051201

• Review article: prevention of stress-related mucosal bleeding with proton-pump inhibitors.

  Alimentary pharmacology & therapeutics 20051201

• Review article: the role of antisecretory therapy in the management of non-variceal upper gastrointestinal bleeding.

  Alimentary pharmacology & therapeutics 20051201

• Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.

  Expert review of anti-infective therapy 20051201

• High-output stoma after small-bowel resections for Crohn's disease.

  Nature clinical practice. Gastroenterology & hepatology 20051201

• Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.

  Journal of gastroenterology and hepatology 20051201

• Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data.

  Clinical pharmacology and therapeutics 20051201

• Pharmacokinetics of oral omeprazole in llamas.

  Journal of veterinary pharmacology and therapeutics 20051201

• Pharmacodynamic study of a long-acting parenteral formulation of omeprazole in horses.

  Journal of veterinary pharmacology and therapeutics 20051201

• Gastroprotection and effect of the simultaneous administration of Cuachalalate (Amphipterygium adstringens) on the pharmacokinetics and anti-inflammatory activity of diclofenac in rats.

  The Journal of pharmacy and pharmacology 20051201

• A furazolidone-based quadruple therapy for Helicobacter pylori retreatment in patients with peptic ulcer disease.

  Clinics (Sao Paulo, Brazil) 20051201

• Rabeprazole experience in Korea; focus on CYP2C19 polymorphism.

  Journal of gastroenterology and hepatology 20051201

• CYP2C19 genotype and the PPIs--focus on rabeprazole.

  Journal of gastroenterology and hepatology 20051201

• Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20051201

• Pharmacokinetics of esomeprazole following varying intravenous administration rates.

  Basic & clinical pharmacology & toxicology 20051201

• All PPIs equivalent for treatment of GERD.

  The Journal of family practice 20051201

• [Comparison of Helicobacter pylori eradication rate according to different PPI-based triple therapy--omeprazole, rabeprazole, esomeprazole and lansoprazole--].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20051201

• Acute pancreatitis associated with omeprazole.

  International journal of clinical pharmacology and therapeutics 20051201

• Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study.

  The American journal of gastroenterology 20051201

• Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trial.

  The American journal of gastroenterology 20051201

• [Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy].

  Nihon rinsho. Japanese journal of clinical medicine 20051201

• Gastrointestinal tract.

  Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 20051201

• Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer.

  Journal of experimental & clinical cancer research : CR 20051201

• [Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis].

  Likars'ka sprava 20051201

• Comparison of pantoprazole- vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20051201

• Helicobacter pylori eradication in peptic dyspepsia.

  East African medical journal 20051201

• Idiopathic pure red cell aplasia: case report with review of literature.

  South Dakota journal of medicine 20051201

• Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin.

  Alimentary pharmacology & therapeutics 20051115

• Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20051115

• Effects of treatment with omeprazole or ranitidine on gastric squamous ulceration in racing Thoroughbreds.

  Journal of the American Veterinary Medical Association 20051115

• Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura.

  Annals of hematology 20051101

• Enantiomer/enantiomer interactions between the S- and R- isomers of omeprazole in human cytochrome P450 enzymes: major role of CYP2C19 and CYP3A4.

  The Journal of pharmacology and experimental therapeutics 20051101

• Nasal pain disrupting sleep as a presenting symptom of extraesophageal acid reflux in children.

  International journal of pediatric otorhinolaryngology 20051101

• Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics.

  The Annals of pharmacotherapy 20051101

• A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051101

• Review article: the management of heartburn in pregnancy.

  Alimentary pharmacology & therapeutics 20051101

• Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.

  Alimentary pharmacology & therapeutics 20051101

• Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20051101

• Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone.

  Alimentary pharmacology & therapeutics 20051101

• Balanced perspective essential in erosive oesophagitis treatment.

  Alimentary pharmacology & therapeutics 20051101

• Proton-pump inhibitor for peptic ulcer bleeding.

  Alimentary pharmacology & therapeutics 20051101

• General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: a pharmacoepidemiological study.

  British journal of clinical pharmacology 20051101

• In vivo metabolic activity of CYP2C19 and CYP3A in relation to CYP2C19 genetic polymorphism in chronic liver disease.

  Journal of clinical pharmacology 20051101

• Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease.

  Digestive diseases and sciences 20051101

• Development and validation of the Gastroesophageal Reflux Disease Treatment Satisfaction Questionnaire.

  Digestive diseases and sciences 20051101

• Gastric fundal polyps with cellular atypia in a patient using esomeprazole (Nexium).

  Digestive diseases and sciences 20051101

• Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.

  Journal of gastroenterology and hepatology 20051101

• Nonsecretory variant of immunoproliferative small intestinal disease: a case report with pathologic, immunophenotypic, and molecular findings.

  Archives of pathology & laboratory medicine 20051101

• Review of immediate-release omeprazole for the treatment of gastric acid-related disorders.

  Expert opinion on pharmacotherapy 20051101

• [Ingestion of foreign bodies containing lead].

  Anales de pediatria (Barcelona, Spain : 2003) 20051101

• Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20051101

• Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.

  The American journal of medicine 20051101

• A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication.

  The American journal of gastroenterology 20051101

• Helicobacter pylori: factors affecting eradication and recurrence.

  The American journal of gastroenterology 20051101

• Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.

  Gastroenterology 20051101

• Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20051101

• [The impact of rabeprazole treatment on the quality of life in patients with reflux esophagitis and non-erosive reflux disease].

  Zhonghua nei ke za zhi 20051101

• Identification and synthesis of potential impurities of rabeprazole sodium.

  Die Pharmazie 20051101

• 'Proton-pump inhibitor-first' strategy versus 'step-up' strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan.

  Journal of gastroenterology 20051101

• Effects of dietary oils on the development of gastric ulcers in mares.

  American journal of veterinary research 20051101

• Helicobacter pylori treatment.

  Southern medical journal 20051101

• Effect of N-acetyl cysteine on Helicobacter pylori.

  Southern medical journal 20051101

• [Gastroesophageal reflux and obstructive sleep apnea syndrome].

  Acta otorrinolaringologica espanola 20051101

• [Guidelines in the management of H. pylori infection in Japan].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Establishment of 2nd line treatment regimen for H. pylori infection--future prospect for the application for national health insurance system in Japan].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [H. pylori motility analysis].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Cap polyposis and Helicobacter pylori].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Recent topics on important drugs for H. pylori eradication: Omeprazole].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Recent topics on important drugs for H. pylori eradication: Lansoprazole].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Recent topics on important drugs for H. pylori eradication: Rabeprazole].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Recent topics on important drugs for H. pylori eradication: Pantoprazole sodium].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [H. pylori eradication package set (Lansap)].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Concomitant dosing of a H2 receptor antagonist (H2RA) with a triple therapy increases the cure rate of Helicobacter pylori infection].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Quality of ulcer healing and rebamipide].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Triple therapy for eradication of Helicobacter pylori in Japan].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Adverse effects of Helicobacter pylori eradication and its prevention].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Second-line eradication therapy for H. pylori infection--PPI+AMPC+MNZ triple therapy].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [PPI plus bismuth-based quintuple therapy].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Investigation about 3rd line eradication of H. pylori].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Helicobacter pylori eradication therapy for children].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Eradication therapy for the remnant stomach infected with Helicobacter pylori ].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Gastroduodenal erosions observed after Helicobacter pylori eradication].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Influence of cytochrome P450 2C19 genetic polymorphism on H. pylori eradication therapy].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• [Antibacterial activity of a Chinese herbal medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori].

  Nihon rinsho. Japanese journal of clinical medicine 20051101

• Interaction between omeprazole and tacrolimus in renal allograft recipients: a clinical-analytical study.

  Transplantation proceedings 20051101

• Esomeprazole: potent acid suppression in the treatment of acid-related disorders.

  Expert review of clinical immunology 20051101

• Medicine as a corporate enterprise, patient welfare centered profession, or patient welfare centered professional enterprise?

  Mens sana monographs 20051101

• [Acid inhibitors for asthma patients].

  MMW Fortschritte der Medizin 20051020

• [What does the H. pylori eradication bring?].

  MMW Fortschritte der Medizin 20051020

• Comparative study of the enantioselective separation of several antiulcer drugs by high-performance liquid chromatography and supercritical fluid chromatography.

  Journal of chromatography. A 20051014

• [Cytolytic hepatitis and esomeprazole during chemotherapy].

  Presse medicale (Paris, France : 1983) 20051008

• Gastroprotective effect of the Mapuche crude drug Araucaria araucana resin and its main constituents.

  Journal of ethnopharmacology 20051003

• Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma.

  British journal of cancer 20051003

• L-type amino acids stimulate gastric acid secretion by activation of the calcium-sensing receptor in parietal cells.

  American journal of physiology. Gastrointestinal and liver physiology 20051001

• Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20051001

• Gastric ulcer despite no acid in a renal allograft recipient: what is the link?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20051001

• A decade-long sour-taste sensation successfully treated with a proton-pump inhibitor.

  Journal of oral rehabilitation 20051001

• Comment: esomeprazole-induced central fever with severe myalgia.

  The Annals of pharmacotherapy 20051001

• Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis.

  Journal of clinical pharmacology 20051001

• Validity of the Glasgow Aneurysm Score and the Hardman Index in predicting outcome after ruptured abdominal aortic aneurysm repair (Br J Surg 2005; 92: 570-573).

  The British journal of surgery 20051001

• Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage.

  International journal of clinical practice 20051001

• Pharmacokinetic differences between pantoprazole enantiomers in rats.

  Pharmaceutical research 20051001

• Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus.

  Alimentary pharmacology & therapeutics 20051001

• Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg.

  Alimentary pharmacology & therapeutics 20051001

• Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.

  Helicobacter 20051001

• CagA status and Helicobacter pylori eradication among dyspeptic patients.

  Gastroenterologia y hepatologia 20051001

• Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.

  Gastrointestinal endoscopy 20051001

• Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor.

  Digestive diseases and sciences 20051001

• The efficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H2 antagonist therapy.

  Anesthesia and analgesia 20051001

• Additional discussions regarding the altered metabolism and transport of omeprazole after long-term use of St John's wort.

  Clinical pharmacology and therapeutics 20051001

• Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/ reoxygenation induced intestinal injury in newborn rats.

  Pediatric surgery international 20051001

• The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.

  Journal of veterinary pharmacology and therapeutics 20051001

• Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK.

  Current medical research and opinion 20051001

• Gastric pH, sevelamer hydrochloride and omeprazole.

  Clinical nephrology 20051001

• Effect of omeprazole on the hydroxylation of warfarin enantiomers in human: in-vitro studies with liver microsomes and cDNA-expressed cytochrome P450 isozymes.

  Current drug metabolism 20051001

• Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.

  Scandinavian journal of gastroenterology 20051001

• Effect of Cimetidine and Phenobarbital on metabolite kinetics of Omeprazole in rats.

  Archives of pharmacal research 20051001

• [Clinical observation on jiangni hewei decoction in treatment of 45 patients with reflux esophagitis].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20051001

• [The effect of muscovite on the quality of gastric ulcer healing].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20051001

• [Children Helicobacter pylori infection: antibiogram results].

  La Tunisie medicale 20051001

• Analysis of omeprazole, midazolam and hydroxy-metabolites in plasma using liquid chromatography coupled to tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050925

• Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050925

• Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.

  Journal of the National Cancer Institute 20050921

• Positive inotropic and negative chronotropic effects of proton pump inhibitors in isolated rat atrium.

  European journal of pharmacology 20050920

• Cyclo-oxygenase-2 expression and prostaglandin E2 production in experimental chronic gastric ulcer healing.

  European journal of pharmacology 20050920

• Determination of omeprazole in human plasma by liquid chromatography-electrospray quadrupole linear ion trap mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20050915

• Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.

  Bioorganic & medicinal chemistry letters 20050915

• Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD?

  International journal of cardiology 20050915

• [Oesophageal ulcer and doxycycline].

  Atencion primaria 20050915

• Proton pump inhibitors reduce the bioavailability of dietary vitamin C.

  Alimentary pharmacology & therapeutics 20050915

• The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.

  Alimentary pharmacology & therapeutics 20050915

• Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050901

• Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction.

  European journal of clinical pharmacology 20050901

• Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study.

  Journal of clinical gastroenterology 20050901

• Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease.

  European journal of gastroenterology & hepatology 20050901

• Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.

  Journal of gastroenterology and hepatology 20050901

• Management of symptoms in step-down therapy of gastroesophageal reflux disease.

  Journal of gastroenterology and hepatology 20050901

• Determinants of non-response in Helicobacter pylori eradication trials.

  Journal of gastroenterology and hepatology 20050901

• Stool antigen testing for the diagnosis and confirmation of eradication of Helicobacter pylori infection: a prospective blinded trial.

  Internal medicine journal 20050901

• Primary mucosa-associated lymphoid tissue lymphoma occurring in the rectum.

  Gastrointestinal endoscopy 20050901

• Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.

  Archives of disease in childhood 20050901

• The effect of cimetidine or omeprazole on the pharmacokinetics of escitalopram in healthy subjects.

  British journal of clinical pharmacology 20050901

• Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.

  The American journal of gastroenterology 20050901

• Long-term acid suppressive therapy may prevent the relapse of lower esophageal (Schatzki's) rings: a prospective, randomized, placebo-controlled study.

  The American journal of gastroenterology 20050901

• Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment?

  The American journal of gastroenterology 20050901

• Effect on intragastric pH of a PPI with a prolonged plasma half-life: comparison between tenatoprazole and esomeprazole on the duration of acid suppression in healthy male volunteers.

  The American journal of gastroenterology 20050901

• A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences.

  Digestive diseases and sciences 20050901

• Gastrin suppresses growth of CCK2 receptor expressing colon cancer cells by inducing apoptosis in vitro and in vivo.

  Gastroenterology 20050901

• Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms.

  Chest 20050901

• Persistence of resistant Staphylococcus epidermidis after single course of clarithromycin.

  Emerging infectious diseases 20050901

• Hepatic penetration of a single large duodenal ulcer.

  The Ulster medical journal 20050901

• Prostaglandins and ulcer healing.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20050901

• Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising.

  Clinical therapeutics 20050901

• Erythema multiforme in a spotted hyena (Crocuta crocuta).

  Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 20050901

• [Pharmaceutical analysis and validation of hospital prescriptions, a 5-year study].

  Presse medicale (Paris, France : 1983) 20050827

• The effect of gastro-oesophageal reflux and omeprazole on key sleep parameters.

  Alimentary pharmacology & therapeutics 20050815

• Is a long-term ranitidine-based triple therapy against Helicobacter pylori only a heritage of the past? A prospective, randomized clinicopharmacological study.

  Alimentary pharmacology & therapeutics 20050815

• Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20050815

• Long-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression.

  World journal of gastroenterology 20050814

• Comparative study and optimisation of the administration mode of three proton pump inhibitors by nasogastric tube.

  International journal of pharmaceutics 20050811

• High-performance liquid chromatography method for the quantification of pantoprazole in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805

• Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole.

  Gut 20050801

• Functional analysis of six human aryl hydrocarbon receptor variants in a Japanese population.

  Drug metabolism and disposition: the biological fate of chemicals 20050801

• Gastric cytoprotective activity of ilicic aldehyde: structure-activity relationships.

  Bioorganic & medicinal chemistry letters 20050801

• Allergy to lansoprazole: study of cross-reactivity among proton-pump inhibitors.

  Allergy 20050801

• One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050801

• Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels.

  Fundamental & clinical pharmacology 20050801

• Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodine.

  Journal of clinical pharmacology 20050801

• Review article: the long-term use of proton-pump inhibitors.

  Alimentary pharmacology & therapeutics 20050801

• Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.

  Therapeutic drug monitoring 20050801

• An overview of acetic acid ulcer models--the history and state of the art of peptic ulcer research.

  Biological & pharmaceutical bulletin 20050801

• Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.

  The American journal of gastroenterology 20050801

• Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis.

  Alimentary pharmacology & therapeutics 20050801

• Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States.

  Alimentary pharmacology & therapeutics 20050801

• Helicobacter pylori eradication, CYP2C19 and omeprazole doses.

  Alimentary pharmacology & therapeutics 20050801

• Omeprazole-induced hepatitis.

  Pediatric emergency care 20050801

• [The clinical strategy for the Barrett's esophagus].

  Nihon rinsho. Japanese journal of clinical medicine 20050801

• Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-blind, placebo-controlled efficacy study.

  Helicobacter 20050801

• [Comparison of esomeprazole- and omeprazole-based triple therapy regimens for duodenal ulcer with Helicobacter pylori infection].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20050801

• Protective effect of melatonin and omeprazole against alendronat-induced gastric damage.

  Digestive diseases and sciences 20050801

• 13C-urea breath test for success of Helicobacter pylori eradication: study of 5885 Israeli patients.

  Digestive diseases and sciences 20050801

• A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology.

  Digestive diseases and sciences 20050801

• The quantitative prediction of in vivo enzyme-induction caused by drug exposure from in vitro information on human hepatocytes.

  Drug metabolism and pharmacokinetics 20050801

• Proton-pump-inhibitor-induced hepatitis.

  Southern medical journal 20050801

• [The cause of failure of eradication treatment of Helicobacter pylori].

  Rinsho byori. The Japanese journal of clinical pathology 20050801

• Medication errors in an internal medicine department. Evaluation of a computerized prescription system.

  Pharmacy world & science : PWS 20050801

• Mechanisms of action of leptin in preventing gastric ulcer.

  World journal of gastroenterology 20050721

• A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20050715

• Allophylus serratus: a plant with potential anti-ulcerogenic activity.

  Journal of ethnopharmacology 20050714

• Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.

  World journal of gastroenterology 20050714

• Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis.

  World journal of gastroenterology 20050714

• Omeprazole-induced slowing of gastrointestinal transit in mice can be countered with tegaserod.

  European journal of pharmacology 20050704

• Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers.

  American journal of physiology. Gastrointestinal and liver physiology 20050701

• Expression and induction potential of cytochromes P450 in human cryopreserved hepatocytes.

  Drug metabolism and disposition: the biological fate of chemicals 20050701

• Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050701

• A gene expression fingerprint of mouse stomach ECL cells.

  Biochemical and biophysical research communications 20050701

• Variable omeprazole kinetics in healthy Jordanian adults.

  Biopharmaceutics & drug disposition 20050701

• Cost-effectiveness of a 'score and scope' strategy for the management of dyspepsia.

  European journal of gastroenterology & hepatology 20050701

• The effects of apigenin-7-O-beta-D-glucuronopyranoside on reflux oesophagitis and gastritis in rats.

  Autonomic & autacoid pharmacology 20050701

• Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod.

  Alimentary pharmacology & therapeutics 20050701

• Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status.

  Alimentary pharmacology & therapeutics 20050701

• Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.

  British journal of clinical pharmacology 20050701

• Role of sulfur chirality in the chemical processes of biology.

  Chemical Society reviews 20050701

• Pharmacodynamic comparison of pantoprazole enantiomers: inhibition of acid-related lesions and acid secretion in rats and guinea-pigs.

  The Journal of pharmacy and pharmacology 20050701

• Apparent anaphylaxis associated with pantoprazole.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050701

• Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050701

• Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection.

  European journal of clinical pharmacology 20050701

• Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients.

  Pathology international 20050701

• A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.

  The American journal of gastroenterology 20050701

• Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial.

  The American journal of medicine 20050701

• The healing course of thermal esophageal injury: a case report.

  Gastrointestinal endoscopy 20050701

• Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.

  The Laryngoscope 20050701

• Lansoprazole-associated collagenous colitis: a case report.

  Zeitschrift fur Gastroenterologie 20050701

• Pharmacokinetics and pharmacodynamics of pantoprazole in clinically normal neonatal foals.

  Equine veterinary journal 20050701

• Rate-limiting biotransformation of triamterene is mediated by CYP1A2.

  International journal of clinical pharmacology and therapeutics 20050701

• Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer.

  Digestive diseases and sciences 20050701

• The efficacy of high- and low-dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses.

  Digestive diseases and sciences 20050701

• Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry.

  Digestive diseases and sciences 20050701

• Influence of 1-week Helicobacter pylori eradication therapy with rabeprazole, clarithromycin, and metronidazole on 13C-aminopyrine breath test.

  Digestive diseases and sciences 20050701

• Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels?

  Digestive diseases and sciences 20050701

• Eradication of Helicobacter spp. from a rat breeding colony.

  Contemporary topics in laboratory animal science 20050701

• Investigations on the thermal behavior of omeprazole and other sulfoxides.

  Die Pharmazie 20050701

• Helicobacter pylori and recurrent pain abdomen.

  Indian journal of pediatrics 20050701

• EC fines AstraZeneca in Losec antitrust case.

  Nature reviews. Drug discovery 20050701

• Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.

  Naunyn-Schmiedeberg's archives of pharmacology 20050701

• Effects of antisecretory agents on angiogenesis during healing of gastric ulcers.

  Journal of gastroenterology 20050701

• Evaluation of Helicobacter pylori with a stool antigen assay in frail, elderly patients.

  Scandinavian journal of gastroenterology 20050701

• Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus.

  The Tokai journal of experimental and clinical medicine 20050701

• Understanding GERD symptoms in the clinical setting.

  Drugs of today (Barcelona, Spain : 1998) 20050701

• Extraesophageal manifestations of GERD: diagnosis and therapy.

  Drugs of today (Barcelona, Spain : 1998) 20050701

• Molecular characterization of rat gastric mucosal response to potent acid inhibition.

  Physiological genomics 20050616

• Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.

  Alimentary pharmacology & therapeutics 20050615

• High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.

  Alimentary pharmacology & therapeutics 20050615

• Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20050615

• Quality of gastric ulcer healing evaluated by endoscopic ultrasonography.

  World journal of gastroenterology 20050614

• Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes.

  Chirality 20050601

• Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.

  Gut 20050601

• Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050601

• Lack of significant effect of grapefruit juice on the pharmacokinetics of lansoprazole and its metabolites in subjects with different CYP2C19 genotypes.

  Journal of clinical pharmacology 20050601

• CYP35: xenobiotically induced gene expression in the nematode Caenorhabditis elegans.

  Archives of biochemistry and biophysics 20050601

• Six-month management of patients following treatment for gastroesophageal reflux disease symptoms -- a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general medical practitioners setting.

  International journal of clinical practice 20050601

• A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease.

  International journal of clinical practice 20050601

• Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases.

  International journal of clinical practice 20050601

• Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.

  Alimentary pharmacology & therapeutics 20050601

• Empirical treatment for the management of patients presenting with uninvestigated reflux symptoms: a prospective study in an Asian primary care population.

  Alimentary pharmacology & therapeutics 20050601

• The effect of rabeprazole on regional gastric acidity and the postprandial cardia/gastro-oesophageal junction acid layer in normal subjects: a randomized, double-blind, placebo-controlled study.

  Alimentary pharmacology & therapeutics 20050601

• Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis.

  Alimentary pharmacology & therapeutics 20050601

• [Cacosmia related to therapy with esomeprazole].

  La Revue de medecine interne 20050601

• Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer.

  Gastroenterology 20050601

• Effect of orally administered omeprazole on abomasal luminal pH in dairy calves fed milk replacer.

  Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20050601

• Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20050601

• Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20050601

• Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.

  Alimentary pharmacology & therapeutics 20050601

• Effect of famotidine on recurrent bleeding after successful endoscopic treatment of bleeding peptic ulcer.

  Alimentary pharmacology & therapeutics 20050601

• A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.

  Alimentary pharmacology & therapeutics 20050601

• Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.

  Journal of gastroenterology and hepatology 20050601

• Structure and mechanism of the lactose permease.

  Comptes rendus biologies 20050601

• Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050601

• Proton pump inhibitors may reduce tumour resistance.

  Expert opinion on pharmacotherapy 20050601

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies.

  Drug metabolism and pharmacokinetics 20050601

• Desmodium gangeticum: a potent anti-ulcer agent.

  Indian journal of experimental biology 20050601

• Efficacy of local omeprazoles in the treatment of peptic ulcer disease.

  JPMA. The Journal of the Pakistan Medical Association 20050601

• The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer.

  Collegium antropologicum 20050601

• [Application of the proton pump inhibitors in treatment of an acute gastro-intestinal bleeding of the ulcer etiology].

  Klinichna khirurhiia 20050601

• Pharmacist interventions in geriatric nursing facility NSAID therapy: a one-year follow-up study of costs and outcomes.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20050601

• The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.

  Research in social & administrative pharmacy : RSAP 20050601

• Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.

  World journal of gastroenterology 20050528

• Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis.

  World journal of gastroenterology 20050528

• Lexiva: blood levels not lowered when taken simultaneously with Nexium.

  AIDS treatment news 20050527

• Systematic overview of warfarin and its drug and food interactions.

  Archives of internal medicine 20050523

• The role of the third extracellular loop of the Na+,K+-ATPase alpha subunit in a luminal gating mechanism.

  The Journal of physiology 20050515

• Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.

  Alimentary pharmacology & therapeutics 20050515

• Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.

  Alimentary pharmacology & therapeutics 20050515

• Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20050515

• Efficacy of omeprazole paste for prevention of gastric ulcers in horses in race training.

  Journal of the American Veterinary Medical Association 20050515

• Efficacy of omeprazole paste for prevention of recurrence of gastric ulcers in horses in race training.

  Journal of the American Veterinary Medical Association 20050515

• Cylindrospermopsin genotoxicity and cytotoxicity: role of cytochrome P-450 and oxidative stress.

  Journal of toxicology and environmental health. Part A 20050514

• Ischemia of rat stomach mobilizes ECL cell histamine.

  American journal of physiology. Gastrointestinal and liver physiology 20050501

• The effect of pharmacologically altered gastric pH on cadmium absorption from the diet and its accumulation in murine tissues.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20050501

• Impact of stress ulcer prophylaxis algorithm study.

  The Annals of pharmacotherapy 20050501

• Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa.

  European journal of gastroenterology & hepatology 20050501

• Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement.

  Journal of clinical pharmacology 20050501

• Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors.

  The American journal of gastroenterology 20050501

• A simple method for differentiation of monoisotopic drug metabolites with hydrogen-deuterium exchange liquid chromatography/electrospray mass spectrometry.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20050501

• Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms?

  Journal of the European Academy of Dermatology and Venereology : JEADV 20050501

• Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?

  Journal of pediatric gastroenterology and nutrition 20050501

• Antibiotic-resistant Helicobacter pylori strains in Portuguese children.

  The Pediatric infectious disease journal 20050501

• [Pyopneumopericardium caused by perforation of gastric ulcer; report of a case].

  Kyobu geka. The Japanese journal of thoracic surgery 20050501

• A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy.

  Gastroenterology 20050501

• Proton pump inhibitors to be used more?

  Drug discovery today 20050501

• Helicobacter pylori, Republic of Georgia.

  Emerging infectious diseases 20050501

• Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.

  Digestive diseases and sciences 20050501

• Efficacy of triple therapy plus cetraxate for the Helicobacter pylori eradication in partial gastrectomy patients.

  Digestive diseases and sciences 20050501

• [A randomized, comparative study of rabeprazole vs. ranitidine maintenance therapies for reflux esophagitis--multicenter study].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20050501

• Rabeprazole controls GERD symptoms in a patient for whom treatment with lansoprazole failed: first report of 'cluster GERD.'.

  Digestive diseases and sciences 20050501

• [Disappearance of gastric adenocarcinoma in hyperplastic polyp after eradication of Heliobacter pylori. Report of a case].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20050501

• Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia.

  Haematologica 20050501

• Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?

  Journal of gastroenterology 20050501

• A new-generation H2 receptor antagonist: quicker and stronger acid inhibition than proton pump inhibitors in the clinical setting?

  Journal of gastroenterology 20050501

• [Severe gastrointestinal bleeding after allogeneic hematopoietic stem cell transplantation--15 case analysis].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20050501

• [Role of esophageal motility abnormalities in severe reflux esophagitis].

  Zhonghua nei ke za zhi 20050501

• Biotransformation of pantoprazole by the fungus Cunninghamella blakesleeana.

  Xenobiotica; the fate of foreign compounds in biological systems 20050501

• Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers.

  Xenobiotica; the fate of foreign compounds in biological systems 20050501

• Somatostatin inhibits gastric acid secretion more effectively than pantoprazole in patients with peptic ulcer bleeding: a prospective, randomized, placebo-controlled trial.

  Scandinavian journal of gastroenterology 20050501

• What are the effects of cyclooxygenase-2-specific inhibitors on the small bowel?

  Nature clinical practice. Gastroenterology & hepatology 20050501

• Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.

  World journal of gastroenterology 20050428

• Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.

  World journal of gastroenterology 20050421

• Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.

  The Cochrane database of systematic reviews 20050418

• Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults.

  The Cochrane database of systematic reviews 20050418

• Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily--a randomized, two-way crossover study.

  Alimentary pharmacology & therapeutics 20050415

• Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.

  Alimentary pharmacology & therapeutics 20050415

• Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.

  Alimentary pharmacology & therapeutics 20050415

• Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups.

  Arthritis and rheumatism 20050415

• Zegerid--immediate-release omeprazole.

  The Medical letter on drugs and therapeutics 20050411

• [Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office].

  MMW Fortschritte der Medizin 20050407

• Antimicrobial actions of benzimidazoles against oral streptococci.

  Oral microbiology and immunology 20050401

• Hyponatremia with consciousness disturbance associated with esomeprazole.

  The Annals of pharmacotherapy 20050401

• Esomeprazole-induced central fever with severe myalgia.

  The Annals of pharmacotherapy 20050401

• Localization of gastrinomas by selective intra-arterial calcium injection in patients on proton pump inhibitor or H2 receptor antagonist therapy.

  European journal of gastroenterology & hepatology 20050401

• Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease.

  European journal of gastroenterology & hepatology 20050401

• Eradication rate of Helicobacter pylori in dyspeptic patients.

  Medical science monitor : international medical journal of experimental and clinical research 20050401

• Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment.

  Alimentary pharmacology & therapeutics 20050401

• The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients.

  Cancer research 20050401

• Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura.

  The American journal of medicine 20050401

• Comparison of Prilosec OTC (omeprazole magnesium 20.6 mg) to placebo for 14 days in the treatment of frequent heartburn.

  Journal of clinical pharmacy and therapeutics 20050401

• Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients.

  Critical care medicine 20050401

• Clinical inquiries. What is the best treatment for gastroesophageal reflux and vomiting in infants?

  The Journal of family practice 20050401

• Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.

  Journal of gastroenterology and hepatology 20050401

• Cure rate of high dose omeprazole and amoxicillin therapy for treatment-resistant Helicobacter pylori infection.

  Journal of gastroenterology and hepatology 20050401

• Validation of a quality-of-life instrument for laryngopharyngeal reflux.

  Archives of otolaryngology--head & neck surgery 20050401

• FDA notifications. BMS issues letter about omeprazole.

  AIDS alert 20050401

• Comparison of proton pump inhibitor-based triple therapy with losec and the generic drug, Omepradex, for efficacy of Helicobacter pylori eradication.

  Digestive diseases and sciences 20050401

• Effect of high-dose aspirin on Helicobacter pylori eradication.

  Digestive diseases and sciences 20050401

• Efficacy and tolerability of rifampicin-based rescue therapy for Helicobacter pylori eradication failure in peptic ulcer disease.

  Digestive diseases and sciences 20050401

• High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin.

  Digestive diseases and sciences 20050401

• Severe GERD: effective treatment prevents potentially serious complications.

  JAAPA : official journal of the American Academy of Physician Assistants 20050401

• Cyproterone acetate and ethinylestradiol-induced pill oesophagitis: a case report.

  International journal of clinical practice. Supplement 20050401

• Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study.

  Current medical research and opinion 20050401

• Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes.

  Clinical pharmacology and therapeutics 20050401

• [The clinical applications of rabeprazole either alone or combined with anti-Helicobacter pylori agents in peptic ulcer patients].

  Zhonghua nei ke za zhi 20050401

• [The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate].

  Zhonghua nei ke za zhi 20050401

• Ménétrier's disease in a patient with Helicobacter pylori infection is linked to elevated glucagon-like peptide-2 activity.

  Scandinavian journal of gastroenterology 20050401

• How effective are quadruple therapies as first-line H. pylori eradication therapies?

  Nature clinical practice. Gastroenterology & hepatology 20050401

• 'Avoid the crush': hazards of medication administration in patients with dysphagia or a feeding tube.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20050329

• Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux.

  World journal of gastroenterology 20050328

• [Effect of the Helicobacter pylori eradication in patients with functional dyspepsia: randomised placebo-controlled trial].

  Medicina clinica 20050326

• Lack of interaction between atazanavir and lansoprazole.

  AIDS (London, England) 20050324

• Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.

  World journal of gastroenterology 20050321

• One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy.

  World journal of gastroenterology 20050321

• A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study.

  Alimentary pharmacology & therapeutics 20050315

• First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens.

  Alimentary pharmacology & therapeutics 20050315

• New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study.

  Alimentary pharmacology & therapeutics 20050315

• Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer.

  The Journal of biological chemistry 20050311

• Acute interstitial nephritis secondary to esomeprazole.

  The Medical journal of Australia 20050307

• Physical characterization of pantoprazole sodium hydrates.

  International journal of pharmaceutics 20050303

• [Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office].

  MMW Fortschritte der Medizin 20050303

• Cell-based high-throughput bioassays to assess induction and inhibition of CYP1A enzymes.

  Toxicology in vitro : an international journal published in association with BIBRA 20050301

• The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians.

  European journal of clinical pharmacology 20050301

• Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the larynx.

  Head & neck 20050301

• Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: consequences for FK506 assimilation.

  Kidney international 20050301

• Influence of antimicrobial treatment for Helicobacter pylori infection on the intestinal microflora in Japanese macaques.

  Journal of medical microbiology 20050301

• Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotype in healthy Chinese subjects.

  Acta pharmacologica Sinica 20050301

• Motility abnormalities in esophageal body in GERD: are they truly related to reflux?

  Journal of clinical gastroenterology 20050301

• Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial.

  Hepatology (Baltimore, Md.) 20050301

• Failure of nasogastric omeprazole suspension in pediatric intensive care patients.

  Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 20050301

• Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery.

  Circulation journal : official journal of the Japanese Circulation Society 20050301

• Helicobacter pylori status and symptom assessment two years after eradication in pediatric patients from a high prevalence area.

  Journal of pediatric gastroenterology and nutrition 20050301

• Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease.

  Journal of pediatric gastroenterology and nutrition 20050301

• Simultaneous herpetic and candidal esophagitis in an immunocompetent teenager.

  Journal of pediatric gastroenterology and nutrition 20050301

• A comparative study of the early effects of tenatoprazole 40 mg and esomeprazole 40 mg on intragastric pH in healthy volunteers.

  Alimentary pharmacology & therapeutics 20050301

• Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue.

  Virchows Archiv : an international journal of pathology 20050301

• Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment.

  The American journal of gastroenterology 20050301

• PCB exposure and in vivo CYP1A2 activity among Native Americans.

  Environmental health perspectives 20050301

• Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.

  British journal of clinical pharmacology 20050301

• H+/K+-ATPase (proton pump) inhibitors dampen increased cough reflex: more than gastric acid suppression.

  Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20050301

• Attenuating effect of H+K+ATPase inhibitors on airway cough hypersensitivity induced by allergic airway inflammation in guinea-pigs.

  Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20050301

• Esomeprazole in the treatment of patients with heartburn and other upper gastrointestinal symptoms, referred to primary care -- results of the in-practice evaluation program in Romania.

  Romanian journal of gastroenterology 20050301

• Initial-rate method for the determination of pantoprazole in pharmaceutical formulations using 1-fluoro 2,4-dinitrobenzene.

  Die Pharmazie 20050301

• Metabolism of pantoprazole involving conjugation with glutathione in rats.

  The Journal of pharmacy and pharmacology 20050301

• Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole.

  Digestive diseases and sciences 20050301

• Twice-daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomized controlled trial using standard and double doses of omeprazole in triple therapy.

  Digestive diseases and sciences 20050301

• Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole.

  Digestive diseases and sciences 20050301

• On omeprazole and iron replacement.

  Southern medical journal 20050301

• Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.

  American journal of veterinary research 20050301

• Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme.

  Irish medical journal 20050301

• Gastroesophageal reflux disease in bronchial asthma and the response to omeprazole.

  Asian Pacific journal of allergy and immunology 20050301

• [Effectiveness of an intervention to improve medical prescription quality in specialized care].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20050301

• [Omeprazol-associated intersticial nephritis. A case report].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20050301

• A simultaneous assessment of CYP3A4 metabolism and induction in the DPX-2 cell line.

  The AAPS journal 20050301

• Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20050301

• Does laparoscopic Nissen fundoplication prevent the progression of Barrett's oesophagus? Is the length of Barrett's a factor?

  Journal of minimal access surgery 20050301

• Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation.

  World journal of gastroenterology 20050227

• High-performance liquid chromatography method for the quantification of rabeprazole in human plasma using solid-phase extraction.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050225

• Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050225

• The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells.

  European journal of pharmacology 20050221

• Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils.

  World journal of gastroenterology 20050221

• Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication.

  World journal of gastroenterology 20050221

• Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.

  World journal of gastroenterology 20050221

• [Diagnosis of and therapy for peptic ulcer].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20050220

• Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis.

  Alimentary pharmacology & therapeutics 20050215

• Evaluation of early gastric mucosal permeability induced by central thyrotropin-releasing hormone administration.

  American journal of physiology. Gastrointestinal and liver physiology 20050201

• Lansoprazole enantiomer activates human liver microsomal CYP2C9 catalytic activity in a stereospecific and substrate-specific manner.

  Drug metabolism and disposition: the biological fate of chemicals 20050201

• Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient.

  Therapeutic drug monitoring 20050201

• Effects of the association of lansoprazole, clarithromycin and metronidazole for helicobacter Pylori eradication therapy, measured by the 13C Aminopyrine breath test.

  Medical science monitor : international medical journal of experimental and clinical research 20050201

• Intravenous esomeprazole (40 mg and 20 mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies.

  European journal of gastroenterology & hepatology 20050201

• Validation of the Reflux Disease Questionnaire for a German population.

  European journal of gastroenterology & hepatology 20050201

• A randomized controlled trial of equivalence between pantoprazole and esomeprazole that does not have the power to conclude.

  Journal of clinical gastroenterology 20050201

• Omeprazole raises somatostatin and motilin in human plasma.

  Biological & pharmaceutical bulletin 20050201

• The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study.

  Alimentary pharmacology & therapeutics 20050201

• Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism.

  Alimentary pharmacology & therapeutics 20050201

• Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003.

  Helicobacter 20050201

• Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.

  Helicobacter 20050201

• Acute endoscopic intervention in non-variceal upper gastrointestinal bleeding.

  Postgraduate medical journal 20050201

• Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050201

• Rabeprazole-induced acute interstitial nephritis.

  Nephrology (Carlton, Vic.) 20050201

• [Gastroesophageal reflux disease refractory to esomeprazole].

  Gastroenterologia y hepatologia 20050201

• Gastroprotective activity of a new semi-synthetic solidagenone derivative in mice.

  The Journal of pharmacy and pharmacology 20050201

• Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus.

  Gastrointestinal endoscopy 20050201

• A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050201

• Quantification of omeprazole degradation by enteric coating polymers: an UV-VIS spectroscopy study.

  Die Pharmazie 20050201

• Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance.

  Digestive diseases and sciences 20050201

• Atazanavir not to be used with proton pump inhibitors.

  AIDS patient care and STDs 20050201

• Evaluation of the effects of anti-secretory drugs on intragastric acidity: is combined therapy with a proton pump inhibitor and an H2 receptor antagonist effective as initial treatment?

  Journal of gastroenterology 20050201

• Management of bleeding peptic ulcer in France: a national inquiry.

  Gastroenterologie clinique et biologique 20050201

• Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease.

  Expert review of pharmacoeconomics & outcomes research 20050201

• Effect of adsorbents on the absorption of lansoprazole with surfactant.

  International journal of pharmaceutics 20050131

• Hyponatraemia, fever, vomiting, severe abdominal pain, and weight loss associated with omeprazole.

  The New Zealand medical journal 20050128

• [Effect of acid suppression therapy for eradicating Helicobacter pylori infection on bismuth absorption from colloidal bismuth pectin].

  Zhonghua yi xue za zhi 20050126

• Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

  The New England journal of medicine 20050120

• Reducing the risks of gastrointestinal bleeding with antiplatelet therapies.

  The New England journal of medicine 20050120

• The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux.

  Alimentary pharmacology & therapeutics 20050115

• Rebound acid hypersecretion after long-term inhibition of gastric acid secretion.

  Alimentary pharmacology & therapeutics 20050115

• Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis.

  Rheumatology international 20050101

• Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases.

  Cellular signalling 20050101

• High volume bioassays to assess CYP3A4-mediated drug interactions: induction and inhibition in a single cell line.

  Drug metabolism and disposition: the biological fate of chemicals 20050101

• Neuropathy associated with lansoprazole treatment.

  Muscle & nerve 20050101

• Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors.

  The Annals of pharmacotherapy 20050101

• A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects.

  European journal of clinical pharmacology 20050101

• Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis.

  Journal of gastroenterology and hepatology 20050101

• Impact of 24-h esophageal pH monitoring on the diagnosis of gastroesophageal reflux disease: defining the gold standard.

  Journal of gastroenterology and hepatology 20050101

• Persistent cough following pulmonary resection: observational and empiric study of possible causes.

  The Annals of thoracic surgery 20050101

• Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20050101

• Switching prescription drugs to over the counter.

  BMJ (Clinical research ed.) 20050101

• Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese.

  Alimentary pharmacology & therapeutics 20050101

• Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050101

• Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.

  European journal of gastroenterology & hepatology 20050101

• Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management.

  European journal of gastroenterology & hepatology 20050101

• The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole.

  Health and quality of life outcomes 20050101

• Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients?

  The American journal of gastroenterology 20050101

• Esomeprazole was not better than omeprazole for resolving heartburn in endoscopy-negative reflux disease.

  ACP journal club 20050101

• Septic complications after variceal cyanoacrylate injection.

  Gastrointestinal endoscopy 20050101

• Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature.

  Journal of gastroenterology 20050101

• Eradication of Helicobacter pylori decreases mucosal alterations linked to gastric carcinogenesis in Mongolian gerbils.

  Journal of gastroenterology 20050101

• Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness.

  Critical care (London, England) 20050101

• South Dakota Medicaid will now cover OTC Loratadine and OTC Prilosec.

  South Dakota journal of medicine 20050101

• Spillover effects of restrictive drug formularies: a case study of PacifiCare in California.

  The American journal of managed care 20050101

• Probiotics: wanted dead or alive.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101

• Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101

• The early effect of proton pump inhibitor therapy on the accuracy of the 13C-urea breath test.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101

• Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050101

• Pharmacokinetics of rabeprazole following single intravenous and oral administration to healthy subjects.

  International journal of clinical pharmacology and therapeutics 20050101

• Esomeprazole MUPS 40 mg tablets and esomeprazole MUPS 40 mg tablets encapsulated in hard gelatine are bioequivalent.

  International journal of clinical pharmacology and therapeutics 20050101

• Proton pump inhibitors: a survey of prescribing in an Irish general hospital.

  International journal of clinical practice 20050101

• Role of pantoprazole in the treatment of gastro-oesophageal reflux disease.

  Expert opinion on pharmacotherapy 20050101

• Effects of esomeprazole magnesium on nonsteroidal anti-inflammatory drug gastropathy.

  Digestive diseases and sciences 20050101

• [Bronchial asthma and gastroesophageal reflux disease: are they interrelated by chance?].

  Klinicheskaia meditsina 20050101

• [Is anti-helicobacter therapy a rational approach in treatment of erosive and ulcerous lesions of the gastroduodenal mucosa in patients with inflamatory bowel diseases?].

  Klinicheskaia meditsina 20050101

• Degradation of omeprazole induced by enteric polymer solutions and aqueous dispersions: HPLC investigations.

  Drug development and industrial pharmacy 20050101

• [Proton pump inhibitors in paediatrics].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20050101

• Experiments to optimize enzyme substitution therapy in pancreatic duct-ligated pigs.

  Journal of animal physiology and animal nutrition 20050101

• Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro.

  Xenobiotica; the fate of foreign compounds in biological systems 20050101

• The influence of gastroesophageal reflux disease and its treatment on asthmatic cough.

  Lung 20050101

• [Esomeprasol and rabeprasol effects on esophageal acidification in patients with gastroesophageal reflux disease, intensively metabolizing inhibitors of proton pump].

  Terapevticheskii arkhiv 20050101

• [Gastroesophageal acid reflux as a causative factor of paroxysmal atrial fibrillation].

  Kardiologia polska 20050101

• Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy.

  Hepato-gastroenterology 20050101

• Why is this woman smiling? The hard sell of bad medicine.

  Revolution (Oakland, Calif.) 20050101

• Difficulties in assessing cytomegalovirus-associated gastric perforation in an HIV-infected patient.

  BMC infectious diseases 20050101

• Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine.

  Methods and findings in experimental and clinical pharmacology 20050101

• [Prevention and treatment of gastroduodenal hemorrhages in pediatric cardiac surgery].

  Anesteziologiia i reanimatologiia 20050101

• Celecoxib was noninferior to diclofenac plus omeprazole for preventing gastroduodenal ulcer recurrence in high-risk patients with arthritis.

  ACP journal club 20050101

• Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.

  Digestion 20050101

• Pharmacokinetics of proton pump inhibitors in children.

  Clinical pharmacokinetics 20050101

• [Helicobacter pylori infection in patients with chronic hives and asthma].

  Klinicheskaia meditsina 20050101

• Clinicians' management strategies for patients with dyspepsia: a qualitative approach.

  BMC gastroenterology 20050101

• Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.

  Arthritis research & therapy 20050101

• The role of proton pump inhibitors in acute stress ulcer prophylaxis in mechanically ventilated patients.

  Dimensions of critical care nursing : DCCN 20050101

• [Basic principles of successful GERD (gastroesophageal reflux disease) therapy].

  Krankenpflege Journal 20050101

• [Photodistributed cutaneous drug reaction induced by proton pump inhibitors].

  Therapie 20050101

• [Assessment of efficacy and safety of two modes of maintenance therapy with rabeprazole in patients with gastroesophageal reflux disease (GERD) of degrees 0 and 1].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20050101

• The effect of omeprazole pre-treatment on rafts formed by reflux suppressant tablets containing alginate.

  The Journal of international medical research 20050101

• Pancreatitis due to codeine.

  Allergologia et immunopathologia 20050101

• Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre study.

  BMC musculoskeletal disorders 20050101

• Regression of EI2-stage low-grade gastric MALT-lymphoma after H. pylori eradication.

  Hepato-gastroenterology 20050101

• Heal the damage: prescription drug consumer advertisements and relative choices.

  Journal of health law 20050101

• COX inhibition and NSAID-induced gastric damage--roles in various pathogenic events.

  Current topics in medicinal chemistry 20050101

• Simultaneous determination of pantoprazole and its two metabolites in dog plasma by HPLC.

  Journal of chromatographic science 20050101

• Gastroesophageal reflux disease in children with asthma: treatment implications.

  Paediatric drugs 20050101

• Lansoprazole oro-dispersible tablet : pharmacokinetics and therapeutic use in acid-related disorders.

  Drugs 20050101

• Laparoscopic resection of a gastric diverticulum: a case report.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20050101

• The impact of illness in patients with moderate to severe gastro-esophageal reflux disease.

  BMC gastroenterology 20050101

• Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of rabeprazole in human plasma.

  Rapid communications in mass spectrometry : RCM 20050101

• [Pharmacogenomical aspects of gastroesophageal reflux disease].

  Vestnik Rossiiskoi akademii meditsinskikh nauk 20050101

• [Comparison of gastric aspirate volume after intubation in patients with and without symptoms of gastroesophageal reflux disease].

  Revista espanola de anestesiologia y reanimacion 20050101

• An unusual adverse drug reaction?

  Allergologia et immunopathologia 20050101

• Pediatric management problems. GERD.

  Pediatric nursing 20050101

• Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals.

  Arzneimittel-Forschung 20050101

• Drug-drug interactions and the pharmacotherapy of HIV infection.

  Topics in HIV medicine : a publication of the International AIDS Society, USA 20050101

• [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].

  Khirurgiia 20050101

• HIV drug interactions in 2005.

  Positively aware : the monthly journal of the Test Positive Aware Network 20050101

• On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial.

  Digestion 20050101

• State of the art: extraesophageal manifestations of gastroesophageal reflux disease.

  Reviews in gastroenterological disorders 20050101

• Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial.

  Arquivos de gastroenterologia 20050101

• Omeprazole absorption from a compounded transdermal formulation in healthy volunteers.

  Journal of the American Pharmacists Association : JAPhA 20050101

• Omeprazole affects neither electroconvulsive threshold nor anticonvulsant activity of diphenylhydantoin and carbamazepine in mice.

  Pharmacological reports : PR 20050101

• Management of chest pain: exploring the views and experiences of chiropractors and medical practitioners in a focus group interview.

  Chiropractic & osteopathy 20050101

• A flow-injection biamperometric method for determination of pantoprazole in pharmaceutical tablets.

  Journal of AOAC International 20050101

• Validation of a capillary electrophoresis method for analysis of rabeprazole sodium in a pharmaceutical dosage form.

  Journal of AOAC International 20050101

• Current state of therapy for pain and inflammation.

  Arthritis research & therapy 20050101

• Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance.

  Arthritis research & therapy 20050101

• Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs.

  Arthritis research & therapy 20050101

• Balancing the gastrointestinal benefits and risks of nonselective NSAIDs.

  Arthritis research & therapy 20050101

• [Eradication of Helicobacter pylori].

  Krankenpflege Journal 20050101

• Haemorrhagic gastritis and bleeding following rofecoxib administration.

  Clinical and experimental rheumatology 20050101

• Dual effects of rabeprazole on solid-phase gastric emptying assessed by the 13C-octanoate breath test.

  Digestion 20050101

• Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases.

  Acta dermato-venereologica 20050101

• Influence of Helicobacter pylori and omeprazole on celecoxib-induced gastroduodenal mucosal injury.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20050101

• Lansoprazole: in the treatment of gastro-oesophageal reflux disease in children and adolescents.

  Drugs 20050101

• Acupuncture and rehabilitation of the painful shoulder: study protocol of an ongoing multicentre randomised controlled clinical trial [ISRCTN28687220].

  BMC complementary and alternative medicine 20050101

• The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics.

  Clinical pharmacokinetics 20050101

• Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease.

  PharmacoEconomics 20050101

• Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.

  Chinese journal of digestive diseases 20050101

• Participation of vanilloid/capsaicin receptors, calcitonin-gene-related peptide and substance P in gastric protection of omeprazole and omeprazole-like compounds.

  Inflammopharmacology 20050101

• Gastric HCO3- secretion induced by mucosal acidification: different mechanisms depending on acid concentration.

  Inflammopharmacology 20050101

• A novel gastric lesion model induced in rats by partial gastric vascular ligation.

  Inflammopharmacology 20050101

• Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis.

  Inflammopharmacology 20050101

• Effect of pantoprazole administered subcutaneously on the healing of sutured gastric incisions in rats.

  European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20050101

• Primary antibiotic resistance and effectiveness of Helicobacter pylori triple therapy in ulcero-inflammatory pathologies of the upper digestive tract.

  Acta gastro-enterologica Belgica 20050101

• Helicobacter pylori eradication for the treatment of dyspeptic symptoms in chronic renal failure.

  Annals of Saudi medicine 20050101

• No effect of omeprazole on pH of exhaled breath condensate in cough associated with gastro-oesophageal reflux.

  Cough (London, England) 20050101

• Cough: are children really different to adults?

  Cough (London, England) 20050101

• Idiopathic chronic cough: a real disease or a failure of diagnosis?

  Cough (London, England) 20050101

• Voice disorders and gastroesophageal reflux.

  Logopedics, phoniatrics, vocology 20050101

• Different roles for K+ channels in cisplatin-resistant cell lines argue against a critical role for these channels in cisplatin resistance.

  Anticancer research 20050101

• Role of rapid urease test and histopathology in the diagnosis of Helicobacter pylori infection in a developing country.

  BMC gastroenterology 20050101

• Sporadic fundic gland polyps: clinico-pathologic features and associated diseases.

  Polish journal of pathology : official journal of the Polish Society of Pathologists 20050101

• What is potent acid inhibition, and how can it be achieved?

  Drugs 20050101

• Optimising acid inhibition treatment.

  Drugs 20050101

• Clinical response (remission of symptoms) in erosive and non-erosive gastro-oesophageal reflux disease.

  Drugs 20050101

• Healing of oesophagitis.

  Drugs 20050101

• Vitamin status and cognitive function in a long-term care population.

  BMC geriatrics 20050101

• Efficacy and safety of intravenous esomeprazole in gastro-esophageal reflux disease and erosive esophagitis in Indian patients.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20050101

• Intravenous proton pump inhibitor therapy: a rationale for use.

  Reviews in gastroenterological disorders 20050101

• Gastroesophageal reflux disease and extraesophageal disease.

  Reviews in gastroenterological disorders 20050101

• Antimicrobial activities of Eugenol and Cinnamaldehyde against the human gastric pathogen Helicobacter pylori.

  Annals of clinical microbiology and antimicrobials 20050101

• Clinical pharmacology of lumiracoxib: a selective cyclo-oxygenase-2 inhibitor.

  Clinical pharmacokinetics 20050101

• A case of emphysematous cholecystitis managed by laparoscopic surgery.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20050101

• [Efficacy of the drinking magnesium-calcium sulfate mineral water in the combined treatment of duodenal ulcer comorbid with gastroesophageal reflux].

  Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury 20050101

• [Oral cavity manifestations of gastroesophageal reflux disease].

  Klinicheskaia meditsina 20050101

• Metabolism of omeprazole after two oral doses in children 1 to 9 months old.

  Proceedings of the Western Pharmacology Society 20050101

• Endoscopic and histologic findings in Iranian patients with heartburn.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20050101

• Surgical management of acute perforation of peptic ulcers. A single centre experience.

  Acta chirurgica Belgica 20050101

• [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].

  Klinicheskaia meditsina 20050101

• [Reflux therapy in the elderly].

  Krankenpflege Journal 20050101

• [Correlation between chronic idiopathic urticaria and infection due to H. pylori].

  Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20050101

• [Gastroesophageal reflux involvement in ENT disorders].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20050101

• Role of eradication of Cag A Helicobacter pylori in non ulcer dyspepsia.

  Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20050101

• [Gastrin-17 level in the omeprazole treatment of duodenal ulcer].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20050101

• Efficacy of a Low-Dose Omeprazole-Based Triple-Therapy Regimen for Helicobacter pylori Eradication Independent of Cytochrome P450 Genotype : The Japanese MACH Study.

  Clinical drug investigation 20050101

• Proton pump inhibitors in acute treatment of reflux oesophagitis : a cost-effectiveness analysis.

  Clinical drug investigation 20050101

• Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions.

  Clinical drug investigation 20050101

• Acute upper gastrointestinal haemorrhage resulting in transient hepatic failure following liver resection.

  HPB : the official journal of the International Hepato Pancreato Biliary Association 20050101

• [Upper gastrointestinal bleeding after cardiac surgery and invasive cardiology procedures--prophylaxis and therapy].

  Khirurgiia 20050101

• Direct injection, column switching-liquid chromatographic technique for the estimation of rabeprazole in bioequivalence study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041225

• Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers.

  World journal of gastroenterology 20041215

• Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041215

• Conversion of the HIV protease inhibitor nelfinavir to a bioactive metabolite by human liver CYP2C19.

  Drug metabolism and disposition: the biological fate of chemicals 20041201

• Acute colchicine intoxication during clarithromycin administration.

  The Annals of pharmacotherapy 20041201

• Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.

  Biochemical pharmacology 20041201

• A randomized crossover study investigating the influence of ranitidine or omeprazole on the pharmacokinetics of cephalexin monohydrate.

  Journal of clinical pharmacology 20041201

• Review article: treatment for gastro-oesophageal reflux disease--lifestyle advice and medication.

  Alimentary pharmacology & therapeutics 20041201

• The use of subcutaneous omeprazole in the treatment of dyspepsia in palliative care patients.

  Journal of pain and symptom management 20041201

• Less acid + less bleeding = better outcomes and more money!

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20041201

• Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor.

  Alimentary pharmacology & therapeutics 20041201

• Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole.

  Pharmacogenetics 20041201

• Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes.

  Helicobacter 20041201

• Synthesis of novel 2-[2-(substituted amino)phenethyl]-1 H-benzimidazoles; 3,4-dihydro and 1,2,3,4,-tetrahydropyrimido[1,6-a]-benzimidazoles as potential antiulcer agents.

  Die Pharmazie 20041201

• Effects of NO-1886 (Ibrolipim), a lipoprotein lipase-promoting agent, on gene induction of cytochrome P450s, carboxylesterases, and sulfotransferases in primary cultures of human hepatocytes.

  Drug metabolism and pharmacokinetics 20041201

• Comparison of one week and two weeks of triple therapy for the eradication of Helicobacter pylori in a Sri Lankan population: a randomised, controlled study.

  The Ceylon medical journal 20041201

• Bacteriostatic and bactericidal activity of rabeprazole against Helicobacter pylori.

  Journal of chemotherapy (Florence, Italy) 20041201

• Comparison of the pharmacokinetics of lansoprazole 15- and 30-mg sachets for suspension versus intact capsules.

  Clinical therapeutics 20041201

• Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20041201

• The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20041201

• Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.

  Journal of the National Cancer Institute 20041117

• Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.

  Alimentary pharmacology & therapeutics 20041115

• Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study.

  Alimentary pharmacology & therapeutics 20041115

• Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.

  Alimentary pharmacology & therapeutics 20041115

• Classification of dyspepsia and response to treatment with proton-pump inhibitors.

  Alimentary pharmacology & therapeutics 20041115

• Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.

  Alimentary pharmacology & therapeutics 20041115

• [Paradigm change in reflux disease. In reflux patients listening to is often more important than endoscopy].

  MMW Fortschritte der Medizin 20041104

• [Attention! Cough, asthma and Co. are often caused by reflux].

  MMW Fortschritte der Medizin 20041104

• Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance.

  Drug metabolism and disposition: the biological fate of chemicals 20041101

• Identity and regulation of stored and secreted progastrin-derived peptides in sheep.

  Endocrinology 20041101

• Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes.

  European journal of clinical pharmacology 20041101

• Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20041101

• In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19.

  Drug metabolism and disposition: the biological fate of chemicals 20041101

• Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.

  Alimentary pharmacology & therapeutics 20041101

• Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment.

  Alimentary pharmacology & therapeutics 20041101

• Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders.

  Alimentary pharmacology & therapeutics 20041101

• Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes.

  Journal of clinical pharmacology 20041101

• Polar organic chemical integrative sampling and liquid chromatography-electrospray/ion-trap mass spectrometry for assessing selected prescription and illicit drugs in treated sewage effluents.

  Archives of environmental contamination and toxicology 20041101

• Oesophageal pH monitoring is of limited value in the diagnosis of 'reflux-cough'.

  The European respiratory journal 20041101

• Effects of omeprazole, famotidine, and ranitidine on the enzyme activities of carbonic anhydrase from bovine stomach in vitro and rat erythrocytes in vivo.

  Biological & pharmaceutical bulletin 20041101

• Sleep dysfunction in patients with gastro-oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study.

  Alimentary pharmacology & therapeutics 20041101

• Omeprazole 20 mg equal to 40 mg for primary care acid-related dyspepsia.

  The Journal of family practice 20041101

• Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20041101

• Differential effects of Helicobacter pylori eradication on oxidative DNA damage at the gastroesophageal junction and at the gastric antrum.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20041101

• Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study.

  Scandinavian journal of gastroenterology 20041101

• Accuracy of a monoclonal antibody-based stool antigen test in the diagnosis of Helicobacter pylori infection.

  Scandinavian journal of gastroenterology 20041101

• Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils.

  Cancer science 20041101

• Fatal toxic epidermal necrolysis due to lansoprazole.

  Clinical and experimental dermatology 20041101

• A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20041101

• Patent expiration for lansoprazole.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041101

• [Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20041101

• Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.

  Journal of gastroenterology 20041101

• Off-label use of proton pump inhibitors and P-blockers in general practices: an analysis using the Disease Analyzer--mediplus patient database.

  International journal of clinical pharmacology and therapeutics 20041101

• Treatment of gastric hemorrhage by pulverized omeprazole and antacid--concomitant administration via a nasogastric tube.

  International journal of clinical pharmacology and therapeutics 20041101

• Dual-probe 24-hour ambulatory pH monitoring for diagnosis of laryngopharyngeal reflux.

  The Journal of laryngology and otology 20041101

• [Mechanism of mono-hydroxylation of daidzein in human liver microsomes].

  Yao xue xue bao = Acta pharmaceutica Sinica 20041101

• [The best strategies against reflux disease. Acid stomach and the sequelae].

  MMW Fortschritte der Medizin 20041028

• [Choice of proton pump inhibitors--does it play any role?].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20041021

• [The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia].

  Orvosi hetilap 20041017

• Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in patient volunteers with erosive oesophagitis.

  Alimentary pharmacology & therapeutics 20041015

• Effect of low-dose rabeprazole and omeprazole on gastric acidity: results of a double blind, randomized, placebo-controlled, three-way crossover study in healthy subjects.

  Alimentary pharmacology & therapeutics 20041015

• [Galactorrhea induced by lansoprazole].

  Atencion primaria 20041015

• Effect of omeprazole on gastric adenosine A1 and A2A receptor gene expression and function.

  The Journal of pharmacology and experimental therapeutics 20041001

• Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer recurrence induced by tumor necrosis factor-alpha.

  American journal of physiology. Gastrointestinal and liver physiology 20041001

• Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats.

  World journal of gastroenterology 20041001

• Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole.

  Journal of clinical psychopharmacology 20041001

• Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.

  European journal of clinical pharmacology 20041001

• Effects of Helicobacter pylori eradication among adults with intellectual disability.

  Journal of intellectual disability research : JIDR 20041001

• Open, randomized multicenter comparative trial of rabeprazole, ofloxacin and amoxicillin therapy for Helicobacter pylori eradication: 7 vs. 14 day treatment.

  Helicobacter 20041001

• On-demand PPI requirements in patients with endoscopy-negative GERD.

  Journal of clinical gastroenterology 20041001

• The effect of Helicobacter pylori eradication on gastroesophageal reflux disease.

  Journal of clinical gastroenterology 20041001

• Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection.

  European journal of gastroenterology & hepatology 20041001

• Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.

  European journal of gastroenterology & hepatology 20041001

• Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression.

  The American journal of gastroenterology 20041001

• Severe gastroesophageal reflux disease and cow milk hypersensitivity in infants and children: disease association and evaluation of a new challenge procedure.

  Journal of pediatric gastroenterology and nutrition 20041001

• Improvement in clinical course and laryngeal appearance in selected patients with chronic laryngitis after eight weeks of therapy with rabeprazole.

  Medical science monitor : international medical journal of experimental and clinical research 20041001

• Review article: gastric pH -- the most relevant predictor of benefit in reflux disease?

  Alimentary pharmacology & therapeutics 20041001

• Review article: is stringent control of gastric pH useful and practical in GERD?

  Alimentary pharmacology & therapeutics 20041001

• Clinical strategies -- interactive case discussions.

  Alimentary pharmacology & therapeutics 20041001

• Effect of rabeprazole on MDR1-mediated transport of Rhodamine 123 in Caco-2 and Hvr100-6 cells.

  Biological & pharmaceutical bulletin 20041001

• Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20041001

• Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status.

  Clinical pharmacology and therapeutics 20041001

• Lewis and Secretor status and Helicobacter pylori eradication.

  Epidemiology and infection 20041001

• Recurrent anaphylaxis linked to pantoprazole.

  The Journal of allergy and clinical immunology 20041001

• Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial.

  Gastroenterology 20041001

• COX-2-specific inhibitor or proton pump inhibitor plus traditional NSAID: is either approach sufficient for patients at highest risk of NSAID-induced ulcers?

  Gastroenterology 20041001

• Effect of lansoprazole for an idiopathic thrombocytopenic purpura patient with Helicobacter pylori infection who did not respond to prednisolone treatment.

  Clinical and laboratory haematology 20041001

• Endoclipping for gastric perforation after endoscopic polypectomy: an alternative treatment to avoid surgery.

  Surgical laparoscopy, endoscopy & percutaneous techniques 20041001

• Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20041001

• Effect of water intake on pharmacokinetics of lansoprazole from fast disintegrating tablet in human subjects.

  Drug metabolism and pharmacokinetics 20041001

• Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.

  Journal of gastroenterology 20041001

• Excretion of pantoprazole in human breast.

  The Journal of reproductive medicine 20041001

• Gastrointestinal uptake of FDG after N-butylscopolamine or omeprazole treatment in the rat.

  Annals of nuclear medicine 20041001

• Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.

  Clinical therapeutics 20041001

• Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura.

  Archives of internal medicine 20040927

• Determination of lansoprazole in pharmaceutical capsules by flow injection analysis using UV-detection.

  Journal of pharmaceutical and biomedical analysis 20040921

• Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study.

  Alimentary pharmacology & therapeutics 20040915

• [Prescription of drugs in family medicine: on the trail of efficiency].

  Atencion primaria 20040915

• Therapeutic choices in reflux disease: defining the criteria for selecting a proton pump inhibitor.

  The American journal of medicine 20040906

• Gastroesophageal reflux disease: could intervention in childhood reduce the risk of later complications?

  The American journal of medicine 20040906

• Management of acid-related disorders in patients with dysphagia.

  The American journal of medicine 20040906

• A simplified analytical method for a phenotyping cocktail of major CYP450 biotransformation routes.

  Journal of pharmaceutical and biomedical analysis 20040903

• Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.

  Gut 20040901

• Lack of weight-based dose dependency and intraindividual variability of omeprazole for CYP2C19 phenotyping.

  Journal of clinical pharmacology 20040901

• Altered pharmacokinetics of omeprazole in cystic fibrosis knockout mice relative to wild-type mice.

  Drug metabolism and disposition: the biological fate of chemicals 20040901

• Resolution of Helicobacter pylori associated granulomatous gastritis in a child after eradication therapy.

  Journal of pediatric gastroenterology and nutrition 20040901

• Symptomatic response to Helicobacter pylori eradication in children with recurrent abdominal pain: double blind randomized placebo-controlled trial.

  Journal of clinical gastroenterology 20040901

• Review article: efficacy and safety of rabeprazole in treating gastroesophageal reflux disease.

  Journal of gastroenterology and hepatology 20040901

• Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects.

  British journal of clinical pharmacology 20040901

• Suppression of gastric acid production may improve the course of angina pectoris and the results of treadmill stress test in patients with coronary artery disease.

  Medical science monitor : international medical journal of experimental and clinical research 20040901

• A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea.

  The American journal of gastroenterology 20040901

• Prevention of erosive oesophagitis relapse with pantoprazole.

  Alimentary pharmacology & therapeutics 20040901

• Effect of the H, K-ATPase inhibitor, esomeprazole magnesium, on gut total antioxidant capacity in mice.

  The Journal of nutritional biochemistry 20040901

• Clinical inquiries. Is the long-term use of proton pump inhibitors safe?

  The Journal of family practice 20040901

• CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori.

  Clinical pharmacology and therapeutics 20040901

• [Efficacy of 14 day OBMT therapy as a second-line treatment for Helicobacter pylori infection].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20040901

• Omeprazole treatment of Korean patients: effects on gastric pH and gastrin release in relation to CYP2C19 geno- and phenotypes.

  Basic & clinical pharmacology & toxicology 20040901

• Proton pump inhibitors and iron deficiency: is the connection real?

  Southern medical journal 20040901

• Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia.

  Southern medical journal 20040901

• Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20040901

• Pantoprazole for sleepiness associated with acid reflux and obstructive sleep disordered breathing.

  The Laryngoscope 20040901

• Pachydermia is not diagnostic of active laryngopharyngeal reflux disease.

  The Laryngoscope 20040901

• Crohn's disease with isolated esophagus and gastric involvement.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20040901

• Serum cholinesterase inhibition by omeprazole and lansoprazole.

  Die Pharmazie 20040901

• [The effect of rabeprazole on gastric pH in patients with gastric ulcer].

  Zhonghua nei ke za zhi 20040901

• [Study on changes in physiological [18F]fluorodeoxyglucose accumulation in the digestive tube caused by drug treatment].

  [Hokkaido igaku zasshi] The Hokkaido journal of medical science 20040901

• Results of triple eradication therapy in Japanese children: a retrospective multicenter study.

  Journal of gastroenterology 20040901

• Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338.

  European journal of pharmacology 20040823

• Does hormone therapy increase allergic reactions and upper gastrointestinal problems? Results from a population-based study of Swedish woman. The women's health in the Lund area (WHILA) study.

  Maturitas 20040820

• Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study.

  Alimentary pharmacology & therapeutics 20040815

• A novel option in proton pump inhibitor dosing: lansoprazole orally disintegrating tablet dispersed in water and administered via nasogastric tube.

  Alimentary pharmacology & therapeutics 20040815

• The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole.

  Alimentary pharmacology & therapeutics 20040815

• Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?

  Alimentary pharmacology & therapeutics 20040815

• Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?

  Alimentary pharmacology & therapeutics 20040815

• Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.

  Cancer research 20040815

• Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas.

  American journal of physiology. Gastrointestinal and liver physiology 20040801

• Pantoprazole treatment does not invoke anti-inflammatory properties in vivo.

  International immunopharmacology 20040801

• The tautomerism of Omeprazole in solution: a 1H and 13C NMR study.

  Magnetic resonance in chemistry : MRC 20040801

• Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.

  Drug metabolism and disposition: the biological fate of chemicals 20040801

• Total family unit Helicobacter pylori eradication and pediatric re-infection rates.

  Helicobacter 20040801

• Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.

  Helicobacter 20040801

• Helicobacter pylori eradication in children and adolescents by a once daily 6-day treatment with or without a proton pump inhibitor in a double-blind randomized trial.

  Alimentary pharmacology & therapeutics 20040801

• Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract.

  Alimentary pharmacology & therapeutics 20040801

• Reproducibility of a symptom response to omeprazole therapy in functional dyspepsia evaluated by a random-starting-day trial design.

  Alimentary pharmacology & therapeutics 20040801

• Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole.

  Gastrointestinal endoscopy 20040801

• Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations.

  The Journal of pharmacy and pharmacology 20040801

• Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040801

• Pharmacokinetics of lansoprazole in Chinese healthy subjects in relation to CYP2C19 genotypes.

  Acta pharmacologica Sinica 20040801

• Symptom response and healing of erosive esophagitis with proton-pump inhibitors in patients with Helicobacter pylori infection.

  The American journal of gastroenterology 20040801

• One on one. I often have heartburn. Is it safe to use Prilosec OTC long term?

  Mayo Clinic women's healthsource 20040801

• Triple therapy with pantoprazole, clarithromycin and amoxicillin for eradication in patients with Helicobacter pylori positive duodenal ulcers.

  Saudi medical journal 20040801

• The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing.

  Current medical research and opinion 20040801

• Effect of omeprazole paste on intragastric pH in clinically normal neonatal foals.

  American journal of veterinary research 20040801

• [Significance of PPI-test in the diagnosis of GERD].

  Nihon rinsho. Japanese journal of clinical medicine 20040801

• [Test of refractory gastroesophageal reflux disease].

  Nihon rinsho. Japanese journal of clinical medicine 20040801

• [Primary care for GEDR].

  Nihon rinsho. Japanese journal of clinical medicine 20040801

• [Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist].

  Nihon rinsho. Japanese journal of clinical medicine 20040801

• [PPI: new strategies for GERD].

  Nihon rinsho. Japanese journal of clinical medicine 20040801

• Chiral separation of omeprazole and several related benzimidazoles using supercritical fluid chromatography.

  Journal of separation science 20040801

• Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.

  Connecticut medicine 20040801

• Practical considerations for the clinical use of buprenorphine.

  Science & practice perspectives 20040801

• Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection.

  Wiener klinische Wochenschrift 20040731

• [Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].

  Zhonghua yi xue za zhi 20040717

• Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease.

  Alimentary pharmacology & therapeutics 20040715

• [Chronic upper abdominal pain without improvement after using proton pump inhibitors].

  Deutsche medizinische Wochenschrift (1946) 20040709

• Do procalcitonin and C-reactive protein levels have a place in the diagnosis and follow-up of Helicobacter pylori infections?

  Journal of medical microbiology 20040701

• Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication.

  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20040701

• Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.

  Journal of gastroenterology and hepatology 20040701

• Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study.

  Journal of clinical gastroenterology 20040701

• Seven-day therapy for Helicobacter pylori in the United States.

  Alimentary pharmacology & therapeutics 20040701

• Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.

  Alimentary pharmacology & therapeutics 20040701

• A randomized study of the safety of outpatient care for patients with bleeding peptic ulcer treated by endoscopic injection.

  Gastrointestinal endoscopy 20040701

• Voltammetric behaviour of rabeprazole at a glassy carbon electrode and its determination in tablet dosage form.

  Farmaco (Societa chimica italiana : 1989) 20040701

• Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage?

  The American journal of gastroenterology 20040701

• Second opinion. I have tried the new over-the-counter drug Prilosec for my heartburn, and it was very helpful. The package says I should take it for only two weeks and that if my heartburn comes back after that, I should see my doctor. If Prilosec helps, why can't I keep taking it?

  Mayo Clinic health letter (English ed.) 20040701

• CYP2C19 polymorphism and proton pump inhibitors.

  Basic & clinical pharmacology & toxicology 20040701

• Management of haematemesis and melaena.

  Postgraduate medical journal 20040701

• Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats.

  Journal of pharmacological sciences 20040701

• DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.

  Alimentary pharmacology & therapeutics 20040701

• Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis.

  Alimentary pharmacology & therapeutics 20040701

• Helicobacter pylori eradication decreases blood neutrophil and monocyte counts.

  Alimentary pharmacology & therapeutics 20040701

• Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.

  Alimentary pharmacology & therapeutics 20040701

• [Prospective comparative study on protective effect of the proton pump inhibitor and the prostaglandin analog on H. pylori-negative gastric mucosa of healthy subjects against low-dose aspirin].

  [Hokkaido igaku zasshi] The Hokkaido journal of medical science 20040701

• Oral lichenoid eruption secondary to imatinib (Glivec).

  The Journal of dermatological treatment 20040701

• Wyeth found guilty of paying to boost use of a specific medicine.

  BMJ (Clinical research ed.) 20040626

• [New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?].

  Presse medicale (Paris, France : 1983) 20040619

• The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20040615

• Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus.

  Journal of the National Cancer Institute 20040602

• Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040601

• Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care setting.

  Family practice 20040601

• H pylori infection and reflux oesophagitis.

  Gut 20040601

• Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.

  The American journal of medicine 20040601

• Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene-dose effect and intrasubject variability.

  Journal of clinical pharmacology 20040601

• Influence of omeprazole on bioavailability of bismuth following administration of a triple capsule of bismuth biskalcitrate, metronidazole, and tetracycline.

  Journal of clinical pharmacology 20040601

• Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001.

  Journal of medical microbiology 20040601

• Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer.

  British journal of cancer 20040601

• Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.

  Journal of gastroenterology and hepatology 20040601

• Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria.

  Alimentary pharmacology & therapeutics 20040601

• A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe.

  Alimentary pharmacology & therapeutics 20040601

• Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.

  World journal of gastroenterology 20040601

• Helicobacter pylori infection in Turkish children: comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication.

  Helicobacter 20040601

• Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection.

  Helicobacter 20040601

• Empiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12-month follow-up of health-care consumption.

  The American journal of gastroenterology 20040601

• Treat the patients' main dyspepsia complaint, not the ROME criteria.

  The American journal of gastroenterology 20040601

• Effect of antibacterial therapy and salivary secretion on the efficacy of Helicobacter pylori eradication in duodenal ulcer patients.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20040601

• Proton pump inhibitors for acute upper GI bleeding.

  Drug and therapeutics bulletin 20040601

• Over-expression of inducible heat shock protein 70 in the gastric mucosa of partially sleep-deprived rats.

  Scandinavian journal of gastroenterology 20040601

• Retrospective evaluation of the effect of omeprazole on clozapine metabolism.

  Pharmacy world & science : PWS 20040601

• Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study.

  Journal of clinical epidemiology 20040601

• Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040601

• [Long-term therapeutic effect of triple therapy consisted of omeperazole, clarithromycin and amoxycillin in children with Helicobacter pylori infection and approach to re-treatment after failure of the treatment].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20040601

• On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction.

  Digestive diseases and sciences 20040601

• Significance of non-erosive minimal esophageal lesions in gastro-esophageal reflux disorder.

  The Korean journal of internal medicine 20040601

• The influence of pretreatment on cure rates of Helicobacter pylori eradication.

  The Netherlands journal of medicine 20040601

• Evaluation of fast disintegrating lansoprazole tablet in human subjects.

  Drug metabolism and pharmacokinetics 20040601

• [Home-care warning: Christmas Eve in September? Omeprazole and the appearance of auditory hallucinations].

  Atencion primaria 20040531

• [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].

  MMW Fortschritte der Medizin 20040527

• Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solid-phase extraction.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040525

• Management options for patients with ulcer hemorrhage.

  Annals of internal medicine 20040518

• Health-related quality of life in patients with cardiovascular disease--the effect of upper gastrointestinal symptom treatment.

  Alimentary pharmacology & therapeutics 20040515

• Effect of splitting the dose of esomeprazole on gastric acidity and nocturnal acid breakthrough.

  Alimentary pharmacology & therapeutics 20040515

• Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole.

  Alimentary pharmacology & therapeutics 20040515

• The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.

  Alimentary pharmacology & therapeutics 20040515

• Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers.

  Pharmacological research 20040501

• Lansoprazole-tacrolimus interaction in Japanese transplant recipient with CYP2C19 polymorphism.

  The Annals of pharmacotherapy 20040501

• Mucosal concentration of basic fibroblast growth factor in the healing process in human giant gastric ulcers.

  Journal of gastroenterology and hepatology 20040501

• Absence of nocturnal acid breakthrough in Helicobacter pylori-positive subjects treated with twice-daily omeprazole.

  European journal of gastroenterology & hepatology 20040501

• Quantitative prediction of the in vivo inhibition of diazepam metabolism by omeprazole using rat liver microsomes and hepatocytes.

  Drug metabolism and disposition: the biological fate of chemicals 20040501

• Acute necrotizing esophagitis: a large retrospective case series.

  Endoscopy 20040501

• Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.

  Alimentary pharmacology & therapeutics 20040501

• AstraZeneca digs in over advertising criticisms.

  BMJ (Clinical research ed.) 20040501

• A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.

  International journal of antimicrobial agents 20040501

• Fexofenadine does not affect omeprazole pharmacokinetics: both are putative P-glycoprotein substrates.

  Basic & clinical pharmacology & toxicology 20040501

• Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.

  The American journal of gastroenterology 20040501

• Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection.

  The American journal of gastroenterology 20040501

• Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy.

  Archives of surgery (Chicago, Ill. : 1960) 20040501

• By the way, doctor. I've been taking Prilosec for esophageal reflux. My doctor says I may need to take it indefinitely. Is that safe?

  Harvard women's health watch 20040501

• Induction of testosterone metabolism by esomeprazole in a CYP2C19*2 heterozygote.

  The American journal of the medical sciences 20040501

• The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040501

• [Successful treatment of long-standing iron-deficiency anemia in adults by eradication of Helicobacter pylori].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20040501

• Omeprazole and talampanel as two examples of retrometabolic drug design.

  Die Pharmazie 20040501

• Gastric emptying and gastrointestinal transit of liquid in awake rats is delayed after acute myocardial infarction.

  Digestive diseases and sciences 20040501

• [Studies on chiral inversion of dextropantoprazole in human].

  Yao xue xue bao = Acta pharmaceutica Sinica 20040501

• Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate.

  Xenobiotica; the fate of foreign compounds in biological systems 20040501

• Histamine and histidine decarboxylase are hallmark features of ECL cells but not G cells in rat stomach.

  Regulatory peptides 20040415

• Costs and efficacy of three different esomeprazole treatment strategies for long-term management of gastro-oesophageal reflux symptoms in primary care.

  Alimentary pharmacology & therapeutics 20040415

• [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].

  MMW Fortschritte der Medizin 20040408

• The cavity structure for docking the K(+)-competitive inhibitors in the gastric proton pump.

  The Journal of biological chemistry 20040402

• Benzimidazole drugs and modulation of biotransformation enzymes.

  Research in veterinary science 20040401

• Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.

  Langenbeck's archives of surgery 20040401

• Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes.

  British journal of clinical pharmacology 20040401

• A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients: unchanged frequency of erosive oesophagitis and decreased prevalence of non-erosive gastro-oesophageal reflux disease.

  European journal of gastroenterology & hepatology 20040401

• pH probe positioning for 24-hour pH-metry by manometry or pH step-up.

  European journal of gastroenterology & hepatology 20040401

• High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20040401

• Influence of azimilide on CYP2C19-mediated metabolism.

  Journal of clinical pharmacology 20040401

• An audit of argon plasma coagulation, epinephrine injection, and proton-pump infusion therapy in the management of bleeding peptic ulcer disease.

  Endoscopy 20040401

• Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment.

  Gastroenterology 20040401

• Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.

  Helicobacter 20040401

• Protein pump inhibitors go over the counter.

  Home healthcare nurse 20040401

• Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes.

  Journal of pediatric gastroenterology and nutrition 20040401

• Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in israel: are we missing the malignant potential of Helicobacter pylori?

  Journal of clinical gastroenterology 20040401

• 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms.

  Journal of clinical gastroenterology 20040401

• The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura.

  European journal of haematology 20040401

• A comparison of the effects of ranitidine and omeprazole on volume and pH of gastric contents in elective surgical patients.

  European journal of anaesthesiology 20040401

• Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040401

• Helicobacter pylori eradication: efficacy of conventional therapy in India.

  Tropical doctor 20040401

• Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients.

  Scandinavian journal of gastroenterology 20040401

• Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection.

  Journal of the Chinese Medical Association : JCMA 20040401

• Role of individual human cytochrome P450 enzymes in the in vitro metabolism of hydromorphone.

  Xenobiotica; the fate of foreign compounds in biological systems 20040401

• [Curative and preventive treatment of NSAID-associated gastroduodenal ulcers].

  Gastroenterologie clinique et biologique 20040401

• [Long-term course of reflux symptoms following Helicobacter pylori eradication].

  Deutsche medizinische Wochenschrift (1946) 20040326

• [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].

  Deutsche medizinische Wochenschrift (1946) 20040326

• The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiabendazole in rat hepatocytes.

  Life sciences 20040319

• Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers.

  Alimentary pharmacology & therapeutics 20040315

• [Stubborn reflux pain, inconspicuous esophagus. Which therapy brings the fastest relief?].

  MMW Fortschritte der Medizin 20040311

• [Graded therapy in reflux disease. 'In severe cases 40 mg., in milder 20 mg.'].

  MMW Fortschritte der Medizin 20040311

• Efficacy of a triple therapy for Helicobacter pylori eradication in a well-developed urban area in Brazil.

  Sao Paulo medical journal = Revista paulista de medicina 20040304

• Stomach-brain communication by vagal afferents in response to luminal acid backdiffusion, gastrin, and gastric acid secretion.

  American journal of physiology. Gastrointestinal and liver physiology 20040301

• A case of clarithromycin-induced manic episode (antibiomania).

  The international journal of neuropsychopharmacology 20040301

• Outcome of laparoscopic Nissen-Rossetti fundoplication in children with gastroesophageal reflux disease and supraesophageal symptoms.

  Surgical endoscopy 20040301

• Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.

  World journal of gastroenterology 20040301

• Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection.

  World journal of gastroenterology 20040301

• Gastric antiulcer activity of Syngonanthus arthrotrichus SILVEIRA.

  Biological & pharmaceutical bulletin 20040301

• St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.

  Clinical pharmacology and therapeutics 20040301

• Ventilatory compensation of the alkaline tide during digestion in the snake Boa constrictor.

  The Journal of experimental biology 20040301

• Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man.

  European journal of endocrinology 20040301

• Pharmacogenomics of proton pump inhibitors.

  Pharmacogenomics 20040301

• Tableting and stability evaluation of enteric-coated omeprazole pellets.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20040301

• [Antisecretor treatment of digestive hemorrhage associated to peptic ulcer: an approximation to the available evidence].

  Revista clinica espanola 20040301

• [Therapeutic effect of low-dose omeprazole vs. standard-dose ranitidine in mild to moderate reflux esophagitis].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20040301

• [Myoclonic encephalopathy associated with proton pump inhibitors].

  Revue neurologique 20040301

• [Eradication effect of lansoprazole-based triple therapy against H. pylori].

  Nihon rinsho. Japanese journal of clinical medicine 20040301

• [Effect of proton pump inhibitors (PPIs) on wound healing of gastric mucosal cell injury].

  Nihon rinsho. Japanese journal of clinical medicine 20040301

• Hair analysis as a novel investigative tool for the detection of historical drug use/misuse in the horse: a pilot study.

  Equine veterinary journal 20040301

• Drugs in palliative care: results from a representative survey in Germany.

  Palliative medicine 20040301

• The choice of proton pump inhibitor: does it matter?

  Basic & clinical pharmacology & toxicology 20040301

• Validation of a brief inventory for diagnosis and monitoring of symptomatic gastro-oesophageal reflux.

  Scandinavian journal of gastroenterology 20040301

• [Electrochemical behaviour of pantoprazole].

  Die Pharmazie 20040301

• Omeprazole treatment: genotoxicity biomarkers, and potential to induce CYP1A2 activity in humans.

  Human & experimental toxicology 20040301

• Schatzki's ring: to cut or break an unresolved problem.

  Digestive diseases and sciences 20040301

• Early gastric MALT lymphoma.

  Journal of the Chinese Medical Association : JCMA 20040301

• GERD 2003: issues from the past and a consensus for the future.

  Drugs of today (Barcelona, Spain : 1998) 20040301

• The basis of differentiation of PPIs.

  Drugs of today (Barcelona, Spain : 1998) 20040301

• Understanding NSAID-PPI-COX-2 interrelationships.

  Drugs of today (Barcelona, Spain : 1998) 20040301

• [Effectiveness of omeprazole therapy in children with gastroesophageal reflux diseases(GERD)].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20040301

• Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis.

  Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 20040301

• Quality of life after peptic perforation.

  The Journal of the Association of Physicians of India 20040301

• Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.

  Alimentary pharmacology & therapeutics 20040215

• The acidity index: a simple approach to the measurement of gastric acidity.

  Alimentary pharmacology & therapeutics 20040215

• Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20040215

• Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds.

  Toxicology and applied pharmacology 20040215

• Adverse events following discharge from the hospital.

  Annals of internal medicine 20040203

• Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial.

  Gut 20040201

• Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease.

  Gut 20040201

• Review article: epidemiology and management of gastro-oesophageal reflux in children.

  Alimentary pharmacology & therapeutics 20040201

• The effect of eight weeks of rabeprazole therapy on nitric oxide plasma level and esophageal pH and motility and motility nitric oxide plasma level in patients with erosive esophagitis.

  Medical science monitor : international medical journal of experimental and clinical research 20040201

• Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation.

  Molecular pharmacology 20040201

• High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication.

  Journal of clinical gastroenterology 20040201

• Pharmacokinetics of omeprazole in healthy adults and in children with gastroesophageal reflux disease.

  Therapeutic drug monitoring 20040201

• Inhibition of the L-dopa transport system in human epidermal Langerhans cells by omeprazole and its analogues.

  Amino acids 20040201

• Cost-minimization analysis of treatment of gastroesophageal reflux disease. Implications of varying holding time on conclusions.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040201

• Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children--discussion on daily practice.

  Journal of pediatric surgery 20040201

• [Gastric uptake of gallium67 in the human immunodeficiency virus infection].

  Anales de medicina interna (Madrid, Spain : 1984) 20040201

• Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia.

  Alimentary pharmacology & therapeutics 20040201

• Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re-bleeding risk -- a single-blind, randomized controlled study.

  Alimentary pharmacology & therapeutics 20040201

• Investigation into the role of cephalic stimulation of acid secretion on gastric emptying and appetite following a soup meal using the gastric acid inhibitor omeprazole.

  Appetite 20040201

• Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes.

  Biochemical pharmacology 20040201

• Stress-related mucosal disease: risk factors and prophylactic therapy.

  Clinical therapeutics 20040201

• Omeprazole may delay the diagnosis of pyloric stenosis.

  Acta paediatrica (Oslo, Norway : 1992) 20040201

• Nephritis and proton pump inhibitors.

  Prescrire international 20040201

• Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility.

  Digestive diseases and sciences 20040201

• Early epigastric pain after PPI administration: exacerbation of Helicobacter pylori corpus gastritis?

  Helicobacter 20040201

• [Efficacy of Helicobacter pylori eradication in non-ulcer dyspepsia].

  Medicina clinica 20040131

• Severe thrombocytopenia as a complication of acute Epstein-Barr virus infection.

  Wiener klinische Wochenschrift 20040131

• Whither surgery in the treatment of gastroesophageal reflux disease (GERD)?

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20040120

• Immunoproliferative small intestinal disease associated with Campylobacter jejuni.

  The New England journal of medicine 20040115

• Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

  JAMA 20040114

• Notch activity acts as a sensor for extracellular calcium during vertebrate left-right determination.

  Nature 20040108

• Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.

  Expert opinion on pharmacotherapy 20040101

• Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.

  Gut 20040101

• Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.

  Gut 20040101

• Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20040101

• Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression.

  Alimentary pharmacology & therapeutics 20040101

• Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate.

  Journal of internal medicine 20040101

• Divalent cations regulate acidity within the lumen and tubulovesicle compartment of gastric parietal cells.

  Gastroenterology 20040101

• Omeprazole is more effective than a histamine H2-receptor blocker for maintaining a persistent elevation of gastric pH after colon resection for cancer.

  American journal of surgery 20040101

• An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes.

  Drug metabolism and disposition: the biological fate of chemicals 20040101

• Non-operative treatment for perforated gastro-duodenal peptic ulcer in Duchenne muscular dystrophy: a case report.

  BMC surgery 20040101

• Evaluation of urine sucrose concentration for detection of gastric ulcers in horses.

  American journal of veterinary research 20040101

• Acute interstitial nephritis due to pantoprazole.

  The Annals of pharmacotherapy 20040101

• Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20040101

• Sensitive sulphur-specific detection of omeprazole metabolites in rat urine by high-performance liquid chromatography/inductively coupled plasma mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20040101

• Quantitative assessment of gastric antrum atrophy shows restitution to normal histology after Helicobacter pylori eradication.

  Digestion 20040101

• The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.

  Journal of gastroenterology 20040101

• Rhabdomyolysis associated with omeprazole.

  Journal of gastroenterology 20040101

• Is an intravenous histamine H2 receptor antagonist superior to an intravenous proton pump inhibitor in acid suppression?

  Journal of gastroenterology 20040101

• Empirical Helicobacter pylori 'rescue' therapy after failure of two eradication treatments.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040101

• Lansoprazole promotes gastric mucosal cell proliferation and migration by activating p44/p42 mitogen-activated protein kinase.

  Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 20040101

• [Effect of CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with rabeprazole-based triple therapy in Chinese].

  Zhonghua nei ke za zhi 20040101

• Parietal cell density during gastric ulcer healing in the rat.

  Scandinavian journal of gastroenterology 20040101

• Managing gastro-oesophageal reflux disease in children.

  Digestion 20040101

• Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.

  Hepato-gastroenterology 20040101

• Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding.

  Hepato-gastroenterology 20040101

• Association of helicobacter pylori infection with nutritional status in hemodialysis patients.

  Transplantation proceedings 20040101

• Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040101

• Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040101

• Inhibition of gastric H,K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML 3000.

  BMC gastroenterology 20040101

• Flavor and taste of lansoprazole strawberry-flavored delayed-release oral suspension preferred over ranitidine peppermint-flavored oral syrup: in children aged between 5-11 years.

  Paediatric drugs 20040101

• Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20040101

• Effectiveness of peripheral hepatogastrostomy versus hepatojejunostomy in the treatment of obstructive cholestasis: results of an experimental model.

  Surgery today 20040101

• Intravenous esomeprazole.

  Drugs 20040101

• Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring.

  BMC medicine 20040101

• Single-isomer drugs: true therapeutic advances.

  Clinical pharmacokinetics 20040101

• Single-enantiomer drugs: elegant science, disappointing effects.

  Clinical pharmacokinetics 20040101

• Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib.

  Clinical pharmacokinetics 20040101

• Efficacy of esomeprazole in patients with acid-peptic disorders.

  Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20040101

• Tumoral calcinosis in systemic sclerosis.

  Clinical and experimental rheumatology 20040101

• Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.

  Hepato-gastroenterology 20040101

• [Cross reactivity among proton pump inhibitors: does it exits?].

  Allergologia et immunopathologia 20040101

• Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis.

  European journal of gastroenterology & hepatology 20040101

• [Comparative efficacy of different therapeutic schemes in gastropathies induced by nonsteroid anti-inflammatory drugs].

  Terapevticheskii arkhiv 20040101

• Reversal of end-stage renal disease after aortic dissection using renal artery stent: a case report.

  BMC nephrology 20040101

• Barrett's oesophagus and adenocarcinoma.

  World journal of surgical oncology 20040101

• The heat shock response is dependent on the external environment and on rapid ionic balancing by pharmacological agents in Saccharomyces cerevisiae.

  Journal of applied microbiology 20040101

• Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.

  Hepato-gastroenterology 20040101

• An extensive metabolizer with recurrent ulcer responding to high dose of lansoprazole.

  Hepato-gastroenterology 20040101

• Enhanced gastric emptying of a liquid gastric load in mice lacking cholecystokinin-B receptor: a study of CCK-A,B, and AB receptor gene knockout mice.

  Journal of gastroenterology 20040101

• Serum IL-8 as a possible marker for determining the status of Helicobacter pylori infection in patients with untreated and treated peptic ulcer.

  Advances in therapy 20040101

• Bioequivalence study of rabeprazole sodium on healthy human volunteers.

  Journal of the Indian Medical Association 20040101

• [Acute interstitial nephritis associated with omeprazole therapy].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101

• Bioequivalence evaluation of two rabeprazole enteric coated formulations in healthy Chinese volunteers.

  European journal of drug metabolism and pharmacokinetics 20040101

• Omeprazole/antacid-powder suspension--Santarus: Acitrel, Rapinex Powder for oral suspension, SAN 05.

  Drugs in R&D 20040101

• Mechanism of antiulcer effect of Neem (Azadirachta indica) leaf extract: effect on H+-K+-ATPase, oxidative damage and apoptosis.

  Inflammopharmacology 20040101

• Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard.

  Arzneimittel-Forschung 20040101

• [Regression of primary low-grade gastric mucosa-associated lymphoma by eradication of Helicobacter pylori infection: case report].

  Annali italiani di chirurgia 20040101

• Omeprazole is more effective than famotidine for preventing acute gastritis in rats.

  Surgery today 20040101

• [Investigation of the effects of efflux pump inhibitors on ciprofloxacin MIC values of high level fluoroquinolone resistant Escherichia coli clinical isolates].

  Mikrobiyoloji bulteni 20040101

• New liquid chromatographic method for determination of rabeprazole sodium in coated tablets.

  Journal of AOAC International 20040101

• Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.

  Digestion 20040101

• Treatment of gastroesophageal reflux disease: pills, knife or scope.

  Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20040101

• Delayed-release lansoprazole plus naproxen.

  Drugs 20040101

• Triple therapy using two dosages of metronidazole along with amoxicillin and omeprazole to eradicate Helicobacter pylori infection: a randomized, open study.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20040101

• Intravenous lansoprazole: in erosive oesophagitis.

  Drugs 20040101

• Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease.

  Clinical pharmacokinetics 20040101

• Perforated duodenal ulcer at seven years after heart-renal transplantation: a case report.

  Hepato-gastroenterology 20040101

• Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.

  Hepato-gastroenterology 20040101

• The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.

  Hepato-gastroenterology 20040101

• Churg-Strauss syndrome (allergic granulomatous angiitis) associated with T lymphoblastic lymphoma.

  In vivo (Athens, Greece) 20040101

• Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.

  Journal of managed care pharmacy : JMCP 20040101

• OTC omeprazole for your heartburn--enormous value-for-money opportunity.

  Journal of managed care pharmacy : JMCP 20040101

• Pantoprazole-induced acute interstitial nephritis.

  Journal of nephrology 20040101

• Extra-esophageal disorders in gastroesophageal reflux disease.

  Digestive diseases (Basel, Switzerland) 20040101

• Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy.

  Digestive diseases (Basel, Switzerland) 20040101

• Omeprazole induces apoptosis in jurkat cells.

  International journal of immunopathology and pharmacology 20040101

• [Experience of application of Esomeprazole in patients with chronic hepatic diseases associated with acid-dependent diseases].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101

• [Particular features of application of proton pump inhibitors (Rabeprazole) in children with the gastroesophageal reflux disease].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101

• Emphysematous cystitis: an unusual disease of the Genito-Urinary system suspected on imaging.

  Annals of clinical microbiology and antimicrobials 20040101

• Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients?

  Current surgery 20040101

• [Efficacy of the dosing regimen of pantoprazole 40 mg, amoxicillin 1000 mg and clarithromycin 500 mg, twice daily for 7 days, in the eradication of Helicobacter pylori in patients with peptic ulcer].

  Arquivos de gastroenterologia 20040101

• The diagnostic value of endoscopy and Helicobacter pylori tests for peptic ulcer patients in late post-treatment setting.

  BMC gastroenterology 20040101

• Direct injection of 96-well organic extracts onto a hydrophilic interaction chromatography/tandem mass spectrometry system using a silica stationary phase and an aqueous/organic mobile phase.

  Rapid communications in mass spectrometry : RCM 20040101

• Rapid determination of five probe drugs and their metabolites in human plasma and urine by liquid chromatography/tandem mass spectrometry: application to cytochrome P450 phenotyping studies.

  Rapid communications in mass spectrometry : RCM 20040101

• Enteral drug absorption in patients with short small bowel : a review.

  Clinical pharmacokinetics 20040101

• Gastro-oesophageal reflux disease: a review of clinical features, investigations and recent trends in management.

  Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria 20040101

• Laboratory diagnosis and susceptibility profile of Helicobacter pylori infection in the Philippines.

  Annals of clinical microbiology and antimicrobials 20040101

• [Erosion caused by gastric reflux in children. Discussion of etiology, clinical appearance and therapy in two cases].

  Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia 20040101

• [Selecting variants of drug treatment of non-complicated duodenal ulcer (based on a study of results of Rabeprazole efficiency)].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101

• [Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101

• [Some comparative aspects of treating the gastroesophageal reflux disease eradication].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101

• Omeprazole/Antacid-powder suspension-Santarus: omeprazole/sodium bicarbonate powder-Santarus, SAN 05.

  Drugs in R&D 20040101

• [Effect of H2-blockers and proton pump inhibitors on intragastric acidity and intraesophageal pH in patients with gastroesophageal reflux disease].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101

• [Problems of excretory insufficiency of the pancreas].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101

• [Clinical and pharmacoeconomic aspects of the antisecretory therapy of gastroesophageal refluxed disease].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101

• Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20040101

• Effectiveness of proton pump inhibitors: beyond cost.

  Reviews in gastroenterological disorders 20040101

• [Peptic ulcer disease etiology, diagnosis and treatment].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20040101

• Paroxysmal laryngospasm: a typical but underrecognized supraesophageal manifestation of gastroesophageal reflux?

  Digestive diseases and sciences 20040101

• Gastric acid and salivary bicarbonate. Is there a relationship in duodenal ulcer patients?

  Roczniki Akademii Medycznej w Bialymstoku (1995) 20040101

• Sleep-related breathing disorders in small children with nocturnal acid gastro-oesophageal reflux.

  Roczniki Akademii Medycznej w Bialymstoku (1995) 20040101

• A pharmacokinetic interaction study between omeprazole and the H2-receptor antagonist ranitidine.

  Drug metabolism and drug interactions 20040101

• Esomeprazole 40 mg administered intravenously has similar safety and efficacy profiles to the oral formulation in patients with erosive esophagitis.

  Digestion 20040101

• Warning: do not combine Reyataz and Prilosec.

  AIDS treatment news 20040101

• Helicobacter pylori infection in Greenlandic patients with dyspepsia.

  International journal of circumpolar health 20040101

• [Evaluation of the symptomatology and quality of life in functional dyspepsia before and after Helicobacter pylori eradication treatment].

  Revista de gastroenterologia de Mexico 20040101

• [Methods to optimize the management of Helicobacter pylori infection. The comparative efficacy of the triple and quadruple therapy used as a first line therapy].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101

• In vivo and in vitro research on the biological effects of deuterium-depleted water: 1. Influence of deuterium-depleted water on cultured cell growth.

  Romanian journal of physiology : physiological sciences 20040101

• [Particular features of the treatment of ulcer recurrence in patients with myocardial infarction].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20040101

• Interface flow process audit: using the patient's career as a tracer of quality of care and of system organisation.

  International journal of integrated care 20040101

• Treatment for patients with gastroesophageal reflux disease.

  Director (Cincinnati, Ohio) 20040101

• Perinatal asphyxia syndrome in the foal: review and a case report.

  Irish veterinary journal 20040101

• Right dorsal colitis in the horse: minireview and reports on three cases in Ireland.

  Irish veterinary journal 20040101

• Enantiomeric determination of the plasma levels of omeprazole by direct plasma injection using high-performance liquid chromatography with achiral-chiral column-switching.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031225

• [The proton pump especially steady in grip. Fast help for nightly reflux complaints].

  MMW Fortschritte der Medizin 20031218

• [Drug treatment of gastro-esophageal reflux disease in pregnant women: consensus guidelines of gastroenterologists and gynaecologists].

  Nederlands tijdschrift voor geneeskunde 20031213

• Demonstration of a functional apical sodium hydrogen exchanger in isolated rat gastric glands.

  American journal of physiology. Gastrointestinal and liver physiology 20031201

• A 100 kDa vanadate and lanzoprazole-sensitive ATPase from Streptococcus mutans membrane.

  Archives of oral biology 20031201

• Gastrointestinal complications in high-risk patients taking aspirin or nonsteroidal anti-inflammatory drugs and omeprazole.

  Current gastroenterology reports 20031201

• Diagnostic and therapeutic options in the management of nonvariceal upper gastrointestinal bleeding.

  Current gastroenterology reports 20031201

• Study of Mimusops elengi bark in experimental gastric ulcers.

  Journal of ethnopharmacology 20031201

• Secondary eradication of Helicobacter pylori was effective against refractory idiopathic thrombocytopenic purpura.

  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20031201

• Effect of omeprazole on the steady-state pharmacokinetics of voriconazole.

  British journal of clinical pharmacology 20031201

• Differential pulse anodic voltammetric determination of pantoprazole in pharmaceutical dosage forms and human plasma using glassy carbon electrode.

  Analytical biochemistry 20031201

• Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.

  Helicobacter 20031201

• Nutcracker oesophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole.

  Alimentary pharmacology & therapeutics 20031201

• Effect of omeprazole 10 mg on intragastric pH in three different CYP2C19 genotypes, compared with omeprazole 20 mg and lafutidine 20 mg, a new H2-receptor antagonist.

  Alimentary pharmacology & therapeutics 20031201

• Retreatment of H. pylori with dual therapy using high doses of rabeprazole or lansoprazole can be effective.

  Alimentary pharmacology & therapeutics 20031201

• Effect of omeprazole on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20031201

• Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole.

  Journal of gastroenterology and hepatology 20031201

• Stomach myoelectrical response of patients with gastroesophageal reflux disease receiving omeprazole treatment.

  Journal of gastroenterology and hepatology 20031201

• Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.

  The American journal of gastroenterology 20031201

• Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer.

  The American journal of gastroenterology 20031201

• Dosage of intravenous pantoprazole.

  The American journal of gastroenterology 20031201

• The Weber-curve pitfall: effects of a forced introduction on reporting rates and reported adverse reaction profiles.

  Pharmacy world & science : PWS 20031201

• Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype.

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20031201

• Iron deficiency anemia as the only sign of infection with Helicobacter pylori: a report of 9 pediatric cases.

  International journal of hematology 20031201

• Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats.

  The Journal of laboratory and clinical medicine 20031201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20031201

• Sufficient control of heartburn in endoscopy-negative gastro-oesophageal reflux disease trials.

  Scandinavian journal of gastroenterology 20031201

• Endoscopy-negative reflux disease: what is the value of a proton-pump inhibitor test in everyday clinical practice?

  Scandinavian journal of gastroenterology 20031201

• [Efficacy of anti-Helicobacter therapy in children with ulcer-like functional dyspepsia].

  Likars'ka sprava 20031201

• [Efficacy of omeprazole in the treatment of Helicobacter pylori-associated duodenal ulcers... in children].

  Likars'ka sprava 20031201

• [Efficacy of controloc in the treatment of acid-dependent diseases].

  Likars'ka sprava 20031201

• Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20031201

• In treatment of active duodenal ulcer and Helicobacter pylori eradication.

  Hepato-gastroenterology 20031201

• Direct effects of proton pump inhibitors on histamine release from rat enterochromaffin-like cells.

  European journal of pharmacology 20031128

• Square-wave adsorptive cathodic stripping voltammetry of pantoprazole.

  Journal of pharmaceutical and biomedical analysis 20031124

• [What treatments can reduce the digestive complications of NSAIDs].

  Presse medicale (Paris, France : 1983) 20031122

• [Role of Helicobacter pylori in drug-induced gastrointestinal bleeding].

  Presse medicale (Paris, France : 1983) 20031122

• [Treatment of Helicobacter pylori infection--results and experiences with an Internet-based collaboration trial].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20031120

• Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.

  British journal of cancer 20031117

• Effect of a single oral dose of rabeprazole on nocturnal acid breakthrough and nocturnal alkaline amplitude.

  World journal of gastroenterology 20031115

• Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20031115

• Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pylori infection in patients with bleeding gastro-duodenal ulcer.

  Alimentary pharmacology & therapeutics 20031115

• Proton-pump inhibitors in a Navy hospital after a formulary change.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031115

• Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes.

  European journal of pediatrics 20031101

• Effect of Helicobacter pylori eradicated therapy on water gastric emptying in patients with active duodenal ulcer.

  Journal of gastroenterology and hepatology 20031101

• CYP2C19- and CYP3A4-dependent omeprazole metabolism in West Mexicans.

  Journal of clinical pharmacology 20031101

• Omeprazole-induced intractable cough.

  The Annals of pharmacotherapy 20031101

• The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery.

  Anesthesia and analgesia 20031101

• Immunoelectron microscopic study for histamine in the gastric enterochromaffin-like cells of rats treated with the proton pump inhibitor lansoprazole.

  Histochemistry and cell biology 20031101

• Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the 'Cooperstown 5+1 cocktail'.

  Clinical pharmacology and therapeutics 20031101

• Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy.

  The Journal of infectious diseases 20031101

• Gastroprotection by coxibs: what do the Celecoxib Long-Term Arthritis Safety Study and the Vioxx Gastrointestinal Outcomes Research Trial tell us?

  Rheumatic diseases clinics of North America 20031101

• Massive gastrointestinal bleeding in infants with ascariasis.

  Journal of pediatric surgery 20031101

• Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis.

  Alimentary pharmacology & therapeutics 20031101

• Comparison of morning and evening administration of rabeprazole for gastro-oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind, cross-over study.

  Alimentary pharmacology & therapeutics 20031101

• The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis.

  Alimentary pharmacology & therapeutics 20031101

• Banishing bleeding ulcers. Direct treatment helps--and long-term follow-up therapy may be unnecessary.

  Health news (Waltham, Mass.) 20031101

• Lansoprazole-induced hepatic dysfunction.

  The Annals of pharmacotherapy 20031101

• [The effect of proton pump inhibitor on intragastric acidity and it relation to S-mephenytoin hydroxylase genetic polymorphism].

  Zhonghua nei ke za zhi 20031101

• Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.

  The American journal of gastroenterology 20031101

• [The treatment of Helicobacter pylori infection in upper gastrointestinal disorders].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20031101

• ['Mirror, mirror on the wall which is the best proton pump inhibitor of all?'].

  Zeitschrift fur Gastroenterologie 20031101

• Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses.

  Equine veterinary journal 20031101

• Association between nocturnal bruxism and gastroesophageal reflux.

  Sleep 20031101

• Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031101

• Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice.

  Digestive diseases and sciences 20031101

• Cowpox with severe generalized eruption, Finland.

  Emerging infectious diseases 20031101

• [Treatment of reflux esophagitis by Xuanfu Daizhe Decoction combined with pantoprazole or omeprazole: a comparative study].

  Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20031101

• [Study of brands in the prescription of generic drugs at 6 health centers in 2001].

  Atencion primaria 20031031

• [Mastopathy after estradiol and pantoprazol treatment].

  Atencion primaria 20031031

• [Laboratory and clinical study of levofloxacin against Helicobacter pylori].

  Zhonghua yi xue za zhi 20031025

• Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative.

  Alimentary pharmacology & therapeutics 20031015

• Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies.

  Alimentary pharmacology & therapeutics 20031015

• Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance.

  Alimentary pharmacology & therapeutics 20031015

• Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.

  Alimentary pharmacology & therapeutics 20031015

• Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.

  Alimentary pharmacology & therapeutics 20031015

• Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial.

  Alimentary pharmacology & therapeutics 20031015

• Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for Leydig cell carcinogenesis.

  Toxicology and applied pharmacology 20031015

• Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates.

  Journal of pharmaceutical and biomedical analysis 20031015

• Identification and prediction of promiscuous aggregating inhibitors among known drugs.

  Journal of medicinal chemistry 20031009

• [Hyponatremia: an unusual case report].

  Praxis 20031008

• Simple and efficient method for enantioselective determination of omeprazole in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031005

• Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.

  Gut 20031001

• Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes.

  Drug metabolism and disposition: the biological fate of chemicals 20031001

• Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031001

• Submucosal microinfusion of endothelin and adrenaline mobilizes ECL-cell histamine in rat stomach, and causes mucosal damage: a microdialysis study.

  British journal of pharmacology 20031001

• Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects.

  Alimentary pharmacology & therapeutics 20031001

• Formulation study for lansoprazole fast-disintegrating tablet. III. Design of rapidly disintegrating tablets.

  Chemical & pharmaceutical bulletin 20031001

• Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formulary.

  The American journal of managed care 20031001

• Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.

  The American journal of gastroenterology 20031001

• PD-136,450: a CCK2 (gastrin) receptor antagonist with antisecretory, anxiolytic and antiulcer activity.

  Molecular and cellular biochemistry 20031001

• Treating patients with acute gastrointestinal bleeding or rebleeding.

  Pharmacotherapy 20031001

• Lactoferrin: milking ulcers?

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001

• Use of bovine lactoferrin for Helicobacter pylori eradication.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001

• Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001

• Proton pump inhibitors in children: a review.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031001

• Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.

  Digestive diseases and sciences 20031001

• Sildenafil, a phosphodiesterase-5 inhibitor, delays gastric emptying and gastrointestinal transit of liquid in awake rats.

  Digestive diseases and sciences 20031001

• Asthma-like syndrome in a teenager.

  Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 20031001

• Pharmacokinetics of omeprazole in patients with liver cirrhosis and extrahepatic portal venous obstruction.

  Methods and findings in experimental and clinical pharmacology 20031001

• [Modern approach to the therapy of gastroesophageal reflux disease].

  Voenno-meditsinskii zhurnal 20031001

• [Heartburn without esophagitis. Symptoms more important than the finding?].

  MMW Fortschritte der Medizin 20030925

• Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.

  Archives of internal medicine 20030922

• One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.

  Archives of internal medicine 20030922

• Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori.

  Annals of internal medicine 20030916

• Summaries for patients. Effects of antibiotic treatment for Helicobacter pylori on normal bowel bacteria.

  Annals of internal medicine 20030916

• Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease.

  Alimentary pharmacology & therapeutics 20030915

• Esomeprazole administered through a nasogastric tube provides bioavailability similar to oral dosing.

  Alimentary pharmacology & therapeutics 20030915

• Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms.

  Alimentary pharmacology & therapeutics 20030915

• Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia.

  Alimentary pharmacology & therapeutics 20030915

• Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy.

  Alimentary pharmacology & therapeutics 20030915

• Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20030915

• A new furoxan NO-donor rabeprazole derivative and related compounds.

  Chembiochem : a European journal of chemical biology 20030905

• Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy.

  European journal of pharmacology 20030905

• Primary duodenogastric reflux in children and adolescents.

  European journal of pediatrics 20030901

• Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: which is suitable for on-demand therapy?

  Journal of gastroenterology and hepatology 20030901

• Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment.

  European journal of gastroenterology & hepatology 20030901

• Minimal surgery for treatment of GERD.

  The Medical letter on drugs and therapeutics 20030901

• Formulation study for lansoprazole fast-disintegrating tablet. II. Effect of triethyl citrate on the quality of the products.

  Chemical & pharmaceutical bulletin 20030901

• Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice.

  The Journal of allergy and clinical immunology 20030901

• Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.

  The American journal of gastroenterology 20030901

• Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.

  The American journal of gastroenterology 20030901

• Paecilomyces lilacinus vaginitis in an immuno-competent patient.

  Emerging infectious diseases 20030901

• Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease.

  The Keio journal of medicine 20030901

• [Retreatment of Helicobacter pylori infection with triple therapy after initial treatment failure].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20030901

• A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20030901

• Selection of patients with gastroesophageal reflux disease for antireflux surgery based on esophageal manometry.

  Digestive diseases and sciences 20030901

• On-demand therapy for Los Angeles grade A and B reflux esophagitis: esomeprazole versus omeprazole.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20030901

• Healing of Helicobacter pylori gastric ulcers: only eradication matters.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20030901

• [Treatment of reflux disease. An international consensus conference put things in its place].

  Revue medicale de la Suisse romande 20030901

• The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison.

  Annals of internal medicine 20030819

• Treatment of patients at high risk for recurrent bleeding from a peptic ulcer.

  Annals of internal medicine 20030819

• Summaries for patients. Combination treatment for peptic ulcers at high risk for recurrent bleeding.

  Annals of internal medicine 20030819

• Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease.

  The American journal of medicine 20030818

• First-order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities.

  Journal of pharmaceutical and biomedical analysis 20030808

• Over-the-counter omeprazole (prilosec OTC).

  The Medical letter on drugs and therapeutics 20030804

• The impact of gastroesophageal reflux disease on quality of life.

  Surgical endoscopy 20030801

• Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein.

  Clinica chimica acta; international journal of clinical chemistry 20030801

• Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter.

  Molecular pharmacology 20030801

• Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine.

  Journal of clinical gastroenterology 20030801

• 13C-urea breath test, referral patterns, and results in children.

  Journal of clinical gastroenterology 20030801

• Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results.

  Gastrointestinal endoscopy 20030801

• Results of a new technique in the treatment of severe esophageal stenosis in children: poliflex stents.

  Journal of pediatric gastroenterology and nutrition 20030801

• The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjects.

  British journal of clinical pharmacology 20030801

• Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori.

  Alimentary pharmacology & therapeutics 20030801

• A screening study on the liability of eight different female sex steroids to inhibit CYP2C9, 2C19 and 3A4 activities in human liver microsomes.

  Pharmacology & toxicology 20030801

• Sodium pentobarbital anesthesia transiently enhances the severity of infection following intragastric, but not intravenous, inoculation of Listeria monocytogenes in mice.

  Microbial pathogenesis 20030801

• Odds of moderate or severe gastric ulceration in racehorses receiving antiulcer medications.

  Journal of the American Veterinary Medical Association 20030801

• [Celecoxib as well as Diclofenac in Combination with Omeprazole can Prevent the Recurrence of NSAIDs-Induced Gastrointestinal Bleeding].

  Zeitschrift fur Gastroenterologie 20030801

• Formulation study for lansoprazole fast-disintegrating tablet. I. Effect of compression on dissolution behavior.

  Chemical & pharmaceutical bulletin 20030801

• The efficacy of furazolidone-based quadruple therapy for eradication of Helicobacter pylori infection in Iranian patients resistant to metronidazole-based quadruple therapy.

  Medical science monitor : international medical journal of experimental and clinical research 20030801

• Gastric juice, gastric tissue and blood antibiotic concentrations following omeprazole, amoxicillin and clarithromycin triple therapy.

  Helicobacter 20030801

• Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen.

  Helicobacter 20030801

• A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.

  Helicobacter 20030801

• Omeprazole disposition in children following single-dose administration.

  Journal of clinical pharmacology 20030801

• Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux.

  The Journal of pediatrics 20030801

• The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine.

  The Journal of pediatrics 20030801

• [A prospective study on rabeprazole-based triple therapy for Helicobacter pylori eradication in patients with peptic ulcer].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20030801

• Childhood Helicobacter pylori infection, clinical presentations, endoscopic, histologic features and results of treatment.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20030801

• [References for reflux therapy. Preventing nocturnal acid recurrence].

  MMW Fortschritte der Medizin 20030724

• Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.

  World journal of gastroenterology 20030715

• Economic analysis of celecoxib versus diclofenac plus omeprazole for the treatment of arthritis in patients at risk of ulcer disease.

  Alimentary pharmacology & therapeutics 20030715

• The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis.

  Alimentary pharmacology & therapeutics 20030715

• Role of human hepatic cytochrome P-450s in territrem A metabolism.

  Journal of toxicology and environmental health. Part A 20030711

• [Pantoprazole-induced hepatitis].

  Deutsche medizinische Wochenschrift (1946) 20030704

• Evidence-based analysis: postoperative gastric bleeding: etiology and prevention.

  Surgical oncology 20030701

• Effect of different doses of furazolidone with amoxicillin and omeprazole on eradication of Helicobacter pylori.

  Journal of gastroenterology and hepatology 20030701

• Rabeprazole in a one-week eradication therapy of Helicobacter pylori: comparison of different dosages.

  Journal of gastroenterology and hepatology 20030701

• Rabeprazole treatment attenuated Helicobacter pylori-associated gastric mucosal lesion formation in Mongolian gerbils.

  Journal of gastroenterology and hepatology 20030701

• Mortality study of 18 000 patients treated with omeprazole.

  Gut 20030701

• Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.

  European journal of gastroenterology & hepatology 20030701

• Intra-oesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole: a crossover study in patients with gastro-oesophageal reflux disease.

  European journal of gastroenterology & hepatology 20030701

• Determination of pantoprazole by adsorptive stripping voltammetry at carbon paste electrode.

  Farmaco (Societa chimica italiana : 1989) 20030701

• Effects of inhibition gastric acid secretion on arterial acid-base status during digestion in the toad Bufo marinus.

  Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 20030701

• Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment.

  Alimentary pharmacology & therapeutics 20030701

• High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20030701

• Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial.

  Alimentary pharmacology & therapeutics 20030701

• Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?

  Alimentary pharmacology & therapeutics 20030701

• Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux disease patients treated with a proton-pump inhibitor.

  Alimentary pharmacology & therapeutics 20030701

• [Treatment strategies for gastroesophageal reflux disease].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20030701

• Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole.

  Scandinavian journal of gastroenterology 20030701

• Adverse reactions to pantoprazole.

  Scandinavian journal of gastroenterology 20030701

• Efficacy of a paste formulation of omeprazole for the treatment of naturally occurring gastric ulcers in training standardbred racehorses in Canada.

  The Canadian veterinary journal = La revue veterinaire canadienne 20030701

• Oral bioavailability of pantoprazole suspended in sodium bicarbonate solution.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030701

• Assessment of potential digoxin-rabeprazole interaction after formulary conversion of proton-pump inhibitors.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030701

• Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.

  Alimentary pharmacology & therapeutics 20030701

• [Helicobacter pylori eradication based upon a drug sensitivity test effectively increased platelet count in a patient with refractory idiopathic thrombocytopenic purpura].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20030701

• A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis.

  Clinical therapeutics 20030701

• Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20030701

• Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030701

• Prilosec, nexium and stereoisomers.

  The Medical letter on drugs and therapeutics 20030623

• [All proton pump inhibitors are equally efficacious in standard dosages].

  Lakartidningen 20030619

• Rat stomach ECL cells: mode of activation of histidine decarboxylase.

  Regulatory peptides 20030615

• Antralization at the edge of proximal gastric ulcers: does Helicobacter pylori infection play a role?

  World journal of gastroenterology 20030615

• Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey.

  Alimentary pharmacology & therapeutics 20030615

• Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors.

  Alimentary pharmacology & therapeutics 20030615

• Long-term observation of reflux oesophagitis developing after Helicobacter pylori eradication therapy.

  Alimentary pharmacology & therapeutics 20030615

• Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?

  Alimentary pharmacology & therapeutics 20030615

• The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity.

  Alimentary pharmacology & therapeutics 20030615

• Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.

  The New England journal of medicine 20030612

• Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.

  The New England journal of medicine 20030612

• Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.

  The New England journal of medicine 20030612

• Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes.

  European journal of clinical pharmacology 20030601

• CD63 expression by flow cytometry in the in vitro diagnosis of allergy to omeprazole.

  Allergy 20030601

• Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interaction.

  The Annals of pharmacotherapy 20030601

• Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up.

  Endoscopy 20030601

• Review article: test and treat or treat and test in reflux disease?

  Alimentary pharmacology & therapeutics 20030601

• One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20030601

• Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole.

  Alimentary pharmacology & therapeutics 20030601

• Variable expression of CYP and Pgp genes in the human small intestine.

  European journal of clinical investigation 20030601

• The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes.

  Clinical pharmacology and therapeutics 20030601

• Effects of 6-12 months of esomeprazole treatment on the gastric mucosa.

  The American journal of gastroenterology 20030601

• Time-dependent amplified pharmacokinetic and pharmacodynamic responses of rabeprazole in cytochrome P450 2C19 poor metabolizers.

  Pharmacotherapy 20030601

• Stability of esomeprazole capsule contents after in vitro suspension in common soft foods and beverages.

  Pharmacotherapy 20030601

• Effect of short-term treatment with regular or high doses of omeprazole on the detection of Helicobacter pylori in bleeding peptic ulcer patients.

  Scandinavian journal of gastroenterology 20030601

• On the mechanisms underlying histamine induction of gastric mucosal lesions in rats with partial gastric vascular occlusion.

  Journal of pharmacological sciences 20030601

• The effects of mebendazole on P4501A activity in rat hepatocytes and HepG2 cells. Comparison with tiabendazole and omeprazole.

  The Journal of pharmacy and pharmacology 20030601

• How can the current strategies for Helicobacter pylori eradication therapy be improved?

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20030601

• [Eradication of Helicobacter pylori infection in Hungary (1993-2002): a meta-analysis].

  Orvosi hetilap 20030601

• [In-vitro activity of rabeprazole, lansoprazole, and esomeprazole against Helicobacter pylori].

  Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 20030601

• [Progression from intestinal metaplasia to adenocarcinoma in Barrett s esophagus: usefulness of endoscopic surveillance].

  Revista medica de Chile 20030601

• Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection.

  The Netherlands journal of medicine 20030601

• The effectiveness of omeprazole versus lansoprazole along with amoxicillin and clarithromycin in Turkish population with duodenal ulcer.

  Minerva gastroenterologica e dietologica 20030601

• Update on health-related quality of life in patients with gastroesophageal reflux disease.

  Expert review of pharmacoeconomics & outcomes research 20030601

• Psychiatric side effects of medications prescribed in internal medicine.

  Dialogues in clinical neuroscience 20030601

• Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment.

  BMJ (Clinical research ed.) 20030524

• [Causes of otalgia from outside the ear].

  Nederlands tijdschrift voor geneeskunde 20030517

• Effects of antireflux treatment on bronchial hyper-responsiveness and lung function in asthmatic patients with gastroesophageal reflux disease.

  World journal of gastroenterology 20030515

• Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori.

  World journal of gastroenterology 20030515

• Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20030515

• Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use.

  Alimentary pharmacology & therapeutics 20030515

• The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.

  Alimentary pharmacology & therapeutics 20030515

• [Proton pump inhibitors and chronic requirement].

  Lakartidningen 20030515

• Structural and functional characterization of gastric mucosa and central nervous system in histamine H2 receptor-null mice.

  European journal of pharmacology 20030502

• Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products.

  Drug metabolism and disposition: the biological fate of chemicals 20030501

• Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial.

  Endoscopy 20030501

• Diarrhea associated with lansoprazole.

  Journal of gastroenterology and hepatology 20030501

• Studies on the interactions between drug and estrogen. II. On the inhibitory effect of 29 drugs reported to induce gynecomastia on the oxidation of estradiol at C-2 or C-17.

  Biological & pharmaceutical bulletin 20030501

• Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man.

  European journal of clinical pharmacology 20030501

• Lansoprazole overutilization: methods for step-down therapy.

  The American journal of managed care 20030501

• Globus sensation and gastroesophageal reflux.

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20030501

• Rabeprazole is superior to omeprazole for the inhibition of peptone meal-stimulated gastric acid secretion in Helicobacter pylori-negative subjects.

  Alimentary pharmacology & therapeutics 20030501

• Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies.

  Alimentary pharmacology & therapeutics 20030501

• Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20030501

• Nodular gastritis in adults is caused by Helicobacter pylori infection.

  Digestive diseases and sciences 20030501

• A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux.

  Scandinavian journal of gastroenterology 20030501

• Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study.

  Scandinavian journal of gastroenterology 20030501

• Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features?

  Scandinavian journal of gastroenterology 20030501

• [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].

  Laryngo- rhino- otologie 20030501

• The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.

  The Journal of laryngology and otology 20030501

• Omeprazole reduces clozapine plasma concentrations. A case report.

  Pharmacopsychiatry 20030501

• Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors.

  The American journal of gastroenterology 20030501

• The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.

  The American journal of gastroenterology 20030501

• Acute hyperkalemia associated with intravenous omeprazole therapy.

  The American journal of gastroenterology 20030501

• [Nexium and Losec are equally good].

  Lakartidningen 20030424

• [Nexium is not better than Losec].

  Lakartidningen 20030417

• Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43.

  European journal of pharmacology 20030411

• [When sour does not make merry at all . Fast relief for patients with reflux].

  MMW Fortschritte der Medizin 20030410

• [A new interesting study on coxib].

  Lakartidningen 20030403

• Reflux oesophagitis in adult coeliac disease: beneficial effect of a gluten free diet.

  Gut 20030401

• The role of cytochrome P450 2C19 activity in flunitrazepam metabolism in vivo.

  Journal of clinical psychopharmacology 20030401

• Omeprazole plus azithromycin and either amoxicillin or tinidazole for eradication of Helicobacter pylori infection.

  Journal of clinical gastroenterology 20030401

• Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia.

  Alimentary pharmacology & therapeutics 20030401

• Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20030401

• Determination of the reduction in gastric acidity necessary to prevent pathological oesophageal reflux in patients with gastro-oesophageal reflux disease treated with a proton pump inhibitor.

  Alimentary pharmacology & therapeutics 20030401

• The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism.

  Alimentary pharmacology & therapeutics 20030401

• Esophageal Crohn disease in children: a clinical spectrum.

  Journal of pediatric gastroenterology and nutrition 20030401

• Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in Turkish children.

  Journal of pediatric gastroenterology and nutrition 20030401

• 'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures.

  Helicobacter 20030401

• Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review.

  Helicobacter 20030401

• Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori.

  Helicobacter 20030401

• Sequence diversity and functional characterization of the 5'-regulatory region of human CYP2C19.

  Pharmacogenetics 20030401

• Empiric esomeprazole in the treatment of laryngopharyngeal reflux.

  The Laryngoscope 20030401

• Pharmacogenetics of the proton pump inhibitors: a systematic review.

  Pharmacotherapy 20030401

• [Inmediate antphylactic shock after the administration of intravenous omeprazol].

  Revista clinica espanola 20030401

• Anodic voltammetric assay of lansoprazole and omeprazole on a carbon paste electrode.

  Journal of pharmaceutical and biomedical analysis 20030401

• A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.

  Alimentary pharmacology & therapeutics 20030401

• Reflux symptoms in general practice: diagnostic evaluation of the Carlsson-Dent gastro-oesophageal reflux disease questionnaire.

  Alimentary pharmacology & therapeutics 20030401

• Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.

  Alimentary pharmacology & therapeutics 20030401

• Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone.

  Seminars in oncology 20030401

• [A case of gastric fundic polyps during long-term treatment of reflux esophagitis with omeprazole].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20030401

• Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin.

  Epidemiology and infection 20030401

• Nonoperative treatment of laryngeal granuloma.

  Ear, nose, & throat journal 20030401

• Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburn.

  Scandinavian journal of gastroenterology 20030401

• One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease.

  Scandinavian journal of gastroenterology 20030401

• Helicobacter pylori stimulates inducible nitric oxide synthase in diverse topographical patterns in various gastroduodenal disorders.

  Digestive diseases and sciences 20030401

• Reductions in symptom distress reported by patients with moderately severe, nonerosive gastroesophageal reflux disease treated with rabeprazole.

  Digestive diseases and sciences 20030401

• Molecular modeling of SCH28080 binding to the gastric H,K-ATPase and MgATP interactions with SERCA- and Na,K-ATPases.

  Annals of the New York Academy of Sciences 20030401

• A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030401

• Gastric myoelectrical activity in patients with recurrent gastric or duodenal ulcers.

  Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20030401

• A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical.

  The Journal of biological chemistry 20030328

• Protective effects of steroid saponins from Paris polyphylla var. yunnanensis on ethanol- or indomethacin-induced gastric mucosal lesions in rats: structural requirement for activity and mode of action.

  Bioorganic & medicinal chemistry letters 20030324

• Characterization of an ectonucleoside triphosphate diphosphohydrolase 1 activity in alkaline phosphatase-depleted rat osseous plate membranes: possible functional involvement in the calcification process.

  Biochimica et biophysica acta 20030321

• [Pantoprazole-induced hepatitis].

  Deutsche medizinische Wochenschrift (1946) 20030321

• Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20030315

• Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo.

  Alimentary pharmacology & therapeutics 20030315

• Update on prescribing information for pantoprazole.

  American family physician 20030315

• Helicobacter pylori hiccup.

  Internal medicine journal 20030301

• Helicobacter pylori antigens in stool specimens of gastritis children before and after treatment.

  Journal of pediatric gastroenterology and nutrition 20030301

• Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors.

  Biological & pharmaceutical bulletin 20030301

• Impact of upper endoscopy on satisfaction in patients with previously uninvestigated dyspepsia.

  Gastrointestinal endoscopy 20030301

• Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy.

  British journal of haematology 20030301

• Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus.

  Annals of surgery 20030301

• Enhanced intracellular calcium promotes metabolic and secretory disturbances in rat gastric mucosa during ethanol-induced gastritis.

  Experimental biology and medicine (Maywood, N.J.) 20030301

• Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.

  Chest 20030301

• mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates.

  Xenobiotica; the fate of foreign compounds in biological systems 20030301

• Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.

  The Annals of pharmacotherapy 20030301

• The prophylactic use of a proton pump inhibitor before food and alcohol.

  Alimentary pharmacology & therapeutics 20030301

• High eradication rates of Helicobacter pylori with a new sequential treatment.

  Alimentary pharmacology & therapeutics 20030301

• Rabeprazole-based therapy in the management of symptomatic gastroesophageal reflux disease.

  The American journal of gastroenterology 20030301

• Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure.

  The American journal of gastroenterology 20030301

• Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial.

  The American journal of gastroenterology 20030301

• Antral G cells in rats during dosing with a PPAR alpha agonist: a morphometric and immunocytochemical study.

  Medical electron microscopy : official journal of the Clinical Electron Microscopy Society of Japan 20030301

• Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20030301

• [First line therapy for Helicobacter pylori eradication in France].

  Gastroenterologie clinique et biologique 20030301

• Complications of medical management of dental erosion.

  Dental update 20030301

• Synthesis or rupture: duration of acid inhibition by proton pump inhibitors.

  Drugs of today (Barcelona, Spain : 1998) 20030301

• Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20030301

• Diagnosis and eradication of Helicobacter pylori in patients with duodenal ulceration in the community.

  JPMA. The Journal of the Pakistan Medical Association 20030301

• Oesophageal acid-peptic strictures in the histamine H2 receptor antagonist and proton pump inhibitor era.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030301

• Acid exposure and altered acid clearance in GERD patients treated for Helicobacter pylori infection.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030301

• Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030301

• Spectrophotometric and chromatographic determination of rabeprazole in presence of its degradation products.

  Journal of pharmaceutical and biomedical analysis 20030226

• Omeprazole-induced acute interstitial nephritis.

  The New Zealand medical journal 20030221

• Review article: Esomeprazole--enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion.

  Alimentary pharmacology & therapeutics 20030215

• Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20030215

• [Generous treatment with gastric acid blockers. For patients with gastric reflux the proton pump inhibitor power is cost-effective].

  MMW Fortschritte der Medizin 20030206

• [Exaggerated interaction claims. With esomeprazole the data corroborate safety].

  MMW Fortschritte der Medizin 20030206

• Influence of omeprazole on multidrug resistance protein 3 expression in human liver.

  The Journal of pharmacology and experimental therapeutics 20030201

• Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe.

  Journal of gastroenterology and hepatology 20030201

• Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection.

  Journal of gastroenterology and hepatology 20030201

• Anti-Helicobacter pylori therapy in India: differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin (vacA) gene.

  Journal of gastroenterology and hepatology 20030201

• Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children.

  Journal of pediatric gastroenterology and nutrition 20030201

• Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer.

  Gastrointestinal endoscopy 20030201

• An aspirin a day keeps the cardiologist away (but what about the gastroenterologist?).

  Gastroenterology 20030201

• Reflux disease and Barrett's esophagus.

  Endoscopy 20030201

• Review of esomeprazole in the treatment of acid disorders.

  Expert opinion on pharmacotherapy 20030201

• Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.

  Alimentary pharmacology & therapeutics 20030201

• A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years.

  Alimentary pharmacology & therapeutics 20030201

• Comparative pharmacokinetics and safety of lansoprazole oral capsules and orally disintegrating tablets in healthy subjects.

  Alimentary pharmacology & therapeutics 20030201

• Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain.

  Alimentary pharmacology & therapeutics 20030201

• Pharmacokinetics of budesonide controlled-release capsules when taken with omeprazole.

  Alimentary pharmacology & therapeutics 20030201

• Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study.

  Alimentary pharmacology & therapeutics 20030201

• Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice.

  The Journal of antimicrobial chemotherapy 20030201

• Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori.

  The Journal of antimicrobial chemotherapy 20030201

• A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution.

  The Journal of antimicrobial chemotherapy 20030201

• A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole.

  Nature reviews. Drug discovery 20030201

• Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.

  The American journal of gastroenterology 20030201

• Severe colchicine-macrolide interactions.

  Prescrire international 20030201

• Acid inhibitory potency of twice a day omeprazole is not affected by eradication of Helicobacter pylori in healthy volunteers.

  Helicobacter 20030201

• Review article: esomeprazole--the first proton pump inhibitor to be developed as an isomer.

  Alimentary pharmacology & therapeutics 20030201

• Review article: pharmacology of esomeprazole and comparisons with omeprazole.

  Alimentary pharmacology & therapeutics 20030201

• Review article: gastric acidity--comparison of esomeprazole with other proton pump inhibitors.

  Alimentary pharmacology & therapeutics 20030201

• Review article: initial therapy of reflux disease with esomeprazole.

  Alimentary pharmacology & therapeutics 20030201

• Review article: esomeprazole, 40 mg once daily, compared with lansoprazole, 30 mg once daily, in healing and symptom resolution of erosive oesophagitis.

  Alimentary pharmacology & therapeutics 20030201

• Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.

  Alimentary pharmacology & therapeutics 20030201

• Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+ -ATPase inhibitors and other xenobiotics.

  Xenobiotica; the fate of foreign compounds in biological systems 20030201

• Inhibitory effect of troleandomycin on the metabolism of omeprazole is CYP2C19 genotype-dependent.

  Xenobiotica; the fate of foreign compounds in biological systems 20030201

• Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.

  The journal of medical investigation : JMI 20030201

• Impact of long-term ranitidine and pantoprazole on accuracy of [13C]urea breath test.

  Digestive diseases and sciences 20030201

• Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders.

  Digestive diseases and sciences 20030201

• 13C-urea breath test to validate eradication of Helicobacter pylori in an Israeli population.

  The Israel Medical Association journal : IMAJ 20030201

• [Guidelines in the management of Helicobacter pylori infection in Japan].

  Nihon rinsho. Japanese journal of clinical medicine 20030201

• A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands.

  Clinical therapeutics 20030201

• Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20030201

• Pharyngolaryngeal reflux in outpatient clinical practice: personal experience.

  Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20030201

• A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.

  Singapore medical journal 20030201

• Lansoprazole quantification in human plasma by liquid chromatography-electrospray tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030115

• Stereospecific analysis of omeprazole in human plasma as a probe for CYP2C19 phenotype.

  Journal of pharmaceutical and biomedical analysis 20030115

• Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymes.

  Archives of biochemistry and biophysics 20030101

• High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20030101

• Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.

  Gut 20030101

• Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.

  Gut 20030101

• Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.

  Drugs 20030101

• Severe esophagitis healed in less than a week with intravenous pantoprazole.

  Journal of clinical gastroenterology 20030101

• Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance.

  Alimentary pharmacology & therapeutics 20030101

• Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients.

  Alimentary pharmacology & therapeutics 20030101

• Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis.

  Alimentary pharmacology & therapeutics 20030101

• Why aren't lower, effective, OTC doses available earlier by prescription?

  The Annals of pharmacotherapy 20030101

• Dissolution test for liquid formulations of omeprazole enteric-coated products.

  The Annals of pharmacotherapy 20030101

• Safety and pharmacokinetics of oral lansoprazole in preadolescent rats exposed from weaning through sexual maturity.

  Reproductive toxicology (Elmsford, N.Y.) 20030101

• What's new: proton pump inhibitors and pediatrics.

  Pediatrics in review 20030101

• Cost-effectiveness of low dose corticosteroids versus non-steroidal anti-inflammatory drugs and COX-2 specific inhibitors in the long-term treatment of rheumatoid arthritis.

  Rheumatology (Oxford, England) 20030101

• Ulcers and nonvariceal bleeding.

  Endoscopy 20030101

• The use of proton pump inhibitors in children: a comprehensive review.

  Paediatric drugs 20030101

• Lansoprazole: in the management of gastroesophageal reflux disease in children.

  Paediatric drugs 20030101

• Gastric heterotopia in the proximal esophagus complicated by stricture.

  Gastrointestinal endoscopy 20030101

• Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population.

  Journal of gastroenterology and hepatology 20030101

• Effect of proton pump inhibitors on the continuous real time (13)C-urea breath test.

  The American journal of gastroenterology 20030101

• A 59-year-old woman with gastroesophageal reflux disease and Barrett esophagus.

  JAMA 20030101

• The pharmacovigilance of pantoprazole: the results of postmarketing surveillance on 11 541 patients in England.

  Drug safety 20030101

• Early events in proton pump inhibitor-associated exacerbation of corpus gastritis.

  Alimentary pharmacology & therapeutics 20030101

• Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial.

  Alimentary pharmacology & therapeutics 20030101

• Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole.

  Alimentary pharmacology & therapeutics 20030101

• Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin.

  Alimentary pharmacology & therapeutics 20030101

• Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.

  European journal of gastroenterology & hepatology 20030101

• Diagnostic test with omeprazole in patients with posterior laryngitis.

  Medicina (Kaunas, Lithuania) 20030101

• [New triple therapy for Helicobacter pylori infection in Japan].

  Nihon rinsho. Japanese journal of clinical medicine 20030101

• [Tailor-made medicine in Helicobacter pylori eradication therapy].

  Nihon rinsho. Japanese journal of clinical medicine 20030101

• Cell kinetics of the oesophageal epithelium in the rat: effects of hypergastrinaemia.

  Scandinavian journal of gastroenterology 20030101

• Prevention and treatment of stress ulcers in critically ill patients.

  Seminars in gastrointestinal disease 20030101

• FDA approves generic drug for persistent heartburn.

  FDA consumer 20030101

• Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection.

  Hepato-gastroenterology 20030101

• Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.

  Digestive diseases and sciences 20030101

• Effects of rabeprazole sodium on gastric emptying, electrogastrography, and fullness.

  Digestive diseases and sciences 20030101

• [The diverse etiology of hiccups].

  Harefuah 20030101

• [Clinical efficacy of combined anti-Helicobacter treatment of patients with duodenal ulcer].

  Klinicheskaia meditsina 20030101

• [The state of immune system and effects of current therapy and immunomodulators].

  Klinicheskaia meditsina 20030101

• [Therapeutic tactics for treating patient with duodenal ulcer complicated my hemorrhage].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• Utility and limitations of a method for detecting Helicobacter pylori-specific antigens in the stool.

  Journal of gastroenterology 20030101

• Acceleration of gastric ulcer healing by omeprazole in portal hypertensive rats. Is its action mediated by gastrin release and the stimulation of epithelial proliferation?

  European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20030101

• The effect of commonly used drugs on angiogenesis.

  Anticancer research 20030101

• Efficacy of omeprazole for the prevention of exercise-induced gastritis in racing Alaskan sled dogs.

  Journal of veterinary internal medicine 20030101

• [Esomeprazole in treating duodenal ulcer in various modes of anti-Helicobacter therapy].

  Terapevticheskii arkhiv 20030101

• COX-2: where are we in 2003?--distinction from NSAIDs becoming blurred.

  Arthritis research & therapy 20030101

• Triple therapy for 7 days vs. triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection. A double blind placebo controlled trial.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030101

• Omeprazole was effective in the short term for uninvestigated dyspepsia.

  ACP journal club 20030101

• Lansoprazole fast disintegrating tablet: a new formulation for an established proton pump inhibitor.

  Digestion 20030101

• Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.

  Digestion 20030101

• Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.

  Journal of gastroenterology 20030101

• Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori.

  Journal of gastroenterology 20030101

• Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.

  Hepato-gastroenterology 20030101

• Celecoxib was as effective as diclofenac plus omeprazole in reducing recurrent ulcer bleeding in arthritis.

  ACP journal club 20030101

• Determination of omeprazole in bulk and injectable preparations by liquid chromatography.

  Journal of AOAC International 20030101

• [Four different treatment protocols for Helicobacter pylori infection--a clinical pilot study].

  Medicinski arhiv 20030101

• The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review.

  PharmacoEconomics 20030101

• Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20030101

• [Medico-economic efficacy of eradication schemes in helicobacter infections in patients with duodenal ulcers].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• [Effectiveness of eradication anti-helicobacter therapy in patients with duodenal ulcer in different drug dosage regimens].

  Klinicheskaia meditsina 20030101

• Is Helicobacter pylori infection associated with chronic idiopathic urticaria?

  Allergologia et immunopathologia 20030101

• Compartment theory in Helicobacter pylori-associated gastric carcinogenesis.

  Anticancer research 20030101

• [Pharmacotherapy in complex treatment of ulcerous stenosis].

  Vestnik khirurgii imeni I. I. Grekova 20030101

• Quality of life and cost-effectiveness of combined therapy for reflux esophagitis.

  Journal of Zhejiang University. Science 20030101

• Safety and efficacy of rabeprazole in gastroesophageal reflux disease: report of a multicenter study.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20030101

• Influence of Helicobacter pylori infection and omeprazole treatment on gastric regional CO2.

  Digestion 20030101

• [Prescription, dispensation and sustitution of prescription forms of omeprazole].

  Gaceta sanitaria 20030101

• Impact of cotherapy with some proton pump inhibitors on medical claims among HMO patients already using other common drugs also cleared by cytochrome P450.

  American journal of therapeutics 20030101

• Switching omeprazole in Sweden and the United States.

  American journal of therapeutics 20030101

• ['Visual assessment' does not replace quality control with instrumental methods].

  Wiener medizinische Wochenschrift (1946) 20030101

• Relaxant effect of omeprazole and lansoprazole in guinea pig gallbladder muscle strips in vitro.

  Journal of gastroenterology 20030101

• [Efficacy of antihelicobacter therapy in NSAID-induced gastropathies].

  Klinicheskaia meditsina 20030101

• Improving health-related quality of life in gastro-oesophageal reflux disease.

  Drugs 20030101

• COX-2 inhibition versus gastroprotection with dual COX inhibitors: an evidence-based approach.

  Current pharmaceutical design 20030101

• [Omeprazole, amoxicillin and clarithromycin in the treatment of helicobacterpylori, in 7 and 10-day regimens].

  Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20030101

• The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy.

  Arquivos de gastroenterologia 20030101

• [Use of omeprazole and esomeprazole in patients suffering from bronchial asthma with associated gastroesophageal reflux disease].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• [Combination therapy of chronic pancreatitis (double-blind, placebo-controlled, pilot studies)].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens.

  Journal of gastroenterology 20030101

• The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.

  Journal of gastroenterology 20030101

• Simple closure of chronic duodenal ulcer perforation in the era of Helicobacter pylori: an old procedure, today's solution.

  Hepato-gastroenterology 20030101

• One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.

  Hepato-gastroenterology 20030101

• Both selective COX-1 and COX-2 inhibitors aggravate gastric damage induced in rats by 2-deoxy-D-glucose. relation to gastric hypermotility and COX-2 expression.

  Digestion 20030101

• Improvement in gastric histology following Helicobacter pylori eradication therapy in Japanese peptic ulcer patients.

  The Journal of international medical research 20030101

• [Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease].

  Klinicheskaia meditsina 20030101

• An overview of proton pump inhibitors.

  Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20030101

• Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection.

  Journal of gastroenterology 20030101

• [Evaluation of the efficacy of pariet in patients with gastroesophageal reflux disease with thoracic pain not connected with cardiac disease].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• [Therapeutic effect of gastrozolum in stomach ulcers].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• [Comparative clinical and economic efficiency of new generation proton pump inhibitors in the treatment of gastroesophageal reflux].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• Outcomes of minimally invasive antireflux operations in the elderly: a comparative review.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20030101

• [Therapy with cytokines and thymic factors in a complicated case of common variable immunodeficiency].

  Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20030101

• Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20030101

• Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity.

  Health and quality of life outcomes 20030101

• Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.

  Drugs & aging 20030101

• [Antisecretory therapy for prevention of stenoses of bougienage after-burn of esophageal strictures].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• [Possible treatment with immune system modulators of patients with pathology of the digestive organs. Informational letter].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• [Experience with the application of the preparation nexium in patients by using the BioEnterics Intragastgric Balloon].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• Gastroesophageal reflux disease in children: need for long-term medical treatment.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20030101

• [Level of Helicobacter pylori infection of the gastric mucosa in the optimization of a daily dose of antihelicobacter drugs].

  Klinicheskaia meditsina 20030101

• Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.

  Drugs 20030101

• Alternative dosing for PPI therapy: rationale and options.

  Reviews in gastroenterological disorders 20030101

• Epigastric pain in dyspepsia and reflux disease.

  Reviews in gastroenterological disorders 20030101

• Sleep issues in gastroesophageal reflux disease: beyond simple heartburn control.

  Reviews in gastroenterological disorders 20030101

• The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.

  Reviews in gastroenterological disorders 20030101

• [Treatment of laryngeal granuloma with anti-extraesophageal reflux medication].

  Acta otorrinolaringologica espanola 20030101

• Symptomatic and endoscopic outcome of heartburn 3-4.5 years after starting lansoprazole therapy: a prospective study of 142 patients.

  Journal of gastroenterology 20030101

• Gastroesophageal reflux disease: current treatment approaches.

  Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20030101

• Proton pump inhibitors in pediatrics: relevant pharmacokinetics and pharmacodynamics.

  Journal of pediatric gastroenterology and nutrition 20030101

• Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers.

  Digestion 20030101

• How to eradicate Helicobacter pylori using amoxicillin and omeprazole in the remnant stomach.

  Hepato-gastroenterology 20030101

• Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion.

  Hepato-gastroenterology 20030101

• High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin.

  Hepato-gastroenterology 20030101

• Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.

  Digestion 20030101

• Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.

  The Journal of international medical research 20030101

• [Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer].

  Terapevticheskii arkhiv 20030101

• [Acid-supressing capacity of omeprazole 20 mg tablets vs pantoprazole 20 and 40 mg tablets. A pilot study in volunteers].

  Acta gastroenterologica Latinoamericana 20030101

• The gastroprotective effect of tannins extracted from duhat (Syzygium cumini Skeels) bark on HCl/ethanol induced gastric mucosal injury in Sprague-Dawley rats.

  Clinical hemorheology and microcirculation 20030101

• Cilostazol: a review of its use in intermittent claudication.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20030101

• [Cost-minimization study on the prescription of intravenous proton pump inhibitors: pantoprazole versus omeprazole].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20030101

• [Comparative analysis of the effectiveness of two Helicobacter pylori eradication plans based on omeprazole, clarithromycin and amoxicillin in patients with duodenal peptic ulcer: results of a randomized double-blind, controlled study].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• [Place and significance of proton pump inhibitors in current treatment of peptic ulcers].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• [Clarithromycin--standard component of anti-Helicobacter therapy].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• [Secretolytic therapy of acid-dependent diseases of the digestive system from the point of view of a clinician].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• [Comparative effectiveness of the antisecretory action of rabeprazole and esomeprazole in people with rapid metabolism of proton pump inhibitors].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• [Comparative efficacy of proton pump inhibitors in children].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• Not a usual suspect; rabeprazole therapy presenting as a severe neuropsychiatric illness: case report.

  International journal of psychiatry in medicine 20030101

• [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].

  Revista de gastroenterologia de Mexico 20030101

• [Clinical effectiveness of omeprazole, azithromycin and amoxicillin in ulcer healing and eradication of Helicobacter pylori infection].

  Medicinski arhiv 20030101

• Protein profile of Helicobacter pylori strains by isoelectrofocusing in patients affected by chronic gastritis.

  European review for medical and pharmacological sciences 20030101

• Clinical and endoscopic evaluation of gastroesophageal reflux disease in patients successfully treated with esomeprazole.

  Arquivos de gastroenterologia 20030101

• Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.

  The New England journal of medicine 20021226

• NSAIDs, Helicobacter pylori, and Pandora's Box.

  The New England journal of medicine 20021226

• Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).

  Journal of medicinal chemistry 20021219

• Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs.

  The American journal of medicine 20021215

• Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium.

  Gut 20021201

• Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats.

  The Journal of pharmacology and experimental therapeutics 20021201

• The pharmacology and clinical relevance of proton pump inhibitors.

  Current gastroenterology reports 20021201

• Treatment and management of Helicobacter pylori infection.

  Current gastroenterology reports 20021201

• Influence of the urine flow rate on some caffeine metabolite ratios used to assess CYP1A2 activity.

  Therapeutic drug monitoring 20021201

• Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.

  Alimentary pharmacology & therapeutics 20021201

• One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.

  Alimentary pharmacology & therapeutics 20021201

• Identification and functional characterization of new potentially defective alleles of human CYP2C19.

  Pharmacogenetics 20021201

• Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.

  Endoscopy 20021201

• An update on bimatoprost in glaucoma therapy.

  Expert opinion on pharmacotherapy 20021201

• The effects of nocturnal acid breakthrough on Helicobacter pylori eradication.

  Helicobacter 20021201

• Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication.

  Helicobacter 20021201

• Pseudomembranous colitis requiring surgical intervention following triple therapy for Helicobacter pylori eradication.

  ANZ journal of surgery 20021201

• Facial swelling and eosinophilia in a 44-year-old woman.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20021201

• Persistent gastroesophageal reflux disease symptoms on standard proton-pump inhibitor therapy.

  Gastroenterology clinics of North America 20021201

• A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia.

  The American journal of gastroenterology 20021201

• Low-dose aspirin: protection from the panacea.

  The American journal of gastroenterology 20021201

• Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole.

  Journal of critical care 20021201

• Characteristics of diarrhoea in 10,008 users of lansoprazole in daily practice: which co-factors contribute?

  Pharmacoepidemiology and drug safety 20021201

• Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.

  Scandinavian journal of gastroenterology 20021201

• Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.

  Scandinavian journal of gastroenterology 20021201

• [Ongoing treatment with omeprazole and appearance of oropharyngeal candidiasis].

  Atencion primaria 20021201

• An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based study.

  Clinical therapeutics 20021201

• [Influence of ion pump-inhibiting drugs on the accumulation of ofloxacin and grepafloxacin in human polymorphonuclear leukocytes].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20021201

• On-demand proton pump inhibitor therapy in patients with gastro-oesophageal reflux disease.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20021201

• [Hypertonic saline 7.5% in the treatment of severe hypochloremic metabolic alkalosis].

  Revista espanola de anestesiologia y reanimacion 20021201

• Transport through liquid membranes containing omeprazole and lansoprazole.

  Indian journal of biochemistry & biophysics 20021201

• Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid-liquid extraction.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20021125

• [Hypergastrinemia associated with Helicobacter pylori infection and sideropenic anemia in a 15-year-old girl].

  Casopis lekaru ceskych 20021122

• Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin.

  The New England journal of medicine 20021114

• Identification of glutathione conjugates of troglitazone in human hepatocytes.

  Chemico-biological interactions 20021110

• Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations.

  Journal of pharmaceutical and biomedical analysis 20021107

• [A case for proton pump blocker... When cough comes from the stomach].

  MMW Fortschritte der Medizin 20021107

• Gastroprotective effect of Neem (Azadirachta indica) bark extract: possible involvement of H(+)-K(+)-ATPase inhibition and scavenging of hydroxyl radical.

  Life sciences 20021101

• Coordinated regulation of gastric chloride secretion with both acid and alkali secretion.

  American journal of physiology. Gastrointestinal and liver physiology 20021101

• Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.

  Alimentary pharmacology & therapeutics 20021101

• Restoration of acid secretion following treatment with proton pump inhibitors.

  Gastroenterology 20021101

• Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration.

  The Journal of antimicrobial chemotherapy 20021101

• Central Orexin-A stimulates pancreatic exocrine secretion via the vagus.

  Pancreas 20021101

• Endogenous cyclo-oxygenase activity regulates mouse gastric surface pH.

  The Journal of physiology 20021101

• Lansoprazole-associated microscopic colitis: a case series.

  The American journal of gastroenterology 20021101

• Pantoprazole-induced recurrent anaphylactic shock.

  The American journal of gastroenterology 20021101

• [Microbiological factors that influence the eradication of Helicobacter pylori in adults and children].

  Enfermedades infecciosas y microbiologia clinica 20021101

• Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation.

  Transplantation proceedings 20021101

• Delivery of esomeprazole magnesium enteric-coated pellets through small caliber and standard nasogastric tubes and gastrostomy tubes in vitro.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20021101

• Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy.

  European journal of gastroenterology & hepatology 20021101

• Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study.

  European journal of gastroenterology & hepatology 20021101

• The effect of perendoscopic sclerosing agent injection in Forrest's II ulcers -- a pilot study from Turkey.

  Medical science monitor : international medical journal of experimental and clinical research 20021101

• Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.

  British journal of clinical pharmacology 20021101

• Effects of omeprazole and ascorbate on gastric emptying and antioxidant levels in a mouse model of glutathione depletion.

  Digestive diseases and sciences 20021101

• Rabeprazole improves health-related quality of life in patients with erosive gastroesophageal reflux disease.

  Digestive diseases and sciences 20021101

• Iron deficiency anemia: induced by long-term ingestion of omeprazole.

  Digestive diseases and sciences 20021101

• Gastric polyps and nodules in children receiving long-term omeprazole therapy.

  Journal of pediatric gastroenterology and nutrition 20021101

• Factors affecting ammonium uptake by C11 clone of MDCK cells.

  Pflugers Archiv : European journal of physiology 20021101

• [Helicobacter pylori induced gastritis: recent topics on eradication therapy].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20021101

• Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients.

  Scandinavian journal of gastroenterology 20021101

• Hydrogen-potassium ATPase inhibitors induce relaxation on rabbit prostatic strips in vitro.

  International journal of urology : official journal of the Japanese Urological Association 20021101

• Prevention of non-steroidal antiinflammatory drugs-induced gastropathy: follow up of protocol adherence.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20021101

• Peptic ulcer disease.

  Current opinion in gastroenterology 20021101

• Might proton pump inhibitors prevent the antiplatelet effects of low- or very low-dose aspirin?

  Archives of internal medicine 20021028

• Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs.

  Archives of internal medicine 20021028

• [Patient with increased stomach cancer risk. Helicobacter can cause damage here].

  MMW Fortschritte der Medizin 20021024

• Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care.

  The Medical journal of Australia 20021021

• Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer.

  World journal of gastroenterology 20021015

• Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training.

  Journal of the American Veterinary Medical Association 20021015

• [In small steps to far ahead. Diminished risk of interactions as definite advantage].

  MMW Fortschritte der Medizin 20021010

• Asymmetries in H+/K+-ATPase and cell membrane potentials comprise a very early step in left-right patterning.

  Cell 20021004

• Functional dyspepsia: bye-bye to PPIs.

  Gut 20021001

• Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats.

  Gut 20021001

• Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients.

  Gut 20021001

• Stereoselective metabolism of bufuralol racemate and enantiomers in human liver microsomes.

  The Journal of pharmacology and experimental therapeutics 20021001

• A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system.

  The Journal of pharmacology and experimental therapeutics 20021001

• Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers.

  Alimentary pharmacology & therapeutics 20021001

• Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring.

  Journal of clinical gastroenterology 20021001

• Factors associated with treatment failure of Helicobacter pylori infection in a developing country.

  Journal of clinical gastroenterology 20021001

• In vivo action of novel alkyl methyl quinolone alkaloids against Helicobacter pylori.

  The Journal of antimicrobial chemotherapy 20021001

• Omeprazole-induced relaxation in rat aorta is partly dependent on endothelium.

  Pharmacological research 20021001

• Quantification of Helicobacter pylori resistance in functional and organic dyspepsia.

  Journal of clinical pharmacy and therapeutics 20021001

• Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.

  The American journal of gastroenterology 20021001

• Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori.

  The American journal of gastroenterology 20021001

• Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia?

  The American journal of gastroenterology 20021001

• Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole.

  Clinical pharmacology and therapeutics 20021001

• The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH.

  European journal of clinical pharmacology 20021001

• Prospective study on the incidence of chronic ear complaints related to gastroesophageal reflux and on the outcome of antireflux therapy.

  The Annals of otology, rhinology, and laryngology 20021001

• Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection.

  Helicobacter 20021001

• Melatonin: reducing the toxicity and increasing the efficacy of drugs.

  The Journal of pharmacy and pharmacology 20021001

• Medication errors. Liquid lansoprazole: gumming up the works.

  Nursing 20021001

• Effect of Helicobacter pylori infection on fibrinogen level in elderly patients with ischaemic heart disease.

  Acta cardiologica 20021001

• A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication.

  Internal medicine (Tokyo, Japan) 20021001

• [Omeprazole. Antiulcer and gastric anti-secretory agent: one of the most prescribed drugs in France].

  Revue de l'infirmiere 20021001

• An open non-comparative clinical study for the evaluation of safety and efficacy of esomeprazole in patients of reflux oesophagitis in Indian population.

  Journal of the Indian Medical Association 20021001

• [Antisecretory effect of losec and pariet in peptic ulcer therapy].

  Voenno-meditsinskii zhurnal 20021001

• [Double blind randomized multicentre study of a seven-day eradication regime of Helicobacter pylori by omeprazole, clarithromycin and ornidazole vs. omeprazole, clarithromycin and metronidazole].

  Vnitrni lekarstvi 20021001

• [Anti-inflammatory non-steroidal selective cyclooxygenase 2 inhibitors and gastroduodenal lesions].

  Presse medicale (Paris, France : 1983) 20020928

• [Proton pump inhibitor in reflux disease. Administer for maximum effect from the beginning].

  MMW Fortschritte der Medizin 20020926

• [Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection].

  Zhonghua yi xue za zhi 20020925

• [Prognostic factors for response to treatment and recurrence of uncomplicated symptomatic gastroesophageal reflux in ambulatory care medicine].

  Presse medicale (Paris, France : 1983) 20020921

• Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).

  Circulation 20020903

• Randomized comparative study of omeprazole and famotidine in reflux esophagitis.

  Journal of gastroenterology and hepatology 20020901

• Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study.

  Journal of gastroenterology and hepatology 20020901

• Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.

  Gut 20020901

• Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.

  Gut 20020901

• Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.

  Gut 20020901

• Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin.

  Clinical chemistry 20020901

• Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20020901

• Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20020901

• Interaction of Helicobacter pylori (Hp) and nonsteroidal anti-inflammatory drugs (NSAID) on gastric mucosa and risk of ulcerations.

  Medical science monitor : international medical journal of experimental and clinical research 20020901

• Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazole.

  The Journal of rheumatology 20020901

• Regression of CD5-positive and Helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma of the rectum after administration of antibiotics: report of a case.

  Diseases of the colon and rectum 20020901

• Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.

  The American journal of gastroenterology 20020901

• Motion--Helicobacter pylori worsens GERD: arguments for the motion.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020901

• Motion--Helicobacter pylori causes or worsens GERD: arguments against the motion.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020901

• Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions.

  Die Pharmazie 20020901

• Short-term therapeutic trial of proton pump inhibitors in suspected extraesophageal reflux.

  Journal of voice : official journal of the Voice Foundation 20020901

• Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020901

• Probiotics and Helicobacter pylori eradication.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020901

• [Long-term curative effects of suture plus proximal gastric vagotomy or triad-therapy for duodenal ulcer with acute perforation].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20020901

• [The short term effect of rabeprazol versus omeprazole on symptom relief of duodenal ulcer].

  Zhonghua nei ke za zhi 20020901

• Gateways to Clinical Trials.

  Methods and findings in experimental and clinical pharmacology 20020901

• [Pharma clinics medication of the month. Esomeprazole].

  Revue medicale de Liege 20020901

• Proton pump inhibitors in the elderly population.

  European journal of gastroenterology & hepatology 20020901

• [Helicobacter pylori--overview of therapy].

  Lijecnicki vjesnik 20020901

• Treatment and prevention of aspirin-induced gastroduodenal ulcers and gastrointestinal bleeding.

  Expert opinion on drug safety 20020901

• The effect of Helicobacter pylori eradication on symptoms and gastric emptying in patients with nonulcer dyspepsia.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20020901

• Decreasing eradicaton rate of Helicobacter pylori infection with metronidazole-based triple therapy. A randomised study.

  Minerva gastroenterologica e dietologica 20020901

• Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence.

  British journal of cancer 20020827

• COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer.

  British journal of cancer 20020827

• [Does intake of gastric acid pump inhibitor affect the evaluation of the Lundh test?].

  Ugeskrift for laeger 20020826

• [Symptomatic therapy of rheumatic diseases. How they reduce pain and thereby safe costs].

  MMW Fortschritte der Medizin 20020822

• Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori.

  Lancet (London, England) 20020817

• Characterization of human CYP1A1/1A2 induction by DNA microarray and alpha-naphthoflavone.

  Biochemical and biophysical research communications 20020809

• Tetany secondary to the use of a proton-pump inhibitor.

  Annals of internal medicine 20020806

• Impact of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on gastric ulcerogenesis in experimental animals and in humans.

  European journal of pharmacology 20020802

• Melatonin protects against gastric ulceration and increases the efficacy of ranitidine and omeprazole in reducing gastric damage.

  Journal of pineal research 20020801

• Gastroprotective effect of fenugreek seeds (Trigonella foenum graecum) on experimental gastric ulcer in rats.

  Journal of ethnopharmacology 20020801

• Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura.

  British journal of haematology 20020801

• Localization of [14C]clarithromycin in rat gastric tissue when administered with lansoprazole and amoxicillin.

  The Journal of antimicrobial chemotherapy 20020801

• Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori.

  Helicobacter 20020801

• Chronic urticaria induced by eradication therapy of Helicobacter pylori: a case report.

  Helicobacter 20020801

• [The influence of various adjuvant drugs used in intensive care on monocyte chemotaxis].

  Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20020801

• Medical or surgical therapy for erosive reflux esophagitis: cost-utility analysis using a Markov model.

  Annals of surgery 20020801

• Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months.

  European journal of gastroenterology & hepatology 20020801

• One week regimen of esomeprazole based triple therapy is sufficient for duodenal ulcer healing and Helicobacter pylori eradication in patients with duodenal ulcer disease.

  European journal of gastroenterology & hepatology 20020801

• Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.

  Endoscopy 20020801

• Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme.

  Alimentary pharmacology & therapeutics 20020801

• Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20020801

• [Prevention and treatment of gastro-duodenal ulcers in elderly--from theory-based toward evidence-based].

  Nihon rinsho. Japanese journal of clinical medicine 20020801

• [Reflux esophagitis].

  Nihon rinsho. Japanese journal of clinical medicine 20020801

• [Eradication therapy of Helicobacter pylori for elderly patients in Japan].

  Nihon rinsho. Japanese journal of clinical medicine 20020801

• [Management of gastrointestinal mucosal damage in patients with cerebrovascular disease].

  Nihon rinsho. Japanese journal of clinical medicine 20020801

• [Treatment of peptic ulcer related to rheumatic diseases].

  Nihon rinsho. Japanese journal of clinical medicine 20020801

• [Chronic respiratory disease and gastroesophageal reflux].

  Nihon rinsho. Japanese journal of clinical medicine 20020801

• [Several points that should be noticed during PPI treatment for peptic ulcers in elderly patients].

  Nihon rinsho. Japanese journal of clinical medicine 20020801

• Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker.

  Clinical pharmacology and therapeutics 20020801

• Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children.

  Calcified tissue international 20020801

• Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease.

  Scandinavian journal of gastroenterology 20020801

• Bioavailability of lansoprazole granules administered in juice or soft food compared with the intact capsule formulation.

  Clinical therapeutics 20020801

• [Ranitidine-bismuth citrate versus omeprazole plus two antibiotics for seven days for the eradication of Helicobacter pylori: a non-concluding clinical essay].

  Anales de medicina interna (Madrid, Spain : 1984) 20020801

• Gastric acid secretion in the dog: a mechanism-based pharmacodynamic model for histamine stimulation and irreversible inhibition by omeprazole.

  Journal of pharmacokinetics and pharmacodynamics 20020801

• Induction of aneuploidy in male mouse germ cells detected by the sperm-FISH assay: a review of the present data base.

  Mutation research 20020725

• Esomeprazole: a clinical review.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020715

• Proton pump inhibitors: an update.

  American family physician 20020715

• Impact of safety alerts upon prescribing of cisapride to children in New Zealand.

  The New Zealand medical journal 20020702

• Review article: esomeprazole in the treatment of Helicobacter pylori.

  Alimentary pharmacology & therapeutics 20020701

• Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy.

  Gastrointestinal endoscopy 20020701

• The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole.

  Anesthesia and analgesia 20020701

• Is omeprazole helpful in the management of children with reflux oesophagitis?

  Archives of disease in childhood 20020701

• Bleeding peptic ulcers: what's new?

  Gastrointestinal endoscopy 20020701

• Effect of omeprazole on oral and intravenous RS-methadone pharmacokinetics and pharmacodynamics in the rat.

  Journal of pharmaceutical sciences 20020701

• Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload. Role of gastric acid secretion.

  Nephron 20020701

• Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype.

  Journal of gastroenterology and hepatology 20020701

• [Eradication of helicobacter pylori: symptomatic treatment of reflux disease?].

  Zeitschrift fur Gastroenterologie 20020701

• Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations.

  Biological & pharmaceutical bulletin 20020701

• Genotyping of Helicobacter pylori in paraffin-embedded gastric biopsy specimens: relation to histological parameters and effects on therapy.

  The American journal of gastroenterology 20020701

• Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots.

  The American journal of gastroenterology 20020701

• Esophagogastroduodenoscopy in chronic hemodialysis patients: 2-year clinical experience in a renal unit.

  Clinical nephrology 20020701

• Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis.

  Digestive diseases and sciences 20020701

• Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS).

  Digestive diseases and sciences 20020701

• Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis.

  Journal of pediatric gastroenterology and nutrition 20020701

• One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.

  Alimentary pharmacology & therapeutics 20020701

• Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.

  Alimentary pharmacology & therapeutics 20020701

• Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects.

  Alimentary pharmacology & therapeutics 20020701

• An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy.

  Alimentary pharmacology & therapeutics 20020701

• Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.

  Clinical pharmacology and therapeutics 20020701

• Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19.

  Clinical pharmacology and therapeutics 20020701

• Assessment of the afferent vagal nerve in patients with gastroesophageal reflux.

  Surgical endoscopy 20020701

• [Treatment of NSAID-associated gastric ulcer].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20020701

• Early relief of upper gastrointestinal dyspeptic symptoms: a survey of empirical therapy with pantoprazole in Canadian clinical practice.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020701

• Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.

  Managed care (Langhorne, Pa.) 20020701

• Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.

  Scandinavian journal of gastroenterology 20020701

• Protective effect of omeprazole against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.

  Pharmacological research 20020701

• [Allergic vasculitis following ingestion of celecoxib?].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20020701

• Proton pump inhibitors--differences emerge in hepatic metabolism.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020701

• Mid- and long-term quality of life assessments after laparoscopic fundoplication and refundoplication: a single unit review of more than 500 antireflux procedures.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020701

• The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.

  Wiener klinische Wochenschrift 20020628

• Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.

  The New England journal of medicine 20020627

• Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate.

  BMJ (Clinical research ed.) 20020622

• From the Food and Drug Administration.

  JAMA 20020612

• Eradication of Helicobacter pylori may be beneficial in the management of chronic open-angle glaucoma.

  Archives of internal medicine 20020610

• [Proton pump inhibitors according to need. Always for heartburn].

  MMW Fortschritte der Medizin 20020606

• Upper gastrointestinal complications after renal transplantation: a 3-yr sequential study.

  Clinical transplantation 20020601

• Pharmacologic management of gastroesophageal reflux disease.

  Current gastroenterology reports 20020601

• Determination of drug interactions occurring with the metabolic pathways of irinotecan.

  Drug metabolism and disposition: the biological fate of chemicals 20020601

• Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial.

  Alimentary pharmacology & therapeutics 20020601

• Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.

  Alimentary pharmacology & therapeutics 20020601

• Duodenal ulcer healing with 1-week eradication triple therapy followed, or not, by anti-secretory treatment: a multicentre double-blind placebo-controlled trial.

  Alimentary pharmacology & therapeutics 20020601

• Amoxicillin and ampicillin are not transferred to gastric juice irrespective of Helicobacter pylori status or acid blockade by omeprazole.

  Alimentary pharmacology & therapeutics 20020601

• High dose Omeprazole in esophagitis with stenosis after surgical treatment of esophageal atresia.

  Journal of pediatric surgery 20020601

• Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori.

  Helicobacter 20020601

• Symptomatic ulceration of an acid-producing oesophageal inlet patch colonized by helicobacter pylori.

  Endoscopy 20020601

• Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up.

  Zeitschrift fur Gastroenterologie 20020601

• Thalidomide metabolism by the CYP2C subfamily.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020601

• A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial.

  European journal of gastroenterology & hepatology 20020601

• Views on esomeprazole-based triple therapy to treat duodenal ulcer disease and Helicobacter pylori infection.

  European journal of gastroenterology & hepatology 20020601

• Pharmacology of acid suppression in the hospital setting: focus on proton pump inhibition.

  Critical care medicine 20020601

• Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit.

  Critical care medicine 20020601

• Acute upper gastrointestinal bleeding in critically ill patients: causes and treatment modalities.

  Critical care medicine 20020601

• Intravenous proton pump inhibitors in the critical care setting.

  Critical care medicine 20020601

• Protection against aspiration with the Proseal laryngeal mask airway.

  Anaesthesia and intensive care 20020601

• Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial.

  The American journal of gastroenterology 20020601

• Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.

  The American journal of gastroenterology 20020601

• Pantoprazole-induced recurrent anaphylactic shock.

  The American journal of gastroenterology 20020601

• Osteoporosis with underlying connective tissue disease: an unusual case.

  Annals of the New York Academy of Sciences 20020601

• On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole.

  Scandinavian journal of gastroenterology 20020601

• Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection.

  Internal medicine (Tokyo, Japan) 20020601

• [Changes of rat gastric mucosal barrier under stress conditions].

  Zhonghua nei ke za zhi 20020601

• [Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences].

  Bulletin de la Societe de pathologie exotique (1990) 20020601

• Gastric atrophy and intestinal metaplasia changes 8 years after Helicobacter pylori eradication. A blind, randomised study.

  Minerva gastroenterologica e dietologica 20020601

• Influence of aging on gastric ulcer healing activities of cimetidine and omeprazole.

  European journal of pharmacology 20020531

• Nonhealing gastric ulcer caused by chronic alendronate administration.

  MedGenMed : Medscape general medicine 20020522

• A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.

  British journal of cancer 20020520

• [Management of dyspepsia, gastroduodenal ulcer and Helicobacter pylori infection in primary care].

  Atencion primaria 20020515

• Stability of pantoprazole in an extemporaneously compounded oral liquid.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020515

• Effects of Ostertagia ostertagi and omeprazole treatment on feed intake and gastrin-related responses in the calf.

  Veterinary parasitology 20020510

• Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.

  European journal of pharmacology 20020503

• pH-Hp: implications for dyspepsia management.

  Gut 20020501

• Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms?

  Gut 20020501

• The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies.

  Gut 20020501

• Approaches to uninvestigated dyspepsia.

  Gut 20020501

• Use of antisecretory agents as a trial of therapy.

  Gut 20020501

• A modification of the quininium resin test for assessing gastric acidity.

  Alimentary pharmacology & therapeutics 20020501

• Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression.

  Alimentary pharmacology & therapeutics 20020501

• Lansoprazole-induced thrombocytopenia.

  The Annals of pharmacotherapy 20020501

• Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor.

  The Annals of pharmacotherapy 20020501

• Combination drug therapy for gastroesophageal reflux disease.

  The Annals of pharmacotherapy 20020501

• Pharmacokinetic study of esomeprazole in patients with hepatic impairment.

  European journal of gastroenterology & hepatology 20020501

• Discussion on simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole.

  Gastroenterology 20020501

• Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity.

  Critical care medicine 20020501

• Proton pump inhibitors and stress ulcer prophylaxis: pause for thought?

  Critical care medicine 20020501

• Gastric hyperemic response induced by acid back-diffusion in rat stomachs following barrier disruption -- relation to vanilloid type-1 receptors.

  Medical science monitor : international medical journal of experimental and clinical research 20020501

• Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children.

  Clinical pharmacology and therapeutics 20020501

• Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study.

  Journal of clinical pharmacology 20020501

• Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease.

  Digestive diseases and sciences 20020501

• Oral cavity as a potential source of gastric reinfection by Helicobacter pylori.

  Digestive diseases and sciences 20020501

• Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR.

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20020501

• Primary hyperparathyroidism with duodenal ulcer and H. pylori infection.

  Internal medicine (Tokyo, Japan) 20020501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20020501

• Pantoprazole IV (Protonix IV).

  The Medical letter on drugs and therapeutics 20020429

• Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.

  BMJ (Clinical research ed.) 20020427

• How to calculate the dose of chemotherapy.

  British journal of cancer 20020422

• Induction of CYP1A1 and CYP1A2 expressions by prototypic and atypical inducers in the human lung.

  Cancer letters 20020408

• Esomeprazole for acid peptic disorders.

  The Annals of pharmacotherapy 20020401

• Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with lansoprazole and Nissen fundoplication: a case report.

  Gastrointestinal endoscopy 20020401

• Analysis of the CYP2C19 polymorphism in a North-eastern Thai population.

  Pharmacogenetics 20020401

• One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies.

  Alimentary pharmacology & therapeutics 20020401

• Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers.

  Alimentary pharmacology & therapeutics 20020401

• Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups.

  Alimentary pharmacology & therapeutics 20020401

• Patient perceptions of a proton pump inhibitor therapeutic interchange program across the continuum of care.

  Pharmacotherapy 20020401

• Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans.

  European journal of gastroenterology & hepatology 20020401

• Selective colonization by Helicobacter pylori of the deep gastric glands and intracellular canaliculi of parietal cells in the setting of chronic proton pump inhibitor use.

  European journal of gastroenterology & hepatology 20020401

• Wine stimulates gastric acid secretion in isolated rabbit gastric glands via two different pathways.

  Alimentary pharmacology & therapeutics 20020401

• Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori.

  Alimentary pharmacology & therapeutics 20020401

• Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19.

  British journal of clinical pharmacology 20020401

• Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection.

  Helicobacter 20020401

• Does reduction in gastric acid secretion in bariatric surgery increase diet-induced thermogenesis?

  Obesity surgery 20020401

• Effect of hypergastrinemia on pancreatic carcinogenesis.

  American journal of surgery 20020401

• Is lansoprazole (Prevacid) or omeprazole (Prilosec) more effective in treating erosive esophagitis?

  The Journal of family practice 20020401

• A review of epidemiological studies on cancer in relation to the use of anti-ulcer drugs.

  European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20020401

• Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20020401

• Influence of Helicobacter pylori infection on healing and relapse of acetic acid ulcers in Mongolian gerbils.

  Digestive diseases and sciences 20020401

• Melatonin prevents ethanol-induced gastric mucosal damage possibly due to its antioxidant effect.

  Digestive diseases and sciences 20020401

• Gastroprotective activity of oleanolic acid derivatives on experimentally induced gastric lesions in rats and mice.

  The Journal of pharmacy and pharmacology 20020401

• Role of GERD in chronic resistant sinusitis: a prospective, open label, pilot trial.

  The American journal of gastroenterology 20020401

• Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection.

  The American journal of gastroenterology 20020401

• Laryngeal manifestations of gastroesophageal reflux disease in children.

  Acta oto-laryngologica 20020401

• Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa.

  Pathology international 20020401

• [Regeneration of the gastric epitheliocytes during treatment of duodenal ulcer with pariet].

  Voenno-meditsinskii zhurnal 20020401

• Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.

  Gastroenterologie clinique et biologique 20020401

• Chickenpox oesophagitis and haematemesis in an immunocompetent adult.

  The Journal of infection 20020401

• Single isomer versus racemate: is there a difference? Clinical comparisons in allergy and gastroenterology.

  CNS spectrums 20020401

• [Effect of proton pump inhibitors. In vivo is decisive].

  MMW Fortschritte der Medizin 20020328

• [Practice guidelines for diagnosis and treatment of Helicobacter pylori infections and their application in clinical practice].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20020320

• Determination of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry.

  Journal of chromatography. A 20020308

• Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography.

  Journal of chromatography. A 20020308

• Review article: rabeprazole-based therapy in Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20020301

• Inhibition of cytochromes P450 by antifungal imidazole derivatives.

  Drug metabolism and disposition: the biological fate of chemicals 20020301

• Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough.

  Gastroenterology 20020301

• Acid suppression in healthy subjects following lansoprazole or pantoprazole.

  Alimentary pharmacology & therapeutics 20020301

• Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis.

  Alimentary pharmacology & therapeutics 20020301

• Integrated acidity and rabeprazole pharmacology.

  Alimentary pharmacology & therapeutics 20020301

• Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.

  Alimentary pharmacology & therapeutics 20020301

• A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20020301

• The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.

  Alimentary pharmacology & therapeutics 20020301

• Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20020301

• Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis.

  Alimentary pharmacology & therapeutics 20020301

• Different effects of short-term omeprazole, lansoprazole or pantoprazole on the accuracy of the (13)C-urea breath test.

  Alimentary pharmacology & therapeutics 20020301

• The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.

  Alimentary pharmacology & therapeutics 20020301

• Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies.

  Alimentary pharmacology & therapeutics 20020301

• Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen.

  Alimentary pharmacology & therapeutics 20020301

• Drugs for bleeding peptic ulcer.

  Alimentary pharmacology & therapeutics 20020301

• Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion.

  British journal of pharmacology 20020301

• Omeprazole and ultrastructural modifications occurring in reflux esophagitis.

  Gastroenterology 20020301

• Eradication of Helicobacter pylori in duodenal ulcer disease tetracycline & furazolidone vs. metronidazole & amoxicillin in omeprazole based triple therapy.

  Medical science monitor : international medical journal of experimental and clinical research 20020301

• Helicobacter pylori eradication in dyspeptic primary care patients: a randomized controlled trial of a pharmacy intervention.

  The Western journal of medicine 20020301

• Omeprazole increases permeability across isolated rat gastric mucosa pre-treated with an acid secretagogue.

  The Journal of pharmacy and pharmacology 20020301

• Gastroprotective activity of solidagenone on experimentally-induced gastric lesions in rats.

  The Journal of pharmacy and pharmacology 20020301

• A comparative study on the activity of lansoprazole, omeprazole and PD-136450 on acidified ethanol- and indomethacin-induced gastric lesions in the rat.

  Clinical and experimental pharmacology & physiology 20020301

• Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19).

  Clinical pharmacology and therapeutics 20020301

• Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.

  The American journal of gastroenterology 20020301

• Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy.

  The American journal of gastroenterology 20020301

• An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.

  International journal of clinical practice 20020301

• Nizatidine and omeprazole enhance the effect of metronidazole on Helicobacter pylori in vitro.

  International journal of antimicrobial agents 20020301

• Influence of fluconazole on the pharmacokinetics of omeprazole in healthy volunteers.

  Biopharmaceutics & drug disposition 20020301

• Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week.

  European journal of gastroenterology & hepatology 20020301

• Failure of Helicobacter pylori eradication: is poor compliance the main cause?

  Gastroenterologie clinique et biologique 20020301

• Anti-ulcerogenic and analgesic activities of the leaves of Wilbrandia ebracteata in mice.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20020301

• The pharmacology of cilostazol.

  Diabetes, obesity & metabolism 20020301

• Posterior laryngitis: effects of treatment with omeprazole alone.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20020301

• Mutagenic and clastogenic activity of gastric juice in human gastric diseases.

  Mutation research 20020215

• Acute fulminant hepatitis after treatment with rabeprazole and terbinafine: is rabeprazole the culprit?

  Archives of internal medicine 20020211

• Recurrence of Helicobacter pylori infection and the long-term outcome of peptic ulcer after successful eradication in Japan.

  Journal of clinical gastroenterology 20020201

• Collagenous colitis associated with lansoprazole.

  Journal of clinical gastroenterology 20020201

• Cutaneous leucocytoclastic vasculitis associated with omeprazole.

  Postgraduate medical journal 20020201

• Nonvariceal upper gastrointestinal bleeding.

  Endoscopy 20020201

• Omeprozole therapy in pediatric patients after liver and intestinal transplantation.

  Journal of pediatric gastroenterology and nutrition 20020201

• Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study.

  Scandinavian journal of gastroenterology 20020201

• Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole.

  Digestive diseases and sciences 20020201

• [Long-term prophylaxis with omeprazol is superior to eradication therapy in H. pylori-positive NSAIDs taking patients].

  Zeitschrift fur Gastroenterologie 20020201

• Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.

  Alimentary pharmacology & therapeutics 20020201

• The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20020201

• Effect of Helicobacter pylori eradication on duodenal ulcer scar in patients with no clinical history of duodenal ulcer.

  Alimentary pharmacology & therapeutics 20020201

• Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies.

  Alimentary pharmacology & therapeutics 20020201

• Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors.

  Alimentary pharmacology & therapeutics 20020201

• High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.

  Alimentary pharmacology & therapeutics 20020201

• Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus.

  The American journal of gastroenterology 20020201

• Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.

  The American journal of gastroenterology 20020201

• Resolution of collagenous colitis after treatment for Helicobacter pylori.

  The American journal of gastroenterology 20020201

• In support of 'step-up therapy' for gastroesophageal reflux disease.

  The American journal of gastroenterology 20020201

• The effect of immobilization stress on the pharmacokinetics of omeprazole in rats.

  Acta medica Okayama 20020201

• Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users.

  Helicobacter 20020201

• [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20020201

• Protonix. First i.v. proton pump inhibitor approved.

  Nursing 20020201

• [Drug-drug interaction in pharmacogenetics and pharmacogenomics].

  Rinsho byori. The Japanese journal of clinical pathology 20020201

• Hepatic lysosomal enzymes activity and liver morphology after short-time omeprazole administration.

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20020201

• Proton pump inhibitors or surgery for gastro-oesophageal reflux disease.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020201

• Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020201

• Nonallergic anaphylaxis to pantoprazole.

  Allergy 20020201

• [The outline of medical treatment of peptic ulcer].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Guidelines for the management of Helicobacter pylori infection in Japan].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Guidelines of Helicobacter pylori eradication in children].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [New triple therapy for Helicobacter pylori infection].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Dual therapy for Helicobacter pylori resistance to anti microbial agents].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Second line treatment regimen of PPI + AMPC + MNZ for patients with clarithromycin-resistant Helicobacter pylori infection].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Minocycline-containing eradication therapy for patients with clarithromycin-resistant Helicobacter pylori infection].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Adverse effects of H. pylori eradication therapy and its measure].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Acute mucosal lesion of the upper-gastrointestinal tract observed after H. pylori-eradication].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [H. pylori eradication therapy and natural history of peptic ulcer].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Continuation of acid suppression therapy after H. pylori eradication].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Treatment of NSAIDs induced ulcers].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Prophylaxis against non-steroidal anti-inflammatory drug-associated ulcers and erosions].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Intractable ulcer].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Gastroduodenal ulcer in childhood].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Peptic ulcer in the elderly].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Proton pump inhibitors: Omeprazole].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Proton pump inhibitors: Rabeprazole].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Proton pump inhibitors: Tenatoprazole (TU-199)].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Proton pump inhibitors: Pantoprazole].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Amoxicillin (AMPC)].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Sucralfate].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Plaunotol].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Sofalcone].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Ecabet sodium].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Polaprezinc].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Non-ulcer dyspepsia and H. pylori].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Cause and prevention of nocturnal gastric acid breakthrough].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Helicobacter heilmannii-associated gastritis].

  Nihon rinsho. Japanese journal of clinical medicine 20020201

• [Appearance of Helicobacter pylori antigen in stool specimens of children with chronic gastritis].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20020201

• [Clinical management of reflux laryngitis].

  HNO 20020201

• Life cycle of a block buster drug: discovery and development of omeprazole (Prilosec).

  Molecular interventions 20020201

• Conformational analysis: a new approach by means of chemometrics.

  Journal of computational chemistry 20020130

• Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).

  Archives of internal medicine 20020128

• Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.

  Archives of internal medicine 20020128

• Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation.

  Transplantation 20020127

• [Omeprazole-induced interstitial nephritis: a reversible cause of acute renal failure].

  Medicina clinica 20020119

• Esomeprazole magnesium.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020115

• [Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].

  Medizinische Klinik (Munich, Germany : 1983) 20020115

• Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.

  Cancer 20020115

• Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa.

  The New England journal of medicine 20020110

• Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.

  Lancet (London, England) 20020105

• Enantiomeric determination of pantoprazole in human plasma by multidimensional high-performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020105

• Black tea polyphenols, theaflavins, prevent cellular DNA damage by inhibiting oxidative stress and suppressing cytochrome P450 1A1 in cell cultures.

  Journal of agricultural and food chemistry 20020102

• Noncardiac chest pain.

  Journal of clinical gastroenterology 20020101

• The novel use of an intravenous proton pump inhibitor in a patient with short bowel syndrome.

  Journal of clinical gastroenterology 20020101

• Hypergastrinemia in response to gastric inflammation suppresses somatostatin.

  American journal of physiology. Gastrointestinal and liver physiology 20020101

• O-Dealkylation of fluoxetine in relation to CYP2C19 gene dose and involvement of CYP3A4 in human liver microsomes.

  The Journal of pharmacology and experimental therapeutics 20020101

• Effect of multipolar electrocoagulation on EUS findings in Barrett's esophagus.

  Gastrointestinal endoscopy 20020101

• Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism.

  Pharmacogenetics 20020101

• Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice.

  Gastroenterology 20020101

• Helicobacter pylori, NSAIDs and gastrointestinal haemorrhage.

  European journal of gastroenterology & hepatology 20020101

• Efficacy of Helicobacter pylori eradication in uninvestigated chronic dyspeptic staff members of a large factory: a prospective, long-term, follow-up, workplace outcome study.

  European journal of gastroenterology & hepatology 20020101

• Interaction of sleep disturbances and gastroesophageal reflux in chronic laryngitis.

  American journal of otolaryngology 20020101

• Acute necrotizing gastritis by Escherichia coli in a severely neutropenic patient.

  Haematologica 20020101

• [Progress of tailor-made treatment of peptic ulcer].

  Nihon rinsho. Japanese journal of clinical medicine 20020101

• Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy.

  International journal of antimicrobial agents 20020101

• Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation.

  Journal of gastroenterology 20020101

• [Treatment of perforated gastroduodenal ulcer by simple suture followed by Helicobacter pylori eradication].

  Annales de chirurgie 20020101

• Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients.

  The Journal of dermatology 20020101

• [Duodenal ulcer].

  Nihon rinsho. Japanese journal of clinical medicine 20020101

• Acute manic psychosis induced by triple therapy for H. pylori.

  The Journal of the American Board of Family Practice 20020101

• [The medical treatment of upper gastrointestinal bleeding in the new millennium].

  Harefuah 20020101

• [Piracetam in combined pathogenetic therapy of recurrent duodenal ulcer].

  Klinicheskaia meditsina 20020101

• Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: a pH-metric comparison.

  Alimentary pharmacology & therapeutics 20020101

• Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding.

  Alimentary pharmacology & therapeutics 20020101

• Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20020101

• Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20020101

• Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.

  Alimentary pharmacology & therapeutics 20020101

• Pre and post eradication gastric inflammation in Helicobacter pylori-associated duodenal ulcer.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20020101

• [Circadian monitoring of intragastric pH in evaluation of efficiency of antisecretory therapy of duodenal ulcer].

  Klinicheskaia meditsina 20020101

• [Pharma-clinics medication of the month. Rabeprazole (Pariet)].

  Revue medicale de Liege 20020101

• Regression of duodenal gastric metaplasia in Helicobacter pylori positive patients with duodenal ulcer disease.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020101

• The effects of rabeprazole on parietal cells and enterochromaffin-like cells in rats: a comparison with omeprazole.

  Journal of gastroenterology 20020101

• Rabeprazole: quest for the best PPI.

  Journal of gastroenterology 20020101

• Effect of interlukin-1beta on proliferation of gastric epithelial cells in culture.

  BMC gastroenterology 20020101

• Dual versus triple therapy in eradication of Helicobacter pylori.

  Hepato-gastroenterology 20020101

• Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome.

  Hepato-gastroenterology 20020101

• [Various mechanisms of cytoprotective effect of omeprazole and low intensity laser radiation on the gastroduodenal mucosa in the treatment of patients with duodenal ulcer].

  Likars'ka sprava 20020101

• Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies.

  PharmacoEconomics 20020101

• Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK.

  PharmacoEconomics 20020101

• Atypical and aggressive upper gastrointestinal ulceration associated with aspirin abuse.

  Journal of clinical gastroenterology 20020101

• Prolonged use of proton pump inhibitors, CagA status, and the outcome of Helicobacter pylori gastritis.

  Journal of clinical gastroenterology 20020101

• One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy.

  Journal of clinical gastroenterology 20020101

• Effect of omeprazole on regional and temporal variations in intragastric acidity.

  Digestion 20020101

• Crack cocaine-related prepyloric perforation treated laparoscopically.

  Surgical endoscopy 20020101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20020101

• Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis.

  ACP journal club 20020101

• Esomeprazole: a review of its use in the management of acid-related disorders in the US.

  Drugs 20020101

• Do standard doses of frequently prescribed drugs cause preventable adverse effects in women?

  Journal of the American Medical Women's Association (1972) 20020101

• Determinants of headache in lansoprazole users in The Netherlands: results from a nested case-control study.

  Drug safety 20020101

• Helicobacter pylori infection in skin diseases: a critical appraisal.

  American journal of clinical dermatology 20020101

• Lansoprazole for maintenance of remission of erosive oesophagitis.

  Drugs 20020101

• Gastric MALT-lymphoma, gastrin and cyclooxygenases.

  Acta gastro-enterologica Belgica 20020101

• [Microflora of gastric juice in patients after eradication of Helicobacter pylori and treatment with a proton pump inhibitor].

  Wiadomosci lekarskie (Warsaw, Poland : 1960) 20020101

• [The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Treatment of patients with ulcer associated with Helicobacter pylori (experience with a triple therapy regimen].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Inhibitors of proton pump in the treatment of non-ulcer functional dyspepsia of the reflux-like type].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Regeneration of the esophagus epitheliocytes. Evaluation of pariet efficacy in the treatment of patients with reflux esophagitis].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Efficacy of the one week treatment with esomeprazole (nexium), clarythromycin, and amoxycillin of duodenal ulcer associated with Helicobacter pylori].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• Gastric neuroendocrine tumors in a 2-year oncogenicity study with CD-1 mice.

  Toxicologic pathology 20020101

• Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20020101

• [Intravenous 3-day Helicobacter pylori eradication therapy is highly effective in patients with bleeding peptic ulcer].

  Gastroenterologia y hepatologia 20020101

• Severe upper gastrointestinal hemorrhage in the newborn.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20020101

• Rabeprazole.

  Journal of postgraduate medicine 20020101

• Esomeprazole: a review of its use in the management of acid-related disorders.

  Drugs 20020101

• Confounding factors in diagnosing brain death: a case report.

  BMC neurology 20020101

• [Treatment of gastritis-associated Helicobacter pylori infection in children].

  Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20020101

• Long-term clinical outcome of elderly patients with reflux esophagitis: a six-month to three-year follow-up study.

  American journal of therapeutics 20020101

• Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials.

  BMC gastroenterology 20020101

• Gastroesophageal reflux disease: new treatments.

  Reviews in gastroenterological disorders 20020101

• [Effect of various antisecretory drugs on morphological changes in rat gastric mucosa in experimental stomach ulcers].

  Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20020101

• [Helicobacter pylori eradication in patients with peptic ulcer after two treatment failures: a prospective culture-guided study].

  Gastroenterologia y hepatologia 20020101

• Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.

  Hepato-gastroenterology 20020101

• Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer.

  Revista do Hospital das Clinicas 20020101

• The management of rosacea.

  American journal of clinical dermatology 20020101

• [Evaluation of efficacy, safety and tolerability rabeprazole in treatment of acid-peptic diseases ].

  Arquivos de gastroenterologia 20020101

• [Reactive polyarthritis and painful dermatographism caused by Helicobacter pylori].

  Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20020101

• Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotype.

  Drug metabolism and drug interactions 20020101

• Clinical significance of the cytochrome P450 2C19 genetic polymorphism.

  Clinical pharmacokinetics 20020101

• Pharmacokinetics of omeprazole given by continuous intravenous infusion to patients with varying degrees of hepatic dysfunction.

  Clinical pharmacokinetics 20020101

• The role of triple therapy, age, gender and smoking on the genotoxic effects of Helicobacter pylori infection.

  The Journal of international medical research 20020101

• Polymorphism of CYP2C19 and gastric emptying in patients with proton pump inhibitor-resistant gastric ulcers.

  The Journal of international medical research 20020101

• Long-term effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease.

  Hepato-gastroenterology 20020101

• Patients have treatment preferences: a multicentre, double-blind, crossover study comparing rabeprazole and omeprazole.

  Current medical research and opinion 20020101

• Gastroesophageal reflux in children: pathogenesis, prevalence, diagnosis, and role of proton pump inhibitors in treatment.

  Paediatric drugs 20020101

• [Effectiveness of pariet (rabeprazole) in the treatment of gastroesophageal reflux disease (at the reflux-esophagitis stage)].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Seven-day antihelicobacter therapy of duodenal ulcer associated with Helicobacter pylori and prospects for treating patients].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Pariet in eradication therapy plans].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Clinico-functional evaluation of the efficacy of treating gastroesophageal reflux disease combined with bronchial asthma with omeprazole].

  Terapevticheskii arkhiv 20020101

• [Fromilid (clarithromycin) in eradication patients in patients with duodenal ulcer associated with Helicobacter pylori (comparison of two treatment variations)].

  Terapevticheskii arkhiv 20020101

• Liquid chromatography/tandem mass spectrometric bioanalysis using normal-phase columns with aqueous/organic mobile phases - a novel approach of eliminating evaporation and reconstitution steps in 96-well SPE.

  Rapid communications in mass spectrometry : RCM 20020101

• [Fromilide (clarithromycin) in eradication of Helicobacter pylori in patients with duodenal ulcer].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101

• Hyponatraemia in very old nonhospitalised people: association with drug use.

  Drugs & aging 20020101

• The effect of Helicobacter pylori retreatment with ranitidine bismuth citrate, clarithromycin, and metronidazole depends on the first-line therapy.

  Journal of clinical gastroenterology 20020101

• Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebo-controlled double blind study.

  Allergologia et immunopathologia 20020101

• [Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ].

  Klinicheskaia meditsina 20020101

• [Concerning the discussion article by I. A. Morozov 'Choice of the gastroenterologist'].

  Klinicheskaia meditsina 20020101

• Mixed infection due to leptospira and dengue.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20020101

• Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease.

  Therapie 20020101

• Long-term effects of Helicobacter pylori eradication in Mongolian gerbils.

  Journal of gastroenterology 20020101

• The clinical importance of proton pump inhibitor pharmacokinetics.

  Digestion 20020101

• [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].

  Wiadomosci lekarskie (Warsaw, Poland : 1960) 20020101

• Omeprazole, furazolidone, and tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease.

  Revista do Hospital das Clinicas 20020101

• Presence on human chromosome 10 of omeprazole-sensitivity gene whose product mediates CYP1A1 induction.

  Cytogenetic and genome research 20020101

• [Microcirculation in gastric mucosa as related to its secretory activity in patients with peptic ulcer].

  Likars'ka sprava 20020101

• Tenatoprazole. Benatoprazole, TU 199.

  Drugs in R&D 20020101

• Anaphylaxis to proton pump inhibitors.

  Allergologia et immunopathologia 20020101

• [Typical and atypical symptoms of laryngopharyngeal reflux disease].

  Medicina (Kaunas, Lithuania) 20020101

• Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression?

  Reviews in gastroenterological disorders 20020101

• Eradication therapy with rabeprazole versus omeprazole in the treatment of active duodenal ulcer.

  Digestion 20020101

• Esomeprazole: update and clinical review.

  Reviews in gastroenterological disorders 20020101

• Stress ulcer prophylaxis in trauma patients.

  Critical care (London, England) 20020101

• Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors.

  Drugs & aging 20020101

• The sixth decision regarding perforated duodenal ulcer.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20020101

• [Esophageal epithelial cells renewal in evaluation of the pariet efficacy in the treatment of patients with reflux esophagitis].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [A case of the successful treatment of the esophageal leukoplakia with rabeprazole].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Acid-base blood balance in patients with ulcer under treatment by the gastric secretion inhibitors and antacids].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Pharmacoeconomic aspects of the 1-week eradication treatment of duodenal ulcer associated with Helicobacter pylori].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Visual documentation of the stability of intravenous solutions of omeprazole (Losec) and pantoprazole (Pantoloc)].

  Wiener medizinische Wochenschrift (1946) 20020101

• Modulation of the phototoxic effect of hypericin in human leukemia CEM cell line by N-ethylmaleimide, amiloride and omeprazole.

  Physiological research 20020101

• Interaction between various resistance modifiers and apoptosis inducer 12H-benzo[alpha]phenothiazine.

  Anticancer research 20020101

• ATPase inhibitors suppress actinomycin D-induced apoptosis in leukemia cells.

  Anticancer research 20020101

• Effect of omeprazole on plasma zinc levels after oral zinc administration.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20020101

• In vitro study on capsule formulations of omeprazole containing enteric coated granules.

  Bollettino chimico farmaceutico 20020101

• Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children.

  Journal of pediatric gastroenterology and nutrition 20020101

• Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children.

  Journal of pediatric gastroenterology and nutrition 20020101

• Pharmacokinetics and pharmacodynamics of lansoprazole in children with gastroesophageal reflux disease.

  Journal of pediatric gastroenterology and nutrition 20020101

• Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability.

  Journal of pediatric gastroenterology and nutrition 20020101

• Assessment of effectiveness of different dosage regimens of pantoprazole in controlling symptoms and healing esophageal lesions of patients with mild erosive esophagitis.

  Arquivos de gastroenterologia 20020101

• [Clinical aspects of using pariet in treating chronic pancreatitis].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Pharmacoeconomics of ulcers: a view from Saint-Petersburg].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• [Rhabdomyolysis during treatment with rabeprazole (Pariel), a proton pump inhibitor combined with domperidone (Peridys)].

  Therapie 20020101

• Validation of a single-patient drug trial methodology for personalized management of gastroesophageal reflux disease.

  Journal of managed care pharmacy : JMCP 20020101

• [Changes in the ultrastructure of the stomach mucous membrane parietal cells caused by inhibitors of hydrochloric acid secretion].

  Arkhiv patologii 20020101

• Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial).

  Wiener klinische Wochenschrift 20011217

• Duodenal mucosa-associated lymphoid tissue lymphoma treated by eradication of Helicobacter pylori: report of 2 cases including EUS findings.

  Gastrointestinal endoscopy 20011201

• Localization of [14C]amoxicillin in rat gastric tissue when administered with lansoprazole and clarithromycin.

  The Journal of antimicrobial chemotherapy 20011201

• Effect of inhibition of gastric acid secretion on antropyloroduodenal motor activity and duodenal acid hypersensitivity in functional dyspepsia.

  Alimentary pharmacology & therapeutics 20011201

• Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH.

  Alimentary pharmacology & therapeutics 20011201

• Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage.

  Alimentary pharmacology & therapeutics 20011201

• Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20011201

• Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs.

  European journal of gastroenterology & hepatology 20011201

• One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease.

  European journal of gastroenterology & hepatology 20011201

• [Long-term therapy of gastrooesophageal reflux disease: Medical treatment or anti-reflux surgery?].

  Zeitschrift fur Gastroenterologie 20011201

• Transfer of clarithromycin to gastric juice is enhanced by omeprazole in Helicobacter pylori-infected individuals.

  Scandinavian journal of gastroenterology 20011201

• Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study.

  Scandinavian journal of gastroenterology 20011201

• Helicobacter pylori and nonsteroidal anti-inflammatory drugs.

  Gastroenterology clinics of North America 20011201

• Gastroesophageal reflux in infants and children.

  American family physician 20011201

• The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancao-tang.

  Biological & pharmaceutical bulletin 20011201

• Pretreatment gastric histology is helpful to predict the symptomatic response after H. pylori eradication in patients with nonulcer dyspepsia.

  Digestive diseases and sciences 20011201

• Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.

  Naunyn-Schmiedeberg's archives of pharmacology 20011201

• Clinical efficacy of proton pump inhibitor therapy in neurologically impaired children with gastroesophageal reflux: prospective study.

  Hong Kong medical journal = Xianggang yi xue za zhi 20011201

• Oral pantoprazole for acid suppression in the treatment of patients with Zollinger-Ellison syndrome.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20011201

• Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.

  The American journal of gastroenterology 20011201

• Acute interstitial nephritis due to omeprazole.

  The American journal of gastroenterology 20011201

• Proton pump inhibitors and gastric acid secretion.

  The American journal of gastroenterology 20011201

• Omeprazole versus ranitidine in the medical treatment of acute upper gastrointestinal bleeding: assessment by early repeat endoscopy.

  International journal of clinical practice 20011201

• Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20011201

• Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers.

  The Annals of pharmacotherapy 20011201

• Doctor, there's a fly in my soup! Angiotensin-converting enzyme inhibitors, endogenous opioids and visual hallucinations.

  The Israel Medical Association journal : IMAJ 20011201

• Gastroesophageal reflux and obstructive sleep apnea.

  The Laryngoscope 20011201

• Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.

  The Laryngoscope 20011201

• [Medical treatment of hemorrhaging ulcer].

  Presse medicale (Paris, France : 1983) 20011201

• Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011201

• [Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20011201

• Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes.

  European journal of clinical pharmacology 20011201

• Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France.

  European journal of clinical pharmacology 20011201

• Helicobacter pylori eradication: do we have another ace up our sleeve?

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011201

• Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura.

  British journal of haematology 20011201

• Problems associated with the clinical use of proton pump inhibitors.

  Pharmacology & toxicology 20011201

• [Helicobacter pylori increases the antisecretory activity of omeprazole in the parietal cell and the proton pump].

  Gastroenterologie clinique et biologique 20011201

• [Hydrotalcite in the treatment of reflux esophagitis: a multicenter clinical study].

  Zhonghua nei ke za zhi 20011201

• A systematic gene expression screen of Caenorhabditis elegans cytochrome P450 genes reveals CYP35 as strongly xenobiotic inducible.

  Archives of biochemistry and biophysics 20011115

• Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011115

• Intravenous omeprazole after endoscopic treatment of bleeding peptic ulcers.

  Gut 20011101

• Duodenal fat intensifies the perception of heartburn.

  Gut 20011101

• Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease.

  Gastroenterology 20011101

• Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis.

  Alimentary pharmacology & therapeutics 20011101

• Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan.

  Alimentary pharmacology & therapeutics 20011101

• A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.

  Alimentary pharmacology & therapeutics 20011101

• Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study.

  Alimentary pharmacology & therapeutics 20011101

• A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastric pH.

  Alimentary pharmacology & therapeutics 20011101

• Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa.

  Alimentary pharmacology & therapeutics 20011101

• Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease.

  Annals of surgery 20011101

• Regression of primary high-grade gastric B-cell lymphoma following Helicobacter pylori eradication.

  European journal of gastroenterology & hepatology 20011101

• Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole.

  European journal of gastroenterology & hepatology 20011101

• CYP2C19 genotype determines enzyme activity and inducibility of S-mephenytoin hydroxylase.

  Clinica chimica acta; international journal of clinical chemistry 20011101

• Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients.

  Annals of neurology 20011101

• Fundic gland polyps are not induced by proton pump inhibitor therapy.

  American journal of clinical pathology 20011101

• Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial.

  The Journal of pediatrics 20011101

• Health-Related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine.

  Digestive diseases and sciences 20011101

• Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: a multiple logistic regression analysis.

  Digestive diseases and sciences 20011101

• Assessment of cytochrome P450 activity by a five-drug cocktail approach.

  Clinical pharmacology and therapeutics 20011101

• Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19.

  Clinical pharmacology and therapeutics 20011101

• Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.

  The American journal of gastroenterology 20011101

• Effect of long-term omeprazole treatment on antral G and D cells in children.

  Journal of pediatric gastroenterology and nutrition 20011101

• Antiulcerogenic effect of Hippophae rhamnoides L.

  Phytotherapy research : PTR 20011101

• Fine-needle aspiration biopsy of an intra-abdominal inflammatory mass secondary to a penetrating duodenal ulcer mimicking neoplasm.

  Diagnostic cytopathology 20011101

• Pill-induced esophagitis caused by lansoprazole.

  Journal of gastroenterology 20011101

• Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011101

• Two new treatment regimens for Helicobacter pylori eradication: a randomised study.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011101

• Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011101

• Improving opportunities for effective management of gastro-oesophageal reflux disease.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011101

• Treatment of erosive oesophagitis with omeprazole: a comparison with different delivery system.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011101

• Correlation between omeprazole hydroxylase and CYP2C19 genotype in North Indians.

  European journal of clinical pharmacology 20011101

• Laryngospasm: an atypical manifestation of severe gastroesophageal reflux disease (GERD).

  The Laryngoscope 20011101

• In vitro study of the interaction between omeprazole and the metal ions Zn(II), Cu(II), and Co(II).

  Die Pharmazie 20011101

• [Lansoprazole-associated collagenous colitis].

  Gastroenterologie clinique et biologique 20011101

• Cluster headache without autonomic symptoms?

  Cephalalgia : an international journal of headache 20011101

• Vitamin C inhibits corpus gastritis in Helicobacter pylori-infected patients during acid-suppressive therapy.

  Journal of gastroenterology and hepatology 20011101

• Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers.

  Journal of gastroenterology and hepatology 20011101

• Effect of omeprazole-induced achlorhydria on trefoil peptide expression in the rat stomach.

  Journal of gastroenterology and hepatology 20011101

• Slow metabolism and long half life of methadone in a patient with lung cancer and cirrhosis.

  Annales de medecine interne 20011101

• The stomach divalent ion-sensing receptor scar is a modulator of gastric acid secretion.

  The Journal of biological chemistry 20011026

• Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.

  Biochemistry 20011009

• Intragastric pH regulates conversion from net acid to net alkaline secretion by the rat stomach.

  American journal of physiology. Gastrointestinal and liver physiology 20011001

• The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery.

  Gut 20011001

• Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.

  Drug metabolism and disposition: the biological fate of chemicals 20011001

• Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome?

  Alimentary pharmacology & therapeutics 20011001

• Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.

  Alimentary pharmacology & therapeutics 20011001

• Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis.

  Alimentary pharmacology & therapeutics 20011001

• Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.

  Best practice & research. Clinical gastroenterology 20011001

• Black esophagus: an unusual finding during routine endoscopy.

  Endoscopy 20011001

• Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8 mg/hour on intragastric pH.

  Critical care medicine 20011001

• Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats.

  Scandinavian journal of gastroenterology 20011001

• Proton pump inhibitor resistance in the treatment of laryngopharyngeal reflux.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20011001

• Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011001

• Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults.

  Gastroenterology 20011001

• First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori.

  Gastroenterology 20011001

• Laryngeal pyogenic granulomas do not express oestrogen or progesterone receptors.

  The Journal of laryngology and otology 20011001

• What is the best pharmacologic approach to managing moderate to severe heartburn?

  The Journal of family practice 20011001

• [GERD (gastroesophageal reflux disease)].

  Nihon rinsho. Japanese journal of clinical medicine 20011001

• Clinical relevance of genetic polymorphisms in the human CYP2C subfamily.

  British journal of clinical pharmacology 20011001

• [Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20011001

• Endogenous gastrin stimulates regeneration of remnant pancreas after partial pancreatectomy.

  Digestive diseases and sciences 20011001

• Bioequivalence between omeprazole MUPS 20 mg as tablet and omeprazole MUPS 20 mg as tablet encapsulated in a hard gelatine capsule.

  International journal of clinical pharmacology and therapeutics 20011001

• A bioavailability/bioequivalence study of two oral lansoprazole formulations after single administration to healthy volunteers.

  Die Pharmazie 20011001

• Heartburn. The new purple pill is it any better?

  Harvard health letter 20011001

• Search for antiulcer agents at IDR.

  Die Pharmazie 20011001

• The role of treatment with proton pump inhibitors and anti-Helicobacter therapy in functional dyspepsia.

  The American journal of gastroenterology 20011001

• Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.

  The American journal of gastroenterology 20011001

• Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study.

  The American journal of gastroenterology 20011001

• Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.

  The American journal of gastroenterology 20011001

• Effects of acid inhibition on somatostatin-producing cells in the rat gastric fundus.

  Acta histochemica 20011001

• [Laryngeal manifestations of gastroesophageal reflux disease (GERD) in pediatric patients: the usefulness of therapeutic (proton pump inhibitor (PPI)) trials].

  Nihon Jibiinkoka Gakkai kaiho 20011001

• Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux.

  Acta oto-laryngologica 20011001

• Gastroesophageal reflux in infants and children. When to reassure and when to go further.

  Canadian family physician Medecin de famille canadien 20011001

• Optimizing acid-suppression therapy.

  Managed care (Langhorne, Pa.) 20011001

• [Modern means of anti-Helicobacter therapy].

  Voenno-meditsinskii zhurnal 20011001

• Clinical pharmacology and safety profile of esomeprazole, the first enantiomerically pure proton pump inhibitor.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011001

• Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.

  Expert opinion on pharmacotherapy 20011001

• Cervical osteophyte induced dysphagia.

  The Journal of the Association of Physicians of India 20011001

• Effects of CCK2 receptor blockade on growth parameters in gastrointestinal tract and pancreas in rats.

  Pharmacology & toxicology 20011001

• Noninvasive Helicobacter pylori testing for the 'test-and-treat' strategy: a decision analysis to assess the effect of past infection on test choice.

  Archives of internal medicine 20010924

• Clinical and ethical concerns about switching patient treatment to 'therapeutically interchangeable' medications.

  Archives of internal medicine 20010924

• [Comparative study of proton pump inhibitors].

  Orvosi hetilap 20010909

• Does short-term treatment with proton pump inhibitors cause rebound aggravation of symptoms?

  Journal of clinical gastroenterology 20010901

• Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs.

  Epidemiology (Cambridge, Mass.) 20010901

• Gastric leptin and Helicobacter pylori infection.

  Gut 20010901

• Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points.

  Gut 20010901

• Insulin-like growth factor I accelerates gastric ulcer healing by stimulating cell proliferation and by inhibiting gastric acid secretion.

  Scandinavian journal of gastroenterology 20010901

• Intragastric volatile N-nitrosamines, nitrite, pH, and Helicobacter pylori during long-term treatment with omeprazole.

  Gastroenterology 20010901

• High-dose omeprazole in esophagitis with stenosis after surgical treatment of esophageal atresia.

  Journal of pediatric surgery 20010901

• Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole.

  Alimentary pharmacology & therapeutics 20010901

• Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.

  Alimentary pharmacology & therapeutics 20010901

• Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis.

  Alimentary pharmacology & therapeutics 20010901

• Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis.

  Alimentary pharmacology & therapeutics 20010901

• Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora.

  Alimentary pharmacology & therapeutics 20010901

• Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism.

  Alimentary pharmacology & therapeutics 20010901

• Intragastric distribution of Helicobacter pylori during short-term omeprazole therapy: study using Carnoy's fixation and immunohistochemistry for detection of bacteria.

  Alimentary pharmacology & therapeutics 20010901

• [Progress in study for mechanism of gastric mucosal injury].

  Nihon rinsho. Japanese journal of clinical medicine 20010901

• Review article: long-term use of proton pump inhibitors in GORD--help or hindrance?

  Alimentary pharmacology & therapeutics 20010901

• Review article: tackling the 'dyspeptic problem'.

  Alimentary pharmacology & therapeutics 20010901

• Review article: managing the dyspeptic patient--an interactive discussion.

  Alimentary pharmacology & therapeutics 20010901

• Recommended dose antacids and severe hypercalcaemia.

  British journal of clinical pharmacology 20010901

• Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer.

  The American journal of medicine 20010901

• Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori.

  The American journal of gastroenterology 20010901

• Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20010901

• Impairment of gastric secretion modulation in duodenal ulcer and in long-term PPI treatment: quantitative morphologic findings and pathophysiologic implications.

  Digestive diseases and sciences 20010901

• Remission of a high-grade gastric mucosa associated lymphoid tissue (MALT) lymphoma following Helicobacter pylori eradication and highly active antiretroviral therapy in a patient with AIDS.

  The American journal of medicine 20010901

• Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients.

  Journal of pediatric gastroenterology and nutrition 20010901

• Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B(12) deficiency?

  Journal of pediatric gastroenterology and nutrition 20010901

• Involvement of heat shock proteins in the healing of acetic acid-induced gastric ulcers in rats.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20010901

• Histamine in stress ulcer prophylaxis in rats.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20010901

• Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.

  Pathologie-biologie 20010901

• [Comparative antisecretory activity of famotidine, omeprazole, and rabeprazole (pariet) in ulcer disease based on daily pH-monitoring].

  Voenno-meditsinskii zhurnal 20010901

• Helicobacter pylori infection and recurrent abdominal pain in Turkish children.

  Helicobacter 20010901

• A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.

  Helicobacter 20010901

• Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism.

  European journal of clinical pharmacology 20010901

• [Complementary observational study of the efficacy, tolerance and safety of lansoprazole 15 mg as maintenance therapy of reflux esophagitis in daily medical practice in Belgium (record RU49749/R002].

  Revue medicale de Liege 20010901

• Evolution of reflux disease management and the role of Nexium. Proceedings of a symposium. Porto, Portugal, 7 October 2000.

  European journal of gastroenterology & hepatology 20010901

• Resolution of Menetrier's disease after Helicobacter pylori eradication therapy.

  The New Zealand medical journal 20010824

• Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010815

• Membrane potential changes after infection of monocytes by Toxoplasma gondii.

  International journal for parasitology 20010801

• The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human cyp1a1 expression.

  Drug metabolism and disposition: the biological fate of chemicals 20010801

• The effectiveness of one-week triple eradication therapy for perforated duodenal ulcer patients treated with simple closure.

  Journal of clinical gastroenterology 20010801

• SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health.

  Journal of clinical epidemiology 20010801

• Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen.

  Alimentary pharmacology & therapeutics 20010801

• Relaxation induced by omeprazole does not change in diabetic rabbit corpus cavernosum.

  BJU international 20010801

• Effect of acid secretion blockade by omeprazole on the relative bioavailability of orally administered furazolidone in healthy volunteers.

  British journal of clinical pharmacology 20010801

• Effect of grapefruit juice on the disposition of omeprazole.

  British journal of clinical pharmacology 20010801

• High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients.

  Scandinavian journal of gastroenterology 20010801

• A study of 13 patients with gastric tube in place after esophageal resection: use of omeprazole to decrease gastric acidity and volume.

  Journal of clinical anesthesia 20010801

• Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication.

  The American journal of medicine 20010801

• The relationship between gastric-oral Helicobacter pylori and oral hygiene in patients with vitamin B12-deficiency anemia.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20010801

• No clinical benefit of adding cisapride to pantoprazole for treatment of gastro-oesophageal reflux disease.

  European journal of gastroenterology & hepatology 20010801

• Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection.

  European journal of gastroenterology & hepatology 20010801

• A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20010801

• Strategies for diagnosis and short and long term treatment: respondent overview.

  The American journal of gastroenterology 20010801

• Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.

  The American journal of gastroenterology 20010801

• [Administration of proton pump inhibitor caused esophageal stenosis in two patients with severe reflux esophagitis].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20010801

• [Manifestations of gastroesophageal reflux in the otorhinolaryngology tract].

  Laryngo- rhino- otologie 20010801

• Dyspepsia: challenges in diagnosis and selection of treatment.

  Clinical therapeutics 20010801

• Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction.

  Clinical therapeutics 20010801

• Intravenous omeprazole in children: pharmacokinetics and effect on 24-hour intragastric pH.

  Journal of pediatric gastroenterology and nutrition 20010801

• Remission of idiopathic thrombocytopenic purpura by eradicating Helicobacter pylori after omeprazole monotherapy.

  International journal of hematology 20010801

• Key topics in Helicobacter pylori eradication in the management of the dyspeptic patient: a panel discussion.

  European journal of gastroenterology & hepatology 20010801

• Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit.

  European journal of gastroenterology & hepatology 20010801

• Diagnostic methods for detecting forms and strains of Helicobacter pylori and evaluation of its eradication.

  Bulletin of experimental biology and medicine 20010801

• Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20010801

• ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.

  Journal of medicinal chemistry 20010719

• Cost-effectiveness of proton-pump inhibitors for maintenance therapy of erosive reflux esophagitis.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010715

• Acute fulminant hepatitis after treatment with rabeprazole and terbinafine.

  Archives of internal medicine 20010709

• Preventing upper gastrointestinal bleeding in patients with Helicobacter pylori infection.

  The New England journal of medicine 20010705

• Anticonvulsant activity of omeprazole in rats.

  Epilepsy research 20010701

• ClC-2 Cl- channels in human lung epithelia: activation by arachidonic acid, amidation, and acid-activated omeprazole.

  American journal of physiology. Cell physiology 20010701

• The pharmacological effect of omeprazole on water gastric emptying: A study based on an impedance measure.

  Pharmacology 20010701

• Pathological documentation of complete elimination of Barrett's metaplasia following endoscopic multipolar electrocoagulation therapy.

  Gut 20010701

• Increasing concerns about chronic proton pump inhibitor use.

  Journal of clinical gastroenterology 20010701

• Effect of long-term, continuous versus alternate-day omeprazole therapy on serum gastrin in patients treated for reflux esophagitis.

  Journal of clinical gastroenterology 20010701

• Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.

  Alimentary pharmacology & therapeutics 20010701

• The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety.

  Alimentary pharmacology & therapeutics 20010701

• Economic analysis of four triple regimens for the treatment of Helicobacter pylori-related peptic ulcer disease in in-patient and out-patient settings in Hong Kong.

  Alimentary pharmacology & therapeutics 20010701

• Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?

  Alimentary pharmacology & therapeutics 20010701

• Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'.

  Alimentary pharmacology & therapeutics 20010701

• Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole.

  Alimentary pharmacology & therapeutics 20010701

• Is a one-week course of triple anti-Helicobacter pylori therapy sufficient to control active duodenal ulcer?

  Alimentary pharmacology & therapeutics 20010701

• Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment.

  Alimentary pharmacology & therapeutics 20010701

• Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.

  Alimentary pharmacology & therapeutics 20010701

• Quadruple therapy for symptomatic spontaneous duodenal ulcer disease.

  Postgraduate medical journal 20010701

• Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori.

  Gastrointestinal endoscopy 20010701

• Follow-up of Barrett's epithelium after ablation by endoscopic argon plasma coagulation.

  Gastrointestinal endoscopy 20010701

• Noninvasive stool antigen assay can effectively screen Helicobacter pylori Infection and assess success of eradication therapy in hemodialysis patients.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20010701

• A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection.

  Journal of pediatric surgery 20010701

• Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damage.

  Toxicology and applied pharmacology 20010701

• Neuroendocrine-specific and gastrin-dependent expression of a chromogranin A-luciferase fusion gene in transgenic mice.

  Gastroenterology 20010701

• Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.

  Scandinavian journal of gastroenterology 20010701

• Helicobacter pylori and iron deficiency anaemia in children.

  Scandinavian journal of gastroenterology 20010701

• Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.

  Scandinavian journal of gastroenterology 20010701

• A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism.

  Journal of gastroenterology and hepatology 20010701

• Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.

  Gastrointestinal endoscopy 20010701

• Chronic middle ear disease and gastroesophageal reflux disease: a causal relation?

  Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20010701

• Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19.

  Clinical pharmacology and therapeutics 20010701

• Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.

  The American journal of gastroenterology 20010701

• Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.

  European journal of gastroenterology & hepatology 20010701

• Impact of a formulary change in proton pump inhibitors on health care costs and patients' symptoms.

  Digestive diseases and sciences 20010701

• Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection.

  Digestive diseases and sciences 20010701

• Pseudomembranous colitis without diarrhoea following Helicobacter pylori eradication therapy.

  Hospital medicine (London, England : 1998) 20010701

• Possible phototoxicity with subsequent progression to discoid lupus following pantoprazole administration.

  Clinical and experimental dermatology 20010701

• Short-term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients.

  Zeitschrift fur Gastroenterologie 20010701

• Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.

  Clinical therapeutics 20010701

• [Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days].

  Anales de medicina interna (Madrid, Spain : 1984) 20010701

• Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease.

  Expert opinion on pharmacotherapy 20010701

• Efficacy of a nitroimidazole containing tripletherapy regime in Singapore.

  Singapore medical journal 20010701

• A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control.

  Regulatory peptides 20010615

• Inhibitor effect of omeprazole in isolated human myometrial smooth muscle.

  Life sciences 20010615

• High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes.

  Journal of chromatography. B, Biomedical sciences and applications 20010605

• Determination of sulfadoxine in human blood plasma using packed-column supercritical fluid chromatography.

  Journal of chromatography. B, Biomedical sciences and applications 20010605

• Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.

  Lancet (London, England) 20010602

• Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.

  International journal of oncology 20010601

• Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.

  Drug metabolism and disposition: the biological fate of chemicals 20010601

• Proton pump inhibitors: a study of GPs' prescribing.

  Family practice 20010601

• Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1beta.

  Gut 20010601

• Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus.

  Gastrointestinal endoscopy 20010601

• Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole.

  Gastroenterology 20010601

• Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans.

  Microscopy research and technique 20010601

• Omeprazole determination using HPLC with coulometric detection.

  Journal of pharmaceutical and biomedical analysis 20010601

• Eradication of Helicobacter pylori infection in patients with duodenal ulcer and non-ulcer dyspepsia and analysis of one-year reinfection rates.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20010601

• Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes.

  Alimentary pharmacology & therapeutics 20010601

• Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study.

  Alimentary pharmacology & therapeutics 20010601

• Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20010601

• Pantoprazole.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010601

• Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.

  Best practice & research. Clinical gastroenterology 20010601

• Role of acid suppressants in prophylaxis of NSAID damage.

  Best practice & research. Clinical gastroenterology 20010601

• Laryngopharyngeal reflux symptoms improve before changes in physical findings.

  The Laryngoscope 20010601

• [The role of tetracycline in the retreatment after Helicobacter pylori eradication failure].

  Minerva medica 20010601

• Proton-pump inhibitors for acute peptic ulcer bleeding.

  The Annals of pharmacotherapy 20010601

• Treatment of gastroesophageal reflux disease: to step or not to step.

  The American journal of gastroenterology 20010601

• Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.

  The American journal of gastroenterology 20010601

• Pantoprazole therapy in the long-term management of severe acid peptic disease: clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies.

  The American journal of gastroenterology 20010601

• Surgery versus medical therapy for gastroesophageal reflux disease.

  The American journal of gastroenterology 20010601

• Discoloured tongue: a new cause?

  The British journal of dermatology 20010601

• Helicobacter pylori and early duodenal ulcer status post-treatment: a review.

  Helicobacter 20010601

• Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori.

  Helicobacter 20010601

• Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe?

  Helicobacter 20010601

• Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection.

  Journal of gastroenterology and hepatology 20010601

• Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection. How long should it be given?

  Scandinavian journal of gastroenterology 20010601

• Effects of omeprazole and pirenzepine on enterochromaffin-like cells and parietal cells in rat stomach.

  Journal of gastroenterology 20010601

• An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity.

  European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20010601

• Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin.

  Pharmacogenetics 20010601

• The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori.

  European journal of gastroenterology & hepatology 20010601

• Long-term management of gastro-eosophageal reflux disease with omeprazole or open antireflux surgery.

  European journal of gastroenterology & hepatology 20010601

• Inhibition of hyphal growth of Candida albicans by activated lansoprazole, a novel benzimidazole proton pump inhibitor.

  Medical mycology 20010601

• Is untargeted outreach visiting in primary care effective? A pragmatic randomized controlled trial.

  Journal of public health medicine 20010601

• Factors associated with non-response in proton pump inhibitor users: a study of lansoprazole therapy.

  Pharmacy world & science : PWS 20010601

• CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects.

  Pharmaceutical research 20010601

• Helicobacter pylori eradication versus one-year maintenance therapy: effect on relapse and gastritis outcome.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20010601

• Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20010601

• Acute gastrointestinal bleeding: Part I.

  Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 20010601

• Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients.

  AIDS (London, England) 20010525

• Editorial comment on Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients.

  AIDS (London, England) 20010525

• Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog.

  Chemico-biological interactions 20010516

• [Effect of octreotide on intragastric pH in patients with duodenal ulcer bleeding].

  Zhonghua yi xue za zhi 20010510

• Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy.

  European journal of obstetrics, gynecology, and reproductive biology 20010501

• Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome.

  Archives of disease in childhood 20010501

• Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study.

  Gastrointestinal endoscopy 20010501

• Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats.

  British journal of pharmacology 20010501

• Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg.

  Alimentary pharmacology & therapeutics 20010501

• Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.

  Alimentary pharmacology & therapeutics 20010501

• The safety of proton pump inhibitors.

  Alimentary pharmacology & therapeutics 20010501

• The association between antiulcer medication and initiation of cobalamin replacement in older persons.

  Journal of clinical epidemiology 20010501

• Eradication of Helicobacter pylori from the stomach and duodenum of patients with duodenal ulcers.

  International journal of antimicrobial agents 20010501

• Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases.

  Digestive diseases and sciences 20010501

• Low incidence of Helicobacter pylori infection in patients with duodenal ulcer and chronic liver disease.

  Scandinavian journal of gastroenterology 20010501

• Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up.

  The American journal of gastroenterology 20010501

• Long-term omeprazole treatment and fundic gland polyps: a very authoritative proof against a link?

  The American journal of gastroenterology 20010501

• Erythrodermia induced by omeprazole.

  International journal of clinical pharmacology and therapeutics 20010501

• Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.

  Inflammatory bowel diseases 20010501

• Asthma and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted?

  Respiratory medicine 20010501

• A review of omeprazole use in the treatment of acid-related disorders in children.

  Clinical therapeutics 20010501

• Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.

  Clinical therapeutics 20010501

• Proton pump inhibitors and their drug interactions: an evidence-based approach.

  European journal of gastroenterology & hepatology 20010501

• Restoration of enamel and dentin erosion due to gastroesophageal reflux disease: a case report.

  Practical procedures & aesthetic dentistry : PPAD 20010501

• An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19.

  European journal of clinical pharmacology 20010501

• Lansoprazole triple therapy for Turkish children with Helicobacter pylori infections.

  Journal of pediatric gastroenterology and nutrition 20010501

• Shortcomings of the first-generation proton pump inhibitors.

  European journal of gastroenterology & hepatology 20010501

• Improving on PPI-based therapy of GORD.

  European journal of gastroenterology & hepatology 20010501

• New-generation proton pump inhibitors: overcoming the limitations of early-generation agents.

  European journal of gastroenterology & hepatology 20010501

• Physicochemical characterization and evaluation of buccal adhesive tablets containing omeprazole.

  Drug development and industrial pharmacy 20010501

• CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability.

  Pharmaceutical research 20010501

• [Safety profile of pariet clinical use (a literature review)].

  Voenno-meditsinskii zhurnal 20010501

• Esomeprazole (nexium).

  The Medical letter on drugs and therapeutics 20010430

• Assay of omeprazole and omeprazole sulfone by semi-microcolumn liquid chromatography with mixed-function precolumn.

  Journal of chromatography. B, Biomedical sciences and applications 20010425

• Omeprazole, its isomers, and the carcinoid question.

  Lancet (London, England) 20010421

• Omeprazole isomer approved by FDA.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010415

• Pharmacokinetic comparison of omeprazole capsules and a simplified omeprazole suspension.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010415

• [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].

  La Revue du praticien 20010415

• Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).

  World journal of gastroenterology 20010415

• From the Food and Drug Administration.

  JAMA 20010404

• Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus.

  Diabetes research and clinical practice 20010401

• A new cause of Zollinger-Ellison syndrome: non-small cell lung cancer.

  Gastroenterology 20010401

• Effects of lansoprazole, clarithromycin and pH gradient on uptake of [14C]amoxycillin into rat gastric tissue.

  The Journal of antimicrobial chemotherapy 20010401

• Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010401

• Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.

  Alimentary pharmacology & therapeutics 20010401

• Maximal acid reflux control for Barrett's oesophagus: feasible and effective.

  Alimentary pharmacology & therapeutics 20010401

• Pantoprazole and cyclosporine or tacrolimus.

  Alimentary pharmacology & therapeutics 20010401

• Antireflux surgery in children suffering from reflux-associated respiratory disease?

  Pediatric pulmonology 20010401

• Which patients with ulcer- or reflux-like dyspepsia will respond favorably to omeprazole?

  The Journal of family practice 20010401

• Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19.

  Clinical pharmacology and therapeutics 20010401

• Intragastric acidification reduces the occurrence of false-negative urea breath test results in patients taking a proton pump inhibitor.

  The American journal of gastroenterology 20010401

• Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease.

  The American journal of gastroenterology 20010401

• Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.

  The American journal of gastroenterology 20010401

• Does gastric juice pH influence tonometric PCO2 measured by automated air tonometry?

  American journal of respiratory and critical care medicine 20010401

• Prevalence of gastric myoelectrical abnormalities in patients with nonulcer dyspepsia and H. pylori infection: resolution after H. pylori eradication.

  Digestive diseases and sciences 20010401

• Intragastric nitric oxide/nitrite in Helicobacter pylori-infected subjects.

  Scandinavian journal of gastroenterology 20010401

• Gastric corpus atrophy following eradication of Helicobacter pylori.

  European journal of gastroenterology & hepatology 20010401

• Effects of pirenzepine, omeprazole, lansoprazole, and rabeprazole on human neutrophil functions.

  Canadian journal of anaesthesia = Journal canadien d'anesthesie 20010401

• 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.

  Zeitschrift fur Gastroenterologie 20010401

• Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine.

  European journal of clinical pharmacology 20010401

• Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa.

  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20010401

• [Pariet in current patterns of eradication of Helicobacter pylori infection].

  Voenno-meditsinskii zhurnal 20010401

• Omeprazole and excessive sweating.

  Prescrire international 20010401

• [Adsorptive voltammetric behavior of omeprazole and its application].

  Yao xue xue bao = Acta pharmaceutica Sinica 20010401

• Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.

  The New England journal of medicine 20010329

• [Gynecomastia associated with the simultaneous use of cisapride and lansoprazole].

  Medicina clinica 20010324

• Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice.

  Life sciences 20010309

• [Heartburn. Only a harmless symptom?].

  MMW Fortschritte der Medizin 20010308

• Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.

  Annals of internal medicine 20010306

• Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.

  Gut 20010301

• Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months.

  Alimentary pharmacology & therapeutics 20010301

• One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.

  Alimentary pharmacology & therapeutics 20010301

• Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.

  Alimentary pharmacology & therapeutics 20010301

• Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20010301

• Bioequivalence evaluation of lansoprazole 30-mg capsules (Lanfast and Lanzor) in healthy volunteers.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20010301

• A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication.

  Gastrointestinal endoscopy 20010301

• Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin.

  Clinical pharmacology and therapeutics 20010301

• Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.

  Clinical pharmacology and therapeutics 20010301

• Pharmacokinetic differences between lansoprazole enantiomers and contribution of cytochrome P450 isoforms to enantioselective metabolism of lansoprazole in dogs.

  Biological & pharmaceutical bulletin 20010301

• Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model.

  Journal of clinical pharmacology 20010301

• Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.

  The American journal of gastroenterology 20010301

• Electrochemical studies and differential pulse polarographic analysis of lansoprazole in pharmaceuticals.

  The Analyst 20010301

• The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.

  The Israel Medical Association journal : IMAJ 20010301

• [Long-term results of conservative management of reflux esophagitis].

  Therapeutische Umschau. Revue therapeutique 20010301

• Gastroprotective effect of aparisthman, a diterpene isolated from Aparisthmium cordatum, on experimental gastric ulcer models in rats and mice.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20010301

• Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes.

  European journal of clinical pharmacology 20010301

• Peptic ulcer occurrence in follow-up of chronic gastritis in patients with treated and not eradicated CagA-positive Helicobacter pylori infection.

  Digestive diseases and sciences 20010301

• Efficacy of rabeprazole once daily for acid-related disorders.

  Digestive diseases and sciences 20010301

• Functionally impaired, hypertrophic ECL cells accumulate vacuoles and lipofuscin bodies. An ultrastructural study of ECL cells isolated from hypergastrinemic rats.

  Cell and tissue research 20010301

• A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates.

  Journal of gastroenterology and hepatology 20010301

• Diazoxide, a K(ATP) opener, accelerates restitution of ethanol or indomethacin-induced gastric ulceration in rats independent of polyamines.

  Journal of gastroenterology and hepatology 20010301

• Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20010301

• Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20010301

• Pantoprazole versus lansoprazole in French patients with reflux esophagitis.

  Gastroenterologie clinique et biologique 20010301

• Leishmania plasma membrane Mg2+-ATPase is a H+/K+-antiporter involved in glucose symport. Studies with sealed ghosts and vesicles of opposite polarity.

  The Journal of biological chemistry 20010223

• Analysis of gastrin receptor gene expression in proliferating cells in the neck zone of gastric fundic glands using laser capture microdissection.

  FEBS letters 20010202

• The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy.

  Alimentary pharmacology & therapeutics 20010201

• Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia.

  Alimentary pharmacology & therapeutics 20010201

• The prescribing of acid suppressants prior to the endoscopic diagnosis of Barrett's oesophagus and oesophagitis.

  Alimentary pharmacology & therapeutics 20010201

• Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis.

  Alimentary pharmacology & therapeutics 20010201

• Helicobacter pylori augments the acid inhibitory effect of omeprazole on parietal cells and gastric H(+)/K(+)-ATPase.

  Gut 20010201

• CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam.

  Drug metabolism and disposition: the biological fate of chemicals 20010201

• Relaxation induced by omeprazole does not change in diabetic rabbit corpus cavernosum.

  BJU international 20010201

• Antibiotic-resistance patterns of Helicobacter pylori in Croatia: cohort study.

  Croatian medical journal 20010201

• Pharmacodynamic modeling of pantoprazole's irreversible effect on gastric acid secretion in humans and rats.

  Journal of clinical pharmacology 20010201

• [Recent guidelines for the management of Helicobacter pylori infection].

  Nihon rinsho. Japanese journal of clinical medicine 20010201

• [Selection of antibiotics and planning of eradication for H. pylori infection].

  Nihon rinsho. Japanese journal of clinical medicine 20010201

• [Usefulness of new triple therapy containing PPI].

  Nihon rinsho. Japanese journal of clinical medicine 20010201

• [A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment].

  Nihon rinsho. Japanese journal of clinical medicine 20010201

• Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.

  Journal of the American College of Surgeons 20010201

• Aggressive acid control: minimizing progression of Barrett's esophagus.

  The American journal of managed care 20010201

• Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication.

  Journal of gastroenterology 20010201

• Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer.

  Journal of gastroenterology 20010201

• Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.

  The American journal of gastroenterology 20010201

• Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?

  The American journal of gastroenterology 20010201

• A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers.

  The American journal of gastroenterology 20010201

• Recurrent ulcer bleeding: is intravenous omeprazole the solution?

  The American journal of gastroenterology 20010201

• Re: Ammonia cannot explain the effect of H. pylori on omeprazole-induced acid suppression.

  The American journal of gastroenterology 20010201

• [Suppressive effect of lansoprazole on anti-Candida activity of murine macrophages].

  Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20010201

• Gastroesophageal reflux disease and Barrett's esophagus.

  Endoscopy 20010201

• Improved high performance liquid chromatographic analysis of omeprazole in human plasma.

  Journal of pharmaceutical and biomedical analysis 20010201

• Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats.

  Digestive diseases and sciences 20010201

• Differentiation between reinfection and recrudescence of helicobacter pylori strains using PCR-based restriction fragment length polymorphism analysis.

  Yonsei medical journal 20010201

• Omeprazole maintenance therapy for gastroesophageal reflux disease after failure of fundoplication.

  Journal of pediatric gastroenterology and nutrition 20010201

• Pharmacokinetics and pharmacodynamics of antiulcer agents in llama.

  Journal of veterinary pharmacology and therapeutics 20010201

• Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis.

  Quintessence international (Berlin, Germany : 1985) 20010201

• Propylene glycol toxicosis in a llama.

  Journal of the American Veterinary Medical Association 20010115

• Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.

  Cancer research 20010115

• [Ulcer therapy with a new proton pump inhibitor. One week of treatment is enough].

  MMW Fortschritte der Medizin 20010111

• Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.

  The American journal of medicine 20010108

• Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.

  The American journal of medicine 20010108

• Biochemical properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-.

  European journal of pharmacology 20010105

• Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-.

  European journal of pharmacology 20010105

• Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy.

  Alimentary pharmacology & therapeutics 20010101

• A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China.

  Alimentary pharmacology & therapeutics 20010101

• Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.

  Alimentary pharmacology & therapeutics 20010101

• Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers.

  Alimentary pharmacology & therapeutics 20010101

• Switching between intravenous and oral pantoprazole.

  Journal of clinical gastroenterology 20010101

• Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer.

  Journal of clinical gastroenterology 20010101

• Allergic contact dermatitis due to lansoprazole, a proton pump inhibitor.

  Contact dermatitis 20010101

• Does pantoprazole alleviate mouth dryness in patients with Sjögren's syndrome?

  Rheumatology (Oxford, England) 20010101

• Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.

  Digestion 20010101

• The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents.

  Arthritis research 20010101

• Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis.

  Pediatric pulmonology 20010101

• c-myc gene mutation in gastric mucosa-associated lymphoid tissue (MALT) lymphoma and diffuse large B-cell lymphoma.

  Oncology reports 20010101

• Microsatellite instability at D18S61 is associated with no regression of gastric mucosa-associated lymphoid tissue lymphoma after Helicobacter pylori eradication.

  Oncology reports 20010101

• Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.

  The American journal of gastroenterology 20010101

• Randomized study of two 'rescue' therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.

  The American journal of gastroenterology 20010101

• Effect of polaprezinc on impaired healing of chronic gastric ulcers in adjuvant-induced arthritic rats--role of insulin-like growth factors (IGF)-1.

  Medical science monitor : international medical journal of experimental and clinical research 20010101

• Level of malondialdehyde after short-time omeprazole administration.

  Medical science monitor : international medical journal of experimental and clinical research 20010101

• Clinical onset of the Crohn's disease after eradication therapy of Helicobacter pylori infection. Does Helicobacter pylori infection interact with natural history of inflammatory bowel diseases?

  Medical science monitor : international medical journal of experimental and clinical research 20010101

• Management of GERD: medical versus surgical.

  Seminars in gastrointestinal disease 20010101

• Gastroesophageal reflux disease: extraesophageal manifestations and therapy.

  Seminars in gastrointestinal disease 20010101

• Approach to the patient with unexplained chest pain.

  Seminars in gastrointestinal disease 20010101

• Study of the electrospray ionization mass spectrometry of the proton pump inhibiting drug Omeprazole.

  Rapid communications in mass spectrometry : RCM 20010101

• Upper gastrointestinal bleeding as a metastatic manifestation of breast cancer: a case report and review of the literature.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20010101

• [Prevalence and treatment of Helicobacter pylori in gastro-duodenal ulcers. An experience in Liege].

  Revue medicale de Liege 20010101

• Omeprazole therapy and salivary flow rate in duodenal ulcer patients.

  Medical science monitor : international medical journal of experimental and clinical research 20010101

• Pharmacokinetic study of esomeprazole in the elderly.

  Clinical pharmacokinetics 20010101

• New OTC drugs and devices 2000: a selective review.

  Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) 20010101

• Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.

  Arzneimittel-Forschung 20010101

• Drug interaction: omeprazole and phenprocoumon.

  BMC gastroenterology 20010101

• Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole.

  Xenobiotica; the fate of foreign compounds in biological systems 20010101

• [Relations of acid-base balance and gastric secretion of hydrogen carbonate ions in patients with peptic ulcer].

  Terapevticheskii arkhiv 20010101

• Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease.

  Digestion 20010101

• Delayed healing of gastric ulcers in adjuvant arthritis rats: role of acid secretion and basic fibroblast growth factor.

  Digestion 20010101

• Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer.

  Revista do Hospital das Clinicas 20010101

• The suitability of hepatocyte culture models to study various aspects of drug metabolism.

  ALTEX 20010101

• Complete regression of primary gastric MALT-lymphoma after double eradication Helicobacter pylori therapy: role and importance of endoscopic ultrasonography.

  Anticancer research 20010101

• Effect of omeprazole on the pharmacokinetics of sustained-release carbamazepine in healthy male volunteers.

  Methods and findings in experimental and clinical pharmacology 20010101

• Bioavailability of a crushed pantoprazole tablet after buffering with sodium hydrogencarbonate or magaldrate relative to the intact enteric coated pantoprazole tablet.

  Methods and findings in experimental and clinical pharmacology 20010101

• Adenocarcinoma of the rat esophagus in the presence of a proton pump inhibitor: a pilot study.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20010101

• Pseudomembranous colitis after eradication of Helicobacter pylori infection with a triple therapy.

  Medical science monitor : international medical journal of experimental and clinical research 20010101

• Effects of lansoprazole on human gastric lipase secretion and intragastric lipolysis in healthy human volunteers.

  Digestion 20010101

• Drugs versus diets: disillusions with Dutch health care.

  Acta biotheoretica 20010101

• A randomized comparison of triple therapy Helicobacter pylori eradication regimens in children with peptic ulcers.

  The Journal of international medical research 20010101

• Effects of eradication therapy on gastric emptying in patients with Helicobacter pylori-positive duodenal ulcers.

  The Journal of international medical research 20010101

• Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole.

  Clinical pharmacokinetics 20010101

• [Efficacy and safety of intravenously administered pantoprazole in the treatment of gastrinoma].

  Recenti progressi in medicina 20010101

• Safety and efficacy of long term esomeprazole therapy in patients with healed erosive oesophagitis.

  Drug safety 20010101

• [Lower gastrointestinal bleeding due to Dieulafoy's in the upper colon].

  Gastroenterologia y hepatologia 20010101

• [A new blocker of proton pump pariet: pharmacological properties and effectiveness of clinical application].

  Klinicheskaia meditsina 20010101

• A 3-day anti-Helicobacter pylori therapy is a good alternative for bleeding peptic ulcer patients with Helicobacter pylori infection.

  Hepato-gastroenterology 20010101

• Sporadic fundic gland polyps, GERD and omeprazole usage: is there a little piece of information missed?

  Polish journal of pathology : official journal of the Polish Society of Pathologists 20010101

• [Omeprazole and misoprostol for NSAID-induced gastropathies: comparative efficiency of their short-term treatment].

  Klinicheskaia meditsina 20010101

• Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole.

  Clinical pharmacokinetics 20010101

• [Current principles of the use of laparoscopic surgery in gastroduodenal ulcer].

  Khirurgiia 20010101

• [The effectiveness of 7-day combined Helicobacter eradication therapy in patients with peptic ulcer and chronic gastritis].

  Klinicheskaia meditsina 20010101

• [Experience in the use of losek (omeprazole) in gastroenterology].

  Terapevticheskii arkhiv 20010101

• Efficacy of Helicobacter pylori eradication therapies: a single centre observational study.

  BMC gastroenterology 20010101

• A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.

  Digestive diseases (Basel, Switzerland) 20010101

• Resolution of Ménétrier's disease after Helicobacter pylori eradicating therapy.

  Digestive diseases (Basel, Switzerland) 20010101

• Advantage of expressing the variations in some digestive parameters as a function of gastric emptying instead of time.

  Digestion 20010101

• [Results of child observation during 3 years after the eradication treatment].

  Rossiiskii gastroenterologicheskii zhurnal : ezhekvartalnyi nauchno-prakticheskii zhurnal 20010101

• The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study.

  Managed care interface 20010101

• [Changes in ultra rapid urease test and histopathological examination for Helicobacter pylori by antisecretory drugs].

  Arquivos de gastroenterologia 20010101

• Gastroesophageal reflux disease presenting as xerophthalmia.

  Journal of pediatric ophthalmology and strabismus 20010101

• Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and methylprednisolone.

  Journal of physiology, Paris 20010101

• Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat.

  Journal of physiology, Paris 20010101

• Ethanol gastric lesion aggravated by lung injury in rat. Therapy effect of antiulcer agents.

  Journal of physiology, Paris 20010101

• Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats.

  Journal of physiology, Paris 20010101

• Gastric mucosal changes induced by long term infection with Helicobacter pylori in Mongolian gerbils: effects of bacteria eradication.

  Journal of physiology, Paris 20010101

• Six regimens for the eradication of Helicobacter pylori (Hp) in duodenal ulcer patients: three consecutive trials (1995-1999).

  Journal of physiology, Paris 20010101

• Gastroesophageal reflux in the patients with asthma.

  Allergologia et immunopathologia 20010101

• Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20010101

• Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?

  Hepato-gastroenterology 20010101

• Risk factors for hospitalization among adults with asthma: the influence of sociodemographic factors and asthma severity.

  Respiratory research 20010101

• [Helicobacter pylori, non-steroidal anti-inflammatory drugs and aspirin: a new piece of the puzzle].

  Gastroenterologie clinique et biologique 20010101

• Lansoprazole: an update of its place in the management of acid-related disorders.

  Drugs 20010101

• Helicobacter pylori: today's treatment, and possible future treatment.

  The European journal of surgery. Supplement. : = Acta chirurgica. Supplement 20010101

• [Diagnosis and treatment of Helicobacter pylori infection. Its relationship with gastrointestinal ulcer and antimicrobial resistance].

  Medicina 20010101

• Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).

  Annals of hematology 20010101

• Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality.

  Scandinavian journal of gastroenterology. Supplement 20010101

• [The search for anti-ulcer agents at IDR].

  Acta pharmaceutica Hungarica 20010101

• A practice-based approach for converting from proton pump inhibitors to less costly therapy.

  Effective clinical practice : ECP 20010101

• Rabeprazole: an update of its use in acid-related disorders.

  Drugs 20010101

• Adenosine deaminase activity in the gastric mucosa of duodenal ulcer patients in relation to the severity of chronic gastritis and gastric acid secretion.

  Roczniki Akademii Medycznej w Bialymstoku (1995) 20010101

• Has the incidence of perforated peptic ulcer decreased over the last decade?

  Digestive surgery 20010101

• Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin.

  Acta medica (Hradec Kralove) 20010101

• Is Helicobacter pylori eradication useful in non-ulcer dyspepsia?

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20010101

• Helicobacter pylori eradication after duodenal ulcer perforation.

  Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20010101

• [Long-term drug therapy versus antireflux surgery in chronic reflux].

  Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress 20010101

• Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa.

  Digestion 20010101

• Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen.

  Digestion 20010101

• Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol.

  Scandinavian journal of rheumatology 20010101

• The incidence of non ulcer dyspepsia and its response to treatment.

  Journal of Ayub Medical College, Abbottabad : JAMC 20010101

• Triple therapy with clarithromycin, amoxicillin and omeprazole for Helicobacter pylori eradication in children and adolescents.

  Arquivos de gastroenterologia 20010101

• Pediatric management problems.

  Pediatric nursing 20010101

• [Gastroesophageal reflux disease in pregnancy].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20010101

• Esomeprazole magnesium (Nexium).

  Reviews in gastroenterological disorders 20010101

• Helicobacter pylori infection in persons with intellectual disability in residential care in Israel.

  TheScientificWorldJournal 20010101

• Evaluation of the effects of omeprazole on physiological indices of performance of horses during incremental treadmill exercise.

  Veterinary therapeutics : research in applied veterinary medicine 20010101

• Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20001101

• The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.

  British journal of clinical pharmacology 20001001

• Hypercalcaemia and acute interstitial nephritis associated with omeprazole therapy.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20000901

• Reversible renal failure after treatment with omeprazole.

  The Netherlands journal of medicine 20000801

• Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction.

  Drug metabolism and disposition: the biological fate of chemicals 20000701

• Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease.

  Alimentary pharmacology & therapeutics 20000701

• How do we offer clinical relief to patients with gastro-oesophageal reflux disease?

  European journal of gastroenterology & hepatology 20000601

• Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites.

  International journal of clinical pharmacology and therapeutics 20000401

• Prevention and healing of experimental indomethacin-induced gastric lesions: effects of ebrotidine, omeprazole and ranitidine.

  European journal of gastroenterology & hepatology 20000301

• Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.

  The American journal of gastroenterology 20000201

• Omeprazole-induced delirium.

  Journal of neurology 20000101

• [Mental confusion from interaction of a proton-pump inhibitor with benzodiazepines: 3 cases].

  Therapie 20000101

• Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor.

  Journal of gastroenterology 20000101

• Fluorometric screening for metabolism-based drug--drug interactions.

  Journal of pharmacological and toxicological methods 20000101

• Comparison of IY81149 with omeprazole in rat reflux oesophagitis.

  Journal of autonomic pharmacology 20000101

• Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.

  Alimentary pharmacology & therapeutics 19991201

• Rational prescribing: practice audit and drug switch in dyspepsia management.

  International journal of clinical practice 19991201

• Omeprazole-induced acute interstitial nephritis.

  The American journal of gastroenterology 19991101

• Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H2-receptor antagonists.

  Alimentary pharmacology & therapeutics 19990701

• Role of endothelin-1 and constitutive nitric oxide synthase in gastric mucosal resistance to indomethacin injury: effect of antiulcer agents.

  Scandinavian journal of gastroenterology 19990501

• [Losec was probably the cause of interstitial nephritis].

  Lakartidningen 19990407

• Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.

  European journal of pharmacology 19990312

• Anaphylaxis to omeprazole.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 19990101

• Clarithromycin-induced acute psychoses in peptic ulcer disease.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 19990101

• Prostacyclin analog prevents stress-induced expression of immediate early genes and gastric mucosal lesions in the rat stomach.

  Life sciences 19990101

• Prediction of aryl hydrocarbon receptor-mediated enzyme induction of drugs and chemicals by mRNA quantification.

  Chemical research in toxicology 19981201

• Effect of chronic duodenal ulceration and its treatment with lanzoprazole or sucralfate on gastroduodenal mucosal protein turnover and TGF-alpha, bFGF, and EGF receptor expression in humans.

  Digestive diseases and sciences 19981201

• Effects of different antisecretory drugs on gastric potential difference in the rat: comparison with sucralfate.

  Pharmacological research 19981201

• [Interstitial nephritis caused by omeprazole].

  Anales de medicina interna (Madrid, Spain : 1984) 19981101

• Lansoprazole and omeprazole in the prevention of relapse of reflux oesophagitis: a long-term comparative study.

  Alimentary pharmacology & therapeutics 19981001

• Acute hepatitis induced by omeprazole.

  The American journal of emergency medicine 19980901

• Case of psychosis due to prednisone-clarithromycin interaction.

  General hospital psychiatry 19980901

• An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes.

  Chemico-biological interactions 19980703

• Pyrexia, anaemia and acute renal failure secondary to omeprazole.

  Postgraduate medical journal 19980701

• [Polyneuropathy caused by vitamin B12 deficiency secondary to chronic atrophic gastritis and giardiasis].

  Revista de neurologia 19980601

• [Hemolytic anemia and thrombocytopenia associated with anti-omeprazole antibody].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 19980601

• Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome.

  The American journal of medicine 19980501

• Effects of a proton-pump inhibitor in cystic fibrosis.

  Acta paediatrica (Oslo, Norway : 1992) 19980501

• The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].

  Alimentary pharmacology & therapeutics 19980301

• Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?

  Alimentary pharmacology & therapeutics 19980301

• Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 19980301

• Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.

  The Journal of pharmacy and pharmacology 19980301

• Neuromyopathy secondary to omeprazole treatment.

  Muscle & nerve 19980201

• Possible lansoprazole-induced eosinophilic syndrome.

  The Annals of pharmacotherapy 19980201

• Immunoallergic granulomatous interstitial nephritis following treatment with omeprazole.

  American journal of nephrology 19980101

• Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy.

  Alimentary pharmacology & therapeutics 19980101

• Long-term extracorporeal bilirubin elimination: A case report on cascade resin plasmaperfusion.

  Blood purification 19980101

• The role of endogenous gastrin in the development of enterochromaffin-like cell carcinoid tumors in Mastomys natalensis: a study with the specific gastrin receptor antagonist AG-041R.

  The Yale journal of biology and medicine 19980101

• Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells.

  The Journal of biological chemistry 19971212

• One week triple therapy for Helicobacter pylori: does high-dose clarithromycin confer additional benefit?

  Helicobacter 19971201

• Central nervous system side effects after proton pump inhibitor treatment.

  Journal of clinical gastroenterology 19971201

• The plasma membrane H(+)-ATPase of fungi. A candidate drug target?

  Annals of the New York Academy of Sciences 19971103

• A prospective follow-up study of 5669 users of lansoprazole in daily practice.

  Alimentary pharmacology & therapeutics 19971001

• Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.

  The American journal of gastroenterology 19970901

• Omeprazole-induced interstitial nephritis.

  Journal of clinical gastroenterology 19970901

• Ocular damage associated with proton pump inhibitors.

  BMJ (Clinical research ed.) 19970621

• Regulation of dioxin receptor function by omeprazole.

  The Journal of biological chemistry 19970509

• Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors.

  Drug metabolism and disposition: the biological fate of chemicals 19970501

• [Lansoprazole-induced hepatitis].

  Medicina clinica 19970419

• Stereoselective 4'-hydroxylation of phenytoin: relationship to (S)-mephenytoin polymorphism in Japanese.

  British journal of clinical pharmacology 19970401

• Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.

  The American journal of gastroenterology 19970301

• Lethargy with omeprazole.

  BMJ (Clinical research ed.) 19970215

• Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus.

  Alimentary pharmacology & therapeutics 19970201

• Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line.

  Xenobiotica; the fate of foreign compounds in biological systems 19970101

• Omeprazole-induced acute interstitial nephritis.

  Renal failure 19970101

• Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects.

  European journal of clinical pharmacology 19970101

• Lansoprazole compared with histamine2-receptor antagonists in healing gastric ulcers: a meta-analysis.

  Clinical therapeutics 19970101

• [A case of hemolysis induced by lansoprazole].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 19961201

• [Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19961201

• [Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19961201

• Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.

  Helicobacter 19961201

• Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report.

  Helicobacter 19961201

• [Internal medicine therapy in reflux disease].

  Praxis 19961105

• Differences in inducibility of CYP1A1-mRNA by benzimidazole compounds between human and mouse cells: evidences of a human-specific signal transduction pathway for CYP1A1 induction.

  Archives of biochemistry and biophysics 19961015

• Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs.

  European journal of gastroenterology & hepatology 19961001

• Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.

  The American journal of gastroenterology 19960901

• [The milk-alkali syndrome--a rare differential diagnosis for hypercalcemia].

  Deutsche medizinische Wochenschrift (1946) 19960816

• Hyponatremia with consciousness disturbance caused by omeprazole administration. A case report and literature review.

  Digestive diseases and sciences 19960801

• A trial of lansoprazole in refractory gastric ulcer.

  Alimentary pharmacology & therapeutics 19960601

• Erythema nodosum caused by omeprazole.

  Cutis 19960601

• Identification of the human P450 enzymes involved in lansoprazole metabolism.

  The Journal of pharmacology and experimental therapeutics 19960501

• Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism.

  European journal of biochemistry 19960501

• Milk-alkali syndrome induced by 1,25(OH)2D in a patient with hypoparathyroidism.

  Journal of the National Medical Association 19960501

• Short report: severe hiccups secondary to doxycycline-induced esophagitis during treatment of malaria.

  The American journal of tropical medicine and hygiene 19960201

• Effects of long-term omeprazole treatment on adult rat gastric mucosa--enhancement of the epithelial cell proliferation and suppression of its differentiation.

  Biochemical and biophysical research communications 19950925

• Acute interstitial nephritis due to omeprazole.

  Clinical nephrology 19950801

• Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole.

  Fundamental and applied toxicology : official journal of the Society of Toxicology 19950701

• Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.

  European journal of gastroenterology & hepatology 19950701

• Effect of gastrin receptor blockade on gastrin and histidine decarboxylase gene expression in rats during achlorhydria.

  Scandinavian journal of gastroenterology 19950601

• Gynecomastia and sexual disorders after the administration of omeprazole.

  The American journal of gastroenterology 19950601

• [Drugs affecting gastric acidity in the therapy of ulcer disease].

  Vnitrni lekarstvi 19950301

• Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor.

  Digestive diseases and sciences 19950301

• Oxidative metabolism of lansoprazole by human liver cytochromes P450.

  Molecular pharmacology 19950201

• Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.

  Digestion 19950101

• Increased immunoreactivity and concentration of basic fibroblast growth factor in lansoprazole-treated gastric mucosa.

  Journal of clinical gastroenterology 19950101

• Arthralgias and omeprazole.

  BMJ (Clinical research ed.) 19941217

• Acute interstitial nephritis due to omeprazole.

  Lancet (London, England) 19941008

• Protective action of omeprazole against gastric mucosal injury induced by hemorrhagic shock in rats.

  Digestive diseases and sciences 19941001

• Recurrent acute interstitial nephritis on rechallenge with omeprazole.

  Lancet (London, England) 19940820

• Is omeprazole helpful in inflammatory bowel disease?

  Journal of clinical gastroenterology 19940601

• Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.

  The Journal of pharmacology and experimental therapeutics 19940401

• Hepatitis following treatments with famotidine and then cimetidine.

  The Annals of pharmacotherapy 19940101

• Angioedema and urticaria associated with omeprazole confirmed by drug rechallenge.

  Pharmacotherapy 19940101

• Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.

  The American journal of gastroenterology 19930801

• Omeprazole-induced acute interstitial nephritis.

  The American journal of medicine 19930801

• Differential control of somatostatin messenger RNA in rat gastric corpus and antrum. Role of acid, food, and capsaicin-sensitive afferent neurons.

  The Journal of clinical investigation 19930101

• Dideoxyinosine-associated nephrotoxicity.

  AIDS (London, England) 19930101

• Acute interstitial nephritis due to omeprazole.

  The American journal of medicine 19921001

• Subacute myopathy during omeprazole therapy.

  Lancet (London, England) 19920912

• Endocrine adverse effects of omeprazole.

  BMJ (Clinical research ed.) 19920822

• Fulminant hepatic failure related to omeprazole.

  The American journal of gastroenterology 19920401

• [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].

  Nihon rinsho. Japanese journal of clinical medicine 19920101

• [Evaluation of the effect of proton pump inhibitors on stomal ulcer].

  Nihon rinsho. Japanese journal of clinical medicine 19920101

• Painful gynaecomastia during omeprazole therapy.

  Lancet (London, England) 19911102

• Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.

  Japanese journal of pharmacology 19910401

• Hemolytic anemia associated with the use of omeprazole.

  The American journal of gastroenterology 19910201

• H2-receptor antagonist-refractory ulcer: its pathophysiology and treatment.

  Journal of clinical gastroenterology 19910101

• Catatonic reaction to omeprazole and disulfiram in a patient with alcohol dependence.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 19901201

• An unusual side effect of omeprazole: case report.

  The British journal of general practice : the journal of the Royal College of General Practitioners 19900901

• Synthesis of (aryloxy)alkylamines. 1. Novel antisecretory agents with H+K+-ATPase inhibitory activity.

  Journal of medicinal chemistry 19880901

• Substituted 2-[(2-benzimidazolylsulfinyl)methyl]anilines as potential inhibitors of H+/K+ ATPase.

  Journal of medicinal chemistry 19880601